{"Title": ["India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir", "India's Zydus Cadila signs pact with Gilead to make remdesivir", "Kite To Manufacture CAR T Cell Therapies In Europe - Quick Facts", "Is Adaptimmune Therapeutics a Buy?", "Inovio Still a Hot Coronavirus Vaccine Supplier", "Regeneron Begins Human Trials of a Potential COVID-19 Treatment", "Better Buy: bluebird bio vs. Gilead Sciences", "U.S. FDA Commissioner says agency seeks fast review of COVID-19 products", "India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir", "U.S. FDA Commissioner says agency seeks fast review of COVID-19 products", "Gilead Merger Unlikely at This Point, Says 5-Star Analyst", "Study: Remdesivir Prevented Lung Damage In Monkeys Infected With COVID-19", "Is Aprea Therapeutics Stock a Buy?", "GILD Named A Top Socially Responsible Dividend Stock", "Singapore approves remdesivir drug for emergency COVID-19 treatment", "Singapore approves Gilead's remdesivir for COVID-19 treatment", "Better Buy: bluebird bio vs. Gilead Sciences", "10 Stocks Riding on the Covid-19 Recovery", "Aggressive Investors Can Do Much Better Than Merck Stock", "Ex-Dividend Reminder: SpartanNash, STERIS and Gilead Sciences", "AstraZeneca's Acquisition of Gilead Would Create a COVID-19 Colossus -- but Don't Bet on Seeing It Happen", "Gilead's remdesivir slows disease progression in monkeys with COVID-19", "Gilead's remdesivir slows progression of COVID-19 in monkeys - study", "BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Chesapeake Energy, Ideanomics", "What Would a Merger Mean for Gilead? Top Analyst Weighs In", "EU watchdog aims for speedy approval of remdesivir as COVID-19 treatment", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Carnival Corp, Opiant Pharmaceuticals", "Wall Street set to rise on swift economic rebound hopes", "Breakingviews - AstraZeneca M&A puzzle sends shareholder warning", "BUZZ-U.S. STOCKS ON THE MOVE-Gilead, Cisco", "U.S. stock futures rise on optimism over economic revival", "AstraZeneca In Informal Talks With Gilead For Potential Merger: Report", "BUZZ-U.S. STOCKS ON THE MOVE-Sino-Global Shipping, Michaels Companies, Applied DNA", "European stock rally takes step back as tech, healthcare drag", "AstraZeneca shares down 2% after report it approached Gilead over tie-up", "London's FTSE 100 opens lower as AstraZeneca weighs", "European shares pull back from 3-month highs after rally", "AstraZeneca Proposes a Merger With Gilead Sciences", "AstraZeneca contacted Gilead over potential megamerger -Bloomberg News", "Could Gilead's COVID-19 Drug Make $7 Billion Per Year?", "London's FTSE 100 falls as AstraZeneca drops on megamerger report", "7 U.S. Stocks to Buy on Coronavirus Weakness", "What Are the Implications of Gilead\u2019s Increased Focus on Oncology? 5-Star Analyst Weights In", "Noteworthy Thursday Option Activity: GILD, NSSC, LB", "Co-Diagnostics Could Be a Prudent Coronavirus Play", "Is Remdesivir a Disappointment?", "Better Buy: Bristol Myers Squibb vs. Gilead Sciences", "Lyft Looks Poised to Rally Over the Next Few Months", "Fujifilm says COVID-19 drug research may drag on into July", "Air Travel\u2019s Comeback Looks Poised to Lift GE Stock", "Gilead Sciences : Filgotinib Shows Sustained Efficacy In Studies On Rheumatoid Arthritis", "Roche test receives FDA emergency use approval for COVID-19 patients", "Wait for More Clarity Before Buying Gilead Stock, Says Analyst", "BUZZ-U.S. STOCKS ON THE MOVE-Warner Music, Boeing, Pliant Therapeutics", "BUZZ-U.S. STOCKS ON THE MOVE-Glu Mobile, Boeing, American Eagle", "Gilead's remdesivir could see $7 bln in annual sales on stockpiling boost \u2013 analyst", "Biotech Stocks: Buy This, Not That", "Eli Lilly Leaps Past Regeneron's COVID-19 Treatment Candidate", "Abbvie Stock is Offering Investors an Oil Yield Without Oil\u2019s Risk", "S.Korea approves import of anti-viral drug remdesivir for coronavirus treatment", "AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives", "Tuesday Sector Laggards: Healthcare, Technology & Communications", "India approves emergency use of remdesivir to treat COVID-19 patients", "Better Coronavirus Stock: Gilead Sciences or Novavax?", "BUZZ-U.S. STOCKS ON THE MOVE-Coty, Zoom Video, OpGen, Campbell Soup", "India approves emergency use of remdesivir to treat COVID-19 patients", "NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps", "Gold edges lower as economies open up", "GLOBAL MARKETS-Stocks under pressure as Trump vows to end violent protests", "Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Rose Today", "Wall Street closes higher as recovery signs soothe protest, pandemic worries", "Health Care Sector Update for 06/01/2020: ABIO,EBS,GILD,OCGN", "Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions", "U.S. stocks gain as signs of recovery offset protests, economic worries", "BUZZ-U.S. STOCKS ON THE MOVE-Coty, Tesla, Zoom Video, Zynga", "INSIGHT-Scientists hunt pandemic hotspots in race to test vaccines", "Health Care Sector Update for 06/01/2020: EBS,GILD,OCGN", "Wall St gains as recovery hopes overshadow U.S. protests", "Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win", "Stock Alert: Gilead Down 4% On Remdesivir Trial Data", "Wall Street closes higher as recovery signs soothe protest, pandemic worries", "BUZZ-U.S. STOCKS ON THE MOVE-Gilead, Virgin Galactic, General Electric", "3 Biotech Quick Picks to Invest $5,000 This Week", "Wall St rises as recovery hopes offset U.S. protests, China tensions", "TQQQ, CHTR, GILD, QCOM: Large Outflows Detected at ETF", "Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVID-19", "Nasdaq 100 Movers: GILD, ZM", "Gilead says remdesivir helped moderate COVID-19 patients improve", "Wall St flat as recovery hopes offset U.S. protests, China tensions", "Gilead says remdesivir helped moderate COVID-19 patients improve", "Gilead trades that made millions on COVID-19 drug news raise eyebrows", "Gilead Gets a Boost From Positive Coronavirus Research", "EXCLUSIVE-Russia to roll out its first approved COVID-19 drug next week", "INSIGHT-Scientists hunt pandemic hotspots in race to test vaccines", "How One Hedge Fund Billionaire Is Battling to Bring Down Drug Prices in America", "The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA", "Gilead Reports Encouraging Data From Remdesivir 5-day Treatment Course", "Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today", "At The ASCO: ONCY, IMV, CRDF, GILD, TAK\u2026", "EU regulator promises speedy review of potential COVID-19 drug remdesivir", "EU regulator promises speedy review of potential COVID-19 drug remdesivir", "S.Korea seeks to import anti-viral remdesivir as new coronavirus cases emerge", "July 10th Options Now Available For Gilead Sciences (GILD)", "Don't Waste Your Money on Penny Stocks; These 3 Are Better Buys", "7 U.S. Stocks to Buy on Coronavirus Weakness", "Roche mixes Actemra with Gilead's remdesivir in COVID-19 trial", "Genentech Initiates Phase III Trial Of Actemra Plus Remdesivir On Severe COVID-19 Pneumonia", "PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch", "Roche to study remdesivir/Actemra cocktail against severe COVID-19 pneumonia", "Gilead\u2019s Remdesivir May Be a Coronavirus Silver Bullet \u2014 But It\u2019s Already Baked in the Stock Price", "Gilead study shows shorter 5-day course of remdesivir works as well as 10-day one", "Here's Why Arcus Biosciences Is Losing Ground Today", "Coronavirus 2020: Where to Invest $500 Right Now", "AstraZeneca tests diabetes drug for COVID-19 despite risk seen by doctors", "BUZZ-U.S. STOCKS ON THE MOVE-StoneCo, Tuesday Morning, Zynerba Pharma", "Gilead, Arcus Biosciences Ink 10-year Deal To Co-develop Cancer Immunotherapies", "10 Stocks to Buy as They Ride a Coronavirus Tailwind", "BUZZ-U.S. STOCKS ON THE MOVE-IZEA Worldwide, Diffusion Pharma, DouYu International", "WHO expects hydroxychloroquine safety findings by mid-June", "Lilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in Q2", "Gilead Sciences Signs $2 Billion Partnership with Arcus Biosciences", "Merck leaps into COVID-19 development fray with vaccine, drug deals", "BUZZ-U.S. STOCKS ON THE MOVE-Novavax, Tuesday Morning, HPE", "Merck leaps into COVID-19 development fray with vaccine, drug deals", "Britain to provide anti-viral drug remdesivir to some COVID-19 patients", "3 Large-Cap Coronavirus Stocks Still Worth Buying", "Mixed Results for Gilead Sciences' COVID-19 Treatment", "Better Coronavirus Stock: Gilead Sciences or Vir Biotechnology?", "BUZZ-U.S. STOCKS ON THE MOVE-LATAM Airlines, Tuesday Morning, Novavax", "Peer-reviewed data shows Gilead's drug effective against COVID-19 -NIH", "Remdesivir Can\u2019t Cure Covid, But Good Luck Telling Gilead Stock", "Before You Buy Gilead Sciences Stock, Read This", "Gilead Stock Is Worth Owning With or Without a Coronavirus Cure", "U.S. doctors call for remdesivir data to guide coronavirus treatment", "Galapagos and Gilead Sciences Post Successful Yet Disappointing Filgotinib Results", "How a Coronavirus Vaccine Might Move the Stock Market", "Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time", "ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track", "Gilead Still Holds the Winning Hand, Says 5-Star Analyst", "Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals", "Gilead-Galapagos's drug meets main goals of ulcerative colitis study", "Health Care Sector Update for 05/20/2020: HOTH,ALDX,GILD,INO,BDX", "Noteworthy Wednesday Option Activity: GILD, ILMN, ATVI", "Health Care Sector Update for 05/20/2020: ALDX,GILD,INO,BDX", "The Virus Vaccine Race is Fueling Moderna Stock to New Highs", "Why the Next Month Will Determine the Rest of the Year for Gilead's Stock", "GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada", "How The Parts Add Up: SCIU Targets $33", "Where Will Adaptimmune Be in 5 Years?", "BUZZ-U.S. STOCKS ON THE MOVE-Oasis Midstream, L Brands, Diffusion Pharma", "Nasdaq 100 Movers: GILD, EXPE", "GSK's long-acting injection beats Truvada in HIV prevention trial", "Notable ETF Outflow Detected - DGRO, CMCSA, TXN, GILD", "GSK's long-acting injection beats Truvada in HIV prevention trial", "Is Gilead Sciences a Great Dividend Stock?", "Why Gilead's Remdesivir Might Not Be the Mega-Moneymaker Some Think It Will Be", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Could Veeva Systems Be a Millionaire-Maker Stock?", "Gilead to end coronavirus drug trials, adding to access worry -researchers", "Pakistan's Ferozsons to begin producing COVID-19 drug remdesivir", "Remdesivir close to EU's initial authorisation as COVID-19 treatment", "Part of Gilead's coronavirus drug donation allocated to Japan", "France says any Sanofi COVID-19 vaccine for the world, no favourites", "Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir", "2 Recession-Proof Healthcare Stocks to Buy in 2020", "Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir", "Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals", "Takeda says coronavirus treatment trial using recovered patients' blood could start in July", "Buy Good News Gilead Stock Before Other Investors Catch On", "Gilead's Remdesivir Isn't Enough to Drive Its Stock Higher", "Gilead In Deal With 5 Cos. To Make And Sell Remdesivir In 127 Countries", "U.S. accuses China-linked hackers of stealing coronavirus research", "Where Will Gilead Sciences Be in 1 Year?", "U.S. stock futures climb ahead of Fed Chair Powell's address", "Is AbbVie a Buy Now That the Allergan Deal Is Done?", "Gilead Stock Still Looks Poised to Prove the Bears Wrong", "U.S. accuses China-linked hackers of stealing coronavirus research", "Gilead Strikes Deal With Mylan to Supply Remdesivir Internationally", "India's Jubilant signs licensing deal for Gilead's potential COVID-19 drug", "9 Enduring Stocks That You Shouldn\u2019t Sell in May", "EMA recommends expanding compassionate use of Gilead's COVID-19 drug", "EMA recommends expanding compassionate use of Gilead's COVID-19 drug", "The Government Will Distribute Gilead's Remdesivir. This Could Be Bad News for Investors", "MOAT, NOW, PFE, GILD: ETF Inflow Alert", "A tale of two Japanese drugs in tests to fight COVID-19", "Co-Diagnostics Is a Smart Way to Play Coronavirus Testing", "Despite Challenges, GE Is a Long-Term Winner", "3 Top Biotech Stocks to Buy in May", "What Investors Are Missing About Gilead Sciences", "U.S. to allow states to distribute Gilead's remdesivir to fight COVID-19", "The Dow Rose 455 Points Because Job Losses Can't Get Any Worse", "A COVID-19 Strategy: Invest in Companies That Are Doing Good", "NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19", "EXCLUSIVE-Iran-linked hackers recently targeted coronavirus drugmaker Gilead -sources", "Is Gilead Sciences Stock a Buy?", "U.S. Doctors want details on federal distribution of Gilead coronavirus drug", "Doctors want details on federal distribution of Gilead coronavirus drug", "June 26th Options Now Available For Gilead Sciences (GILD)", "The Best Thing Happening During These \u2018Worst of Times\u2019", "NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19", "Japan approves Gilead Sciences' remdesivir as COVID-19 drug", "Japan approves Gilead Sciences' remdesivir as COVID-19 drug", "Will Gilead price its coronavirus drug for public good or company profit?", "How Will Double-Digit Unemployment Affect Your Stock Portfolio?", "4 Safe Stocks That Can Make You Rich in This Economy", "Inovio Pharmaceuticals Is Hurting From Remdesivir but It\u2019s Still Standing", "Israel Reports a \"Breakthrough\" Coronavirus Antibody Treatment", "From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now", "EXPLAINER-Who can make Gilead's coronavirus drug, licence free?", "Is This Coronavirus Drug Authorization Really Good News for Gilead?", "Gilead Sciences Plans to Expand Global Supply of Remdesivir", "Gilead in talks to expand global supply of COVID-19 drug remdesivir", "Gilead in talks to expand global supply of COVID-19 drug remdesivir", "How Can The Stock Market Soar With Rising Unemployment?", "Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This Fall", "Co-Diagnostics Is Becoming More Relevant", "Gilead Sciences Is a Strong Buy Despite What Its Detractors Might Say", "Finding a Coronavirus Cure: 5 Companies Making Moves", "EXCLUSIVE-Bangladesh's Beximco to begin producing COVID-19 drug remdesivir-COO", "Could This Under-the-Radar Biotech Piggyback on Gilead's Remdesivir Success?", "The Dow Rose 26 Points Because an Oil Rebound Lifted Stocks", "Apps cannot replace \"boots-on-the-ground\" in virus fight - WHO", "Earnings Preview: Is SQ Stock a Buy Before Wednesday?", "The Trends are Mostly Friendly for Moderna Stock Investors", "BUZZ-U.S. STOCKS ON THE MOVE-Airlines, banks, insurers, PG&E", "The 3 Best Stocks to Buy in May", "JPMorgan\u2019s Bullish Stance on Gilead Sciences (GILD) Stock Comes to an End", "What Might Gilead's Covid-19 Drug Cost, $10 or $4,500?", "Forget Gilead, These 2 Pharma Dividends Pay up to 10%", "Vir, Alnylam identify COVID-19 therapy candidate, plan human trials by year end", "Despite Gains, Threat, Gilead Is Still Attractive", "BUZZ-U.S. STOCKS ON THE MOVE-Airlines, banks, insurers, oil stocks", "European stock futures drop as U.S., China spar over virus origin", "Foreigners remain net sellers of Japan stocks for 11th straight week", "Gold gains as rising U.S.-China tensions dent risk sentiment", "5 Top Coronavirus Stocks to Buy in May", "Japan aims to fast-track review of anti-viral drug remdesivir", "What Should Investors Make Of Conflicting Results Surrounding Gilead's Remdesivir?", "Gilead's Remdesivir Becomes 1st Drug Allowed For Emergency Use For COVID-19", "Here\u2019s Why It\u2019s Not Too Late to Load Up on Moderna Stock", "Why Foot Locker, Callaway Golf, and Newell Brands Plunged 10% Early Friday", "U.S. FDA authorizes remdesivir drug as emergency treatment for COVID-19", "FDA Allows Emergency Use of Gilead's Covid-19 Drug", "U.S. FDA authorizes remdesivir drug as emergency treatment for COVID-19", "Trump: FDA authorizes Remdesivir drug for COVID-19", "Gilead Aims to Get Its Potential COVID-19 Drug to as Many Patients as Possible", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Medigus, Aemetis", "FDA Authorizes Gilead's Remdesivir for COVID-19", "BUZZ-U.S. STOCKS ON THE MOVE-Medigus Ltd, Western Digital Corp, Aemetis Inc", "Gilead Stock Drops on Wave of Downgrades", "Coronavirus trial drug remdesivir's maker aims for wide distribution -Gilead CEO", "Coronavirus trial drug Redesivir's maker hopes for swift FDA approval -interview", "3 Big Stories in Gilead Sciences' Q1 Results", "Inovio Is in a Race to Develop a COVID-19 Vaccine, but Can It Possibly Win?", "What Does Remdesivir's Promising Study Mean for Gilead's Stock?", "Daily Dividend Report: AAPL,GILD,GLW,TRP,WWD", "7 U.S. Stocks to Buy on Coronavirus Weakness", "Notable Thursday Option Activity: MDB, CASA, GILD", "Gilead Beats Earnings Estimates, but the Stock Falls", "Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-qtr results", "GLOBAL MARKETS-Global equities dip at end of best month since '09", "Gilead Sciences Inc. Q1 adjusted earnings of $1.68 per share", "Yields fall, two-year note touches lowest level since 2011", "Gilead Sciences Inc (GILD) Q1 2020 Earnings Call Transcript", "Is Gilead Sciences Stock a Buy Right Now? This Is What You Need to Know", "IBB, GILD, VRTX, BIIB: ETF Inflow Alert", "U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug - Bloomberg", "GLOBAL MARKETS-Global equities dip; remain on pace for best month on record", "Gilead Awaits FDA Approval on Remdesivir to Treat Covid-19", "PayPal Is the Elixir We Need in This Awful Earnings Season", "Wall St set to slide at open after jobless claims data", "GLOBAL MARKETS-Equities dip but remain on pace for best month on record", "Gilead (GILD) 1st Quarter Earnings: What to Expect", "Dow, S&P 500 futures dip at end of strong month; jobless data eyed", "3 Big Stock Charts for Thursday: Gilead Sciences, Boeing, and Nio", "Dow, S&P 500 futures dip at end of strong month; jobless data awaited", "Have $3,000 to Invest? Here Are 3 Top Coronavirus Stocks to Buy Right Now.", "Moderna Stock Is Near Highs, But Faces Risk", "Gilead Sciences Q1 20 Earnings Conference Call At 4:30 PM ET", "Daily Markets: Nearly 1 In 5 Have Lost Their Jobs in Just 6 Weeks", "European Stocks Pause After Big Asia and Wall Street Rally", "GLOBAL MARKETS-Stocks head for best month on record ahead of ECB", "London stocks hit by Shell's historic dividend cut", "EMERGING MARKETS-Stocks extend gains, Hungary outperforms on reopening plans", "China stocks log best month in five on virus drug trial, policy hopes", "London stocks rise on optimism around virus drug, upbeat earnings", "Tokyo shares end near 8-week high, track Wall Street gains on virus drug hopes", "Indian stocks log best month since 2009, track global cheer on virus drug hopes", "EM ASIA FX-Indonesian rupiah jumps about 3% on higher bond inflows expectation", "Indian shares soar on COVID-19 drug hopes, set for best month since 2009", "GLOBAL MARKETS-Stocks rally on treatment hopes, currencies await ECB", "China stocks touch seven-week high on coronavirus treatment, policy hopes", "GLOBAL MARKETS-Stocks rally on treatment hopes, currencies await ECB", "GLOBAL MARKETS-Asian stocks set to track U.S. gains as virus treatment hopes lift confidence", "Why Discover Financial Stock Jumped 15% Today", "Glenmark to conduct trials in India for potential COVID-19 drug", "The Dow Surged 532 Points Because We're Closer to a Covid-19 Drug", "Breakingviews - Corona Capital: U.S. GDP, Gilead\u2019s drug, Spotify", "Dow Jones Today: Vaccine Hopes Overcame Contracting GDP", "Dow, Oil Close With Strong Wins", "Wall Street rallies on promising coronavirus drug", "Why Novavax Stock Slumped Today", "GLOBAL MARKETS-Shares jump on coronavirus treatment hopes, oil soars", "Why Discover Financial Stock Jumped 15%Today", "This News Has Foot Locker Stock Running Higher Today", "FOREX-Dollar drops as Fed repeats vow to support economy", "Amazon is Wall St's biggest winner from coronavirus", "American Airlines Stock Is Still a Long-Term Winner", "U.S. stocks rally on coronavirus drug hopes", "Restaurant Stocks Soar Wednesday on Positive COVID-19 Developments", "Why Hotel Stocks Are Surging Today", "EMERGING MARKETS-Latam shares, FX rally as hopes of COVID-19 drug lifts sentiment", "Here's Why Visa, Mastercard, and American Express Are Higher on Wednesday", "Wall Street jumps on coronavirus drug hopes; Fed in focus", "BUZZ-U.S. STOCKS ON THE MOVE-Capricor Therapeutics, Liberty Oilfield, Blue Apron", "COVID-19 complication seen in children is \"rare\", WHO says", "Buy Gilead Stock Because Remdesivir Is a Covid-19 Game-Changer", "Stock Market News: Mastercard Charges Ahead; Alphabet Spells Ad Success", "Gold falls as equities drift higher ahead of Fed statement", "What Lies Ahead for Vaccine Development and INO Stock in May?", "BUZZ-U.S. STOCKS ON THE MOVE-Liberty Oilfield, MRC Global, Capricor Therapeutics", "Stock Alert: Gilead Sciences Up 4% On Positive Data On COVID-19 Drug", "Gilead Sciences Says Remdesivir Hit the Mark in COVID-19 Trial", "Wall Street jumps on hopes of potential coronavirus drug", "What to Expect from Gilead Earnings", "Yields down ahead of Fed meeting wrap-up", "Dollar drops as Coronavirus treatment hopes boosts risk sentiment", "Wall St jumps on coronavirus drug hopes; Fed decision awaited", "BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Spotify, Blue Apron", "Wall St set to jump at open on hopes of potential coronavirus drug", "Gilead Sciences Records Positive Data From 10-day Covid-19 Trial Of Remdesivir", "Gilead says remdesivir shows improvement in COVID-19 patients when used early", "US STOCKS SNAPSHOT-Futures jump after Gilead's COVID-19 drug meets main goal", "Gilead's remdesivir meets main goal of trial in COVID-19 patients", "Better Buy: Cara Therapeutics vs. Sangamo Therapeutics", "Wall Street jumps on hopes of potential coronavirus drug", "European shares rise on COVID-19 drug hopes, upbeat outlook from corporates", "Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success", "10 Stocks to Buy for an Aging Population", "The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors", "BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, Zoom Video, U.S. oil companies, Apple, U.S. insurers", "Pfizer Stock Is Much More Than Just a Coronavirus Play", "BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, tanker operators, oil and gas companies, U.S. casinos", "The Cure for Profitably in Buying Gilead Sciences", "Don\u2019t Let Negative Data Dissuade You from Gilead Sciences", "Besides Remdesivir, These 2 COVID-19 Treatments Could Have Promise", "Here's What to Expect With Gilead Sciences' Q1 Earnings Update", "ANALYSIS-Investors bet on testing, treatments for restart of U.S. economy", "Moderna Scores Huge Grant, Leads Charge Toward Coronavirus Vaccine", "ANALYSIS-Investors bet on testing, treatments for restart of U.S. economy", "Why Is the Stock Market Hanging Its Hopes on Gilead's Remdesivir?", "BUZZ-U.S. STOCKS ON THE MOVE-Tanker operators, oil and gas companies, Caterpillar", "Gilead Sciences Disputes Claim That Remdesivir Failed in a COVID-19 Trial", "EXCLUSIVE-Trial of Gilead's potential coronavirus treatment running ahead of schedule -researcher", "EXCLUSIVE-Trial of Gilead's potential coronavirus treatment running ahead of schedule -researcher", "EXCLUSIVE-Trial of Gilead's potential coronavirus treatment running ahead of schedule -researcher", "GLOBAL MARKETS-Stocks struggle with muddled government pandemic response", "Why Remdesivir Clinical Studies Will Lift Gilead Sciences", "3 Top Stocks Under $5 to Buy Now", "While Big Pharma Tanked, Gilead Sciences and Regeneron Soared", "The Coronavirus Makes iBio Finally Relevant", "European shares slide as EU stimulus fails to impress", "Oil selloff weighs on FTSE as retail sales sink", "EMERGING MARKETS-Set for weekly losses as doubts arise over COVID-19 drug efficacy", "GLOBAL MARKETS-Stocks fall on worries over EU stimulus details, coronavirus drug", "FTSE 100 tracks global mood lower as retail sales sink", "European shares slide as pandemic jitters return", "GLOBAL MARKETS-Global equities edge higher as oil continues rebound", "Sanofi confirms targets, strong demand for pain killers lifts Q1", "GLOBAL MARKETS-Asian stocks fall, Europe set to follow on doubts over coronavirus drug", "SE Asia Stocks-Most slide on lockdown extension in parts of region, weak global data", "GLOBAL MARKETS-Asian shares fall on coronavirus drug, economic damage concerns", "GLOBAL MARKETS-Asian stocks poised to rise after Wall Street gains slip away", "Gilead Sciences Rebuts Report Claiming Covid-19 Drug Remdesivir Trial Failed", "5 Top Stock Trades for Friday: GILD, INO, LVS, DPZ, LLY", "EM ASIA FX-Currencies ease on lockdown extensions, coronavirus drug report", "Gilead's Remdesivir Reportedly Flopped in Chinese COVID-19 Study", "Jobs Data, Treatment Buzz Keep Stock Gains in Check", "S&P 500 slips after report on coronavirus drug trial", "S&P 500 slips after report on coronavirus drug trial", "WHO to launch initiative to share COVID-19 drugs, tests and vaccines-statement", "Wall Street trims gains after report on coronavirus drug trial", "Buy the Dip in Gilead Stock Because Remdesivir May Not Be a Flop", "Stock Market Wrap-Up: Why Zoom and Royal Caribbean Shares Jumped Today", "7 Safe Stocks to Buy on the Coronavirus Dip", "Wall St rises on hopes worst for labor market is over", "Notable Thursday Option Activity: COF, GILD, WYNN", "Wall Street pares gains on report of potential coronavirus drug failing trial", "Gilead's coronavirus drug flops in first trial - FT", "First Week of GILD July 17th Options Trading", "BUZZ-U.S. STOCKS ON THE MOVE-Expedia Group, Crocs, Enzo Biochem", "BUZZ-U.S. STOCKS ON THE MOVE-Sleep Number, Crocs, Cassava Sciences", "BUZZ-U.S. STOCKS ON THE MOVE-Aytu BioScience, QEP Resources, Immunomedics", "Is It Too Late to Buy Gilead Sciences?", "Better Buy: AbbVie vs. Gilead Sciences", "Foreigners remain net sellers of Japan stocks for 10th week", "How Banks Have Prepared for a Slowdown", "Artificial Intelligence and Drug Discovery: The Companies Leading The Way", "The 10 Best Dividend Stocks for 2020", "BUZZ-U.S. STOCKS ON THE MOVE-Immunomedics, Helix Energy, Sleep Number Corp", "Gilead Sciences Races to Manufacture Remdesivir, but Chemistry Has Speed Limits", "4 Reasons Why Chesapeake Energy Stock Can Survive", "3 Great Reasons to Buy Gilead Sciences Stock", "Gilead, ONKo-innate Announce Research Collaboration For Cancer Therapy", "Gilead Sciences: Possible COVID-19 Treatment Already Priced in the Stock, Says Analyst", "Why These COVID-19 Vaccine Stocks Soared Today", "Alexion Pharmaceuticals to Initiate Phase 3 Study for Ultomiris as a Potential Coronavirus Treatment", "Does British American Tobacco's COVID-19 Vaccine Make It a Buy?", "BUZZ-U.S. STOCKS ON THE MOVE-Co-Diagnostics, Xeris Pharma, Cyclacel Pharma", "Notable ETF Inflow Detected - VYM, GILD, CME, USB", "Gilead Sciences Reaches Analyst Target Price", "Stock market gains alongside economic pain; some worry about over-optimism", "Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19", "Novartis, U.S. regulators agree to malaria drug trial against COVID-19", "Stock market gains alongside economic pain; some worry about over-optimism", "There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye", "2 Best Stocks to Buy Now", "Can Gilead Sciences\u2019 Coronavirus Gains Continue?", "Why Restaurant Stocks Jumped Today", "EMERGING MARKETS-Mexican peso rises on stimulus, Latam FX ends week in losses", "Wall Street gains on Boeing surge and coronavirus drug hopes", "4 Top Stock Trades for Monday: BA, MRNA, SLB, KSU", "GLOBAL MARKETS-Stocks rally as investors take heart on U.S. economic reopening plan", "If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now", "Health Care Sector Update for 04/17/2020: GENE,GILD,WORX", "Wall Street gains on Boeing news, Trump's reopening plan", "Gilead Stock Isn\u2019t Worth Chasing Now Despite Recent Remdesivir Success", "Why Shares of AMC, Cinemark, Live Nation, and Planet Fitness Popped Today", "Health Care Sector Update for 04/17/2020: GENE,GILD,WORX", "Wall St climbs on Boeing, Trump's reopening plan", "Whether or Not Gilead Sciences Produces a Successful COVID-19 Therapeutic, It's a Bargain", "Wall Street gains on Boeing surge, coronavirus drug hopes", "Gilead's shares rise on report of experimental drug's promise in COVID-19", "GLOBAL MARKETS-Stocks race toward second weekly gain", "BUZZ-U.S. STOCKS ON THE MOVE-Schlumberger, Biohaven Pharmaceutical, Spirit AeroSystems", "Wall St gains on Boeing, Trump's restart plan", "Here's Why JPMorgan Chase and Other Bank Stocks Are Up on Friday", "Stock Market News: Coronavirus Hopes Boost These 2 Stocks", "Boeing, Trump's restart plan boost Wall Street", "BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Cutera, Moderna", "Gilead's Remdesivir Shows Promise Against COVID-19 in Sneak Peek at Clinical Trial Data", "Nasdaq 100 Movers: CTXS, GILD", "U.S. housing secretary says Gilead's remdesivir appears promising for COVID-19 -Fox Business", "Gilead's shares rise on report of experimental drug's promise in COVID-19", "BUZZ-U.S. STOCKS ON THE MOVE-Schlumberger, Banks, Spirit AeroSystems, State Street", "Health Care Sector Update for 04/17/2020: MRNA, GILD, WORX", "Boeing, lockdown easing hopes set to lift Wall Street", "EMERGING MARKETS-Latam FX topped by Chile's peso, but eyes weekly losses", "BUZZ-U.S. STOCKS ON THE MOVE-Pulmatrix, Cutera, Moderna, Spirit AeroSystems", "Coronavirus Drug Results Send Gilead Sciences Stock Flying; JPMorgan Weighs In", "GLOBAL MARKETS-Super-charged stocks race towards second weekly gain", "Daily Markets: Investors Cheer Gilead Results and Reopening Roadmap", "U.S. stocks futures jump on Trump's restart plan, coronavirus drug hopes", "Don't Waste Your Money on Penny Stocks, These 2 Stocks Are Better Buys", "US STOCKS-Futures jump on Trump's restart plan, coronavirus drug hopes", "Institutional investors tell Big Pharma to cooperate on coronavirus", "BUZZ-U.S. STOCKS ON THE MOVE-Pulmatrix, Cutera, Moderna, Spirit AeroSystems", "EMERGING MARKETS-Equities buoyed by U.S. optimism as currencies dip", "Lonza focuses on coronavirus projects as epidemic brings in new business", "South African rand stronger at end of torrid week", "GLOBAL MARKETS-Asian stocks rise as re-open of U.S economy offsets China GDP slump", "Nikkei scales 6-week high on hopes for virus treatment, U.S. plan to reopen", "Hopes for virus treatment, U.S. reopening snuff out dollar rally", "UK shares surge on signs of U.S. restart, Rio Tinto results", "Dollar wobbles as fresh hopes for virus treatment prop up risk appetite", "Report says COVID-19 patients respond to Gilead's remdesivir, shares surge", "GLOBAL MARKETS-Asian stocks set to rise as markets brace for China GDP data", "U.S. stock futures jump late following data on potential virus treatment, Trump guidelines", "Gilead surges after report suggests COVID-19 patients responding to remdesivir", "Gilead Sciences Drug Shows Promising Results In Covid-19 Patients; Stock Up 14%", "Why Gilead Sciences Stock Is on Fire Today", "Dollar slips as hopes for virus treatment prop up risk appetite", "Is Exelixis a Buy?", "Why Arcus Biosciences Stock Is Skyrocketing Today", "Gilead Sciences\u2019 Remdesivir Data Release Brings Much Needed Relief for Patients and Investors", "Health Care Sector Update for 04/16/2020: SNGX, GILD, RCUS, RAD, JNJ, PFE, ABT, MRK, AMGN", "AstraZeneca to Test Blood Cancer Drug for COVID-19 Treatment", "Chinese Researchers Suspend Trial of Experimental Coronavirus Treatment", "BUZZ-U.S. STOCKS ON THE MOVE-U.S. oil stocks, retailers, restaurants, BofA, J.C. Penny, IBM, Gilead, LyondellBasell", "Report: Gilead Is Considering Taking a Stake in Arcus Biosciences", "Initial Coronavirus Treatment Trials Look Good for Gilead Stock", "Gilead Stock Could Get a Lift From a Coronavirus Treatment", "Is Moderna a Good Coronavirus Stock To Buy?", "Three Reasons to Consider Buying Regeneron Stock", "How Good Is Gilead's Latest News for Coronavirus Drug Remdesivir?", "AMRN Chugs Along, ATHX To Initiate Pivotal COVID-19 Trial, WORX Soars 550%", "Health Care Sector Update for 04/13/2020: PSTI,WORX,GILD,CANF", "Buying Gilead Sciences Stock Means Buying Into Political Risk", "Health Care Sector Update for 04/13/2020: WORX,GILD,CANF", "BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Amazon.com, Dish Network, GE, AMC Entertainment, Aurora Cannabis", "BUZZ-U.S. STOCKS ON THE MOVE-Amazon.com, Netflix, Royal Caribbean Cruises, Sabre Corp, Pluristem Therapeutics", "Wall Street Week Ahead-Health, tech, staples could shine through earnings gloom", "Wall Street set to dip as focus turns to earnings", "Health Care Sector Update for 04/13/2020: CANF, CTSO, GILD, JNJ, PFE, ABT, MRK, AMGN", "BUZZ-U.S. STOCKS ON THE MOVE-Carnival Corp, Gilead Sciencs, Pluristem Therapeutics, Dropbox, Scworx, Quintana Energy", "Reasons for hope: the drugs, tests and tactics that may conquer coronavirus", "3 Top Biotech Stocks to Buy in April", "Is Galapagos Stock a Buy?", "Eli Lilly Starts Clinical Trial for Potential COVID-19 Treatment", "Early Look at Gilead Sciences' Experimental Coronavirus Treatment Disappoints", "5 Biotech Stocks Winning the Coronavirus Race", "Bristol-Myers' win in U.S. patent case against Gilead boosted to $1.2 bln", "Health Care Sector Update for 04/09/2020: BIOC,BHC,BHC.TO,RTIX,GILD", "US STOCKS-Futures fall as focus turns to corporate earnings", "3 Top Biotech Stocks to Buy in April", "Nasdaq 100 Movers: CTXS, UAL", "Gilead Canada Submits SNDS To Health Canada For Descovy - Quick Facts", "Why Forty Seven Stock Skyrocketed 64.5% in March", "Good News for Remdesivir Is Good News for Gilead Sciences Stock", "Better Coronavirus Stock: Emergent BioSolutions vs. Gilead Sciences", "Novavax to start human trial for novel coronavirus vaccine", "Health Care Sector Update for 04/09/2020: BHC,BHC.TO,RTIX,GILD", "Investors await data on coronavirus drugs as market rally builds", "Tuesday Sector Laggards: Utilities, Healthcare", "BUZZ-U.S. STOCKS ON THE MOVE-Activision Blizzard, Gilead Sciences, Royal Caribbean, Kohl's", "Is Inovio Pharmaceuticals a Good Buy on Coronavirus Potential?", "BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean, Kohl's, Gilead Sciences, Electronic Arts", "BUZZ-U.S. STOCKS ON THE MOVE-Roadrunner Transportation, Gannett Co, Liminal BioSciences", "Gilead Unit Completes Acquisition Of Forty Seven - Quick Facts", "GRAPHIC-Wall St volatility raises fears of another selloff", "Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing", "My Top Biotech Stocks to Buy in the Market Crash", "Gilead Sciences Pins Its Hopes on Remdesivir", "Doctors embrace drug touted by Trump for COVID-19, without hard evidence it works", "Monday Sector Laggards: Healthcare, Energy", "Coronavirus Fighter Gilead Sciences Might Be Expensive, but It\u2019s Still Worth Owning", "BUZZ-U.S. STOCKS ON THE MOVE-Gilead Sciences, Wayfair, Immunomedics, Akers Bioscience", "BUZZ-U.S. STOCKS ON THE MOVE-Roadrunner Transportation, Trevi Therapeutics, Gannett Co", "BUZZ-U.S. STOCKS ON THE MOVE-Carnival Corp, Capri Holdings, Kohl's, Immunomedics", "BUZZ-U.S. STOCKS ON THE MOVE-Kohl's, Carnival Corp, Akers Bioscience, Immunomedics", "Nasdaq 100 Movers: CTXS, ULTA", "It\u2019s Tough to Admit, but Our New Normal Might Justify Buying IBIO Stock", "Gilead To Donate 1.5 Mln Doses Of Investigational COVID-19 Drug Remdesivir", "GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln", "BUZZ-U.S. STOCKS ON THE MOVE-Borr Drillng, Millendo Therapeutics, Menlo Therapeutics, Immunomedics Inc", "GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln", "Gilead, Second Genome Enter Four-year Strategic Collaboration - Quick Facts", "Gilead Has Treated More Than 1,700 COVID-19 Patients With Remdesivir", "The 5 Best Coronavirus Stocks To Buy Right Now", "Should You Buy Gilead Sciences Stock Right Now?", "Yes, the Stock Market Will Probably Go Lower. Here's Why You Should Invest Anyway.", "3 Coronavirus Stocks That Could Lead the Market to Recovery", "Should You Buy Forty Seven Before Gilead Sciences' Acquisition Closes?", "BUZZ-U.S. STOCKS ON THE MOVE-Crescent Point Energy, Millendo Therapeutics, Menlo Therapeutics", "Why Gilead Sciences Is the Hottest Stock to Buy Today", "Noteworthy Friday Option Activity: MTSI, GILD, WYNN", "Gilead Sciences\u2019 Coronavirus Treatment Has Big-Time Potential", "EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules", "EMA recommends compassionate use of Gilead's remdesivir for COVID-19", "Why Gilead Sciences Shares Rose 7.79% in March", "Better Buy: Gilead Sciences vs. Biogen", "Is the End of Quarter Market Run-Up Just Wall Street Dressing the Window?", "GILD Stock Remains a Smart Play Now and in the Future", "Top 3 Healthcare Stocks to Buy Right Now", "Better Coronavirus Stock: Abbott Labs vs. Gilead Sciences", "My Top Pharma Stocks to Buy in the Market Crash", "Is iBio Stock Worth the Risk as Coronavirus Continues to Spread?", "5 Hot Stocks for 2020 That Are Soaring While the Market Plunges", "Gilead\u2019s Cash and the Coronavirus Make GILD Stock Look Cheap", "GILD May 22nd Options Begin Trading", "4 Reasons Drug Stocks Are a Buy Right Now", "Is It Time To Buy Stocks Or Is The Market Heading Even Lower?", "Gilead Expands Access To Investigational Anti-coronavirus Drug", "Gilead Sciences Expands Access to Experimental COVID-19 Treatment", "3 Coronavirus-Proof Dividend Stocks That Are Perfect for Retirees", "2 Biotech Stocks in the Hunt for New Coronavirus Drugs; Oppenheimer Weighs In", "The 3 Most Resilient Stocks in the Bear Market Today", "Look For Better Buys Than Coronavirus Play INO Stock", "Noteworthy ETF Outflows: RSP, REGN, GILD, AMD", "Nasdaq 100 Movers: EXPE, GILD", "For Gilead, Its Coronavirus Treatment Is Icing on the Cake", "3 Things to Know if Chloroquine Wins the COVID-19 Treatment Race", "7 U.S. Stocks to Buy on Coronavirus Weakness", "This PR Nightmare for GILD Stock Will Eventually Fade", "May 8th Options Now Available For Gilead Sciences (GILD)", "First Week of GILD November 20th Options Trading", "1 Safe-Haven Stock for the Near Term", "GILD Seeks To Revoke Coveted Status, ELOX Pauses Trial, PRQR On Watch", "A COVID-19 Immunity Test Is on the Way", "Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19", "Health Care Sector Update for 03/25/2020: GILD,ASTC,VTGN,ALLK", "How Are Market Caps Doing in a Downturn", "Moderna CEO Says a Coronavirus Vaccine Could Be Available in Emergencies This Fall", "Better Coronavirus Stock: Gilead Sciences vs. Moderna", "5 Stocks to Buy in the Coronavirus Bear Market", "4 Reasons Biotech Stocks Are a Buy Right Now", "Coronavirus Drugs Already in the Pipeline", "10 Stocks to Buy as They Ride a Coronavirus Tailwind", "Top-Notch Vaccine Technology Makes iBio Stock a Smart Bet", "Inovio Could Be a Bargain Using Probability Analysis", "3 Biotech Stocks Fighting the Coronavirus; Here\u2019s What to Expect", "Wednesday Sector Laggards: Technology & Communications, Healthcare", "Why Consider These 2 Stocks When Markets Are Crashing?", "Gilead Stock Flies High With a Potential Coronavirus Treatment", "Gilead Sciences Stops Accepting Emergency-Use Applications for Remdesivir", "Don\u2019t Forget About Stocks to Buy During the Coronavirus Crisis", "3 Things To Watch In The Coronavirus Bear Market This Week", "Coronavirus Crisis: 3 Biotech Stocks to Buy Right Now", "All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them", "Top Pharma Stocks Under $5", "Gilead\u2019s Coronavirus Vaccine Candidate Shows Promise, Says Cowen", "Trump\u2019s Coronavirus News Conference on Thursday: 3 Key Things That Investors Should Know", "3 of the Strongest Stocks to Buy", "These 4 Top Stocks Are Bear-Market Tested", "Is It Too Late to Buy Coronavirus Biotech Stocks?", "Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment", "China Reports No New Coronavirus Outbreaks, First Time Since Outbreak Began", "Nonprofit Group Starts Multiple COVID-19 Clinical Studies", "Coronavirus-Fighting Tech Makes iBio Stock an Interesting Play", "Japanese-Developed Flu Drug Avigan Seems Effective Against COVID-19", "Noteworthy ETF Inflows: ESGU, NEE, ADBE, GILD", "Big Pharma's Fight Against the Coronavirus Pandemic: Good News and Bad News", "Better Coronavirus Stock: Gilead Sciences or Regeneron Pharmaceuticals?", "Trump Signs Coronavirus Relief Bill Into Law", "Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S.", "Remdesivir, Other Positive Catalysts Should Lift Gilead Stock", "How to Survive the Economic Fallout from COVID-19", "8 Best Performing Stocks During the 2020\u2019s Market Meltdown", "Why Regeneron Pharmaceuticals Stock Is Bolting Higher Today", "3 Cloud Computing Stocks That Are Winning From the Coronavirus", "Coronavirus Correction: 3 Must-Own Dividend Stocks", "Will Your Elective Surgery Be Delayed by Coronavirus?", "Will COVID-19 Derail New Drugs?", "Why Is Everyone Talking About Gilead Sciences?", "7 Biotech Stocks to Buy and Hold in 2020", "Can This American Biotech Company Save the Global Economy?", "Why This Coronavirus Stock Will Keep Growing Long After the Outbreak is Over", "When Will the Coronavirus Market Crash Be Over? Watch These 3 Stocks", "Early Results Dampen Outlook for Experimental COVID-19 Treatment", "Eli Lilly Joins the Hunt for a Coronavirus Treatment", "European Medicines Agency Offers Free Advice for Drugmakers Working on Coronavirus Treatments", "Why iBio Pharma Stock Is Not for Timid Investors Despite Great Potential", "CDC Releases List of Conditions That Increase the Risk of Severe Coronavirus Illness", "10 Health and Pharmaceutical Companies Fighting the Coronavirus", "CDC: Gilead Sciences' Remdesivir Is Being Used to Treat Coronavirus Patients", "World Health Organization: Coronavirus Disease COVID-19 Now a Pandemic", "Nasdaq 100 Movers: WDC, NTES", "S&P 500 Movers: WCG, DXC", "The 12 Best Low-Volatility Stocks of the Market Crash", "Better Coronavirus Stock: Gilead Sciences vs. Inovio Pharmaceuticals", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "FDA Postpones All Foreign Inspections Over Coronavirus", "The Gates Foundation and Friends Launch COVID-19 Treatment Accelerator", "COVID-19 Nearing Pandemic Level, WHO Warns", "IBB, GILD, VRTX, BIIB: Large Outflows Detected at ETF", "Nasdaq 100 Movers: GILD, TSLA", "Will Moderna Make a Fortune Off Its Coronavirus Vaccine?", "AbbVie to Test HIV Drug as a Potential Coronavirus Treatment", "7 Big Pharma Companies Trump Asked to Fight the Coronavirus Outbreak", "How to Be Greedy When Others Are Fearful", "3 Profitable Healthcare Stocks That Are Trouncing the Market During the Coronavirus Correction", "GILD Stock Looks Poised for a Serious Coronavirus Bump", "CDC Says Coronavirus Spread to Continue Into 2021", "Study Warns Number of U.S. COVID-19 Cases Much Higher Than Reported", "S&P 500 Movers: WCG, APA", "Is Inovio Pharmaceuticals Stock the Cure for Your Portfolio?", "FDA Warns Companies Selling Fraudulent COVID-19 Products", "Moderna Stock\u2019s Winning Streak Seems Likely to End", "Will Gilead Sciences Make a Fortune Off Its Coronavirus Drug?", "GILD Crosses Above Average Analyst Target", "Better Buy: Amgen vs. Gilead Sciences", "Gilead Sciences Could Be the First to Beat the Coronavirus", "CDC Advises Americans to Postpone Cruises", "3 Stocks That Are Actually Up Because of the Coronavirus", "4 Top Stock Trades for Monday: AMD, WMT, CRM, GILD", "Is There a Cure for the SARS-CoV-2 Coronavirus?", "Amid the Coronavirus Frenzy, Novavax Remains a Risky Bet", "EPA Releases List of Disinfectants to Protect Against Coronavirus", "3 Top U.S. Stocks to Watch in March", "Here's My Top Stock to Buy in March", "Coronavirus Market Correction: Where to Invest $1,000 Right Now", "Inovio Pharmaceuticals Rapidly Becoming The Premier Coronavirus Play", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Nasdaq 100 Movers: AAL, NTES", "Is Inovio Stock a Buy on Coronavirus Cure Potential?", "Up 2000% on Coronavirus Worries, CODX Stock Is a Short-Term Buy", "3 Biotech Stocks That Are Coronavirus Safe Havens", "Is Inovio Stock Still a Buy After Its Massive 150% Leap This Year?", "Congress Approves $8.3 Billion Coronavirus Funding Bill", "China Approves a Treatment for COVID-19 Complications", "Wednesday's ETF with Unusual Volume: MDIV", "Why It\u2019s Probably Safe to Start Buying AMD Stock on Weakness", "Is Gilead Sciences the Best Buy in the Coronavirus Sell-Off?", "Why Forty Seven Stock Soared 57% in February", "Buy Regeneron Stock for Coronavirus 2.0 and Beyond", "Barrick Gold Isn\u2019t the Best Hedge Against the Coronavirus", "Moderna CEO Says Its Coronavirus Vaccine Will Be Affordable", "Trump Administration Considers Reimbursing Hospitals to Treat Uninsured Coronavirus Patients", "Kids May Be the Hidden Carriers of COVID-19", "Inovio Has Potential Beyond Its Speculative Coronavirus Vaccine", "Nasdaq 100 Movers: ADSK, TSLA", "Nasdaq CEO Says Capital Is Part of Curing the Coronavirus", "Dow Jones Recovers 1,300 Points Despite Increase in U.S. Coronavirus Deaths", "Health Care Sector Update for 03/02/2020: CODX,FTSV,GILD,APDN,UMRX", "Trump Considering Expanded Travel Ban in Effort to Slow the Spread of Coronavirus", "Now Is the Time to Buy the Dip in Amazon Stock for the Long Term", "Gilead Sciences Acquiring Cancer-Focused Biotech Forty Seven for $4.9 Billion", "Why Gilead Sciences, Forty Seven, and Trillium Therapeutics Are Moving Higher Today", "Health Care Sector Update for 03/02/2020: FTSV, GILD, KPTI, CODX, JNJ, PFE, ABT, MRK, AMGN", "3 Top Biotech Stocks to Buy in March", "Daily Markets: Investors Hoping Central Banks Will Relieve Coronavirus Pressures", "Forty Seven's Stock Surges As Gilead Sciences To Buy Company In $4.9 Bln Deal", "Health Care Sector Update for 03/02/2020: APDN,FTSV,GILD,UMRX", "2 Biotech Stocks Winning the Coronavirus Race", "2 Stocks That Can Help You Protect Your Wealth From a Coronavirus Pandemic", "Better Buy: Gilead Sciences vs. Pfizer", "7 Stocks to Buy as a Hedge Against The Coronavirus Threat", "All the Stocks I'm Selling If the Coronavirus Keeps Spreading", "FDA Approves Coronavirus Tests in Academic Laboratories Across U.S.", "Coronavirus: Emerging Numbers Provide Reasons for Calm", "Biotech Stocks Facing FDA Decision In March 2020", "Here's Why Hype Around Companies Working on Coronavirus Treatments Is Overblown", "3 Small-Caps That Are Soaring Because of Coronavirus Panic", "Dow Falls Another 350 Points on Coronavirus Concerns, Worst Week Since 2008", "Health Care Sector Update for 02/28/2020: DNLI,ALT,FTSV,GILD,CLSN", "Gilead Sciences (GILD) Shares Cross 4% Yield Mark", "Gilead Reportedly in Talks to Acquire Cancer Biotech Forty Seven", "Health Care Sector Update for 02/28/2020: ALT,FTSV,GILD,CLSN", "Investors Endure Wild Ride in This Biotech Taking on COVID-19", "Stock Alert: Forty Seven Surges 30%", "Forty Seven (FTSV) Soars On Reports Of Takeover Interest", "Health Care Sector Update for 02/28/2020: FTSV, GILD, SGMO, BHVN, JNJ, PFE, ABT, MRK, AMGN", "How Gilead Sciences Is Driving Forty Seven and Trillium Therapeutics Higher Today", "This Under-the-Radar Stock Is the Biggest Winner From the Coronavirus Outbreak", "Noteworthy Thursday Option Activity: SAIA, GILD, MA", "April 9th Options Now Available For Gilead Sciences (GILD)", "Traders Are Treating Inovio Like 2018\u2019s Pot Stock Stars", "Nasdaq 100 Movers: AAL, GILD", "S&P 500 Movers: FLIR, PWR", "Stock Alert: GILD Gains After Initiating Phase 3 Studies For COVID-19 Treatment", "Momentum Stocks Benefitting From Coronavirus", "Why Inovio Pharmaceuticals, Gilead Sciences, Moderna, and Novavax Are All Jumping Today", "Fighting The Deadly Coronavirus", "Buy Microsoft Stock On The Dip Over Coronavirus", "Wait for Tesla Stock to Drop Below $700 on Coronavirus Fears", "Nasdaq 100 Movers: AAL, GILD", "Resilience to Coronavirus Concern Is a Bullish Sign for Alibaba Stock", "Novavax to Begin Clinical Testing of Coronavirus Vaccine by Late Spring", "Noteworthy ETF Inflows: IBB, GILD, VRTX, BIIB", "7 Safe Stocks to Buy on the Coronavirus Dip", "Gilead\u2019s Coronavirus Drug Could Propel GILD Stock Much Higher", "Should You Buy Inovio Pharmaceuticals Stock Right Now?", "Gilead Sciences Initiates Late-Stage Testing of Its Promising Coronavirus Drug", "U.S. Health Official Warns: COVID-19 Will Hit the United States", "U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus Treatment", "NIO Stock Will Sustain Momentum in 2020 Despite Coronavirus Concerns", "Nasdaq 100 Movers: GILD, REGN", "8 of the Best Stocks to Buy for ESG Investors", "Is It Too Late to Buy High-Flying Galapagos?", "11 Best Stocks to Ride Out the Coronavirus Outbreak", "Meet the Company That Just Might Prevent a Global Recession", "Health Care Sector Update for 02/24/2020: NGM,UTHR,GILD,EPZM", "Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official", "Health Care Sector Update for 02/24/2020: UTHR,GILD,EPZM", "Stock Market News: Berkshire Sinks Despite Buffett Optimism; Gilead Rises on Coronavirus Hopes", "Nasdaq 100 Movers: AAL, GILD", "S&P 500 Movers: AAL, GILD", "3 Dividend Stocks That Raised Their Payouts in February", "Moderna's New COVID-19 Vaccine Ready for Human Trials; Stock Up 15%", "A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward", "Nasdaq 100 Movers: ALGN, BMRN", "Notable Thursday Option Activity: STX, UNP, GILD", "Why Wells Fargo Stock Looks Poised to Rebound", "3 Contrarian Stocks to Buy Now for Absolute Returns", "Where Will Gilead Sciences Be in 10 Years?", "Report: Gilead Struggling to Find Subjects for COVID-19 Drug Trial", "Is Gilead Sciences Stock a Buy?", "2 Reasons to Be Optimistic About Gilead Sciences\u2019 Future", "IBB, GILD, VRTX, BIIB: ETF Outflow Alert", "Is Viking Therapeutics' Stock a Buy?", "Moderna Will Rebound, But Wait for a Dip Lower to Buy Shares", "The FDA Has a Plan to Deal With the Coronavirus", "Better Buy: AbbVie vs. Gilead Sciences", "3 High-Yielding U.S. Pharmaceutical Companies to Consider", "Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19", "White House Claims Other Countries Are \"Free-Riding\" on U.S. Drug Development", "Inovio\u2019s Surge on a Coronavirus Vaccine Was Just Speculation", "3 Biotech Stocks That Made Early Shareholders Millionaires", "Notable Wednesday Option Activity: EGLE, GILD, SEAS", "Nasdaq 100 Movers: CERN, CSGP", "Is Moderna a Buy?", "Pandemic Fears Not Enough to Buy Inovio Stock", "S&P 500 Analyst Moves: GILD", "Better Buy: bluebird bio vs. Gilead Sciences", "Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development", "Coronavirus Gets an Official Name From the WHO", "Johnson & Johnson Is Racing Against Time to Develop the First Coronavirus Vaccine", "Is Gilead Sciences an Acquisition Target?", "3 Pros and 3 Cons For INO Stock Amid Chinese Coronavirus Outbreak", "FDA Grants a Priority Review To Gilead Sciences' Cancer Therapy", "Gilead Sciences Looks Ready to Outpace AbbVie", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Could These 5 Stocks Benefit From the Coronavirus Outbreak?", "FDA Grants Priority Review For Kite's KTE-X19 BLA - Quick Facts", "1 Big Question to Ask Yourself Before Buying Gilead Sciences Stock", "Gilead Sciences: Still on the Path to Recovery", "Health Officials Say U.S. Coronavirus Vaccine is Making Good Progress", "4 Internet Stocks to Buy That Are Surging Higher", "Monday's ETF with Unusual Volume: PJP", "Multiple Positive Catalysts Make JD.com Stock Worth Buying", "Health Care Sector Update for 02/05/2020: VVUS,CERN,AIMT,GILD", "WHO Confirms 3,100 New Confirmed Coronavirus Infections Yesterday", "Health Care Sector Update for 02/05/2020: CERN,AIMT,GILD", "Health Care Sector Update for 02/05/2020: CERN,AIMT,GILD", "Notable Wednesday Option Activity: IBM, MSFT, GILD", "Daily Dividend Report: MMM, GILD, CG, PSX, SYK", "3 Big Stock Charts for Friday: Barrick Gold, Gilead Sciences, and Cloudflare", "3 Important Things to Know About Gilead Sciences' Q4 Results", "Gilead Sciences Inc (GILD) Q4 2019 Earnings Call Transcript", "FDA Approves Emergency Use of Coronavirus Test", "FDA Approves Emergency Use of Coronavirus Test", "Gilead Sciences Q4 Profit Misses Estimates", "Gilead Announces Q4 Financial Results, Misses EPS Target", "Gilead Sciences Inc. Q4 adjusted earnings Miss Estimates", "Gilead Sciences: Patience Required", "3 Important Things to Know About Gilead Sciences' Q4 Results", "Gilead Sciences Inc (GILD) Q4 2019 Earnings Call Transcript", "Gilead Sciences Q4 19 Earnings Conference Call At 4:30 PM ET", "Gilead's Ebola Drug Shows Positive Signs in Treating Coronavirus", "Gilead's Ebola Drug Shows Positive Signs in Treating Coronavirus", "Here's Why Inovio Pharmaceuticals and Vir Biotechnology Shares Have Fallen Today", "GILD Crosses Above Key Moving Average Level", "Gilead Sciences Q4 19 Earnings Conference Call At 4:30 PM ET", "Why Gilead Sciences Stock Is Up 13% Today", "3 Big Drugmakers Are Taking On the Coronavirus", "Daily Markets: Coronavirus Delivers Sharp Shift To The Markets", "Where Will Vertex Pharmaceuticals Be in 10 Years?", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Noteworthy ETF Outflows: IBB, GILD, VRTX, BIIB", "Near a 7-Year Low, Is Gilead Sciences a Buy?", "S&P 500 Movers: WCG, GILD", "5 Biotech Stocks to Watch With the Coronavirus Scare", "Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences?", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences", "Better Buy: Amgen vs. Gilead Sciences", "Gilead Considering Ebola Drug as Potential Coronavirus Treatment", "2 Dividend-Paying Biotech Stocks Worth Owning in 2020", "Why Novavax Shares Are Jumping Again Today", "2 Small-Cap Biotech Stocks to Watch in 2020", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "PJP's Underlying Holdings Could Mean 14% Gain Potential", "Notable Monday Option Activity: AIMT, NKE, GILD", "Gilead Sciences To Present At J.P. Morgan Conference; Webcast At 12:30 PM ET", "IBB, GILD, VRTX, BIIB: Large Inflows Detected at ETF", "Gilead Invests In Kyverna Therapeutics, Enters License Agreement - Quick Facts", "Where Will Intercept Pharmaceuticals Be in 5 Years?", "7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount", "Gilead Sciences Licenses Portfolio Of HIV Antibodies From Rockefeller", "Better Buy: Gilead Sciences vs. Biogen", "IBB, GILD, VRTX, BIIB: ETF Outflow Alert", "Biotech's Most Volatile Binary Events for Q1", "Vascepa\u2019s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock", "Notable Two Hundred Day Moving Average Cross - GILD", "Better Buy: Biogen vs. Gilead Sciences", "3 Dividend Stocks to Buy for 2020", "Better Buy: Editas Medicine vs. CRISPR Therapeutics", "Interesting GILD Put And Call Options For August 2020", "Gilead's Japan Unit In Deal With Eisai To Co-Promote RA Drug Filgotinib", "Did Cellectis Just Provide a Glimpse of the Future of Cellular Medicine?", "iShares Russell 1000 Value ETF Experiences Big Outflow", "20 High-Yield Dividend Stocks to Buy in 2020", "3 Big Pharma Stocks That Pay Big Dividends", "Health Care Sector Update for 12/20/2019: GILD,TXG,BIO,NLNK,MRK,ABEO", "Noteworthy Friday Option Activity: GILD, MET, PYPL", "2 Must-Own Dividend Growth Stocks in 2020", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "7 Biotech Stocks to Buy and Hold in 2020", "Drugs That Missed Key Goals In Phase III Trials", "Amarin\u2019s Vascepa Approval Seems Fishy for Patients and AMRN Investors", "How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition", "Gilead: Phase 2 ATLAS Data Shows Consistent Improvements In Liver Histology", "Better Buy: Gilead Sciences vs. Amgen", "Bristol-Myers Wins $752 Mln In US Patent Case Against Gilead Sciences", "IBB, GILD, VRTX, ILMN: ETF Outflow Alert", "GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch", "Noteworthy Wednesday Option Activity: GILD, GKOS, DERM", "GILD Named A Top Socially Responsible Dividend Stock", "Is Amarin a $20 Billion Stock?", "APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges", "No CRISPR Required: This Forgotten Gene Editing Stock Is Up 50% in 5 Weeks", "Thursday Sector Laggards: Energy, Healthcare", "IBB, GILD, VRTX, ILMN: Large Outflows Detected at ETF", "Better Buy: Editas Medicine or Sangamo Therapeutics?", "5 Top Stock Trades for Tuesday: NVDA, TSLA, GILD", "Does Amarin Have a Dark Horse Suitor?", "Ex-Dividend Reminder: El Paso Electric, Conmed and Gilead Sciences", "3 Dividend Stocks to Buy on Sale", "Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales", "January 2020 Options Now Available For Gilead Sciences (GILD)", "3 Recovering Healthcare Stocks to Buy That Already Escaped Flu Season", "Notable Thursday Option Activity: GILD, GEO, TTWO", "Gilead Sciences (GILD) Shares Cross 4% Yield Mark", "3 Big Stock Charts for Thursday: Gilead Sciences, DocuSign and Western Digital", "Better Buy: AbbVie vs. GlaxoSmithKline", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Will Its HIV Lineup Save Gilead Sciences?", "US Files Complaint Against Gilead Sciences For Patent Infringement", "Is The Future Finally Looking Up For Gilead Sciences?", "Here's Why Galapagos Stock Rose 20.5% in October", "Up 19.2%, Is Viking Therapeutics Stock Still a Buy?", "These 3 European Biotechs Can Help Recession-Proof Your Portfolio", "These Superior Dividend Stocks Are Found in Some Odd Industries", "Noteworthy ETF Outflows: IBB, CELG, GILD, VRTX", "Notable Friday Option Activity: GILD, AMED, TGT", "3 Reasons CRISPR Therapeutics Stock Can Reach Record Highs Again", "The 3 Best Sectors for Long-Term Earnings", "Can New Drugs Help Gilead Sciences Rebound?", "IBB, CELG, GILD, ILMN: ETF Outflow Alert", "Better Buy: Abbott Laboratories vs. Novo Nordisk", "GILD Crosses Above Key Moving Average Level", "4 Top Stock Trades for Monday: TSLA, GILD, GLD, VZ", "Gilead Sciences Q3 Revenue Is Flat, and R&D Hits Earnings", "Daily Dividend Report: VFC, BRO, COG, GRC, GILD", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "What's Behind Gilead Sciences' Lackluster Q3 Earnings Results", "Gilead Sciences Inc (GILD) Q3 2019 Earnings Call Transcript", "Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates", "5 Top Healthcare ETFs", "Noteworthy Tuesday Option Activity: GILD, APLS, MAT", "TQQQ, COST, CHTR, GILD: ETF Outflow Alert", "Gilead Sciences Names Andrew Dickinson CFO - Quick Facts", "3 Top Healthcare Dividend Stocks That Are Great Picks for Retirees", "Better Buy: Gilead Sciences vs. Johnson & Johnson", "Health Care Sector Update for 10/11/2019: ACRS, GERN, GILD, GLPG, JNJ, PFE, ABT, MRK, AMGN", "MITO Empowered, FPRX Cuts Another 70 Jobs, Second Death In Legionnaires Outbreak", "Interesting GILD Put And Call Options For December 6th", "3 Big Pharma Companies Driving Price Inflation", "3 Companies To Watch For At November\u2019s Society for Immunotherapy of Cancer Meeting", "Gilead Announces NDA Submission For Filgotinib In Japan - Quick Facts", "Noteworthy ETF Outflows: IBB, CELG, GILD, ILMN", "FDA Approves Descovy, Second Drug To Prevent HIV Infection", "Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth Stock", "Notable Thursday Option Activity: ABBV, GILD, SWKS", "Biotech Stocks Facing FDA Decision In October 2019", "Is GlaxoSmithKline a Buy?", "Notable Thursday Option Activity: CALM, GILD, EPAY", "OEF, GILD, AXP, MS: ETF Outflow Alert", "OEF, GILD, AXP, MS: ETF Outflow Alert", "3 Big Stock Charts for Tuesday: Baker Hughes, Gilead Sciences and Jefferies Financial Group", "Meet the Revolutionary New Diabetes Drug You've Probably Never Heard Of", "Better Buy: Gilead Sciences vs. Pfizer", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "3 Biotechs With the Biggest Cash Stockpiles", "An Investor's Guide to Disrupting Drugmakers", "PBE, GILD, ALXN, INCY: Large Outflows Detected at ETF", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Better Buy: Celgene vs. Gilead Sciences", "Interesting GILD Put And Call Options For November 1st", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 12, 2019", "4 Key Questions for Gilead Sciences' New CEO", "Ex-Dividend Reminder: Gilead Sciences, Conmed and Crown Castle International", "Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD", "IVE, COST, MDLZ, GILD: ETF Outflow Alert", "Sum Up The Parts: ESGL Could Be Worth $35", "'Serving on a Board Made Me a Better CFO'", "Notable Wednesday Option Activity: AXDX, GILD, MDB", "Better Buy: Gilead Sciences vs. Biogen", "Notable Wednesday Option Activity: JNJ, GILD, GLNG", "Noteworthy ETF Outflows: IBB, GILD, CELG, VRTX", "3 Big Stock Charts for Monday: Intuit, Gilead Sciences and Nike", "5 Top ESG Stocks on RBC Capital's 'Best Ideas' List", "VTV, GE, MO, GILD: ETF Outflow Alert", "3 Big Stock Charts for Monday: Xilinx, News Corp and Gilead Sciences", "3 High-Yield Dividend Stocks to Buy on Sale", "Fidelity National Information Services Achieves #72 Analyst Rank, Surpassing Gilead Sciences", "Analysts Anticipate SUSA To Hit $133", "Gilead Sciences a Top 25 Dividend Giant With 3.94% Yield", "DERM On Watchlist, FDA Panel Nod For GILD, So Long, CVRS And AVDR", "Notable Tuesday Option Activity: GILD, EVRI, PLT", "GILD Crosses Above 4% Yield Territory", "Notable ETF Outflow Detected - IBB, GILD, CELG, ILMN", "3 Embarrassingly Cheap Dividend Stocks", "2 Small-Cap Stocks That Could Make You Rich", "Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings?", "Gilead Sciences Reports Improving Revenue in the 2nd Quarter", "After Hours: Apple, Mastercard, and Gilead Sciences Report Earnings", "Gilead Sciences Inc. Q2 adjusted earnings Beat Estimates", "Noteworthy Tuesday Option Activity: GRMN, GILD, MCD", "Gilead (GILD) 2nd Quarter Earnings: What to Expect", "Here's Why Galapagos NV Rose 34.5% in July", "Marijuana Stock Cann('t)Trust, and What's Behind Gilead's Latest Megadeal", "Biotech Stocks Facing FDA Decision In August 2019", "Weekly Market Preview: Six Stocks To Watch For the Coming Week (BYND, GILD, AAPL, AMD, QCOM, SQ)", "3 'Perfect 10' Biotech Companies to Buy", "Health Care Sector Update for 07/24/2019: GILD,GHDX,EFII,EW,SGEN", "5 Biotech Stocks to Buy for a Strong Growth Prognosis", "8 More Big Pharma Events in 2019 You Don't Want to Miss", "Gilead Sciences Q2 19 Earnings Conference Call At 4:30 PM ET", "Notable ETF Inflow Detected - IBB, GILD, CELG, VRTX", "Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis", "3 Top Healthcare Stocks to Buy Right Now", "The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On", "Gilead's Galapagos Deal: What It Means for Investors", "3 Soaring Biotech Stocks With More Fuel in the Tank", "What Happened in the Stock Market Today", "Friday Sector Laggards: Utilities, Healthcare", "Health Care Sector Update for 07/15/2019: CAPR,GLPG,GILD,OMCL,TEVA", "Monday Sector Leaders: Utilities, Healthcare", "Galapagos Deal: GLPG Stock Rockets Higher on Gilead Stake", "Health Care Sector Update for 07/15/2019: GLPG,GILD,OMCL,TEVA", "GILD Crosses Above Key Moving Average Level", "Nasdaq 100 Movers: SYMC, GILD", "Health Care Sector Update for 07/15/2019: CAPR, GLPG, GILD, NTGN, JNJ, PFE, ABT, MRK, AMGN", "Nasdaq Today: Bitcoin & Libra; What\u2019s Broadcom Doing?", "IBB, GILD, CELG, ILMN: Large Outflows Detected at ETF", "August 23rd Options Now Available For Gilead Sciences (GILD)", "We Did The Math OVLU Can Go To $30", "Are Natural Killer Cells the Next Big Thing in Immunotherapy?", "VTI, C, GE, GILD: ETF Inflow Alert", "After Hours: Sarin Scare at Facebook, Gilead to Make Arthritis Drug Submission Soon", "First Week of February 2020 Options Trading For Gilead Sciences (GILD)", "Why Galapagos NV Stock Is Soaring Today", "The 10 Biggest Biotech Stocks", "3 Drugs Under FDA Review With Blockbuster Potential", "3 Large-Cap Biotech Stocks to Buy for Massive Gains", "GILD Crosses Above Key Moving Average Level", "3 Big Stock Charts for Tuesday: McKesson, Dish Network and Gilead Sciences", "3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal", "5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Better Buy: Aurora Cannabis vs. Gilead Sciences", "3 Top Dividend Stocks to Buy in June", "Notable Wednesday Option Activity: EXAS, GILD, PSTG", "Is the Newest Gene Editing Stock a Buy?", "Is Gilead Sciences Worth the Wait?", "How The Pieces Add Up: RNDV Targets $25", "Vanguard Total World Stock ETF Experiences Big Outflow", "Notable ETF Outflow Detected - IBB, GILD, BIIB, VRTX", "5 Top Stock Trades for Wednesday: GILD, NVDA, AMD", "Noteworthy Tuesday Option Activity: UAL, GILD, HP", "Nasdaq 100 Movers: MYL, AMD", "10 Top Pot Stocks to Buy", "IBB, CELG, GILD, AMGN: ETF Inflow Alert", "3 Top Biotech Stocks to Buy Right Now", "3 Cancer Stocks Given a Lift by Amgen", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Who Had the Better Quarter: Gilead Sciences or Amgen?", "IBB, GILD, CELG, BIIB: ETF Outflow Alert", "Is It Finally Time to Buy Gilead Sciences?", "Goldfinch Bio Partners With Gilead Sciences - Quick Facts", "Where Will Gilead Sciences Spend Its Cash?", "Analysts Expect VOOV To Hit $124", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "Has Gilead Sciences Turned the Corner?", "Gilead Sciences Returns to Growth in the First Quarter", "Gilead Sciences Inc (GILD) Q1 2019 Earnings Call Transcript", "Daily Dividend Report: EOG, GILD, DUK, ECL, ICE", "Gilead Sciences Inc. Q1 adjusted earnings Beat Estimates", "June 14th Options Now Available For Gilead Sciences (GILD)", "5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm", "Gilead (GILD) 1st Quarter Earnings: What to Expect", "Gilead Sciences Q1 19 Earnings Conference Call At 4:30 PM ET", "3 Things You Can Expect in Gilead Sciences' Q1 Earnings Update", "Will Gilead Stock Get A Needed Boost From This Week\u2019s Earnings Report?", "2 Reasons Gilead Sciences' NASH Program Could Bounce Back", "How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life", "Notable ETF Inflow Detected - IBB, CELG, GILD, BIIB", "Better Buy: Vertex Pharmaceuticals vs. Galapagos", "Gilead (GILD) 1st Quarter Earnings: What to Expect", "Top Gene-Sequencing Stocks for 2019", "Noteworthy Thursday Option Activity: GM, GILD, ICPT", "Noteworthy Thursday Option Activity: GM, GILD, ICPT", "Noteworthy ETF Inflows: VLUE, GM, GILD, EXC", "Is TG Therapeutics a Buy?", "Why Amgen Stock Could Break Out to New Highs", "2 Best Biotech Buyout Plays", "Interesting GILD Put Options For May 31st", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "Gilead to Collaborate with Novo Nordisk for NASH Treatment", "Better Buy: Gilead Sciences vs. Biogen", "Better Buy: Amgen vs. Gilead Sciences", "Novo Nordisk and Gilead team up to test fatty liver disease treatment", "Gilead teams up with insitro for experimental NASH treatments", "Noteworthy Thursday Option Activity: ADSK, GILD, HUM", "Why Galapagos NV Stock Bolted Higher in March", "3 Dividend Stocks Perfect for Retirees", "Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know", "Gilead Files sNDA for Label Expansion of HIV Therapy Descovy", "Where Will Gilead Sciences Be in 5 Years?", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Noteworthy Thursday Option Activity: ADSK, GILD, HUM", "IBB, GILD, CELG, VRTX: Large Outflows Detected at ETF", "2 Incredibly Cheap Pharma Stocks to Buy Now", "Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know", "Why BlackBerry, Galapagos, and Progress Software Jumped Today", "Health Care Sector Update for 03/29/2019: GLPG,GILD,FTSV,SEEL,AZN,AZN.L", "Why Galapagos Stock Is Crushing It Today", "Shares in Galapagos jump 15 pct after arthritis drug results", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Health Care Sector Update for 03/29/2019: GLPG,GILD,FTSV,SEEL,AZN,AZN.L", "ARDS On The Move, GLPG Reports Positive Data, PRTO Plunges On PATENCY-2 Results", "3 Top Dividend Stocks to Add to Your Watchlist", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Biogen Stock Fell Too Far on Unfortunate News", "Why BlackBerry, Galapagos, and Progress Software Jumped Today", "Does Recent AbbVie Stock Weakness Make It A Buy? 3 Pros, 3 Cons", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "YETI, Gilead, Dick's, FedEx and Amazon highlighted as Zacks Bull and Bear of the Day", "Bear of the Day: Gilead Sciences (GILD)", "After Hours Most Active for Mar 18, 2019 : ELAN, LLY, BAC, MRK, HPQ, WMB, QCOM, GILD, CMCSA, PEP, EBAY, ATVI", "Better Buy: Amgen vs. Gilead Sciences", "Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up", "Conatus (CNAT) Declines on Failure of NASH Fibrosis Study", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2019", "Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know", "3 Top Biotech Stocks to Buy in March", "Don\u2019t Abandon Gilead Stock After Weak Q4 Results", "Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy", "2 Biotech Stocks With Major Incoming Catalysts", "Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy", "IBB, CELG, BIIB, GILD: Large Inflows Detected at ETF", "Why Is Gilead (GILD) Down 4.9% Since Last Earnings Report?", "3 Big Pharmas Trying to Pop the Rebate Bubble", "Gilead Sciences (GILD) Shares Cross 4% Yield Mark", "Why Sangamo Therapeutics Lost 22.9% of Its Value in February", "Sum Up The Pieces: QQXT Could Be Worth $58", "Eli Lilly seeks to quell drug price anger with cheaper insulin", "After Hours Most Active for Mar 4, 2019 : LTHM, LLY, ATVI, BAC, S, OHI, GE, GILD, CMCSA, IMGN, AAPL, SGMS", "World's second man cleared of AIDS virus invigorates quest for cure", "Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus", "Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended", "Is Viking Therapeutics a Buy?", "Better Buy: bluebird bio vs. Gilead Sciences", "2 Frustrating Flops, Plus Welcome to the Wrinkle Wars", "The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis", "What Pharma Investors Need to Know About Pfizer's Latest Disaster", "The 3 Oldest Members of Biotech's Billion-Burned Club", "Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More", "Intercept Reports Positive Top-Line Data for NASH, Shares Up", "Intercept's fatty liver drug meets late-stage main goal, shares soar", "Tuesday's ETF with Unusual Volume: PBE", "Better Buy: Celgene vs. Gilead Sciences", "U.S. Medicare plans to track CAR-T cancer therapy outcomes", "Should You Buy Viking Therapeutics After Gilead Drug Failure?", "Intercept Pharmaceuticals Investors Strap In for a Wild Ride", "Celgene vs. Gilead Stock: What\u2019s the Better Biotech Buy?", "Noteworthy ETF Outflows: XLV, JNJ, GILD, CVS", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 14, 2019", "Biotech Stock Roundup: Regeneron Impresses in Q4, Gilead Slumps, MacroGenics Soars", "Nasdaq 100 Movers: GILD, EA", "Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN", "Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings", "Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails", "Health Care Sector Update for 02/12/2019: JAZZ,GILD,KMDA,OHI", "5 Must-See Stock Charts for Wednesday: GILD, NFLX, EA", "Here's Why Viking Therapeutics Rose as Much as 13.9% Today", "Health Care Sector Update for 02/12/2019: GILD,KMDA,OHI", "Notable Tuesday Option Activity: EA, GILD, NKE", "Gilead Sciences Stock Slides Lower on NASH Drug Failure", "Better Buy: Gilead Sciences vs. Pfizer", "Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails", "Is Intercept Pharmaceuticals a Buy?", "Why Agenus Inc. Stock Took Flight in January", "The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO", "Amgen a Top Socially Responsible Dividend Stock With 3.1% Yield (AMGN)", "Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink", "Wednesday Sector Leaders: Healthcare, Technology & Communications", "Gilead misses key goal in NASH liver disease trial, shares sink", "Health Care Sector Update for 02/05/2019: OPGN, CNC, GILD, JNJ, PFE, ABT, MRK, AMGN", "7 Key Things You Need to Know From Gilead Sciences' Q4 Earnings Update", "UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day", "Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat", "Is Gilead Sciences a Bad News Buy?", "Gilead Sciences' HCV Albatross Weighs on Its Results Yet Again", "Stock Market Today: Alphabet Grows While Gilead Sciences Shrinks", "Nasdaq 100 Movers: GILD, JD", "Daily Dividend Report: GILD, EXC, AVB, CHD, UTX", "5 of the Best Biotech Stocks to Buy Now", "Midday Stock Market News: Alphabet, Gilead Earnings on Tap", "Gilead (GILD) 4th Quarter Earnings: What to Expect", "Gilead Sciences, Inc. (GILD) Q4 2018 Earnings Conference Call Transcript", "Gilead Sciences Q4 18 Earnings Conference Call At 4:30 PM ET", "Gilead Sciences Earnings: GILD Stock Dips on Q4 EPS Miss, Revenue Beat", "5 Top Stock Trades for Wednesday: GOOGL, GILD, EL, BA", "Daily Dividend Report: GILD, EXC, AVB, CHD, UTX", "Gilead Sciences (GILD) Misses Q4 Earnings Estimates", "Gilead fourth-quarter profit misses Wall Street estimate, shares fall", "Notable Monday Option Activity: BABY, GILD, VRNT", "After-Hours Earnings Report for February 4, 2019 : GOOGL, GILD, AVB, HIG, ITUB, ARE, STX, QGEN, AIV, KRC, LEG, OLN", "Novartis's cancer therapy wins UK backing after initial lymphoma snub", "3 Top Large-Cap Stocks to Buy in February", "Gilead 4th-qtr profit misses Wall Street estimate, shares fall", "A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype", "Gilead Sciences (GILD) Gains But Lags Market: What You Should Know", "Avalon GloboCare Stock Is an Expensive Mystery", "Nasdaq 100 Movers: AMD, PCAR", "The Biggest Biotech Binary Event in 2019 Is Just Around the Corner", "Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for", "iShares U.S. Healthcare ETF Experiences Big Inflow", "Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?", "3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss", "Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know", "3 Top Healthcare Stocks to Buy in January", "7 Stupidly Cheap Stocks to Buy Now", "After Hours Most Active for Jan 22, 2019 : GRPN, QQQ, INTC, XEL, GILD, AMD", "Better Buy: Biogen vs. Gilead Sciences", "Notable Friday Option Activity: WYNN, GS, GILD", "Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?", "Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon", "1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet)", "Will Dividend Stocks be the Hot Stocks of 2019?", "Here's Why Verastem Tumbled 34.1% in December", "Value Added: 7 Top Stocks for 2019", "Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus", "7 Things to Expect for Gilead Sciences in 2019", "Why Gilead Sciences Stock Sank by 12.7% in 2018", "Why Agenus Stock Is Spiking Today", "Gilead Sciences To Present At J.P. Morgan Conference; Webcast At 12:30 PM ET", "Merck loses bid to revive $200 mln Gilead verdict at U.S. high court", "Gilead (GILD) Collaborates With Yuhan for NASH Candidates", "Gilead Sciences (GILD) Gains But Lags Market: What You Should Know", "After Hours Most Active for Jan 7, 2019 : CMCSA, ABEV, BAC, AMAT, GILD, FDC, MSFT, CTL, SYMC, QQQ, EXC, EMR", "2019 J.P. Morgan Healthcare Conference Roundup", "Japan Okays Approves Gilead Sciences' Epclusa", "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "3 Biopharma Stocks to Buy for Their Robust Dividend Yields", "3 Pharma Stocks Revving for Growth", "Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know", "Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018", "3 Biotech Stocks That Are Too Cheap to Ignore", "Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal", "Better Buy: Gilead Sciences vs. Amgen", "Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder", "Acorda Gets FDA Approval for Parkinson's Disease Drug Inbrija", "2 Beaten-Down Biotech Stocks That Look Like Bargains Now", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead", "Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer", "Why Agenus Stock Is Soaring Today", "Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III", "US Futures Inch Higher After Fed Move", "Bristol-Myers to Sell French Consumer Health Unit for $1.6B", "3 Top Healthcare Stocks to Buy in December", "Gilead Partners with Scholar Rock for Fibrotic Disease Drugs", "Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint", "Forget bluebird bio, Amgen Is a Better Biotech Stock", "Gilead Sciences, Scholar Collaborate On Novel Therapies For Fibrotic Diseases", "Wall Street Sees Cautiously Higher Open After Fed Move", "What Happened With CAR-T Stocks in 2018", "Bristol-Myers' Label Expansion of Sprycel Gets CHMP Nod", "3 Biotechs With Potential Blockbusters Near the Finish Line", "Evofem Shares Up as Birth Control Gel Succeeds in Phase III", "Why Dova Pharmaceuticals Is Nosediving Today", "Gilead Sciences (GILD) Stock Moves -0.69%: What You Should Know", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 12/16/2018", "Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer", "3 Biotechs Gilead Sciences Could Buy in March", "Mylan (MYL) Gets Favorable Ruling Against Sanofi's Lantus", "AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals", "The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis", "Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals", "Gilead Sciences a Top Socially Responsible Dividend Stock With 3.4% Yield (GILD)", "Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate", "2 Sets of Disasters Biotech Will Pay For in 2019", "Notable Wednesday Option Activity: NDSN, GILD, TLRD", "The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen", "Ex-Dividend Reminder: New Jersey Resources, Conmed and Gilead Sciences", "4 Biotech Stocks Investors Can Add to Their Portfolio in 2019", "Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO", "Roche's Tecentriq Gets FDA Approval for First-Line NSCLC", "Don\u2019t Punish Gilead Stock for Doing Its Job", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018", "Why CRSP Stock Has Added Layers of Risk", "Did Gilead Sciences Make an $11 Billion Blunder?", "VLUE, GM, MU, GILD: ETF Outflow Alert", "Biogen (BIIB) In-Licenses ALS Candidate BIIB067 From Ionis", "Gilead's (GILD) Harvoni and Descovy Get Approval in China", "Amgen's BiTE Immunotherapies Show Promise in Early Studies", "Gilead (GILD) Announces Data on CAR T Therapy Candidate", "Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know", "FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate", "Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know", "Monday's ETF Movers: XBI, XLV", "Key Pharma Players With HIV Focus Ahead of World Aids Day", "3 Top Dividend Stocks With Yields Over 3%", "How Google Is Helping Make Advances In Medical Technology", "Catalyst's Firdapse Receives FDA Approval for Rare Disease", "Shire's Takhzyro Gets European Nod for Hereditary Angioedema", "Merck (MRK) Receives Approval for 2 HIV Medicines in EU", "Aileron Inks Collaboration Deal With Pfizer for Cancer Combo", "Novartis (NVS) Receives EC Approval for Neulasta Biosimilar", "Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity", "Celgene & Bluebird's CAR T Therapy Study Completes Enrollment", "5 Biotech Stocks to Scoop Up for Big Dividends", "Eyenovia Initiates Phase III Study for Mydriasis Candidate", "How The Parts Add Up: RNDV Targets $24", "Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial", "Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate", "Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial", "Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth", "After Hours Most Active for Nov 26, 2018 : CTL, GE, QQQ, RF, TEVA, HAL, BAC, INTC, AAPL, GILD, XEL, STLD", "Better Buy: Gilead Sciences vs. Celgene", "Novartis Gets Approval for Gene Therapy Luxturna in Europe", "Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors", "Nasdaq 100 Movers: TSLA, ADSK", "Should Value Investors Consider Gilead (GILD) Stock Now?", "Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint", "Gilead's Vemlidy Gets Approval in China for HBV Infection", "Tesaro Stock Sinks in Aftermath of Sale Rumors", "Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension", "Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta", "Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal", "IBB, GILD, CELG, ILMN: ETF Outflow Alert", "Bristol-Myers' Opdivo Receives Positive CHMP Opinion for RCC", "Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes", "Acorda Down More Than 30% in the Past 3 Months: Here's Why", "Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018", "Roche's Tecentriq Gets Priority Review for Breast Cancer", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 11/18/2018", "Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus", "Cronos (CRON) to Report Q3 Earnings: What's in the Offing?", "Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?", "Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales", "Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat", "PDL BioPharma (PDLI) Q3 Earnings Top, Revenues Rise, Stock Up", "Prothena (PRTA) Reports Narrower-Than-Expected Loss in Q3", "Amarin's Vascepa Cuts Heart Risk in Outcomes Test, Stock Down", "Aerie (AERI) Q3 Earnings Miss, Rhopressa Gains Traction", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 08, 2018", "Pacira (PCRX) Q3 Earnings and Revenues Surpass Estimates", "Why Gilead Sciences, Inc. Stock Broke Down in October", "Puma Biotech (PBYI) Q3 Loss Narrows, Nerlynx Pulls Stock Down", "3 Top Biotech Stocks With P/Es Below 14", "Emergent (EBS) Q3 Earnings and Revenues Fall Shy of Estimates", "Validea Benjamin Graham Strategy Daily Upgrade Report - 11/8/2018", "bluebird (BLUE) Q3 Loss Narrower Than Expected, Revenues Beat", "Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss", "Agios (AGIO) Q3 Earnings Beat, Tibsovo Sales Drive Stock", "Acorda (ACOR) Q3 Earnings Top Estimates, Ampyra Sales View Up", "3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte", "The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals", "Intercept (ICPT) Gains on Earnings and Revenue Beat in Q3", "Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates", "SPTM, TXN, GILD, LMT: Large Inflows Detected at ETF", "Nasdaq 100 Movers: EA, NFLX", "Market Close Report: NASDAQ Composite index closes at 7,305.90 up 144.25 points", "Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q3, DRNA Soars on LLY Deal", "Better Buy: Celgene Corporation vs. Gilead Sciences", "Can the Strong Economy Save the Stock Market?", "7 Rising Healthcare Stocks to Consider", "Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag", "The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2", "AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated", "Where Will Gilead Sciences, Inc. Be in 5 Years?", "Daily Dividend Report: MAC, COG, GILD, AGN, DUK", "Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View", "Analysts See 18% Upside For The Holdings of JKF", "The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)", "Gilead Sciences Inc (GILD) Q3 2018 Earnings Conference Call Transcript", "Vertex (VRTX) Q3 Earnings and Revenues Surpass Estimates", "Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View", "Sarepta (SRPT) Q3 Earnings & Sales Miss, Exondys 51 Sales Up", "New Batch of Q3 Earnings: AMZN, GOOGL, INTC & More", "Earnings Reaction History: Gilead Sciences Inc., 58.3% Follow-Through Indicator, 4.5% Sensitive", "Gilead Sciences' 3rd Quarter: Good News Gets Better, Bad News Gets Worse", "Investors Are Underestimating Gilead Sciences Stock", "Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG", "3 Top Healthcare Stocks to Buy Right Now", "Noteworthy Wednesday Option Activity: GILD, WING, VEEV", "Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook", "The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers", "Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today", "After-Hours Earnings Report for October 25, 2018 : AMZN, GOOGL, INTC, GILD, SYK, FTV, DFS, DLR, RSG, CERN, FE, BMRN", "Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?", "Can UnitedHealth Group and Johnson & Johnson Continue Their Winning Ways?", "Is Sangamo Therapeutics Inc. a Buy?", "Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know", "Forget Gilead Sciences: Intercept Pharmaceuticals, Inc. Is a Better Growth Stock", "Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD", "Can This Tiny Biotech Revolutionize a $35 Billion Market?", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better", "IBB, GILD, BIIB, CELG: Large Inflows Detected at ETF", "Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know", "Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates", "Biotech Stock Roundup: GILD, BIIB Present Data, VTGN Gains on Fast Track Status", "The 5 Best Dividend Stocks to Buy, Hands Down", "Better Buy: Crispr Therapeutics AG vs. Editas", "Notable Tuesday Option Activity: GS, CMG, GILD", "Gilead Sciences (GILD) Stock Moves -0.24%: What You Should Know", "Merck Reports Positive Efficacy Data from Phase III HIV Study", "Notable ETF Outflow Detected - IBB, GILD, BIIB, CELG", "J&J's Phase III Data Shows Switch to its HIV Drug Beneficial", "Better Buy: Gilead Sciences, Inc. vs. Pfizer", "Noteworthy Thursday Option Activity: CBLK, GILD, AMTD", "7 Healthcare Stocks to Buy Right Now", "Gilead Announces Positive Data From Ongoing Biktarvy Study", "Gilead, HiFiBiO Collaborate to Develop T-Cell Receptors", "5 Top Healthcare Mutual Funds to Buy in October", "3 Reasons Why Buying Viking Therapeutics on the Dip Could Pay Off Big", "5 Reasons to Buy Gilead Stock Today", "Better Buy: Vertex Pharmaceuticals Incorporated vs. Galapagos NV", "Alexion (ALXN) to Acquire Biotech Syntimmune for $1.2 Billion", "Look Under The Hood: SPYV Has 11% Upside", "Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs", "IBB, BIIB, GILD, CELG: ETF Inflow Alert", "Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars", "Gilead Sciences' Latest Tactic? Go Generic", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "Notable Wednesday Option Activity: ISRG, CELG, GILD", "Gilead Is Undercutting Its Own Drugs: Here's Why", "5 Biotech Stocks to Play the Sector\u2019s Next Big Trend: NASH", "Guide to CRISPR Stocks & Latest Apple, Fed, GDP News | Free Lunch", "3 Ways to Unpack Some Hidden Treasure in Tesaro Stock", "Exelixis, Ipsen Receive Positive CHMP Opinion for Cabometyx", "CHMP Reconfirms Negative Opinion for Sarepta's Exondys", "3 Top Biotech Stocks to Buy Right Now", "How Do Drugs Compete Against Each Other?", "FDA Confirms Positive Safety Profile of Acadia's Nuplazid", "Is iShares Nasdaq Biotechnology ETF a Buy?", "Gilead (GILD) to Launch Generics for Leading HCV Treatments", "The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Celgene, Sanofi and Gilead Sciences", "Exelixis' Partner Ipsen Gets Approval for Cabometyx in Canada", "Ultragenyx's Shares Surge More Than 80% in the Year So Far", "Biotech Stock Roundup: CELG, REGN Present Data, VKTX Soars on Drug's Success", "Viking Therapeutics Liver Candidate Passes Test, Shares Soar", "Dr. Reddy's (RDY) Presence in Generics Market Remains Strong", "Is Gilead (GILD) a Suitable Stock for Value Investors Now?", "Molecular Templates Surges 50%, Inks Cancer Deal With Takeda", "Theravance, Mylan Report Positive Data on COPD Drug Yupelri", "Agenus Receives Milestone Payment of $5 Million from Incyte", "Is Galapagos NV a Buy Now?", "After Hours Most Active for Sep 18, 2018 : F, T, ABEV, SYMC, QQQ, MO, NLY, INTC, GILD, FE, FOXA, GRPN", "Viking Therapeutics and Madrigal Pharmaceuticals Are Racing to the Finish Line in NASH", "Should Value Investors Pick Gilead Sciences (GILD) Stock?", "Why Gilead Stock Is a Sleepy Giant Waiting to Break Out", "Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know", "IBB, BIIB, GILD, CELG: Large Outflows Detected at ETF", "Unity (UBX) Catches Eye: Stock Jumps 8.8%", "A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis", "Gilead Inks Gene Editing Collaboration Deal for HBV Infection", "Company News For Sep 13, 2018", "Better Buy: Gilead Sciences, Inc. vs. Biogen", "What's Next for Gilead Sciences After Its Latest Clinical Success", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 9/16/2018", "Biotech Stock Roundup: GILD's Arthritis Drug Successful in Phase III, PRQR Soars", "Nasdaq 100 Movers: MXIM, GILD", "Merck's Antibacterial Drug Succeeds in Label Expansion Study", "Regeneron/Sanofi's sBLA for Praluent to be Reviewed by FDA", "3 Top Stocks for Investing in Pharma's Next $35 Billion Market", "Incyte, Foundation Medicine Partner for Companion Diagnostics", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 13, 2018", "Here's Why Galapagos NV Is Skyrocketing 18.3% Today", "Why Altria Group, Galapagos, and Laredo Petroleum Jumped Today", "Gilead's Rheumatoid Arthritis Drug Successful in Phase III", "Endocyte Announces FDA's Acceptance of Trial Endpoint Change", "Ex-Dividend Reminder: El Paso Electric, DTE Energy and Gilead Sciences", "Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth", "The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE", "Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know", "Gilead Sciences Reports Market-Moving News", "Inovio Initiates Dosing in Phase I/IIa Study on MERS Vaccine", "Top Research Reports for Abbott, Gilead & FedEx", "Noteworthy Friday Option Activity: UBNT, ROKU, GILD", "Arrowhead Stock Is Not Done Rallying After Its 38% Jump", "ProQR Up More Than 120% on Favorable Eye Disorder Study Data", "Puma Biotech Gets EU Nod for Breast Cancer Drug Nerlynx", "IBB, GILD, CELG, REGN: Large Outflows Detected at ETF", "Shire's ADHD Portfolio Remains Strong Amid Competition", "bluebird (BLUE) Reports Updated Data on Lenti-D Gene Therapy", "Gilead, Galapagos Spondylitis Drug Meets Primary Endpoint", "MannKind Stock Up on Licensing Deal With United Therapeutics", "Horizon Pharma Completes Enrollment in Eye Disease Study", "Bayer (BAYRY) Misses on Q2 Earnings, Closes Monsanto Buyout", "Inovio (INO) Initiates Phase I Study on Hepatitis C Vaccine", "Is Now a Good Time to Buy Gilead Sciences?", "3 Top Big Pharma Stocks to Buy Now", "Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events (revised)", "AstraZeneca's Lupus Drug Misses Primary Endpoint in Study", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "Glaxo's Asthma Drug Gets EU Nod for Pediatric Population", "Vertex Inks Deal With Genomics to Make Serious Disease Drugs", "Bayer's (BAYRY) Jivi Gets FDA Approval to Treat Hemophilia A", "Alnylam Gets European Nod for First-Ever RNAi Therapeutic", "Alnylam's Shares Up as Onpattro Gets FDA and EU Approvals", "Bristol-Myers' Sprycel Seeks Label Expansion in the U.S.", "5 Enticing Dividend Stocks Primed for Long-Term Growth", "Ultragenyx to File NDA for LC-FAOD Candidate on Existing Data", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know", "Affimed (AFMD) Surges on Collaboration Contract with Roche (revised)", "Bausch (BHC) Resubmits NDA for Duobrii for Plaque Psoriasis", "Merck (MRK) Receives FDA Approval for Two HIV Medicines", "Biotech Stock Roundup: GILD Gets EC Nod for Yescarta, AMGN Submits Kyprolis sNDA", "3 Top Healthcare Stocks to Buy Right Now", "Time to Take Some Profits in Sarepta Therapeutics Stock", "Amgen Files for Once-Weekly Regimen for Myeloma Drug Kyprolis", "Gilead's CAR-T Therapy Yescarta Gets Approval in Europe", "3 Top Healthcare Stocks to Buy This Week", "Ultragenyx's Rare Disease Drug Mepsevii Gets EU Approval", "Affimed (AFMD) Surges On Collaboration Contract With Roche", "Play The Future of Gene Therapy With These 5 Biotech Stocks", "Notable ETF Outflow Detected - IBB, BIIB, GILD, CELG", "Novartis' CAR-T Therapy Kymriah Gets Approval in Europe", "Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events", "Bausch (BHC) Gets FDA Approval for Altreno for Acne Vulgaris", "Why Is Gilead (GILD) Down 6.2% Since Last Earnings Report?", "Shire's Takhzyro Gets FDA Nod for Hereditary Angioedema", "Bayer's Blood Thinner Xarelto Fails in Line Extension Studies", "3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?", "AbbVie Posts Positive Data on Elagolix for Uterine Fibroids", "Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer", "4 Biotech Stocks Investors Can Bet on Post Solid Q2 Earnings", "Mallinckrodt's Stannsoporfin Gets Complete Response Letter", "Don't Worry About An Inverted Yield Curve...YET", "Pacira (PCRX) Rides High on Robust Exparel Performance", "Roche (RHHBY) Gets FDA Approval for Cobas EFGR Mutation Test", "Infinity Focuses on Developing IPI-549 for Solid Tumors", "Alnylam Completes Enrollment in Phase III Givosiran Study", "5 Drug Stocks to Buy While the Pharma Sector Is on Sale", "Alexion's BLA for ALXN1210 Gets Priority Review From FDA", "China Biologic Products (CBPO) Looks Good: Stock Adds 8.7% in Session", "The Zacks Analyst Blog Highlights: Amazon, Petroleo Brazileiro, Gilead Sciences and KLA-Tencor", "The Cost of Cures: How Investing in Biotech Stocks Could Soon Be Radically Changed", "Allergan Falls on FDA's Rejection of Uterine Fibroids Drug", "8 Undervalued Biotech Stocks to Watch", "Bristol-Myers' Opdivo Gets FDA Nod for Small Cell Lung Cancer", "Novo Nordisk Buys Ziylo to Develop Glucose Responsive Insulin", "Time for Jackson Hole: Global Week Ahead", "Is Viking Therapeutics, Inc. a Buy?", "Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year?", "Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year?", "Japan Nods to AstraZeneca's Tagrisso for First-Line NSCLC", "8 Undervalued Biotech Stocks to Watch", "Glaxo, J&J's Dual Drug HIV Regimen Succeeds in Phase III Study", "Notable Friday Option Activity: ADBE, FB, GILD", "Inovio Pharmaceuticals Initiates Dosing in HIV Vaccine Study", "Lessons from a Legendary Value Investor", "Vertex's Cystic Fibrosis Drug Gets FDA Nod for Children", "Should Gilead Be Worried About This New Monthly HIV Medication?", "Regeneron, Teva Announce Positive Data on Osteoarthritis Drug", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 16, 2018", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2018", "Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit", "Shire, Shionogi File NDA for Intuniv for Adults in Japan", "Ligand (LGND) Proposes to Buy U.K.'s Drug Discovery Biotech", "Alnylam (ALNY) Gets FDA Nod for First-Ever RNAi Therapeutic", "Amicus (FOLD) Gets FDA Nod for Fabry Disease Drug Galafold", "GILD Makes Notable Cross Below Critical Moving Average", "Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat", "GILD a Top 25 Dividend Giant With $5.23B Held By ETFs", "Biotech ETFs in Focus on String of Q2 Earnings Beat", "Keryx's (KERX) Loss Wider Than Expected in Q2, Sales Lag", "PDL BioPharma (PDLI) Q2 Earnings Top, Revenues Slump Y/Y", "Is Crispr Therapeutics Stock Grossly Overvalued?", "Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well", "Puma Biotech (PBYI) Q2 Loss Narrows, Nerlynx Drives Sales", "Noteworthy Thursday Option Activity: PRGO, OXY, GILD", "Novo Nordisk (NVO) Beats Q2 Earnings and Sales Estimates", "Inovio (INO) Q2 Loss Narrows, Revenues Surpass Estimates", "AVEO Pharmaceuticals (AVEO) Q2 Loss In Line, Revenues Miss", "Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q2", "VIVUS (VVUS) Q2 Loss Wider Than Expected, Revenues Up Y/Y", "Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.", "Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise", "Biotech Stock Roundup: Regeneron Shines, BLUE Surges, ONCE Plunges", "3 Top Biotech Stocks to Buy in August", "Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up", "Alnylam's (ALNY) Q2 Loss Wider Than Expected, Sales Beat", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Q2 Scorecard & Research Reports for Gilead, American Tower & Others", "bluebird (BLUE) Q2 Loss Wider Than Expected, Revenues Miss", "Prothena (PRTA) Q2 Earnings Lag Estimates, Pipeline in Focus", "Intercept (ICPT) Gains on Solid Q2 Results, Ocaliva Recovers", "Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM", "Ultragenyx (RARE) Posts Narrower-than-Expected Loss in Q2", "Epizyme (EPZM) Q2 Loss Narrows, Shares Crash 24% on Setbacks", "5 Cheap PEG Stocks Suitable for GARP Investors", "Zoetis (ZTS) Beats on Q2 Earnings & Sales, Updates '18 View", "The 5 Best Dividend Stocks to Buy, Hands Down", "Acorda (ACOR) Q2 Earnings and Revenues Surpass Estimates", "Endocyte (ECYT) Posts Narrower-Than-Expected Loss in Q2", "Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit", "Sanofi's (SNY) Q2 Earnings Surpass Estimates, Sales Miss", "Better Buy: Biogen Inc. vs. Gilead Sciences, Inc.", "Is Gilead Sciences' Sudden Change in Leadership a Good Thing?", "3 Cheap Big Pharma Dividend Stocks That You Can Buy Now and Hold for Years", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Shire's (SHPG) Earnings and Revenues Beat Estimates in Q2", "After Hours Most Active for Jul 27, 2018 : QQQ, WFC, CSCO, MS, DB, NOK, CZR, MO, KO, GILD, SOXX, SYMC", "2 Reasons the Market Frowned After AbbVie's Blowout Q2 -- and 1 Reason It Should Be Excited", "Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan", "AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up", "Alexion's (ALXN) Earnings Beat Estimates in Q2, Guidance Up", "Microsoft, H&R Block, Facebook, Qualcomm and Gilead highlighted as Zacks Bull and Bear of the Day", "Gilead (GILD) Q2 Earnings & Sales Beat Eclipsed by CEO Exit", "Forget Gilead Sciences' CEO Departure -- This Was the Biotech's Big News", "Daily Dividend Report: SCHW, MCK, CVX, CMCSA, GILD", "Thursday's ETF with Unusual Volume: FBT", "Biotech Stock Roundup: Biogen Gains on Q2 Results, Agios Gets FDA Nod For Leukemia Drug", "Facebook Misses 1st Time in 11 Quarters; Plus GILD, QCOM", "Gilead Sciences (GILD) Q2 Earnings and Revenues Surpass Estimates", "Notable Wednesday Option Activity: GRPN, GILD, SPWR", "After-Hours Earnings Report for July 25, 2018 : FB, V, PYPL, GILD, QCOM, SU, MDLZ, LVS, VRTX, F, NOW, ALGN", "CEO Departure at Gilead Sciences Upstages Good Second-Quarter Results", "Daily Dividend Report: SCHW, MCK, CVX, CMCSA, GILD", "Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again?", "Better Buy: Gilead Sciences, Inc. vs. Celgene", "3 Big Stock Charts for Monday: Wells Fargo, Philip Morris and Gilead Sciences", "Will Strong HIV Sales Fuel Gilead (GILD) In Q2 Earnings?", "Why I Finally Sold my Gilead Sciences Stock Position", "Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?", "4 Biotech Bets to Watch as Industry Rebounds in a Month", "3 Top Healthcare Stocks to Buy in July", "Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings?", "Noteworthy ETF Outflows: IBB, BIIB, GILD, AMGN", "5 Biotech Stocks Well Poised to Beat Q2 Earnings Estimates", "J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod", "4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?", "3 Key Things to Watch in Gilead Sciences' Q2 Earnings Report", "3 Best Big Pharma Stocks to Buy for the 2nd Half of 2018", "3 Biotech Stocks With Big News Coming in NASH", "If You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do It", "Noteworthy ETF Inflows: IBB, GILD, AMGN, BIIB", "3 Huge Biotech Winners in 2018 (So Far)", "Gilead Sciences (GILD) Shares Cross 3% Yield Mark", "The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 7/15/2018", "Is Invesco Zacks Multi-Asset Income ETF (CVY) a Hot ETF Right Now?", "Top Research Reports for Mastercard, Gilead & Goldman Sachs", "Bullish Two Hundred Day Moving Average Cross - GILD", "Biotech ETFs Surge on Biogen's Positive Drug Trial Result", "Why Biotech Stocks Rallied on Biogen's Alzheimer's Test", "Noteworthy Friday Option Activity: GILD, OMC, ADSK", "Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More", "Trade of the Day: Gilead Sciences (GILD)", "Is Gilead Sciences a Great Stock for Value Investors?", "Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion", "Novartis to Spin-Off Alcon as Separate Trading Company", "4 Biotech Stocks to Bet on in the Second Half of 2018", "Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod", "Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection", "After Hours Most Active for Jun 26, 2018 : PFE, F, QQQ, MSFT, FLNT, ON, BWP, TEVA, GILD, T, INTC, MDT", "IBB, GILD, AMGN, BIIB: Large Outflows Detected at ETF", "Health Care Sector Update for 06/25/2018: DRIO, SYBX, GILD", "We Did The Math QQXT Can Go To $58", "Health Care Sector Update for 06/25/2018: DRIO,VLRX,GILD,SYBX", "Health Care Sector Update for 06/25/2018: VLRX,GILD,SYBX", "2 High-Flying Biotech Stocks With Even More Room to Grow", "CRISPR Science and Stocks: Knowing Enough to Invest", "3 Great Reasons to Buy Gilead Sciences", "IBB, GILD, BIIB, CELG: ETF Inflow Alert", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 6/17/2018", "1 Under-the-Radar Dividend Growth Stock to Buy Right Now", "Noteworthy ETF Outflows: IBB, BIIB, GILD, CELG", "Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant", "NASH Space in Focus as Galmed (GLMD) Posts Positive Data", "Galmed (GLMD) Soars on Positive NASH Data on Aramchol", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2018", "Novartis Announces Positive Data on CAR-T Therapy, Kymriah", "Noteworthy Wednesday Option Activity: ANET, TPX, GILD", "Ex-Dividend Reminder: Chesapeake Utilities, Gilead Sciences and Owens & Minor", "After Hours Most Active for Jun 12, 2018 : CMCSA, F, EDR, MU, KNX, WMB, GE, MGM, AMAT, INTC, GILD, AGNC", "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space", "Gilead Sciences a Top Socially Responsible Dividend Stock With 3.2% Yield (GILD)", "Should You Stick With Gilead Sciences?", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Drug Stocks: The Next Hot Industry or Value Traps?", "2 Cheap Dividend Stocks You Can Buy Right Now", "Gilead Collaborates with Hookipa for HBV and HIV Therapies", "Noteworthy Monday Option Activity: MA, GILD, WDC", "3 Reasons Gilead Sciences Is a Better Value Stock Than Amgen", "Has the Gilead Sciences Buy Argument Collapsed?", "Better Know Biotech: 2 Stocks You've Got to Know About", "Madrigal's NASH Study Data Encouraging, Stock Skyrockets", "Biotech Stock Roundup: Regeneron, Celgene, Amgen Impress at ASCO", "2 Cheap Dividend Stocks You Can Buy Right Now", "Is GlaxoSmithKline plc Stock a Buy?", "Gilead & Galapagos Announce Positive Data on Filgotinib", "2018 ASCO Conference Roundup", "Why Is Gilead Sciences (GILD) Down 7.2% Since Its Last Earnings Report?", "ASCO Conference Preview: Here's What Biotech Investors Need to Watch", "Read This Before You Buy Immuno-Oncology Stocks", "5 Top Stocks to Buy in June", "3 Top Value Stocks to Buy Now", "3 Healthcare Stocks That Are Undeniably Dirt Cheap Right Now", "Noteworthy ETF Outflows: XLV, GILD, TMO, CVS", "bluebird's Lenti-D Gets Breakthrough Therapy Status From FDA", "We Did The Math MGV Can Go To $86", "Glaxo and J&J's Two-Drug HIV Regimen Juluca Gets EU Approval", "3 Biotechs on the FDA's Naughty List That Should Be on Investors' Buy Lists", "Biotech Stock Roundup: GILD Epclusa's China Approval, BMRN Palynziq's FDA Nod", "XLV, MRK, AMGN, GILD: ETF Inflow Alert", "3 High-Yield Stocks With Virtual Monopolies", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2018", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2018", "Why Bristol-Myers Squibb Stock Crashed in April", "3 Stocks That Turned $10,000 Into $1 Million", "Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Lag", "Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest", "After Hours Most Active for May 7, 2018 : CMCSA, QQQ, GILD, MU, FNSR, CRZO", "Top Stock Reports for BP, Gilead, Enterprise Products & Colgate", "Celgene (CELG) Q1 Earnings & Sales Beat on Revlimid Strength", "5 Value Stocks to Book Gains Using Price-to-Book Ratio", "Is Gilead Sciences Stock Finally a Bargain?", "Notable Friday Option Activity: GILD, EXEL, RIG", "Gilead Sciences, Inc. Stock Will Recover\u2026 Eventually", "The Zacks Analyst Blog Highlights: BP, Gilead, Enterprise Products and Colgate", "Company News for May 3, 2018", "Thursday\u2019s Vital Data: Snap Inc (SNAP), Gilead Sciences, Inc. (GILD) and Weatherford International plc (WFT)", "Earnings Season Is Keeping the Markets Wobbly", "5 Reasons You Shouldn't Worry About Gilead Sciences' Ugly Q1 Results", "Relative Strength Alert For Gilead Sciences", "Nasdaq 100 Movers: GILD, AAPL", "The Zacks Analyst Blog Highlights: Apple, Snap, Gilead and T-Mobile U.S.", "Did Gilead Sciences Make a Big Mistake?", "Company News for May 3, 2018", "Gilead Sciences' First-Quarter Twist: Weak HIV Sales", "Market Close Report: NASDAQ Composite index closes at 7,100.90 down -29.80 points", "Why Molson Coors, Gilead Sciences, and Yum China Holdings Slumped Today", "5 Top Stock Trades for Thursday Morning", "XLV, MRK, AMGN, GILD: Large Outflows Detected at ETF", "Gilead Sciences, Inc. (GILD) Q1 2018 Earnings Conference Call Transcript", "Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1", "Better Buy: Biogen Inc. vs. Gilead Sciences Inc.", "Apple (AAPL) iPhone Sales Off the Mark, Shares Up; Also SNAP, GILD & TMUS", "Gilead (GILD) Shares Slip on Earnings Miss, Revenues Down Over 20%", "After-Hours Earnings Report for May 1, 2018 : AAPL, GILD, SU, MDLZ, APC, ALL, FISV, OKE, CXO, EIX, DVN, VRSK", "Earnings Reaction History: Gilead Sciences Inc., 54.5% Follow-Through Indicator, 4.3% Sensitive", "Is a Beat in the Cards for Agios (AGIO) in Q1 Earnings?", "What's in Store for ImmunoGen (IMGN) This Earnings Season?", "Gilead Sciences, Inc. Stock Declined After Earnings Miss", "Better Buy: Biogen Inc. vs. Gilead Sciences Inc.", "Apple (AAPL) iPhone Sales Off the Mark, Shares Up; Also SNAP, GILD & TMUS", "Gilead (GILD) Shares Slip on Earnings Miss, Revenues Down Over 20%", "AbbVie's First Quarter: Can We Quit Worrying About Humira Now?", "What's in the Cards for Conatus (CNAT) This Earnings Season?", "3 Things You Need to Know About AbbVie's Monster Q1 Earnings", "Health Care Sector Update for 04/27/2018: ACAD,GILD,HRC,SNY", "Will Agenus (AGEN) Disappoint Investors This Earnings Season?", "Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More", "Glaxo (GSK) Q1 Earnings Lag, Shingrix Vaccines Sales Solid", "Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings?", "What's in the Cards for Immune Design (IMDZ) in Q1 Earnings?", "What's in the Offing for Keryx (KERX) This Earnings Season?", "Better Buy: Celgene Corporation vs. Gilead Sciences", "An Eye On Biotech - Today's Editors' Picks", "HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?", "Interesting GILD Put And Call Options For July 20th", "Stocks Drop as 10-Year Yield Touches 3%", "Is Bellicum Pharmaceuticals, Inc. a Buy?", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "3 Bargain Stocks You Can Buy Right Now", "Your Guide to Investing in Zinc-Finger (ZFN) Gene Editing", "Is a Beat in Store for Bristol-Myers (BMY) in Q1 Earnings?", "Notable Thursday Option Activity: MAR, GILD, ABBV", "Interesting GILD Put And Call Options For July 20th", "See Which Of The Latest 13F Filers Holds Gilead Sciences", "Better Buy: Gilead Sciences, Inc. (GILD) vs. Pfizer (PFE)", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research", "4 Beaten-Down Funds Set to Soar (with dividends up to 10.9%)", "Health Care Sector Update for 04/19/2018: NVS, DHR, ALGN, GILD, 4503.T", "Analysts Expect 14% Gains Ahead For SPYG", "Top Research Reports for IBM, McDonald's & Gilead", "Health Care Sector Update for 04/19/2018: GILD,NVS,DHR", "Big Biotech ETF Can Bounce Back", "Biotech Stock Roundup: ALKS Up, CLDX Down, ALXN to Acquire Wilson Therapeutics", "Gilead (GILD) Presents Encouraging Data on NASH Therapies", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 4/15/2018", "Bristol-Myers Collaborates With Harvard Fibrosis Network", "Health Care Sector Update for 04/19/2018: AGN,SHPG,GILD,NVS,DHR", "Top Research Reports for IBM, McDonald's & Gilead", "Health Care Sector Update for 04/19/2018: GILD,NVS,DHR", "Why One Drug Flop Tanked Incyte's Stock", "This Little-Known Company Should Have Gilead's and Celgene's Investors Nervous", "Is Gilead Sciences, Inc. (GILD) a Buy?", "Biotech Fire Sale: 2 Top Stocks to Buy Next Week", "4 Top Stocks for Investing in Pharma's Next $35 Billion Market", "3 Top Healthcare Stocks to Buy in April", "Can Been-There Biotech Entrepreneur Arie Belldegrun Do It Yet Again?", "Pfizer Inks New CAR-T Deal, In Talks With P&G for Unit Sale", "Which Big Pharma CEOs Least Deserved Their Big Pay Increases?", "The Zacks Analyst Blog Highlights: United Technologies, Medtronic, Gilead, Hewlett Packard and Yum! Brands", "Top Stock Reports for United Technologies, Medtronic & Gilead", "Better Buy: Celgene Corporation vs. Gilead Sciences", "Celgene Loses 17.8% in 3 Months: Time to Reshuffle Portfolio?", "Is Cellectis SA Stock a Buy Now?", "Can Been-There Biotech Entrepreneur Arie Belldegrun Do It Yet Again?", "Pfizer Inks New CAR-T Deal, In Talks With P&G for Unit Sale", "Better Buy: Gilead Sciences, Inc. vs. Biogen Inc.", "Gilead Sciences' Investors Better Watch This Regeneron-Alnylam Deal", "Celgene Corporation Looks Cheap, Considering Its Potential", "Stemline Therapeutics Inc Stock Investors Are Betting, Not Investing", "Gilead Sciences (GILD) Shares Cross 3% Yield Mark", "Is Gilead Sciences a Beaten-Up Biotech Stock to Buy?", "Notable Two Hundred Day Moving Average Cross - GILD", "Why It's So Dang Hard to Value Biotech Deals", "Despite Struggles Celgene Corporation Stock Is Still A Buy", "Validea's Top Five Healthcare Stocks Based On David Dreman - 3/18/2018", "Gilead Sciences' $14 Billion-Per-Year Threat", "3 Revolutionary Cancer Treatments", "5 Must-See Quotes From AbbVie's Management", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "Is Gilead Sciences (GILD) a Great Stock for Value Investors?", "IBB, AMGN, GILD, REGN: ETF Outflow Alert", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 15, 2018", "Bull of the Day: Regeneron (REGN)", "Notable Wednesday Option Activity: DDD, GILD, HD", "Is Gilead Sciences Trying to Put Itself Out of Business?", "3 Biotech Stocks With Rising Earnings Estimates Post Q4", "3 Reasons CRISPR Stocks Could Keep Soaring", "How Pricing Can Be Vital to a Drugmaker's Profitability", "How Drugmakers Approach Efficacy Is the Key to Success", "After Hours Most Active for Mar 12, 2018 : PFE, QCOM, F, CBS, BAC, QQQ, CELG, HST, SOHU, GE, CTSH, GILD", "Here's What Lifted Sangamo Therapeutics Inc. in February", "The Revolutionary New HIV Drug You've Probably Never Heard Of", "How Biopharmas Battle for Billions", "Gilead Sciences (GILD) Down 3.4% Since Earnings Report: Can It Rebound?", "The 1 Big Risk That Every Drugmaker Fears", "Biotech Stock Round Up: Regeneron Submits sBLA, Biogen to Withdraw Zinbryta", "Noteworthy ETF Outflows: IWB, AMGN, GILD, UTX", "Gilead Announces Positive Data on New HIV Therapy Biktarvy", "Notable Tuesday Option Activity: GILD, LE, PYPL", "Here's Why Crispr Therapeutics AG Jumped Again in February", "Here\u2019s Why Gilead Sciences' Jump Into Gene Editing Is Important", "The Zacks Analyst Blog Highlights: Gilead, BNY Mellon, State Street, Alliant Energy and Dillard's", "2 Cheap Growth Stocks to Buy Right Now", "Intangibles Hold the Key to Valeant Pharmaceuticals Intl Inc Stock", "Apple's Cure for Soaring Costs? Tech-Savvy Healthcare Clinics", "Biotech ETFs Head to Head: XBI vs. IBB.", "Health Care Sector Update for 02/28/2018: HTBX, SGYP, CODX, GILD", "Health Care Sector Update for 02/28/2018: GILD,SGYP,CPH.TO,HTBX,CODX", "Top Analyst Reports for Gilead, BNY Mellon & State Street", "Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo", "Gilead Sciences' History Points to Future Success", "Gilead Sciences: The Oncology Company?", "How Gilead Sciences Is Betting Big on Gene Editing", "Why Sangamo Therapeutics Rocketed Higher Today", "Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD", "5 Drugs That Are Critical for Gilead Sciences' Future", "Health Care Sector Update for 02/22/2018: CLVS,SGMO,GILD,BKD", "Health Care Sector Update for 02/22/2018: CLVS,SGMO,GILD,BKD", "SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 2/18/2018", "How Celgene Hopes to Cash In on CAR-T", "Noteworthy ETF Inflows: SPYG, CRM, GILD, CHTR", "Intercept (ICPT) Q4 Earnings & Sales Lag on Dull Ocaliva", "3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2018", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2018", "Is AbbVie or Gilead Sciences Stock a Better Buy?", "How Huge Is the Latest HIV Drug Approval for Gilead Sciences?", "Why Biotech Stocks Soared in Trump's First Year in Office", "Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc", "3 ETFs to Watch on Biotech Earnings", "Glaxo's (GSK) Begins Phase III HIV Two-Drug Regimen Study", "Glaxo (GSK) Earnings and Revenues Surpass Estimates in Q4", "FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up", "Intercept Starts OCA Trial for NASH Patients With Cirrhosis", "Is Gilead Sciences, Inc. Stock Still a Solid Value Play?", "Why Crispr Therapeutics AG Stock Bolted Higher in January", "Gilead (GILD) Beats on Q4 Earnings, 2018 View Lacks Lustre", "The Zacks Analyst Blog Highlights: Walt Disney, Chipotle, Snap and Gilead Sciences", "Gilead Sciences Inc. Delivers Deja Vu in the Fourth Quarter", "Daily Dividend Report: GILD, CTSH, ICE, APC, GLW", "5 Things Gilead Sciences' Management Just Said That You Need to Know", "Here's What Gilead Sciences Just Said About Its Future", "Gilead Sciences Inc. (GILD) Q4 2017 Earnings Conference Call Transcript", "Gilead Sciences, Inc. (GILD) Shares Slide on Weak Outlook", "New Quarterly Earnings Results for DIS, CMG, SNAP and More", "Gilead (GILD) Posts Earnings Beat, Total Product Sales See YoY Decline", "Earnings Reaction History: Gilead Sciences Inc., 63.6% Follow-Through Indicator, 4.4% Sensitive", "After-Hours Earnings Report for February 6, 2018 : DIS, GILD, APC, PXD, CERN, MCHP, MKL, PAA, AKAM, UDR, JKHY, ATO", "Noteworthy Monday Option Activity: CMI, MU, GILD", "Gilead (GILD) 4th Quarter Earnings: What to Expect", "Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings?", "3 Top Biotherapeutics Stocks to Buy Now", "Will Gilead (GILD) Disappoint Investors in Q4 Earnings?", "Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Vertex (VRTX) & Other Drug Stocks with FDA Catalysts this February", "3 Headwinds in Q4 Earnings Results That Make Merck a Mediocre Stock", "3 Big Biotech Stocks With Major Catalysts on the Way", "After Hours Most Active for Jan 30, 2018 : ETP, MSFT, ETE, FE, EPD, MRK, T, CSCO, INTC, QQQ, GILD, FB", "US Stocks Slump as Declines in Telecom, Utilities Sectors Weigh", "Nasdaq 100 Movers: WYNN, GILD", "Gilead Sciences, Take-Two Interactive Hit Buys After Vertex Breakout", "Monday Sector Leaders: Consumer Products, Healthcare", "3 Small Biotechs That Big Drugmakers Are Probably Drooling Over", "GILD Crosses Above Average Analyst Target", "Why This Biopharma 'Behemoth' Could Soon Become Acquisitive", "Don\u2019t Chase AbbVie Inc Stock After Its Huge Earnings Win", "5 Biotech and Pharmaceutical Stocks Going Bonkers", "Notable Friday Option Activity: SBUX, GILD, ITW", "Celgene (CELG) Q4 Earnings & Sales Beat on Solid Revlimid", "Will 2018 Be Bellicum Pharmaceuticals, Inc.'s Best Year Yet?", "Celgene Reverses In Fourth Quarter As Otezla Sales Rebound", "Is It Finally Safe to Buy Gilead Sciences Stock? 1 Analyst Thinks So", "Celgene (CELG) to Acquire Juno Therapeutics for $9 Billion", "Analysts More Bullish On Celgene-Juno, But Sales Outlook Nags", "Celgene's $9 Billion Buyout of Juno: Is It a Good Deal for Investors?", "3 Stocks the World's Best Investors Are Buying Right Now", "Noteworthy ETF Outflows: IWB, AMGN, GILD, ABT", "What to Expect From Amgen, Inc. in 2018", "Better Buy: GlaxoSmithKline plc vs. Eli Lilly", "Bluebird Up on Buyout Speculation After Celgene/Juno Deal", "The Zacks Analyst Blog Highlights: Apple, JPMorgan, AbbVie, Gilead and Simon Property Group", "Gilead Collaborates with Pfizer for Yescarta Combo Study", "The Top 10 Value Stocks in the S&P 500", "Merck & Co., Inc. Stock Could Still Soar Another 10% From Here", "3 Top-Ranked Drug Stocks That Are Broker Favorites", "Novartis sBLA for CAR-T Therapy Kymriah Accepted by FDA", "No Reason To Rush Into Juno Therapeutics Inc Stock After This Big Pop", "Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.", "Top Research Reports for Apple, JPMorgan & AbbVie", "Juno Hits 52-Week High on Celgene's Rumored Buyout Interest", "Why Celgene's Rumored Acquisition Of Juno Actually Makes Sense", "Why Juno Therapeutics Stock Is Soaring Today", "What's Juno Therapeutics Worth to Celgene?", "Is Celgene (CELG) Looking to Take Over Juno Therapeutics?", "3 Top-Ranked Drug Stocks that are Broker Favorites", "Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News", "Juno Therapeutics Stock Rockets On Report That Celgene Is In Buyout Talks", "Noteworthy Tuesday Option Activity: GILD, WDC, BMY", "10 Value Stocks to Buy for 2018 and Beyond", "XLV, MRK, AMGN, GILD: ETF Outflow Alert", "2017 Was a Year to Forget for Gilead Sciences, Inc., but This Year Could Be Better", "3 Reasons Dividend-Monster Pfizer Inc. Could Explode Higher", "Is Gilead Sciences, Inc. a Buy in 2018?", "Big Pharma CEOs Speak About Impact of Tax Reform on M&A", "7 Must-See Numbers from AbbVie's J. P. Morgan Presentation", "Valeant Pharmaceuticals Intl Inc Stock Is Worth the Risk", "Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference in Focus", "3 Top Healthcare Stocks to Buy in January", "5 Ways Gilead Sciences Plans to Return to Growth", "Galapagos Reports Topline Data From Osteoarthritis Study", "Can Biotech Keep Last Year's Momentum Alive in 2018?", "Big Pharma CEOs Speak About Impact of Tax Reform on M&A", "Why 2017 Was a Year to Remember for Gilead Sciences, Inc.", "Dynavax To Launch Hepatitis B Vaccine \u2014 Is An Acquisition Coming?", "Biotech: The Tide Is Turning", "Noteworthy Friday Option Activity: GILD, AVXS, UAA", "Why Juno Therapeutics Stock Cooled Off in December", "XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF", "Celgene to Acquire Impact Biomedicines to Boost Pipeline", "Why This Is the Perfect Level to Buy Celgene Corporation Stock", "Generalists On Biotech Sidelines As Tax Reform Sweeps The U.S.", "3 Biotech and Pharma Stocks with FDA Catalysts this January", "Here's How bluebird bio, Inc. Crushed It in 2017", "Why 2017 Was a Year to Remember for Juno Therapeutics", "Why These 2 Biotechs Could Outperform Amid 'Hyper-Competition'", "3 Biggest Breakthroughs in Cancer Treatment in 2017", "18 Reasons I Like Biotech Stocks in 2018", "Celgene (CELG) in Troubled Waters in '17: What Does 2018 Hold?", "Why Gilead Sciences Stock Should Be Avoided in 2018", "5 of the Best-Performing Biotech Stocks of 2017", "Noteworthy ETF Outflows: XLV, GILD, LLY, BIIB", "4 Biotech Stocks Ready to Crush the Market in 2018", "Notable Wednesday Option Activity: RL, WBA, GILD", "Q&A: Vertex Chief Talks About Company's 'Transformational Year'", "Intercept (ICPT) Stock Loses Sheen in 2017: What Lies Ahead?", "Gilead: Maybe 2018 Won't Be Its Year Either", "Interesting GILD Put And Call Options For August 2018", "3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2018", "Biotechs: Not So 'Darn Scary' After All", "Biotechs: Not So 'Darn Scary' After All - An SA Marketplace Roundtable", "3 Questions Keeping Juno Therapeutics' Investors Up at Night", "Why These Biotech Stocks Could Be Taken Over In 2018", "Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb", "3 Top Stocks That Are Cash Cows", "Even in This Rich Market, Gilead Sciences, Inc. Is Offering Investors Value", "Noteworthy ETF Inflows: VYM, ABBV, GILD, LLY", "Galapagos Cozies Up Closer to Gilead Sciences", "CAR T Stocks in Focus with ASH 2017 Meet: GILD, JUNO & More", "Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales?", "After Hours Most Active for Dec 18, 2017 : EPD, GM, INTC, BP, ETE, QQQ, LC, AAPL, MPLX, GILD, CMCSA, AKAM", "Why No Large-Cap Biotech Franchise Is Safe From Threats In 2018", "3 Top Stocks That Are Cash Cows", "Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs", "Ex-Dividend Reminder: Conmed, Merck and Gilead Sciences", "Bluebird's Shares Jump on Strong Data for CAR-T Therapy", "ASH 2017: CAR-T Wallops Blood Cancer", "Juno Reports Additional Data on CAR-T Therapy, Shares Drop", "Notable Friday Option Activity: INTC, LMT, GILD", "Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today", "Company News For Dec 11, 2017", "3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise", "Health Care Sector Update for 12/11/2017: VSTM, MRK, IONS, GILD, IMGN, JUNO, CELG, REGN, BIVV", "Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta", "Novartis Reports Updated Results from Kymriah's JULIET Study", "What's Causing Juno Therapeutics Shares to Tumble 11.9% Today", "Jim Simons: Pioneer Quant Manager", "Is Now the Perfect Time to Buy Juno Therapeutics Stock?", "You'll Be Stunned by How Many Cancer Immunotherapies Are Being Developed", "Why Biotech Stocks May Wait A While Before Feeling The Love", "Gilead Sciences to Acquire Cell Design Labs for $567 Million", "Noteworthy Friday Option Activity: UAL, GILD, ABBV", "Notable Two Hundred Day Moving Average Cross - GILD", "Notable ETF Inflow Detected - VLUE, GILD, F, NSC", "Is Gilead Sciences, Inc. a Buy?", "Is Now the Perfect Time to Buy Juno Therapeutics Stock?", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 12/6/2017", "5 Top Biotech Stocks to Buy Now", "Gilead & 3 Other Drug Stocks in Focus this World AIDS Day", "Glaxo Begins Phase III Study on Injection to Prevent HIV", "10 Blockbuster Drugs of the Future for Big Pharma Stocks", "Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.", "Why Gilead Could Have 'Greatest' Ever In HIV Drug Launches", "No. 1-Ranked Medical Stock Tests Support In New Base", "5 Biotech and Pharma Stocks with FDA Catalysts this December", "Does Gilead's Kite Acquisition Offer A New Buying Opportunity?", "Gilead Sciences Stock Upgraded: This Is the Power of Free", "Notable ETF Inflow Detected - QUAL, BLK, MMC, GILD", "3 Dividend Stocks With Better Yields Than McDonald's", "How Will U.S. Tax Reform Impact Pharma/Biotech Industry?", "Morning Movers: Sears Soars on Earnings; Kroger Gains", "Glaxo, Pfizer's ViiV Healthcare Begins HIV Drug Combo Study", "Gilead (GILD) Down 7.9% Since Earnings Report: Can It Rebound?", "Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ...", "Hedge Funds Are Snapping Up These 3 \u2018Strong Buy\u2019 Stocks", "Biotech Poised for Growth: 3 Healthy Fund Choices", "J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space", "CAR-T Therapy Space 2017 Progress Report", "Health Care Sector Update for 11/28/2017: COOL,PZRX,PETX, MDT,GILD,PFE", "The 1 Thing Missing From Gilead Sciences' 2018 Priority List", "United Therapeutics PAH Drug's Exclusivity Period Extended", "Gilead Sciences Enters Oversold Territory", "After Hours Most Active for Nov 20, 2017 : ACM, QQQ, BAC, LC, EUFN, PFE, WFC, T, URBN, FITB, GILD, AAPL", "Better Buy: Biogen Inc. vs. Gilead Sciences", "Celgene CAR-T Therapy Gets Breakthrough Therapy Designation", "Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3", "J&J & Glaxo Get FDA Approval for First Two-Drug HIV Regimen", "Biotech Industry: Small Innovators Outflank Big Caps As Blockbuster Drug Patent Cliff Looms", "Hampstead Capital LLP Buys Merck Inc, American International Group Inc, Pioneer Natural ...", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16, 2017", "Gilead Sciences Inc (GILD) President and CEO John F Milligan Sold $16 million of Shares", "GILD Makes Notable Cross Below Critical Moving Average", "Temasek Holdings (private) Ltd Buys Visa Inc, Virtu Financial Inc, Ctrip. ...", "Biotechs Sell Off In Droves \u2014 Are Investors Seeking Mergers?", "Summit Street Capital Management, LLC Buys Fluor Corp, Hawaiian Holdings Inc, Kulicke & ...", "What Investors Need to Know About Investing in Low PE Stocks", "3 Top Biotech Stocks for 2018", "Notable Friday Option Activity: ICPT, GILD, CLVS", "You'll Be Stunned by Gilead Sciences CEO's Prediction for 2018", "Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted", "Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ...", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 09, 2017", "7 Life Science Stocks to Buy Today", "3 ETFs to Watch on Biotech Earnings", "3 Things You'll Want to Closely Watch in CVS Health's Q3 Results", "3 Reasons It's Smart to Buy Celgene's Stock Now", "WestEnd Advisors, LLC Buys Bank of America Corporation, SPDR Portfolio Short Term Corporate ...", "Intercept (ICPT) Q3 Loss Narrower Than Expected, Sales Beat", "5 Biotech and Pharma Stocks with Key FDA Catalysts this November", "Sharp Drop Celgene Corporation Stock May Have Just Created an Entry Point", "3 Stocks Changing the Future of Healthcare", "What's Behind Gilead Sciences Inc.'s $7.8 Billion Slide in October?", "Why Juno Therapeutics Shares Are Going Up 21.2% Today", "How Blood-Disease Data Sent These 2 Biotech Stocks Flying", "Can Juno Therapeutics Outmaneuver Its CAR-T Competitors?", "See Which Of The Latest 13F Filers Holds Gilead Sciences", "The Zacks Analyst Blog Highlights: JPMorgan Chase, Gilead, ConocoPhillips, General Electric and Walgreens", "Ionis Down Big on Analyst Miss", "Notable Thursday Option Activity: VMC, GILD, MIC", "What's in the Cards for PFE, INCY and ACOR in Q3 Earnings?", "Nasdaq 100 Movers: JBHT, SHPG", "Company News For Oct 30, 2017", "How Celgene, Gilead's Pricing Woes Continue To Haunt Biotech Stocks", "Top Research Reports for JPMorgan Chase, Gilead & ConocoPhillips", "Gilead Sciences, Inc. (GILD) Stock Isn\u2019t Worth It Here", "5 Things You Need to Know From Gilead Sciences' Q3 Update", "iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow", "Validea Benjamin Graham Strategy Daily Upgrade Report - 10/28/2017", "Gilead (GILD) Down on Weak HCV Sales Despite Q3 Earnings Beat", "Dow Stock Merck, AbbVie Top Earnings Views, Light On Sales", "3 Stocks to Watch on Friday: Baidu Inc (ADR) (BIDU), Gilead Sciences, Inc. (GILD) and Mattel, Inc. (MAT)", "Daily Dividend Report: SPG, PFG, GILD, AGN, ITW", "Gilead Sciences, Inc. Stock Is a Buy When It Seems Like It Shouldn\u2019t Be", "Gilead Sciences, Inc. Stock Looks Good Regardless of Quarterly Earnings Report", "3 ETFs to Watch on Biotech Earnings", "Gilead (GILD) Q3 Earnings and Revenues Sink", "RSI Alert: Gilead Sciences Now Oversold", "Gilead Tops Sales, Profit Views But Misses On Hep C; Shares Fall", "5 Biotech Stocks That Are Getting Battered Too Hard for Comfort", "Earnings Reaction History: Gilead Sciences Inc., 66.7% Follow-Through Indicator, 4.8% Sensitive", "After-Hours Earnings Report for October 26, 2017 : MSFT, AMZN, GOOGL, INTC, GILD, BIDU, CB, SYK, WDC, FTV, CERN, EXPE", "Is a Beat in Store for Agenus (AGEN) This Earnings Season?", "Gilead Sciences Inc. Still Singing the HCV Blues in the 3rd Quarter", "Biotech Stock Roundup: Biogen Tops Q3 Earnings, Gilead's CAR T Drug Gets FDA Nod", "Noteworthy Wednesday Option Activity: GILD, WYN, ORLY", "Is a Beat in Store for Alexion (ALXN) This Earnings Season?", "Better Buy: Gilead Sciences, Inc. vs. Amgen", "3 Healthcare Value Stocks", "Why Agenus Inc. Stock Briefly Popped Today", "Is Gilead (GILD) Poised for a Beat This Earnings Season?", "Is a Surprise Coming for Gilead Sciences (GILD) This Earnings Season?", "Biotech Stock Roundup: Biogen Tops Q3 Earnings, Gilead's CAR T Drug Gets FDA Nod", "3 Things You Should Expect in Gilead Sciences' Q3 Results", "IBD's No. 1 Group Under Pressure; These 6 Key Earnings Loom; S&P 500 Futures", "What's in Store for BioMarin (BMRN) This Earnings Season?", "Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences", "Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval", "Gilead Sciences Shows Rising Relative Price Performance; Still Shy Of Key Threshold", "Gilead Drug Approval Fuels Interest in CAR-T Space: 3 Stocks to Consider", "iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow", "Nasdaq 100 Movers: CTRP, ADBE", "Does Gilead Now Have A New Multi-Billion-Dollar Franchise?", "Zacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna", "Gilead Slaps Mega-Price on Its Newly Approved CAR-T", "After Hours Most Active for Oct 19, 2017 : V, AAPL, CMCSA, BABA, PYPL, PFE, T, KW, GE, QQQ, ADBE, GILD", "S&P 500 Futures: These 5 Top Stocks Are Big Overnight Movers", "Sellers Come Into Nasdaq As Apple Lags; Another IPO Soars", "iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow", "Where to Find Value in Healthcare Stocks", "Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics", "IBD Biotech Innovator Awards", "Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field", "Notable Monday Option Activity: TGTX, GILD, RT", "Trump Likely To Sign Executive Order On Drug Pricing 'Any Day'", "Top Stock Reports for IBM, Celgene and Procter & Gamble", "Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen", "Bristol-Myers (BMY), TARGET Extend Partnership for NASH Study", "Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy", "3 Healthcare Value Stocks", "Why These Biotech Players Look Poised To Crush Earnings Views", "ANTIPODES PARTNERS Ltd Buys KT Corp, Michael Kors Holdings, Oracle Corp, Sells Dynegy Inc, ...", "This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due", "Exane Asset Management Buys AT&T Inc, Verizon Communications Inc, CNH Industrial NV, Sells ...", "5 Game-Changing Cancer Drug Innovations Being Developed Right Now", "Is AbbVie the Best Dividend Stock in Healthcare?", "Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow", "$50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much", "Horan Capital Management Buys TJX Inc, Chipotle Mexican Grill Inc, Nike Inc, Sells Berkshire ...", "Healthcare: Are These the Best Dividend Stocks to Buy Now?", "Bitcoin vs. Biotech: Which Is the Smarter Investment?", "Non-Alcoholic Steatohepatitis 2017 Progress Update", "This Dirt-Cheap Biotech Stock Is a Bargain to Buy", "Here's Why Juno Therapeutics Stock May Still Be Worth Buying", "Intercept Dives Along With Ocaliva Prescriptions On FDA Warning", "5 Stocks the Bull Market Left Behind", "Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now?", "Here's What's Has Happened in the HCV Space Lately", "5 Undervalued Stocks With Free Cash Flow to Burn", "AbbVie's Fast Becoming a Top Stock to Buy Now", "Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation", "5 ETF Picks for October", "Why bluebird bio, Inc. Stock Gained 10% in September", "Will Gilead & AbbVie Benefit from Merck's Decision to Drop Two HCV Programs?", "The 5 Best M&A Deals of 2017 (So Far!)", "Good News and Bad News for Gilead Sciences: Which Carries More Weight?", "Here's Why Bluebird Bio (BLUE) Stock Is Falling Today", "FXH, ALNY, ALGN, GILD: Large Inflows Detected at ETF", "Merck Drops Two HCV Combination Programs Amid Competition", "4 Biotech Stocks (and 1 ETF) to Buy As They Bolt Higher", "Best Buy: Johnson & Johnson, Pfizer, or Gilead Sciences?", "Keep Riding the GoPro Inc (GPRO) Stock Wave!", "Go Long Costco Wholesale Corporation (COST) Stock for Big-Time Gains", "Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back", "How Will Trump\u2019s Proposed Tax Reform Impact Drug Companies?", "Better Buy: Gilead Sciences, Inc. vs. Pfizer", "Gilead (GILD) Gets Approval for HCV Drug Sovaldi in China", "Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?", "Why Gilead Sciences, Pier 1 Imports, and PetMed Express Slumped Today", "Market Close Report: NASDAQ Composite index closes at 6,453.45 up .19 points", "Gilead Tumbles On Report HIV-Drug Whistleblower Case Reopened", "Noteworthy Thursday Option Activity: GILD, BMY, XOM", "Indexes Mixed, Apple And Gilead Down; Here Is The Threat To Autohome Stock", "Novartis Could Acquire This Biotech \u2014 Why A Deal Is 'Very Logical'", "Gilead (GILD) Gets Approval for HCV Drug Sovaldi in China", "Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?", "If Familiarity Breeds Contempt, What Do Debt And Complacency Breed?", "Noteworthy ETF Outflows: FTA, GPS, GILD, LEA", "Kite Pharma Triples So Far in 2017: What's Driving the Rally?", "Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues", "FDA Chief Gottlieb Addresses Opioids, Cancer, New Therapies", "Biotechs Beating The Market, But Are They In Buy Range?", "Biotech Stocks To Watch And Pharma Industry News", "Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?", "3 Big Biotech Stocks to Buy This Fall", "Juno Therapeutics Inc (JUNO) Stock: To Buy or Not to Buy?", "Oddly, Juno Therapeutics Is Jumping 11.3% Today", "Gilead's (GILD) Epclusa Receives Label Expansion in Canada", "Immunize Juno Therapeutics Inc (JUNO) Stock With This Trade", "3 Sector-Specific Trades to Start the Week Off Right", "First Week of May 2018 Options Trading For Gilead Sciences (GILD)", "Should Value Investors Consider Gilead Sciences (GILD) Stock?", "Yes, Juno Therapeutics (JUNO) Just Became a Great CAR-T Trade", "Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors", "3 Biotech Stocks That Are Just Getting Started", "Notable ETF Inflow Detected - MOAT, GILD, GWRE, VFC", "3 Value Stocks for Smart Investors", "3 Biotech Stocks With Major Catalysts Incoming", "3 Great Income Stocks That Could Double Their Dividends", "After Gilead Sciences, More Biotech M&A?", "3 Reasons Why Gilead Sciences Stock Is a Buy Now", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/15/2017", "3 Dividend Healthcare Stocks", "CAR-T Therapy FDA Approved - Slingshot Insights' Idea Of The Month", "Nasdaq 100 Movers: HSIC, CTRP", "Why Bellicum Pharmaceuticals Stock Is Rising Today", "4 Biotech Stocks That Show Promise on Sustainable Growth", "3 Pharma/Biotech Sector Bargains for a Healthy Portfolio", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2017", "3 Biotech Stocks That Have Already Quadrupled in 2017", "Is the Sell-Off of Intercept Pharmaceuticals Stock Overblown?", "Gilead Sciences, Inc.'s Best Investment of 2017 (Hint: It Wasn't Kite Pharmaceuticals)", "Ex-Dividend Reminder: Gilead Sciences, Hill-Rom Holdings and Owens & Minor", "Options Traders Expect Huge Moves in Gilead Sciences (GILD) Stock", "3 Stocks for Future Millionaires", "5 Top-Ranked Biotech Stocks to Buy Right Now", "5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition", "Top Stock Reports for Gilead, Oracle & Morgan Stanley", "The Move in SPDR S&P Biotech (ETF) (XBI) ETF Is Coming \u2014 Get on Board", "Why Exelixis, Inc. Could Be a Gold Mine for Growth Investors", "CAR-T Mania: Could Juno Therapeutics Get Acquired Next?", "The Zacks Analyst Blog Highlights: Gilead, Oracle, Morgan Stanley, Expedia and Kroger", "3 Stocks for Future Millionaires", "Top Ranked Income Stocks to Buy for September 8th", "After Hours Most Active for Sep 8, 2017 : KNX, AAPL, IUSG, IUSV, QQQ, VIPS, ITUB, CHK, GILD, JBLU, T, XOM", "4 Biotech Stocks to Improve Your Portfolio\u2019s Health", "5 Things You'll Want to Know From Celgene Corporation's Latest Presentation", "5 Things Gilead Sciences' Management Just Said That You'll Want to Know", "Kymriah, First CAR-T Therapy Approved: 4 Pharma Stocks in Focus", "Noteworthy ETF Outflows: ITOT, GILD, SLB, CVS", "Buy These 5 Large Caps on Extraordinary ROI Potential", "Mallinckrodt Down as District Court Invalidates Inomax Patents", "Here's What Lifted bluebird bio Inc. Stock 40% Higher in August", "Why Kite Pharma Soared 64.8% in August", "The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Activision Blizzard, Intuit, Alexion Pharmaceuticals and Gilead Sciences", "Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better", "Are These Healthcare Stocks Top Takeover Targets?", "Are You Buying Gilead Sciences, Inc. for the Wrong Reason?", "4 Biotech Stocks to Improve Your Portfolio's Health", "The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500", "Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson", "Here's the Best Dividend Stock in Big Pharma", "Why Gilead Sciences Shares Soared 10.6% in August", "3 Biotech Stocks That Skyrocketed This Week", "Biotech Stocks Back in Favor: Will the Rally Continue?", "Friday\u2019s Vital Data: Apple Inc. (AAPL), Advanced Micro Devices, Inc. (AMD) and Gilead Sciences, Inc. (GILD)", "3 Reasons Gilead Sciences Jumped to Buy Kite Pharma", "5 Winning Stocks to Beat September Blues", "Valeant (VRX) Continues to Lose Ground: Can It Bounce Back?", "Gilead Sciences\u2019 Oncology M&A Strategy Explained", "You Reached Retirement: 3 Stocks to Consider Today", "Wonder Why Gilead Sciences Bought Kite Pharma? Here\u2019s the Answer!", "Gilead Buys Kite, the Future of CAR-T, and A Visit to the New Whole Foods", "Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval", "Stock Market News For August 31, 2017", "Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences", "Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update", "After Hours Most Active for Aug 31, 2017 : DOW, DD, SBAC, BAC, QQQ, MSFT, TEVA, PFE, GE, AMAT, GILD, INTC", "Why bluebird bio Inc Continued Its March Higher Again Today", "Could Gilead Sciences Stock Skyrocket 25%? 1 Analyst Thinks So", "Thursday's ETF with Unusual Volume: BBH", "Zacks.com featured highlights Broadcom, CBRE Group, Sandvik, Applied Materials and Gilead Sciences", "Juno/Bluebird Hot Acquisition Targets After Kite/Gilead Deal", "The Zacks Analyst Blog Highlights: Gilead Sciences, Kite Pharma, AbbVie's and Novartis AG", "Gilead (GILD) Up 2.1% Since Earnings Report: Can It Continue?", "Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?", "Why Analog Devices, Gilead Sciences, and Universal Display Jumped Today", "5 Biotech Stocks That Are Breaking Higher", "Wednesday's ETF with Unusual Volume: PKW", "Amgen Presents New Repatha Analysis from FOURIER Study", "Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow", "Company News For August 29, 2017", "Can Gilead Sciences Squeeze $12 Billion From Kite Pharma?", "5 Top ROE Stocks to Buy as Hurricane Harvey Wreaks Havoc", "Here's What Else Gilead Sciences Gets by Buying Kite Pharma", "Indecision Won't Kill You, But It Will Take Your Money", "Why Novatis' $475K CAR-T Cancer Treatment Is Actually Cheap", "Gilead to Fly High with Kite Pharma Acquisition for $11.9B", "Juno Therapeutics (JUNO) Continues Gains After Gilead-Kite Acquisition", "Why Juno Therapeutics Stock Is Blasting Off Today", "UQM Technologies, Kite Pharma Jump on Monday", "Midday Update: Sectors Split As Hurricane Harvey's Impact Spreads Through Wall Street", "Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?", "3 Reasons to Applaud Gilead Sciences' Acquisition of Kite Pharma", "Get Ready for More Acquisitions by Gilead Sciences", "Health Care Sector Update for 08/28/2017: JNJ, PFE, ABT, MRK, AMGN, KITE, GILD, AVEO, NVS", "Morning Movers: Gilead Jumps on Kite Acquisition; Expedia Drops as CEO Leaves for Uber", "Pre-Market Most Active for Aug 28, 2017 : KITE, WFM, GILD, JUNO, TVIX, MYCC, QQQ, FCAU, BHP, Q, DB, BABA", "Roche's Gazyva Gets Priority Review for Follicular Lymphoma", "AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting", "Close Update: Shares Mixed As Hurricane Batters Energy Sector, Underpins Construction, Home Improvement Stocks", "Novartis Announces Positive Data on Cardiovascular Drug", "Stock Futures Perk Up Despite Potential Economic Damage From Hurricane", "Health Care Sector Update for 08/28/2017: JNJ, PFE, ABT, MRK, AMGN, KITE, GILD, AVEO, NVS", "Why Did Kite Pharma (KITE) Stock Skyrocket Today?", "Gilead's Plan? Cash In on CAR-T", "Why I Love AbbVie Inc.", "Novartis (NVS) Receives EC Approval for Breast Cancer Drug", "Will Endo (ENDP) Continue to Disappoint Investors in 2017?", "Why Thor Industries, IXYS Corporation, and Kite Pharma Jumped Today", "Roche (RHHBY) Hemophilia A Drug Granted Priority Review", "Top Ranked Income Stocks to Buy for August 24th", "Pfizer's Ibrance in First-Line Combo Breast Cancer Study", "Are Glaxo's Successful New Drugs Enough to Drive Growth?", "3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences", "Noteworthy ETF Outflows: FXH, ALGN, CNC, GILD", "Alkermes Initiates Rolling Submission of Depression Drug", "Why I'm Hanging On to a Loser", "Roche (RHHBY) Hemophilia A Drug Granted Priority Review", "3 Value Stocks for Smart Investors", "Monday's ETF with Unusual Volume: BBH", "AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada", "Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada", "Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning", "Mylan Finalizes Settlement Agreement with DOJ for $465M", "4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings", "3 Value Stocks for Retirees", "Falling Earnings Estimates Signal Weakness Ahead for Mylan (MYL)", "Sterneck Capital Management, LLC Buys CorEnergy Infrastructure Trust Inc, Chicago Bridge & ...", "Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Review", "Regeneron's (REGN) RSV Drug Suptavumab Fails NURSERY Trial", "Chiron Investment Management, LLC Buys iShares iBoxx $ Investment Grade Corporate Bond, Gilead ...", "Zacks.com featured highlights: Coca-Cola FEMSA, Banco Bilbao Vizcaya Argentaria, Lantheus Holdings, Gilead Sciences and Lam Research", "Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2017", "Zacks.com featured highlights: Broadcom Limited, CBRE Group, Sandvik AB, Applied Materials and Gilead Sciences", "Gilead (GILD) NDA for HIV Combo Regimen Gets Priority Review", "3 Healthcare Stocks That Are Looking Cheap Right Now", "5 Discounted PEG Stocks for GARP Investors", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2017", "Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?", "Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak", "Forget Teva (TEVA), Buy These 4 Drug Stocks Instead", "Markets Remain Choppy on Continuing Conflicts: 5 Top Picks", "Bb Biotech Ag Buys AveXis Inc, Sells Regeneron Pharmaceuticals Inc, Puma Biotechnology Inc, PTC ...", "Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss", "Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment", "After Hours Most Active for Aug 9, 2017 : VG, ABEV, GGB, T, COR, QQQ, BRCD, MOMO, ODP, ADP, NEE, GILD", "Validea David Dreman Strategy Daily Upgrade Report - 8/9/2017", "iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow", "Forget Bayer, Buy These 3 Drug Stocks Instead", "Pioneer Investments Buys Citigroup, Berkshire, Gilead", "Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak", "Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More", "These 3 Biotechs Just Crushed Analyst Expectations", "Top Ranked Momentum Stocks to Buy for August 7th", "Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View", "Is AbbVie About to Deliver a Blow to Gilead Sciences' Guidance?", "Celgene vs. Gilead Sciences: Who Reported Better Earnings?", "Infinity (INFI) Q2 Loss Wider than Expected, View Intact", "Radius (RDUS) Q2 Loss Wider than Expected on Higher Expenses", "Domini Social Investments LLC Buys First Solar Inc, SunPower Corp, Sells Sunrun Inc, Fitbit Inc", "ITOT, MDT, GILD, SLB: Large Inflows Detected at ETF", "Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons", "10 Reasons Cancer Drugs Usually Cost $100,000 or More a Year", "3 \u201cStrong Buy\u201d High-Yield Dividend Stocks", "Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2", "Top Ranked Income Stocks to Buy for August 2nd", "Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote", "3 ETFs to Watch Out for on Biotech Earnings", "Intercept (ICPT) Posts Narrower-than-Expected Loss in Q2", "Gilead Sciences a Top 25 Dividend Giant With 2.74% Yield (GILD)", "Regeneron (REGN) Beats on Q2 Earnings & Sales, Raises View", "5 Things Gilead Sciences' Q2 Earnings Numbers Didn't Tell You", "United Therapeutics (UTHR) Incurs Loss in Q2, Sales Top", "4 Drug Stocks in Focus this World Hepatitis Day", "Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally", "Whoops! Twitter Inc (TWTR) Stock Tanks as User Growth Vanishes", "Score Hot Profits on a Netflix, Inc. (NFLX) Stock Cooldown", "3 Stocks to Watch on Thursday: Buffalo Wild Wings (BWLD), Gilead Sciences, Inc. (GILD) and PayPal Holdings Inc (PYPL)", "General American Investors Co Inc Buys Oracle Corp, NOW Inc, eBay Inc, Sells Imax Corp, ...", "Validea Benjamin Graham Strategy Daily Upgrade Report - 7/27/2017", "Daily Dividend Report: SU, MCK, SYF, CVX, CMCSA, GILD, UNP", "VOO, MDT, GILD, BMY: Large Outflows Detected at ETF", "Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug", "Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense", "Gilead Sciences, Inc. Boosts Its Full-Year Outlook Thanks to Stronger-Than-Expected Hep C Sales", "Gilead (GILD) Shares Pop on Q2 Earnings and Revenue Beats", "Gilead (GILD) Tops Q2 Earnings& Revenue Estimates, Stock Up", "After-Hours Earnings Report for July 26, 2017 : FB, GILD, PYPL, SU, LVS, VRTX, PSA, LRCX, EW, DFS, ABX, NOW", "Can Intercept (ICPT) Beat Estimates this Earnings Season?", "Will Radius Health (RDUS) Disappoint this Earnings Season?", "Is a Surprise Coming for Gilead Sciences (GILD) This Earnings Season?", "3 Dividend Stocks That Thrive in Bear Markets", "Gilead Sciences, Inc. (GILD) Stock Is a 2-for-1 Deal", "Is a Beat in Store for Agenus (AGEN) this Earnings Season?", "Earnings Reaction History: Gilead Sciences Inc., 72.7% Follow-Through Indicator, 5.1% Sensitive", "Better Buy: Celgene Corporation vs. Gilead Sciences, Inc.", "Better Buy: AbbVie Inc. vs. Johnson & Johnson", "What to Expect from Keryx (KERX) this Earnings Season?", "What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?", "HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates?", "Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?", "Warren Buffett's Net Worth Would Be $100 Billion Right Now if Not for This"], "Elapsed Time": ["19 HOURS AGO", "19 HOURS AGO", "21 HOURS AGO", "23 HOURS AGO", "1 DAY AGO", "1 DAY AGO", "1 DAY AGO", "2 DAYS AGO", "19 HOURS AGO", "2 DAYS AGO", "3 DAYS AGO", "3 DAYS AGO", "3 DAYS AGO", "3 DAYS AGO", "3 DAYS AGO", "3 DAYS AGO", "2 DAYS AGO", "3 DAYS AGO", "4 DAYS AGO", "4 DAYS AGO", "4 DAYS AGO", "4 DAYS AGO", "4 DAYS AGO", "5 DAYS AGO", "3 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "5 DAYS AGO", "6 DAYS AGO", "6 DAYS AGO", "6 DAYS AGO", "5 DAYS AGO", "JUN 6, 2020", "JUN 4, 2020", "JUN 4, 2020", "JUN 4, 2020", "JUN 4, 2020", "JUN 4, 2020", "JUN 4, 2020", "6 DAYS AGO", "JUN 4, 2020", "JUN 4, 2020", "JUN 4, 2020", "JUN 3, 2020", "JUN 3, 2020", "JUN 3, 2020", "JUN 3, 2020", "JUN 4, 2020", "JUN 3, 2020", "JUN 3, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 3, 2020", "JUN 2, 2020", "JUN 2, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 2, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "JUN 1, 2020", "MAY 31, 2020", "MAY 30, 2020", "JUN 1, 2020", "MAY 29, 2020", "MAY 29, 2020", "MAY 29, 2020", "MAY 29, 2020", "MAY 29, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 29, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 27, 2020", "MAY 27, 2020", "MAY 27, 2020", "MAY 28, 2020", "MAY 27, 2020", "MAY 27, 2020", "MAY 27, 2020", "MAY 26, 2020", "MAY 26, 2020", "MAY 26, 2020", "MAY 26, 2020", "MAY 27, 2020", "MAY 26, 2020", "MAY 26, 2020", "MAY 26, 2020", "MAY 26, 2020", "MAY 24, 2020", "MAY 23, 2020", "MAY 23, 2020", "MAY 26, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 22, 2020", "MAY 21, 2020", "MAY 20, 2020", "MAY 20, 2020", "MAY 20, 2020", "MAY 20, 2020", "MAY 20, 2020", "MAY 20, 2020", "MAY 21, 2020", "MAY 20, 2020", "MAY 19, 2020", "MAY 19, 2020", "MAY 19, 2020", "MAY 18, 2020", "MAY 18, 2020", "MAY 18, 2020", "MAY 20, 2020", "MAY 18, 2020", "MAY 17, 2020", "MAY 17, 2020", "MAY 16, 2020", "MAY 16, 2020", "MAY 15, 2020", "MAY 15, 2020", "MAY 18, 2020", "MAY 14, 2020", "MAY 14, 2020", "MAY 14, 2020", "MAY 14, 2020", "MAY 14, 2020", "MAY 14, 2020", "MAY 13, 2020", "MAY 14, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 12, 2020", "MAY 12, 2020", "MAY 12, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 12, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 10, 2020", "MAY 10, 2020", "MAY 9, 2020", "MAY 8, 2020", "MAY 11, 2020", "MAY 8, 2020", "MAY 8, 2020", "MAY 8, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 8, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 7, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 6, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 5, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 3, 2020", "MAY 2, 2020", "MAY 2, 2020", "MAY 2, 2020", "MAY 1, 2020", "MAY 4, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 1, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "MAY 1, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 30, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "APR 28, 2020", "APR 28, 2020", "APR 28, 2020", "APR 27, 2020", "APR 27, 2020", "APR 27, 2020", "APR 29, 2020", "APR 27, 2020", "APR 27, 2020", "APR 27, 2020", "APR 27, 2020", "APR 27, 2020", "APR 26, 2020", "APR 26, 2020", "APR 27, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 25, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 24, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 24, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 23, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 23, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 21, 2020", "APR 20, 2020", "APR 20, 2020", "APR 20, 2020", "APR 22, 2020", "APR 20, 2020", "APR 20, 2020", "APR 20, 2020", "APR 20, 2020", "APR 20, 2020", "APR 20, 2020", "APR 19, 2020", "APR 20, 2020", "APR 19, 2020", "APR 19, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 19, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 16, 2020", "APR 15, 2020", "APR 15, 2020", "APR 15, 2020", "APR 16, 2020", "APR 15, 2020", "APR 15, 2020", "APR 15, 2020", "APR 14, 2020", "APR 14, 2020", "APR 13, 2020", "APR 13, 2020", "APR 15, 2020", "APR 13, 2020", "APR 13, 2020", "APR 13, 2020", "APR 13, 2020", "APR 13, 2020", "APR 13, 2020", "APR 13, 2020", "APR 13, 2020", "APR 12, 2020", "APR 12, 2020", "APR 11, 2020", "APR 11, 2020", "APR 11, 2020", "APR 9, 2020", "APR 9, 2020", "APR 13, 2020", "APR 9, 2020", "APR 9, 2020", "APR 9, 2020", "APR 8, 2020", "APR 8, 2020", "APR 8, 2020", "APR 8, 2020", "APR 9, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 7, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 7, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 5, 2020", "APR 5, 2020", "APR 5, 2020", "APR 5, 2020", "APR 5, 2020", "APR 4, 2020", "APR 6, 2020", "APR 4, 2020", "APR 3, 2020", "APR 3, 2020", "APR 3, 2020", "APR 3, 2020", "APR 3, 2020", "APR 3, 2020", "APR 4, 2020", "APR 2, 2020", "APR 2, 2020", "APR 2, 2020", "APR 2, 2020", "MAR 31, 2020", "MAR 31, 2020", "MAR 31, 2020", "APR 2, 2020", "MAR 30, 2020", "MAR 30, 2020", "MAR 30, 2020", "MAR 29, 2020", "MAR 29, 2020", "MAR 29, 2020", "MAR 28, 2020", "MAR 30, 2020", "MAR 27, 2020", "MAR 27, 2020", "MAR 27, 2020", "MAR 27, 2020", "MAR 26, 2020", "MAR 26, 2020", "MAR 26, 2020", "MAR 27, 2020", "MAR 26, 2020", "MAR 26, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 26, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 24, 2020", "MAR 24, 2020", "MAR 24, 2020", "MAR 24, 2020", "MAR 25, 2020", "MAR 24, 2020", "MAR 23, 2020", "MAR 23, 2020", "MAR 23, 2020", "MAR 23, 2020", "MAR 22, 2020", "MAR 21, 2020", "MAR 24, 2020", "MAR 20, 2020", "MAR 20, 2020", "MAR 20, 2020", "MAR 20, 2020", "MAR 20, 2020", "MAR 19, 2020", "MAR 19, 2020", "MAR 21, 2020", "MAR 19, 2020", "MAR 19, 2020", "MAR 19, 2020", "MAR 19, 2020", "MAR 19, 2020", "MAR 18, 2020", "MAR 18, 2020", "MAR 19, 2020", "MAR 18, 2020", "MAR 17, 2020", "MAR 17, 2020", "MAR 17, 2020", "MAR 17, 2020", "MAR 16, 2020", "MAR 18, 2020", "MAR 18, 2020", "MAR 16, 2020", "MAR 16, 2020", "MAR 15, 2020", "MAR 15, 2020", "MAR 14, 2020", "MAR 13, 2020", "MAR 16, 2020", "MAR 12, 2020", "MAR 12, 2020", "MAR 12, 2020", "MAR 11, 2020", "MAR 11, 2020", "MAR 11, 2020", "MAR 11, 2020", "MAR 13, 2020", "MAR 11, 2020", "MAR 11, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 11, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 10, 2020", "MAR 9, 2020", "MAR 9, 2020", "MAR 10, 2020", "MAR 9, 2020", "MAR 9, 2020", "MAR 9, 2020", "MAR 9, 2020", "MAR 9, 2020", "MAR 9, 2020", "MAR 8, 2020", "MAR 9, 2020", "MAR 8, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 8, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 3, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 2, 2020", "MAR 1, 2020", "MAR 1, 2020", "MAR 1, 2020", "MAR 1, 2020", "MAR 1, 2020", "FEB 29, 2020", "FEB 29, 2020", "MAR 2, 2020", "FEB 29, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 29, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 28, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 26, 2020", "FEB 24, 2020", "FEB 24, 2020", "FEB 24, 2020", "FEB 24, 2020", "FEB 24, 2020", "FEB 24, 2020", "FEB 22, 2020", "FEB 24, 2020", "FEB 21, 2020", "FEB 21, 2020", "FEB 20, 2020", "FEB 20, 2020", "FEB 19, 2020", "FEB 19, 2020", "FEB 18, 2020", "FEB 22, 2020", "FEB 18, 2020", "FEB 18, 2020", "FEB 18, 2020", "FEB 18, 2020", "FEB 17, 2020", "FEB 16, 2020", "FEB 15, 2020", "FEB 18, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 12, 2020", "FEB 12, 2020", "FEB 12, 2020", "FEB 12, 2020", "FEB 14, 2020", "FEB 12, 2020", "FEB 11, 2020", "FEB 11, 2020", "FEB 11, 2020", "FEB 11, 2020", "FEB 10, 2020", "FEB 10, 2020", "FEB 12, 2020", "FEB 10, 2020", "FEB 10, 2020", "FEB 10, 2020", "FEB 9, 2020", "FEB 8, 2020", "FEB 7, 2020", "FEB 7, 2020", "FEB 10, 2020", "FEB 6, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 7, 2020", "FEB 5, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 3, 2020", "FEB 3, 2020", "FEB 3, 2020", "FEB 3, 2020", "FEB 4, 2020", "FEB 3, 2020", "FEB 3, 2020", "FEB 3, 2020", "FEB 2, 2020", "JAN 30, 2020", "JAN 29, 2020", "JAN 29, 2020", "FEB 3, 2020", "JAN 26, 2020", "JAN 26, 2020", "JAN 25, 2020", "JAN 24, 2020", "JAN 24, 2020", "JAN 23, 2020", "JAN 23, 2020", "JAN 27, 2020", "JAN 23, 2020", "JAN 21, 2020", "JAN 14, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 23, 2020", "JAN 10, 2020", "JAN 9, 2020", "JAN 5, 2020", "JAN 3, 2020", "JAN 3, 2020", "DEC 31, 2019", "DEC 30, 2019", "JAN 11, 2020", "DEC 29, 2019", "DEC 27, 2019", "DEC 24, 2019", "DEC 24, 2019", "DEC 23, 2019", "DEC 23, 2019", "DEC 22, 2019", "DEC 30, 2019", "DEC 20, 2019", "DEC 20, 2019", "DEC 19, 2019", "DEC 18, 2019", "DEC 17, 2019", "DEC 17, 2019", "DEC 16, 2019", "DEC 21, 2019", "DEC 16, 2019", "DEC 15, 2019", "DEC 14, 2019", "DEC 13, 2019", "DEC 11, 2019", "DEC 11, 2019", "DEC 11, 2019", "DEC 16, 2019", "DEC 10, 2019", "DEC 9, 2019", "DEC 5, 2019", "NOV 27, 2019", "NOV 26, 2019", "NOV 25, 2019", "NOV 24, 2019", "DEC 10, 2019", "NOV 24, 2019", "NOV 22, 2019", "NOV 21, 2019", "NOV 20, 2019", "NOV 14, 2019", "NOV 14, 2019", "NOV 14, 2019", "NOV 24, 2019", "NOV 12, 2019", "NOV 11, 2019", "NOV 8, 2019", "NOV 8, 2019", "NOV 7, 2019", "NOV 6, 2019", "NOV 6, 2019", "NOV 13, 2019", "NOV 4, 2019", "NOV 1, 2019", "OCT 30, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 28, 2019", "OCT 27, 2019", "NOV 5, 2019", "OCT 25, 2019", "OCT 25, 2019", "OCT 25, 2019", "OCT 25, 2019", "OCT 25, 2019", "OCT 24, 2019", "OCT 24, 2019", "OCT 26, 2019", "OCT 22, 2019", "OCT 15, 2019", "OCT 15, 2019", "OCT 13, 2019", "OCT 12, 2019", "OCT 11, 2019", "OCT 11, 2019", "OCT 24, 2019", "OCT 10, 2019", "OCT 9, 2019", "OCT 8, 2019", "OCT 7, 2019", "OCT 4, 2019", "OCT 2, 2019", "OCT 10, 2019", "SEP 27, 2019", "SEP 27, 2019", "SEP 26, 2019", "SEP 25, 2019", "SEP 25, 2019", "SEP 24, 2019", "SEP 23, 2019", "SEP 29, 2019", "SEP 21, 2019", "SEP 20, 2019", "SEP 18, 2019", "SEP 17, 2019", "SEP 15, 2019", "SEP 14, 2019", "SEP 12, 2019", "SEP 22, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 10, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 4, 2019", "SEP 11, 2019", "SEP 1, 2019", "AUG 28, 2019", "AUG 28, 2019", "AUG 26, 2019", "AUG 19, 2019", "AUG 16, 2019", "AUG 12, 2019", "SEP 1, 2019", "AUG 8, 2019", "AUG 8, 2019", "AUG 8, 2019", "AUG 8, 2019", "AUG 6, 2019", "AUG 6, 2019", "AUG 6, 2019", "AUG 11, 2019", "AUG 1, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 30, 2019", "AUG 5, 2019", "JUL 29, 2019", "JUL 29, 2019", "JUL 28, 2019", "JUL 25, 2019", "JUL 24, 2019", "JUL 23, 2019", "JUL 20, 2019", "JUL 30, 2019", "JUL 19, 2019", "JUL 19, 2019", "JUL 18, 2019", "JUL 17, 2019", "JUL 17, 2019", "JUL 16, 2019", "JUL 15, 2019", "JUL 19, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 15, 2019", "JUL 11, 2019", "JUL 8, 2019", "JUL 8, 2019", "JUL 8, 2019", "JUL 3, 2019", "JUL 1, 2019", "JUN 27, 2019", "JUL 15, 2019", "JUN 25, 2019", "JUN 20, 2019", "JUN 19, 2019", "JUN 18, 2019", "JUN 18, 2019", "JUN 18, 2019", "JUN 17, 2019", "JUN 25, 2019", "JUN 16, 2019", "JUN 14, 2019", "JUN 12, 2019", "JUN 11, 2019", "JUN 9, 2019", "JUN 6, 2019", "JUN 5, 2019", "JUN 17, 2019", "MAY 28, 2019", "MAY 28, 2019", "MAY 28, 2019", "MAY 28, 2019", "MAY 23, 2019", "MAY 23, 2019", "JUN 4, 2019", "MAY 19, 2019", "MAY 17, 2019", "MAY 15, 2019", "MAY 12, 2019", "MAY 8, 2019", "MAY 7, 2019", "MAY 6, 2019", "MAY 19, 2019", "MAY 3, 2019", "MAY 3, 2019", "MAY 3, 2019", "MAY 2, 2019", "MAY 2, 2019", "MAY 2, 2019", "MAY 5, 2019", "MAY 2, 2019", "MAY 2, 2019", "MAY 1, 2019", "APR 30, 2019", "APR 27, 2019", "APR 27, 2019", "APR 25, 2019", "MAY 2, 2019", "APR 22, 2019", "APR 19, 2019", "APR 18, 2019", "APR 18, 2019", "APR 17, 2019", "APR 16, 2019", "APR 16, 2019", "APR 23, 2019", "APR 15, 2019", "APR 15, 2019", "APR 15, 2019", "APR 14, 2019", "APR 13, 2019", "APR 12, 2019", "APR 16, 2019", "APR 11, 2019", "APR 9, 2019", "APR 9, 2019", "APR 8, 2019", "APR 8, 2019", "APR 7, 2019", "APR 2, 2019", "APR 11, 2019", "APR 1, 2019", "APR 1, 2019", "APR 1, 2019", "MAR 29, 2019", "MAR 29, 2019", "MAR 29, 2019", "MAR 29, 2019", "APR 2, 2019", "MAR 29, 2019", "MAR 28, 2019", "MAR 27, 2019", "MAR 25, 2019", "MAR 24, 2019", "MAR 22, 2019", "MAR 22, 2019", "MAR 29, 2019", "MAR 21, 2019", "MAR 19, 2019", "MAR 18, 2019", "MAR 18, 2019", "MAR 18, 2019", "MAR 17, 2019", "MAR 14, 2019", "MAR 22, 2019", "MAR 13, 2019", "MAR 13, 2019", "MAR 9, 2019", "MAR 8, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 7, 2019", "MAR 14, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 6, 2019", "MAR 1, 2019", "MAR 1, 2019", "FEB 27, 2019", "FEB 23, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 21, 2019", "MAR 3, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 17, 2019", "FEB 15, 2019", "FEB 14, 2019", "FEB 20, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 14, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 10, 2019", "FEB 10, 2019", "FEB 8, 2019", "FEB 7, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 11, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 5, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 1, 2019", "JAN 31, 2019", "FEB 4, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 24, 2019", "JAN 31, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 22, 2019", "JAN 22, 2019", "JAN 19, 2019", "JAN 18, 2019", "JAN 24, 2019", "JAN 17, 2019", "JAN 17, 2019", "JAN 16, 2019", "JAN 11, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 8, 2019", "JAN 17, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 6, 2019", "JAN 8, 2019", "JAN 4, 2019", "JAN 3, 2019", "JAN 2, 2019", "DEC 28, 2018", "DEC 28, 2018", "DEC 26, 2018", "DEC 26, 2018", "JAN 6, 2019", "DEC 24, 2018", "DEC 24, 2018", "DEC 23, 2018", "DEC 21, 2018", "DEC 21, 2018", "DEC 21, 2018", "DEC 20, 2018", "DEC 24, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 19, 2018", "DEC 19, 2018", "DEC 19, 2018", "DEC 20, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 17, 2018", "DEC 17, 2018", "DEC 16, 2018", "DEC 18, 2018", "DEC 15, 2018", "DEC 14, 2018", "DEC 14, 2018", "DEC 13, 2018", "DEC 13, 2018", "DEC 13, 2018", "DEC 12, 2018", "DEC 16, 2018", "DEC 12, 2018", "DEC 12, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 10, 2018", "DEC 10, 2018", "DEC 12, 2018", "DEC 10, 2018", "DEC 9, 2018", "DEC 7, 2018", "DEC 7, 2018", "DEC 5, 2018", "DEC 4, 2018", "DEC 4, 2018", "DEC 10, 2018", "DEC 3, 2018", "DEC 3, 2018", "DEC 3, 2018", "NOV 30, 2018", "NOV 30, 2018", "NOV 29, 2018", "NOV 29, 2018", "DEC 3, 2018", "NOV 29, 2018", "NOV 28, 2018", "NOV 28, 2018", "NOV 28, 2018", "NOV 28, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 29, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 26, 2018", "NOV 26, 2018", "NOV 25, 2018", "NOV 23, 2018", "NOV 27, 2018", "NOV 21, 2018", "NOV 21, 2018", "NOV 20, 2018", "NOV 20, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 21, 2018", "NOV 16, 2018", "NOV 16, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 14, 2018", "NOV 14, 2018", "NOV 14, 2018", "NOV 18, 2018", "NOV 12, 2018", "NOV 12, 2018", "NOV 12, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 8, 2018", "NOV 8, 2018", "NOV 13, 2018", "NOV 8, 2018", "NOV 7, 2018", "NOV 5, 2018", "NOV 5, 2018", "NOV 5, 2018", "NOV 3, 2018", "NOV 2, 2018", "NOV 8, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 1, 2018", "NOV 1, 2018", "NOV 1, 2018", "NOV 1, 2018", "NOV 2, 2018", "OCT 31, 2018", "OCT 31, 2018", "OCT 31, 2018", "OCT 31, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 29, 2018", "OCT 31, 2018", "OCT 29, 2018", "OCT 29, 2018", "OCT 29, 2018", "OCT 27, 2018", "OCT 27, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 29, 2018", "OCT 29, 2018", "OCT 26, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 26, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 25, 2018", "OCT 22, 2018", "OCT 18, 2018", "OCT 18, 2018", "OCT 18, 2018", "OCT 16, 2018", "OCT 16, 2018", "OCT 16, 2018", "OCT 22, 2018", "OCT 15, 2018", "OCT 12, 2018", "OCT 12, 2018", "OCT 10, 2018", "OCT 10, 2018", "OCT 10, 2018", "OCT 9, 2018", "OCT 16, 2018", "OCT 5, 2018", "OCT 5, 2018", "OCT 4, 2018", "OCT 4, 2018", "OCT 4, 2018", "OCT 4, 2018", "OCT 4, 2018", "OCT 5, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 2, 2018", "OCT 1, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 27, 2018", "OCT 3, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 27, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 23, 2018", "SEP 21, 2018", "SEP 21, 2018", "SEP 21, 2018", "SEP 25, 2018", "SEP 20, 2018", "SEP 20, 2018", "SEP 20, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 20, 2018", "SEP 18, 2018", "SEP 18, 2018", "SEP 18, 2018", "SEP 18, 2018", "SEP 18, 2018", "SEP 17, 2018", "SEP 17, 2018", "SEP 19, 2018", "SEP 14, 2018", "SEP 14, 2018", "SEP 14, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 16, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 10, 2018", "SEP 10, 2018", "SEP 10, 2018", "SEP 12, 2018", "SEP 7, 2018", "SEP 7, 2018", "SEP 7, 2018", "SEP 7, 2018", "SEP 6, 2018", "SEP 6, 2018", "SEP 6, 2018", "SEP 10, 2018", "SEP 6, 2018", "SEP 6, 2018", "SEP 5, 2018", "SEP 5, 2018", "SEP 5, 2018", "SEP 4, 2018", "SEP 4, 2018", "SEP 6, 2018", "SEP 4, 2018", "SEP 3, 2018", "SEP 2, 2018", "AUG 31, 2018", "AUG 31, 2018", "AUG 31, 2018", "AUG 31, 2018", "SEP 4, 2018", "AUG 31, 2018", "AUG 31, 2018", "AUG 30, 2018", "AUG 30, 2018", "AUG 30, 2018", "AUG 30, 2018", "AUG 30, 2018", "AUG 31, 2018", "AUG 29, 2018", "AUG 29, 2018", "AUG 29, 2018", "AUG 28, 2018", "AUG 28, 2018", "AUG 28, 2018", "AUG 28, 2018", "AUG 29, 2018", "AUG 27, 2018", "AUG 27, 2018", "AUG 27, 2018", "AUG 27, 2018", "AUG 27, 2018", "AUG 24, 2018", "AUG 24, 2018", "AUG 28, 2018", "AUG 24, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 22, 2018", "AUG 24, 2018", "AUG 22, 2018", "AUG 22, 2018", "AUG 22, 2018", "AUG 21, 2018", "AUG 21, 2018", "AUG 21, 2018", "AUG 21, 2018", "AUG 22, 2018", "AUG 20, 2018", "AUG 20, 2018", "AUG 20, 2018", "AUG 20, 2018", "AUG 19, 2018", "AUG 17, 2018", "AUG 17, 2018", "AUG 21, 2018", "AUG 20, 2018", "AUG 17, 2018", "AUG 17, 2018", "AUG 16, 2018", "AUG 16, 2018", "AUG 16, 2018", "AUG 16, 2018", "AUG 17, 2018", "AUG 15, 2018", "AUG 15, 2018", "AUG 14, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 15, 2018", "AUG 10, 2018", "AUG 10, 2018", "AUG 10, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 10, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 7, 2018", "AUG 6, 2018", "AUG 6, 2018", "AUG 6, 2018", "AUG 3, 2018", "AUG 8, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 2, 2018", "AUG 2, 2018", "AUG 2, 2018", "AUG 3, 2018", "AUG 1, 2018", "AUG 1, 2018", "JUL 31, 2018", "JUL 31, 2018", "JUL 30, 2018", "JUL 29, 2018", "JUL 27, 2018", "AUG 1, 2018", "JUL 27, 2018", "JUL 27, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 27, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 24, 2018", "JUL 20, 2018", "JUL 20, 2018", "JUL 20, 2018", "JUL 19, 2018", "JUL 19, 2018", "JUL 18, 2018", "JUL 16, 2018", "JUL 22, 2018", "JUL 15, 2018", "JUL 14, 2018", "JUL 12, 2018", "JUL 11, 2018", "JUL 11, 2018", "JUL 11, 2018", "JUL 10, 2018", "JUL 15, 2018", "JUL 10, 2018", "JUL 9, 2018", "JUL 9, 2018", "JUL 9, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 5, 2018", "JUL 10, 2018", "JUL 3, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUN 29, 2018", "JUN 27, 2018", "JUN 26, 2018", "JUN 26, 2018", "JUL 3, 2018", "JUN 25, 2018", "JUN 25, 2018", "JUN 25, 2018", "JUN 25, 2018", "JUN 20, 2018", "JUN 20, 2018", "JUN 19, 2018", "JUN 25, 2018", "JUN 17, 2018", "JUN 17, 2018", "JUN 15, 2018", "JUN 15, 2018", "JUN 14, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 18, 2018", "JUN 13, 2018", "JUN 12, 2018", "JUN 12, 2018", "JUN 11, 2018", "JUN 11, 2018", "JUN 7, 2018", "JUN 6, 2018", "JUN 13, 2018", "JUN 6, 2018", "JUN 6, 2018", "JUN 4, 2018", "JUN 3, 2018", "JUN 1, 2018", "JUN 1, 2018", "JUN 1, 2018", "JUN 6, 2018", "JUN 6, 2018", "MAY 31, 2018", "MAY 31, 2018", "MAY 31, 2018", "MAY 31, 2018", "MAY 31, 2018", "MAY 30, 2018", "JUN 1, 2018", "MAY 29, 2018", "MAY 27, 2018", "MAY 25, 2018", "MAY 24, 2018", "MAY 23, 2018", "MAY 22, 2018", "MAY 22, 2018", "MAY 30, 2018", "MAY 17, 2018", "MAY 17, 2018", "MAY 15, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 8, 2018", "MAY 21, 2018", "MAY 7, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 7, 2018", "MAY 3, 2018", "MAY 3, 2018", "MAY 3, 2018", "MAY 3, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 3, 2018", "MAY 3, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 2, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "APR 30, 2018", "APR 30, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "APR 28, 2018", "APR 27, 2018", "APR 27, 2018", "APR 27, 2018", "APR 30, 2018", "APR 30, 2018", "APR 26, 2018", "APR 26, 2018", "APR 26, 2018", "APR 26, 2018", "APR 26, 2018", "APR 26, 2018", "APR 27, 2018", "APR 25, 2018", "APR 25, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 23, 2018", "APR 26, 2018", "APR 23, 2018", "APR 23, 2018", "APR 22, 2018", "APR 20, 2018", "APR 20, 2018", "APR 19, 2018", "APR 19, 2018", "APR 23, 2018", "APR 19, 2018", "APR 19, 2018", "APR 18, 2018", "APR 18, 2018", "APR 16, 2018", "APR 15, 2018", "APR 13, 2018", "APR 19, 2018", "APR 19, 2018", "APR 19, 2018", "APR 12, 2018", "APR 11, 2018", "APR 11, 2018", "APR 8, 2018", "APR 8, 2018", "APR 13, 2018", "APR 6, 2018", "APR 4, 2018", "APR 4, 2018", "APR 3, 2018", "APR 2, 2018", "MAR 30, 2018", "MAR 28, 2018", "APR 7, 2018", "APR 6, 2018", "MAR 26, 2018", "MAR 25, 2018", "MAR 24, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 22, 2018", "MAR 27, 2018", "MAR 21, 2018", "MAR 21, 2018", "MAR 19, 2018", "MAR 18, 2018", "MAR 18, 2018", "MAR 17, 2018", "MAR 16, 2018", "MAR 21, 2018", "MAR 15, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 16, 2018", "MAR 12, 2018", "MAR 12, 2018", "MAR 12, 2018", "MAR 11, 2018", "MAR 11, 2018", "MAR 10, 2018", "MAR 8, 2018", "MAR 12, 2018", "MAR 8, 2018", "MAR 6, 2018", "MAR 6, 2018", "MAR 6, 2018", "MAR 4, 2018", "MAR 2, 2018", "MAR 1, 2018", "MAR 8, 2018", "MAR 1, 2018", "MAR 1, 2018", "MAR 1, 2018", "FEB 28, 2018", "FEB 28, 2018", "FEB 28, 2018", "FEB 28, 2018", "MAR 1, 2018", "FEB 26, 2018", "FEB 23, 2018", "FEB 22, 2018", "FEB 22, 2018", "FEB 22, 2018", "FEB 22, 2018", "FEB 22, 2018", "FEB 26, 2018", "FEB 18, 2018", "FEB 17, 2018", "FEB 16, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 14, 2018", "FEB 13, 2018", "FEB 19, 2018", "FEB 12, 2018", "FEB 11, 2018", "FEB 11, 2018", "FEB 10, 2018", "FEB 9, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 13, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 7, 2018", "FEB 7, 2018", "FEB 7, 2018", "FEB 7, 2018", "FEB 7, 2018", "FEB 8, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 5, 2018", "FEB 6, 2018", "FEB 2, 2018", "FEB 2, 2018", "FEB 1, 2018", "FEB 1, 2018", "JAN 31, 2018", "JAN 31, 2018", "FEB 4, 2018", "JAN 30, 2018", "JAN 30, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 28, 2018", "JAN 30, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 26, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 21, 2018", "JAN 21, 2018", "JAN 23, 2018", "JAN 19, 2018", "JAN 19, 2018", "JAN 19, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 21, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 18, 2018", "JAN 17, 2018", "JAN 16, 2018", "JAN 16, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 17, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 10, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 8, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 5, 2018", "JAN 5, 2018", "JAN 5, 2018", "JAN 5, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 8, 2018", "JAN 3, 2018", "JAN 3, 2018", "JAN 2, 2018", "JAN 2, 2018", "JAN 2, 2018", "JAN 2, 2018", "DEC 30, 2017", "JAN 4, 2018", "DEC 29, 2017", "DEC 29, 2017", "DEC 28, 2017", "DEC 27, 2017", "DEC 27, 2017", "DEC 27, 2017", "DEC 22, 2017", "DEC 29, 2017", "DEC 21, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 19, 2017", "DEC 19, 2017", "DEC 22, 2017", "DEC 17, 2017", "DEC 16, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 18, 2017", "DEC 18, 2017", "DEC 17, 2017", "DEC 13, 2017", "DEC 12, 2017", "DEC 12, 2017", "DEC 12, 2017", "DEC 12, 2017", "DEC 15, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 12, 2017", "DEC 10, 2017", "DEC 10, 2017", "DEC 8, 2017", "DEC 8, 2017", "DEC 8, 2017", "DEC 7, 2017", "DEC 7, 2017", "DEC 10, 2017", "DEC 10, 2017", "DEC 6, 2017", "DEC 3, 2017", "DEC 1, 2017", "DEC 1, 2017", "NOV 30, 2017", "NOV 30, 2017", "DEC 6, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 30, 2017", "NOV 28, 2017", "NOV 28, 2017", "NOV 27, 2017", "NOV 27, 2017", "NOV 24, 2017", "NOV 24, 2017", "NOV 24, 2017", "NOV 28, 2017", "NOV 21, 2017", "NOV 21, 2017", "NOV 20, 2017", "NOV 20, 2017", "NOV 18, 2017", "NOV 17, 2017", "NOV 17, 2017", "NOV 22, 2017", "NOV 16, 2017", "NOV 16, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 16, 2017", "NOV 13, 2017", "NOV 12, 2017", "NOV 10, 2017", "NOV 9, 2017", "NOV 9, 2017", "NOV 9, 2017", "NOV 8, 2017", "NOV 14, 2017", "NOV 6, 2017", "NOV 4, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 6, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 1, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 31, 2017", "OCT 31, 2017", "NOV 2, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 29, 2017", "OCT 29, 2017", "OCT 30, 2017", "OCT 28, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 29, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 23, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 18, 2017", "OCT 19, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 18, 2017", "OCT 17, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 11, 2017", "OCT 10, 2017", "OCT 10, 2017", "OCT 10, 2017", "OCT 10, 2017", "OCT 8, 2017", "OCT 12, 2017", "OCT 7, 2017", "OCT 7, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 8, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 2, 2017", "OCT 4, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 1, 2017", "SEP 29, 2017", "SEP 29, 2017", "SEP 29, 2017", "SEP 29, 2017", "OCT 2, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 27, 2017", "SEP 26, 2017", "SEP 26, 2017", "SEP 26, 2017", "SEP 26, 2017", "SEP 28, 2017", "SEP 25, 2017", "SEP 22, 2017", "SEP 22, 2017", "SEP 22, 2017", "SEP 22, 2017", "SEP 22, 2017", "SEP 21, 2017", "SEP 25, 2017", "SEP 21, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 18, 2017", "SEP 18, 2017", "SEP 18, 2017", "SEP 21, 2017", "SEP 17, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 14, 2017", "SEP 14, 2017", "SEP 18, 2017", "SEP 14, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 12, 2017", "SEP 14, 2017", "SEP 12, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 10, 2017", "SEP 10, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 8, 2017", "SEP 8, 2017", "SEP 8, 2017", "SEP 7, 2017", "SEP 7, 2017", "SEP 7, 2017", "SEP 8, 2017", "SEP 6, 2017", "SEP 6, 2017", "SEP 6, 2017", "SEP 6, 2017", "SEP 5, 2017", "SEP 5, 2017", "SEP 7, 2017", "SEP 7, 2017", "SEP 5, 2017", "SEP 4, 2017", "SEP 3, 2017", "SEP 3, 2017", "SEP 3, 2017", "SEP 2, 2017", "SEP 5, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 1, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 30, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 30, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 29, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 27, 2017", "AUG 25, 2017", "AUG 25, 2017", "AUG 28, 2017", "AUG 24, 2017", "AUG 24, 2017", "AUG 23, 2017", "AUG 23, 2017", "AUG 23, 2017", "AUG 22, 2017", "AUG 22, 2017", "AUG 24, 2017", "AUG 22, 2017", "AUG 21, 2017", "AUG 21, 2017", "AUG 18, 2017", "AUG 18, 2017", "AUG 18, 2017", "AUG 18, 2017", "AUG 22, 2017", "AUG 17, 2017", "AUG 16, 2017", "AUG 16, 2017", "AUG 16, 2017", "AUG 16, 2017", "AUG 15, 2017", "AUG 15, 2017", "AUG 17, 2017", "AUG 15, 2017", "AUG 14, 2017", "AUG 14, 2017", "AUG 14, 2017", "AUG 14, 2017", "AUG 14, 2017", "AUG 13, 2017", "AUG 15, 2017", "AUG 11, 2017", "AUG 11, 2017", "AUG 11, 2017", "AUG 10, 2017", "AUG 9, 2017", "AUG 9, 2017", "AUG 9, 2017", "AUG 11, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 9, 2017", "AUG 5, 2017", "AUG 4, 2017", "AUG 4, 2017", "AUG 4, 2017", "AUG 4, 2017", "AUG 3, 2017", "AUG 3, 2017", "AUG 6, 2017", "AUG 3, 2017", "AUG 2, 2017", "AUG 2, 2017", "AUG 2, 2017", "AUG 1, 2017", "AUG 1, 2017", "AUG 1, 2017", "AUG 3, 2017", "JUL 31, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "AUG 1, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 27, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 26, 2017", "JUL 22, 2017", "JUL 22, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 21, 2017"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/indias-zydus-cadila-to-make-gileads-potential-covid-19-drug-remdesivir-2020-06-12", "https://www.nasdaq.com/articles/indias-zydus-cadila-signs-pact-with-gilead-to-make-remdesivir-2020-06-12", "https://www.nasdaq.com/articles/kite-to-manufacture-car-t-cell-therapies-in-europe-quick-facts-2020-06-12", "https://www.nasdaq.com/articles/is-adaptimmune-therapeutics-a-buy-2020-06-12", "https://www.nasdaq.com/articles/inovio-still-a-hot-coronavirus-vaccine-supplier-2020-06-11", "https://www.nasdaq.com/articles/regeneron-begins-human-trials-of-a-potential-covid-19-treatment-2020-06-11", "https://www.nasdaq.com/articles/better-buy%3A-bluebird-bio-vs.-gilead-sciences-2020-06-11", "https://www.nasdaq.com/articles/u.s.-fda-commissioner-says-agency-seeks-fast-review-of-covid-19-products-2020-06-10", "https://www.nasdaq.com/articles/indias-zydus-cadila-to-make-gileads-potential-covid-19-drug-remdesivir-2020-06-12", "https://www.nasdaq.com/articles/u.s.-fda-commissioner-says-agency-seeks-fast-review-of-covid-19-products-2020-06-10", "https://www.nasdaq.com/articles/gilead-merger-unlikely-at-this-point-says-5-star-analyst-2020-06-10", "https://www.nasdaq.com/articles/study%3A-remdesivir-prevented-lung-damage-in-monkeys-infected-with-covid-19-2020-06-10", "https://www.nasdaq.com/articles/is-aprea-therapeutics-stock-a-buy-2020-06-10", "https://www.nasdaq.com/articles/gild-named-a-top-socially-responsible-dividend-stock-2020-06-10", "https://www.nasdaq.com/articles/singapore-approves-remdesivir-drug-for-emergency-covid-19-treatment-2020-06-10", "https://www.nasdaq.com/articles/singapore-approves-gileads-remdesivir-for-covid-19-treatment-2020-06-10", "https://www.nasdaq.com/articles/better-buy%3A-bluebird-bio-vs.-gilead-sciences-2020-06-11", "https://www.nasdaq.com/articles/10-stocks-riding-on-the-covid-19-recovery-2020-06-09", "https://www.nasdaq.com/articles/aggressive-investors-can-do-much-better-than-merck-stock-2020-06-09", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-spartannash-steris-and-gilead-sciences-2020-06-09", "https://www.nasdaq.com/articles/astrazenecas-acquisition-of-gilead-would-create-a-covid-19-colossus-but-dont-bet-on-seeing", "https://www.nasdaq.com/articles/gileads-remdesivir-slows-disease-progression-in-monkeys-with-covid-19-2020-06-09", "https://www.nasdaq.com/articles/gileads-remdesivir-slows-progression-of-covid-19-in-monkeys-study-2020-06-09", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-boeing-chesapeake-energy-ideanomics-2020-06-08", "https://www.nasdaq.com/articles/what-would-a-merger-mean-for-gilead-top-analyst-weighs-in-2020-06-09", "https://www.nasdaq.com/articles/eu-watchdog-aims-for-speedy-approval-of-remdesivir-as-covid-19-treatment-2020-06-08", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-carnival-corp-opiant-pharmaceuticals-2020-06-08", "https://www.nasdaq.com/articles/wall-street-set-to-rise-on-swift-economic-rebound-hopes-2020-06-08", "https://www.nasdaq.com/articles/breakingviews-astrazeneca-ma-puzzle-sends-shareholder-warning-2020-06-08", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gilead-cisco-2020-06-08", "https://www.nasdaq.com/articles/u.s.-stock-futures-rise-on-optimism-over-economic-revival-2020-06-08", "https://www.nasdaq.com/articles/astrazeneca-in-informal-talks-with-gilead-for-potential-merger%3A-report-2020-06-08", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-sino-global-shipping-michaels-companies-applied-dna-2020-06", "https://www.nasdaq.com/articles/european-stock-rally-takes-step-back-as-tech-healthcare-drag-2020-06-08", "https://www.nasdaq.com/articles/astrazeneca-shares-down-2-after-report-it-approached-gilead-over-tie-up-2020-06-08", "https://www.nasdaq.com/articles/londons-ftse-100-opens-lower-as-astrazeneca-weighs-2020-06-08", "https://www.nasdaq.com/articles/european-shares-pull-back-from-3-month-highs-after-rally-2020-06-08", "https://www.nasdaq.com/articles/astrazeneca-proposes-a-merger-with-gilead-sciences-2020-06-07", "https://www.nasdaq.com/articles/astrazeneca-contacted-gilead-over-potential-megamerger-bloomberg-news-2020-06-07", "https://www.nasdaq.com/articles/could-gileads-covid-19-drug-make-%247-billion-per-year-2020-06-07", "https://www.nasdaq.com/articles/londons-ftse-100-falls-as-astrazeneca-drops-on-megamerger-report-2020-06-08", "https://www.nasdaq.com/articles/7-u.s.-stocks-to-buy-on-coronavirus-weakness-2020-06-06", "https://www.nasdaq.com/articles/what-are-the-implications-of-gileads-increased-focus-on-oncology-5-star-analyst-weights-in", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-gild-nssc-lb-2020-06-04", "https://www.nasdaq.com/articles/co-diagnostics-could-be-a-prudent-coronavirus-play-2020-06-04", "https://www.nasdaq.com/articles/is-remdesivir-a-disappointment-2020-06-04", "https://www.nasdaq.com/articles/better-buy%3A-bristol-myers-squibb-vs.-gilead-sciences-2020-06-04", "https://www.nasdaq.com/articles/lyft-looks-poised-to-rally-over-the-next-few-months-2020-06-04", "https://www.nasdaq.com/articles/fujifilm-says-covid-19-drug-research-may-drag-on-into-july-2020-06-07", "https://www.nasdaq.com/articles/air-travels-comeback-looks-poised-to-lift-ge-stock-2020-06-04", "https://www.nasdaq.com/articles/gilead-sciences-%3A-filgotinib-shows-sustained-efficacy-in-studies-on-rheumatoid-arthritis", "https://www.nasdaq.com/articles/roche-test-receives-fda-emergency-use-approval-for-covid-19-patients-2020-06-04", "https://www.nasdaq.com/articles/wait-for-more-clarity-before-buying-gilead-stock-says-analyst-2020-06-03", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-warner-music-boeing-pliant-therapeutics-2020-06-03", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-glu-mobile-boeing-american-eagle-2020-06-03", "https://www.nasdaq.com/articles/gileads-remdesivir-could-see-%247-bln-in-annual-sales-on-stockpiling-boost-analyst-2020-06", "https://www.nasdaq.com/articles/biotech-stocks%3A-buy-this-not-that-2020-06-04", "https://www.nasdaq.com/articles/eli-lilly-leaps-past-regenerons-covid-19-treatment-candidate-2020-06-03", "https://www.nasdaq.com/articles/abbvie-stock-is-offering-investors-an-oil-yield-without-oils-risk-2020-06-03", "https://www.nasdaq.com/articles/s.korea-approves-import-of-anti-viral-drug-remdesivir-for-coronavirus-treatment-2020-06-02", "https://www.nasdaq.com/articles/abbvie-will-be-in-big-trouble-when-its-patent-cliff-arrives-2020-06-02", "https://www.nasdaq.com/articles/tuesday-sector-laggards%3A-healthcare-technology-communications-2020-06-02", "https://www.nasdaq.com/articles/india-approves-emergency-use-of-remdesivir-to-treat-covid-19-patients-2020-06-02-0", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-gilead-sciences-or-novavax-2020-06-02", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-coty-zoom-video-opgen-campbell-soup-2020-06-03", "https://www.nasdaq.com/articles/india-approves-emergency-use-of-remdesivir-to-treat-covid-19-patients-2020-06-02", "https://www.nasdaq.com/articles/ntla-gains-on-amended-regn-deal-gild-reports-simple-results-myov-on-watch-nvus-slumps-2020", "https://www.nasdaq.com/articles/gold-edges-lower-as-economies-open-up-2020-06-01", "https://www.nasdaq.com/articles/global-markets-stocks-under-pressure-as-trump-vows-to-end-violent-protests-2020-06-01", "https://www.nasdaq.com/articles/why-carnival-royal-caribbean-and-norwegian-cruise-line-stocks-rose-today-2020-06-01", "https://www.nasdaq.com/articles/wall-street-closes-higher-as-recovery-signs-soothe-protest-pandemic-worries-2020-06-01-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-01-2020%3A-abioebsgildocgn-2020-06-01", "https://www.nasdaq.com/articles/gileads-next-step-on-coronavirus%3A-inhaled-remdesivir-other-easier-to-use-versions-2020-06", "https://www.nasdaq.com/articles/u.s.-stocks-gain-as-signs-of-recovery-offset-protests-economic-worries-2020-06-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-coty-tesla-zoom-video-zynga-2020-06-01", "https://www.nasdaq.com/articles/insight-scientists-hunt-pandemic-hotspots-in-race-to-test-vaccines-2020-06-01-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-01-2020%3A-ebsgildocgn-2020-06-01", "https://www.nasdaq.com/articles/wall-st-gains-as-recovery-hopes-overshadow-u.s.-protests-2020-06-01", "https://www.nasdaq.com/articles/vir-biotechnology-is-bucking-the-biotech-covid-19-trends-and-stands-to-win-2020-06-01", "https://www.nasdaq.com/articles/stock-alert%3A-gilead-down-4-on-remdesivir-trial-data-2020-06-01", "https://www.nasdaq.com/articles/wall-street-closes-higher-as-recovery-signs-soothe-protest-pandemic-worries-2020-06-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gilead-virgin-galactic-general-electric-2020-06-01", "https://www.nasdaq.com/articles/3-biotech-quick-picks-to-invest-%245000-this-week-2020-06-01", "https://www.nasdaq.com/articles/wall-st-rises-as-recovery-hopes-offset-u.s.-protests-china-tensions-2020-06-01", "https://www.nasdaq.com/articles/tqqq-chtr-gild-qcom%3A-large-outflows-detected-at-etf-2020-06-01", "https://www.nasdaq.com/articles/gilead-reports-positive-late-stage-study-results-for-remdesivir-in-patients-with-moderate", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-gild-zm-2020-06-01", "https://www.nasdaq.com/articles/gilead-says-remdesivir-helped-moderate-covid-19-patients-improve-2020-06-01-0", "https://www.nasdaq.com/articles/wall-st-flat-as-recovery-hopes-offset-u.s.-protests-china-tensions-2020-06-01", "https://www.nasdaq.com/articles/gilead-says-remdesivir-helped-moderate-covid-19-patients-improve-2020-06-01", "https://www.nasdaq.com/articles/gilead-trades-that-made-millions-on-covid-19-drug-news-raise-eyebrows-2020-06-01", "https://www.nasdaq.com/articles/gilead-gets-a-boost-from-positive-coronavirus-research-2020-06-01", "https://www.nasdaq.com/articles/exclusive-russia-to-roll-out-its-first-approved-covid-19-drug-next-week-2020-06-01", "https://www.nasdaq.com/articles/insight-scientists-hunt-pandemic-hotspots-in-race-to-test-vaccines-2020-06-01", "https://www.nasdaq.com/articles/how-one-hedge-fund-billionaire-is-battling-to-bring-down-drug-prices-in-america-2020-05-31", "https://www.nasdaq.com/articles/the-week-that-was%3A-mrk-enters-covid-space-gsks-1bln-dose-target-roche-gild-team-up-for", "https://www.nasdaq.com/articles/gilead-reports-encouraging-data-from-remdesivir-5-day-treatment-course-2020-06-01", "https://www.nasdaq.com/articles/heres-why-arcus-biosciences-stock-gained-as-much-as-15.9-today-2020-05-29", "https://www.nasdaq.com/articles/at-the-asco%3A-oncy-imv-crdf-gild-tak...-2020-05-29", "https://www.nasdaq.com/articles/eu-regulator-promises-speedy-review-of-potential-covid-19-drug-remdesivir-2020-05-29-0", "https://www.nasdaq.com/articles/eu-regulator-promises-speedy-review-of-potential-covid-19-drug-remdesivir-2020-05-29", "https://www.nasdaq.com/articles/s.korea-seeks-to-import-anti-viral-remdesivir-as-new-coronavirus-cases-emerge-2020-05-29", "https://www.nasdaq.com/articles/july-10th-options-now-available-for-gilead-sciences-gild-2020-05-28", "https://www.nasdaq.com/articles/dont-waste-your-money-on-penny-stocks-these-3-are-better-buys-2020-05-28", "https://www.nasdaq.com/articles/7-u.s.-stocks-to-buy-on-coronavirus-weakness-2020-05-30", "https://www.nasdaq.com/articles/roche-mixes-actemra-with-gileads-remdesivir-in-covid-19-trial-2020-05-28", "https://www.nasdaq.com/articles/genentech-initiates-phase-iii-trial-of-actemra-plus-remdesivir-on-severe-covid-19", "https://www.nasdaq.com/articles/phas-to-begin-covid-19-drug-trial-in-june-mrsn-hits-new-high-ljpc-plunges-rcus-on-watch", "https://www.nasdaq.com/articles/roche-to-study-remdesivir-actemra-cocktail-against-severe-covid-19-pneumonia-2020-05-28", "https://www.nasdaq.com/articles/gileads-remdesivir-may-be-a-coronavirus-silver-bullet-but-its-already-baked-in-the-stock", "https://www.nasdaq.com/articles/gilead-study-shows-shorter-5-day-course-of-remdesivir-works-as-well-as-10-day-one-2020-05", "https://www.nasdaq.com/articles/heres-why-arcus-biosciences-is-losing-ground-today-2020-05-27", "https://www.nasdaq.com/articles/coronavirus-2020%3A-where-to-invest-%24500-right-now-2020-05-28", "https://www.nasdaq.com/articles/astrazeneca-tests-diabetes-drug-for-covid-19-despite-risk-seen-by-doctors-2020-05-27", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-stoneco-tuesday-morning-zynerba-pharma-2020-05-27", "https://www.nasdaq.com/articles/gilead-arcus-biosciences-ink-10-year-deal-to-co-develop-cancer-immunotherapies-2020-05-27", "https://www.nasdaq.com/articles/10-stocks-to-buy-as-they-ride-a-coronavirus-tailwind-2020-05-27", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-izea-worldwide-diffusion-pharma-douyu-international-2020-05", "https://www.nasdaq.com/articles/who-expects-hydroxychloroquine-safety-findings-by-mid-june-2020-05-26", "https://www.nasdaq.com/articles/lilly-junshi-biosciences-plan-to-start-human-trials-of-covid-19-antibody-in-q2-2020-05-26", "https://www.nasdaq.com/articles/gilead-sciences-signs-%242-billion-partnership-with-arcus-biosciences-2020-05-27", "https://www.nasdaq.com/articles/merck-leaps-into-covid-19-development-fray-with-vaccine-drug-deals-2020-05-26-0", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-novavax-tuesday-morning-hpe-2020-05-26", "https://www.nasdaq.com/articles/merck-leaps-into-covid-19-development-fray-with-vaccine-drug-deals-2020-05-26", "https://www.nasdaq.com/articles/britain-to-provide-anti-viral-drug-remdesivir-to-some-covid-19-patients-2020-05-26", "https://www.nasdaq.com/articles/3-large-cap-coronavirus-stocks-still-worth-buying-2020-05-24", "https://www.nasdaq.com/articles/mixed-results-for-gilead-sciences-covid-19-treatment-2020-05-23", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-gilead-sciences-or-vir-biotechnology-2020-05-23", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-latam-airlines-tuesday-morning-novavax-2020-05-26", "https://www.nasdaq.com/articles/peer-reviewed-data-shows-gileads-drug-effective-against-covid-19-nih-2020-05-22", "https://www.nasdaq.com/articles/remdesivir-cant-cure-covid-but-good-luck-telling-gilead-stock-2020-05-22", "https://www.nasdaq.com/articles/before-you-buy-gilead-sciences-stock-read-this-2020-05-22", "https://www.nasdaq.com/articles/gilead-stock-is-worth-owning-with-or-without-a-coronavirus-cure-2020-05-22", "https://www.nasdaq.com/articles/u.s.-doctors-call-for-remdesivir-data-to-guide-coronavirus-treatment-2020-05-21", "https://www.nasdaq.com/articles/galapagos-and-gilead-sciences-post-successful-yet-disappointing-filgotinib-results-2020-05", "https://www.nasdaq.com/articles/how-a-coronavirus-vaccine-might-move-the-stock-market-2020-05-21", "https://www.nasdaq.com/articles/peer-reviewed-data-shows-gileads-drug-helps-covid-19-recovery-time-2020-05-22", "https://www.nasdaq.com/articles/atra-abuzz-atos-covid-19-med-effective-ino-and-vxrt-on-track-2020-05-21", "https://www.nasdaq.com/articles/gilead-still-holds-the-winning-hand-says-5-star-analyst-2020-05-20", "https://www.nasdaq.com/articles/higher-dose-of-gilead-galapagos-drug-meets-ulcerative-colitis-study-goals-2020-05-20", "https://www.nasdaq.com/articles/gilead-galapagoss-drug-meets-main-goals-of-ulcerative-colitis-study-2020-05-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-20-2020%3A-hothaldxgildinobdx-2020-05-20", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-gild-ilmn-atvi-2020-05-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-20-2020%3A-aldxgildinobdx-2020-05-20", "https://www.nasdaq.com/articles/the-virus-vaccine-race-is-fueling-moderna-stock-to-new-highs-2020-05-21", "https://www.nasdaq.com/articles/why-the-next-month-will-determine-the-rest-of-the-year-for-gileads-stock-2020-05-20", "https://www.nasdaq.com/articles/glaxosmithkline-pfizer-and-shionogis-hiv-prevention-candidate-outperforms-gileads-truvada", "https://www.nasdaq.com/articles/how-the-parts-add-up%3A-sciu-targets-%2433-2020-05-19", "https://www.nasdaq.com/articles/where-will-adaptimmune-be-in-5-years-2020-05-19", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oasis-midstream-l-brands-diffusion-pharma-2020-05-18", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-gild-expe-2020-05-18", "https://www.nasdaq.com/articles/gsks-long-acting-injection-beats-truvada-in-hiv-prevention-trial-2020-05-18-0", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-dgro-cmcsa-txn-gild-2020-05-20", "https://www.nasdaq.com/articles/gsks-long-acting-injection-beats-truvada-in-hiv-prevention-trial-2020-05-18", "https://www.nasdaq.com/articles/is-gilead-sciences-a-great-dividend-stock-2020-05-17", "https://www.nasdaq.com/articles/why-gileads-remdesivir-might-not-be-the-mega-moneymaker-some-think-it-will-be-2020-05-17", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2020-05-16", "https://www.nasdaq.com/articles/could-veeva-systems-be-a-millionaire-maker-stock-2020-05-16", "https://www.nasdaq.com/articles/gilead-to-end-coronavirus-drug-trials-adding-to-access-worry-researchers-2020-05-15", "https://www.nasdaq.com/articles/pakistans-ferozsons-to-begin-producing-covid-19-drug-remdesivir-2020-05-15", "https://www.nasdaq.com/articles/remdesivir-close-to-eus-initial-authorisation-as-covid-19-treatment-2020-05-18", "https://www.nasdaq.com/articles/part-of-gileads-coronavirus-drug-donation-allocated-to-japan-2020-05-14", "https://www.nasdaq.com/articles/france-says-any-sanofi-covid-19-vaccine-for-the-world-no-favourites-2020-05-14", "https://www.nasdaq.com/articles/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-2020-05-0", "https://www.nasdaq.com/articles/2-recession-proof-healthcare-stocks-to-buy-in-2020-2020-05-14", "https://www.nasdaq.com/articles/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-2020-05-14", "https://www.nasdaq.com/articles/japan-says-drugmaker-gileads-covid-19-treatment-remdesivir-now-in-use-in-hospitals-2020-05", "https://www.nasdaq.com/articles/takeda-says-coronavirus-treatment-trial-using-recovered-patients-blood-could-start-in-july", "https://www.nasdaq.com/articles/buy-good-news-gilead-stock-before-other-investors-catch-on-2020-05-14", "https://www.nasdaq.com/articles/gileads-remdesivir-isnt-enough-to-drive-its-stock-higher-2020-05-13", "https://www.nasdaq.com/articles/gilead-in-deal-with-5-cos.-to-make-and-sell-remdesivir-in-127-countries-2020-05-13", "https://www.nasdaq.com/articles/u.s.-accuses-china-linked-hackers-of-stealing-coronavirus-research-2020-05-13", "https://www.nasdaq.com/articles/where-will-gilead-sciences-be-in-1-year-2020-05-13", "https://www.nasdaq.com/articles/u.s.-stock-futures-climb-ahead-of-fed-chair-powells-address-2020-05-13", "https://www.nasdaq.com/articles/is-abbvie-a-buy-now-that-the-allergan-deal-is-done-2020-05-13", "https://www.nasdaq.com/articles/gilead-stock-still-looks-poised-to-prove-the-bears-wrong-2020-05-13", "https://www.nasdaq.com/articles/u.s.-accuses-china-linked-hackers-of-stealing-coronavirus-research-2020-05-13-0", "https://www.nasdaq.com/articles/gilead-strikes-deal-with-mylan-to-supply-remdesivir-internationally-2020-05-12", "https://www.nasdaq.com/articles/indias-jubilant-signs-licensing-deal-for-gileads-potential-covid-19-drug-2020-05-12", "https://www.nasdaq.com/articles/9-enduring-stocks-that-you-shouldnt-sell-in-may-2020-05-12", "https://www.nasdaq.com/articles/ema-recommends-expanding-compassionate-use-of-gileads-covid-19-drug-2020-05-11", "https://www.nasdaq.com/articles/ema-recommends-expanding-compassionate-use-of-gileads-covid-19-drug-2020-05-11-0", "https://www.nasdaq.com/articles/the-government-will-distribute-gileads-remdesivir.-this-could-be-bad-news-for-investors", "https://www.nasdaq.com/articles/moat-now-pfe-gild%3A-etf-inflow-alert-2020-05-11", "https://www.nasdaq.com/articles/a-tale-of-two-japanese-drugs-in-tests-to-fight-covid-19-2020-05-12", "https://www.nasdaq.com/articles/co-diagnostics-is-a-smart-way-to-play-coronavirus-testing-2020-05-11", "https://www.nasdaq.com/articles/despite-challenges-ge-is-a-long-term-winner-2020-05-11", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-may-2020-05-10", "https://www.nasdaq.com/articles/what-investors-are-missing-about-gilead-sciences-2020-05-10", "https://www.nasdaq.com/articles/u.s.-to-allow-states-to-distribute-gileads-remdesivir-to-fight-covid-19-2020-05-09", "https://www.nasdaq.com/articles/the-dow-rose-455-points-because-job-losses-cant-get-any-worse-2020-05-08", "https://www.nasdaq.com/articles/a-covid-19-strategy%3A-invest-in-companies-that-are-doing-good-2020-05-11", "https://www.nasdaq.com/articles/nih-begins-study-of-remdesivir-with-anti-inflammatory-drug-to-treat-covid-19-2020-05-08", "https://www.nasdaq.com/articles/exclusive-iran-linked-hackers-recently-targeted-coronavirus-drugmaker-gilead-sources-2020", "https://www.nasdaq.com/articles/is-gilead-sciences-stock-a-buy-2020-05-08", "https://www.nasdaq.com/articles/u.s.-doctors-want-details-on-federal-distribution-of-gilead-coronavirus-drug-2020-05-07", "https://www.nasdaq.com/articles/doctors-want-details-on-federal-distribution-of-gilead-coronavirus-drug-2020-05-07", "https://www.nasdaq.com/articles/june-26th-options-now-available-for-gilead-sciences-gild-2020-05-07", "https://www.nasdaq.com/articles/the-best-thing-happening-during-these-worst-of-times-2020-05-07", "https://www.nasdaq.com/articles/nih-begins-study-of-remdesivir-with-anti-inflammatory-drug-to-treat-covid-19-2020-05-08-0", "https://www.nasdaq.com/articles/japan-approves-gilead-sciences-remdesivir-as-covid-19-drug-2020-05-07-0", "https://www.nasdaq.com/articles/japan-approves-gilead-sciences-remdesivir-as-covid-19-drug-2020-05-07", "https://www.nasdaq.com/articles/will-gilead-price-its-coronavirus-drug-for-public-good-or-company-profit-2020-05-06", "https://www.nasdaq.com/articles/how-will-double-digit-unemployment-affect-your-stock-portfolio-2020-05-06", "https://www.nasdaq.com/articles/4-safe-stocks-that-can-make-you-rich-in-this-economy-2020-05-06", "https://www.nasdaq.com/articles/inovio-pharmaceuticals-is-hurting-from-remdesivir-but-its-still-standing-2020-05-06", "https://www.nasdaq.com/articles/israel-reports-a-breakthrough-coronavirus-antibody-treatment-2020-05-06", "https://www.nasdaq.com/articles/from-gilead-to-astrazeneca-investors-should-watch-these-biotech-giants-right-now-2020-05", "https://www.nasdaq.com/articles/explainer-who-can-make-gileads-coronavirus-drug-licence-free-2020-05-06", "https://www.nasdaq.com/articles/is-this-coronavirus-drug-authorization-really-good-news-for-gilead-2020-05-06", "https://www.nasdaq.com/articles/gilead-sciences-plans-to-expand-global-supply-of-remdesivir-2020-05-05", "https://www.nasdaq.com/articles/gilead-in-talks-to-expand-global-supply-of-covid-19-drug-remdesivir-2020-05-05-0", "https://www.nasdaq.com/articles/gilead-in-talks-to-expand-global-supply-of-covid-19-drug-remdesivir-2020-05-05", "https://www.nasdaq.com/articles/how-can-the-stock-market-soar-with-rising-unemployment-2020-05-05", "https://www.nasdaq.com/articles/regeneron-says-its-covid-19-combo-treatment-could-be-ready-for-people-this-fall-2020-05-05", "https://www.nasdaq.com/articles/co-diagnostics-is-becoming-more-relevant-2020-05-06", "https://www.nasdaq.com/articles/gilead-sciences-is-a-strong-buy-despite-what-its-detractors-might-say-2020-05-05", "https://www.nasdaq.com/articles/finding-a-coronavirus-cure%3A-5-companies-making-moves-2020-05-05", "https://www.nasdaq.com/articles/exclusive-bangladeshs-beximco-to-begin-producing-covid-19-drug-remdesivir-coo-2020-05-05", "https://www.nasdaq.com/articles/could-this-under-the-radar-biotech-piggyback-on-gileads-remdesivir-success-2020-05-05", "https://www.nasdaq.com/articles/the-dow-rose-26-points-because-an-oil-rebound-lifted-stocks-2020-05-04", "https://www.nasdaq.com/articles/apps-cannot-replace-boots-on-the-ground-in-virus-fight-who-2020-05-04", "https://www.nasdaq.com/articles/earnings-preview%3A-is-sq-stock-a-buy-before-wednesday-2020-05-04", "https://www.nasdaq.com/articles/the-trends-are-mostly-friendly-for-moderna-stock-investors-2020-05-05", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-airlines-banks-insurers-pge-2020-05-04", "https://www.nasdaq.com/articles/the-3-best-stocks-to-buy-in-may-2020-05-04", "https://www.nasdaq.com/articles/jpmorgans-bullish-stance-on-gilead-sciences-gild-stock-comes-to-an-end-2020-05-04", "https://www.nasdaq.com/articles/what-might-gileads-covid-19-drug-cost-%2410-or-%244500-2020-05-04", "https://www.nasdaq.com/articles/forget-gilead-these-2-pharma-dividends-pay-up-to-10-2020-05-04", "https://www.nasdaq.com/articles/vir-alnylam-identify-covid-19-therapy-candidate-plan-human-trials-by-year-end-2020-05-04", "https://www.nasdaq.com/articles/despite-gains-threat-gilead-is-still-attractive-2020-05-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-airlines-banks-insurers-oil-stocks-2020-05-04", "https://www.nasdaq.com/articles/european-stock-futures-drop-as-u.s.-china-spar-over-virus-origin-2020-05-04-0", "https://www.nasdaq.com/articles/foreigners-remain-net-sellers-of-japan-stocks-for-11th-straight-week-2020-05-04", "https://www.nasdaq.com/articles/gold-gains-as-rising-u.s.-china-tensions-dent-risk-sentiment-2020-05-03", "https://www.nasdaq.com/articles/5-top-coronavirus-stocks-to-buy-in-may-2020-05-02", "https://www.nasdaq.com/articles/japan-aims-to-fast-track-review-of-anti-viral-drug-remdesivir-2020-05-02", "https://www.nasdaq.com/articles/what-should-investors-make-of-conflicting-results-surrounding-gileads-remdesivir-2020-05", "https://www.nasdaq.com/articles/gileads-remdesivir-becomes-1st-drug-allowed-for-emergency-use-for-covid-19-2020-05-01", "https://www.nasdaq.com/articles/heres-why-its-not-too-late-to-load-up-on-moderna-stock-2020-05-04", "https://www.nasdaq.com/articles/why-foot-locker-callaway-golf-and-newell-brands-plunged-10-early-friday-2020-05-01", "https://www.nasdaq.com/articles/u.s.-fda-authorizes-remdesivir-drug-as-emergency-treatment-for-covid-19-2020-05-01-0", "https://www.nasdaq.com/articles/fda-allows-emergency-use-of-gileads-covid-19-drug-2020-05-01", "https://www.nasdaq.com/articles/u.s.-fda-authorizes-remdesivir-drug-as-emergency-treatment-for-covid-19-2020-05-01", "https://www.nasdaq.com/articles/trump%3A-fda-authorizes-remdesivir-drug-for-covid-19-2020-05-01", "https://www.nasdaq.com/articles/gilead-aims-to-get-its-potential-covid-19-drug-to-as-many-patients-as-possible-2020-05-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-medigus-aemetis-2020-05-01", "https://www.nasdaq.com/articles/fda-authorizes-gileads-remdesivir-for-covid-19-2020-05-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-medigus-ltd-western-digital-corp-aemetis-inc-2020-05-01", "https://www.nasdaq.com/articles/gilead-stock-drops-on-wave-of-downgrades-2020-05-01", "https://www.nasdaq.com/articles/coronavirus-trial-drug-remdesivirs-maker-aims-for-wide-distribution-gilead-ceo-2020-05-01", "https://www.nasdaq.com/articles/coronavirus-trial-drug-redesivirs-maker-hopes-for-swift-fda-approval-interview-2020-05-01", "https://www.nasdaq.com/articles/3-big-stories-in-gilead-sciences-q1-results-2020-05-01", "https://www.nasdaq.com/articles/inovio-is-in-a-race-to-develop-a-covid-19-vaccine-but-can-it-possibly-win-2020-05-01", "https://www.nasdaq.com/articles/what-does-remdesivirs-promising-study-mean-for-gileads-stock-2020-05-01", "https://www.nasdaq.com/articles/daily-dividend-report%3A-aaplgildglwtrpwwd-2020-05-01", "https://www.nasdaq.com/articles/7-u.s.-stocks-to-buy-on-coronavirus-weakness-2020-04-30", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-mdb-casa-gild-2020-04-30", "https://www.nasdaq.com/articles/gilead-beats-earnings-estimates-but-the-stock-falls-2020-04-30", "https://www.nasdaq.com/articles/gilead-aims-to-expand-remdesivir-output-for-covid-19-posts-flat-1st-qtr-results-2020-04-30", "https://www.nasdaq.com/articles/global-markets-global-equities-dip-at-end-of-best-month-since-09-2020-04-30", "https://www.nasdaq.com/articles/gilead-sciences-inc.-q1-adjusted-earnings-of-%241.68-per-share-2020-04-30", "https://www.nasdaq.com/articles/yields-fall-two-year-note-touches-lowest-level-since-2011-2020-04-30", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/is-gilead-sciences-stock-a-buy-right-now-this-is-what-you-need-to-know-2020-04-30", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-inflow-alert-2020-04-30", "https://www.nasdaq.com/articles/u.s.-fda-moving-with-lightning-speed-on-gileads-covid-19-drug-bloomberg-2020-04-30", "https://www.nasdaq.com/articles/global-markets-global-equities-dip-remain-on-pace-for-best-month-on-record-2020-04-30", "https://www.nasdaq.com/articles/gilead-awaits-fda-approval-on-remdesivir-to-treat-covid-19-2020-04-30", "https://www.nasdaq.com/articles/paypal-is-the-elixir-we-need-in-this-awful-earnings-season-2020-04-30", "https://www.nasdaq.com/articles/wall-st-set-to-slide-at-open-after-jobless-claims-data-2020-04-30", "https://www.nasdaq.com/articles/global-markets-equities-dip-but-remain-on-pace-for-best-month-on-record-2020-04-30", "https://www.nasdaq.com/articles/gilead-gild-1st-quarter-earnings%3A-what-to-expect-2020-04-30", "https://www.nasdaq.com/articles/dow-sp-500-futures-dip-at-end-of-strong-month-jobless-data-eyed-2020-04-30", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-gilead-sciences-boeing-and-nio-2020-04-30", "https://www.nasdaq.com/articles/dow-sp-500-futures-dip-at-end-of-strong-month-jobless-data-awaited-2020-04-30", "https://www.nasdaq.com/articles/have-%243000-to-invest-here-are-3-top-coronavirus-stocks-to-buy-right-now.-2020-04-30", "https://www.nasdaq.com/articles/moderna-stock-is-near-highs-but-faces-risk-2020-04-30", "https://www.nasdaq.com/articles/gilead-sciences-q1-20-earnings-conference-call-at-4%3A30-pm-et-2020-04-30", "https://www.nasdaq.com/articles/daily-markets%3A-nearly-1-in-5-have-lost-their-jobs-in-just-6-weeks-2020-04-30", "https://www.nasdaq.com/articles/european-stocks-pause-after-big-asia-and-wall-street-rally-2020-04-30", "https://www.nasdaq.com/articles/global-markets-stocks-head-for-best-month-on-record-ahead-of-ecb-2020-04-30", "https://www.nasdaq.com/articles/london-stocks-hit-by-shells-historic-dividend-cut-2020-04-30", "https://www.nasdaq.com/articles/emerging-markets-stocks-extend-gains-hungary-outperforms-on-reopening-plans-2020-04-30", "https://www.nasdaq.com/articles/china-stocks-log-best-month-in-five-on-virus-drug-trial-policy-hopes-2020-04-30", "https://www.nasdaq.com/articles/london-stocks-rise-on-optimism-around-virus-drug-upbeat-earnings-2020-04-30", "https://www.nasdaq.com/articles/tokyo-shares-end-near-8-week-high-track-wall-street-gains-on-virus-drug-hopes-2020-04-30", "https://www.nasdaq.com/articles/indian-stocks-log-best-month-since-2009-track-global-cheer-on-virus-drug-hopes-2020-04-30", "https://www.nasdaq.com/articles/em-asia-fx-indonesian-rupiah-jumps-about-3-on-higher-bond-inflows-expectation-2020-04-30", "https://www.nasdaq.com/articles/indian-shares-soar-on-covid-19-drug-hopes-set-for-best-month-since-2009-2020-04-30", "https://www.nasdaq.com/articles/global-markets-stocks-rally-on-treatment-hopes-currencies-await-ecb-2020-04-30", "https://www.nasdaq.com/articles/china-stocks-touch-seven-week-high-on-coronavirus-treatment-policy-hopes-2020-04-30", "https://www.nasdaq.com/articles/global-markets-stocks-rally-on-treatment-hopes-currencies-await-ecb-2020-04-29", "https://www.nasdaq.com/articles/global-markets-asian-stocks-set-to-track-u.s.-gains-as-virus-treatment-hopes-lift", "https://www.nasdaq.com/articles/why-discover-financial-stock-jumped-15-today-2020-04-29", "https://www.nasdaq.com/articles/glenmark-to-conduct-trials-in-india-for-potential-covid-19-drug-2020-04-30", "https://www.nasdaq.com/articles/the-dow-surged-532-points-because-were-closer-to-a-covid-19-drug-2020-04-29", "https://www.nasdaq.com/articles/breakingviews-corona-capital%3A-u.s.-gdp-gileads-drug-spotify-2020-04-29", "https://www.nasdaq.com/articles/dow-jones-today%3A-vaccine-hopes-overcame-contracting-gdp-2020-04-29", "https://www.nasdaq.com/articles/dow-oil-close-with-strong-wins-2020-04-29", "https://www.nasdaq.com/articles/wall-street-rallies-on-promising-coronavirus-drug-2020-04-29", "https://www.nasdaq.com/articles/why-novavax-stock-slumped-today-2020-04-29", "https://www.nasdaq.com/articles/global-markets-shares-jump-on-coronavirus-treatment-hopes-oil-soars-2020-04-29", "https://www.nasdaq.com/articles/why-discover-financial-stock-jumped-15today-2020-04-29", "https://www.nasdaq.com/articles/this-news-has-foot-locker-stock-running-higher-today-2020-04-29", "https://www.nasdaq.com/articles/forex-dollar-drops-as-fed-repeats-vow-to-support-economy-2020-04-29", "https://www.nasdaq.com/articles/amazon-is-wall-sts-biggest-winner-from-coronavirus-2020-04-29", "https://www.nasdaq.com/articles/american-airlines-stock-is-still-a-long-term-winner-2020-04-29", "https://www.nasdaq.com/articles/u.s.-stocks-rally-on-coronavirus-drug-hopes-2020-04-29", "https://www.nasdaq.com/articles/restaurant-stocks-soar-wednesday-on-positive-covid-19-developments-2020-04-29", "https://www.nasdaq.com/articles/why-hotel-stocks-are-surging-today-2020-04-29", "https://www.nasdaq.com/articles/emerging-markets-latam-shares-fx-rally-as-hopes-of-covid-19-drug-lifts-sentiment-2020-04", "https://www.nasdaq.com/articles/heres-why-visa-mastercard-and-american-express-are-higher-on-wednesday-2020-04-29", "https://www.nasdaq.com/articles/wall-street-jumps-on-coronavirus-drug-hopes-fed-in-focus-2020-04-29", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-capricor-therapeutics-liberty-oilfield-blue-apron-2020-04-29", "https://www.nasdaq.com/articles/covid-19-complication-seen-in-children-is-rare-who-says-2020-04-29", "https://www.nasdaq.com/articles/buy-gilead-stock-because-remdesivir-is-a-covid-19-game-changer-2020-04-29", "https://www.nasdaq.com/articles/stock-market-news%3A-mastercard-charges-ahead-alphabet-spells-ad-success-2020-04-29", "https://www.nasdaq.com/articles/gold-falls-as-equities-drift-higher-ahead-of-fed-statement-2020-04-29", "https://www.nasdaq.com/articles/what-lies-ahead-for-vaccine-development-and-ino-stock-in-may-2020-04-29", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-liberty-oilfield-mrc-global-capricor-therapeutics-2020-04-29", "https://www.nasdaq.com/articles/stock-alert%3A-gilead-sciences-up-4-on-positive-data-on-covid-19-drug-2020-04-29", "https://www.nasdaq.com/articles/gilead-sciences-says-remdesivir-hit-the-mark-in-covid-19-trial-2020-04-29", "https://www.nasdaq.com/articles/wall-street-jumps-on-hopes-of-potential-coronavirus-drug-2020-04-29-0", "https://www.nasdaq.com/articles/what-to-expect-from-gilead-earnings-2020-04-29", "https://www.nasdaq.com/articles/yields-down-ahead-of-fed-meeting-wrap-up-2020-04-29", "https://www.nasdaq.com/articles/dollar-drops-as-coronavirus-treatment-hopes-boosts-risk-sentiment-2020-04-29", "https://www.nasdaq.com/articles/wall-st-jumps-on-coronavirus-drug-hopes-fed-decision-awaited-2020-04-29", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-alphabet-spotify-blue-apron-2020-04-29", "https://www.nasdaq.com/articles/wall-st-set-to-jump-at-open-on-hopes-of-potential-coronavirus-drug-2020-04-29", "https://www.nasdaq.com/articles/gilead-sciences-records-positive-data-from-10-day-covid-19-trial-of-remdesivir-2020-04-29", "https://www.nasdaq.com/articles/gilead-says-remdesivir-shows-improvement-in-covid-19-patients-when-used-early-2020-04-29", "https://www.nasdaq.com/articles/us-stocks-snapshot-futures-jump-after-gileads-covid-19-drug-meets-main-goal-2020-04-29", "https://www.nasdaq.com/articles/gileads-remdesivir-meets-main-goal-of-trial-in-covid-19-patients-2020-04-29", "https://www.nasdaq.com/articles/better-buy%3A-cara-therapeutics-vs.-sangamo-therapeutics-2020-04-29", "https://www.nasdaq.com/articles/wall-street-jumps-on-hopes-of-potential-coronavirus-drug-2020-04-29", "https://www.nasdaq.com/articles/european-shares-rise-on-covid-19-drug-hopes-upbeat-outlook-from-corporates-2020-04-29", "https://www.nasdaq.com/articles/gilead-sciences-gild-remdesivir-sparks-market-hope-with-trial-success-2020-04-29", "https://www.nasdaq.com/articles/10-stocks-to-buy-for-an-aging-population-2020-04-28", "https://www.nasdaq.com/articles/the-abbvie-buyout-is-not-a-sure-thing-for-allergan-stock-investors-2020-04-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-regeneron-zoom-video-u.s.-oil-companies-apple-u.s.-insurers", "https://www.nasdaq.com/articles/pfizer-stock-is-much-more-than-just-a-coronavirus-play-2020-04-27", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-kohls-tanker-operators-oil-and-gas-companies-u.s.-casinos", "https://www.nasdaq.com/articles/the-cure-for-profitably-in-buying-gilead-sciences-2020-04-29", "https://www.nasdaq.com/articles/dont-let-negative-data-dissuade-you-from-gilead-sciences-2020-04-27", "https://www.nasdaq.com/articles/besides-remdesivir-these-2-covid-19-treatments-could-have-promise-2020-04-27", "https://www.nasdaq.com/articles/heres-what-to-expect-with-gilead-sciences-q1-earnings-update-2020-04-27", "https://www.nasdaq.com/articles/analysis-investors-bet-on-testing-treatments-for-restart-of-u.s.-economy-2020-04-27", "https://www.nasdaq.com/articles/moderna-scores-huge-grant-leads-charge-toward-coronavirus-vaccine-2020-04-27", "https://www.nasdaq.com/articles/analysis-investors-bet-on-testing-treatments-for-restart-of-u.s.-economy-2020-04-26", "https://www.nasdaq.com/articles/why-is-the-stock-market-hanging-its-hopes-on-gileads-remdesivir-2020-04-26", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tanker-operators-oil-and-gas-companies-caterpillar-2020-04-27", "https://www.nasdaq.com/articles/gilead-sciences-disputes-claim-that-remdesivir-failed-in-a-covid-19-trial-2020-04-24", "https://www.nasdaq.com/articles/exclusive-trial-of-gileads-potential-coronavirus-treatment-running-ahead-of-schedule-1", "https://www.nasdaq.com/articles/exclusive-trial-of-gileads-potential-coronavirus-treatment-running-ahead-of-schedule-0", "https://www.nasdaq.com/articles/exclusive-trial-of-gileads-potential-coronavirus-treatment-running-ahead-of-schedule", "https://www.nasdaq.com/articles/global-markets-stocks-struggle-with-muddled-government-pandemic-response-2020-04-24", "https://www.nasdaq.com/articles/why-remdesivir-clinical-studies-will-lift-gilead-sciences-2020-04-24", "https://www.nasdaq.com/articles/3-top-stocks-under-%245-to-buy-now-2020-04-24", "https://www.nasdaq.com/articles/while-big-pharma-tanked-gilead-sciences-and-regeneron-soared-2020-04-25", "https://www.nasdaq.com/articles/the-coronavirus-makes-ibio-finally-relevant-2020-04-24", "https://www.nasdaq.com/articles/european-shares-slide-as-eu-stimulus-fails-to-impress-2020-04-24", "https://www.nasdaq.com/articles/oil-selloff-weighs-on-ftse-as-retail-sales-sink-2020-04-24", "https://www.nasdaq.com/articles/emerging-markets-set-for-weekly-losses-as-doubts-arise-over-covid-19-drug-efficacy-2020-04", "https://www.nasdaq.com/articles/global-markets-stocks-fall-on-worries-over-eu-stimulus-details-coronavirus-drug-2020-04-24", "https://www.nasdaq.com/articles/ftse-100-tracks-global-mood-lower-as-retail-sales-sink-2020-04-24", "https://www.nasdaq.com/articles/european-shares-slide-as-pandemic-jitters-return-2020-04-24", "https://www.nasdaq.com/articles/global-markets-global-equities-edge-higher-as-oil-continues-rebound-2020-04-24", "https://www.nasdaq.com/articles/sanofi-confirms-targets-strong-demand-for-pain-killers-lifts-q1-2020-04-24", "https://www.nasdaq.com/articles/global-markets-asian-stocks-fall-europe-set-to-follow-on-doubts-over-coronavirus-drug-2020", "https://www.nasdaq.com/articles/se-asia-stocks-most-slide-on-lockdown-extension-in-parts-of-region-weak-global-data-2020", "https://www.nasdaq.com/articles/global-markets-asian-shares-fall-on-coronavirus-drug-economic-damage-concerns-2020-04-23", "https://www.nasdaq.com/articles/global-markets-asian-stocks-poised-to-rise-after-wall-street-gains-slip-away-2020-04-23", "https://www.nasdaq.com/articles/gilead-sciences-rebuts-report-claiming-covid-19-drug-remdesivir-trial-failed-2020-04-23", "https://www.nasdaq.com/articles/5-top-stock-trades-for-friday%3A-gild-ino-lvs-dpz-lly-2020-04-23", "https://www.nasdaq.com/articles/em-asia-fx-currencies-ease-on-lockdown-extensions-coronavirus-drug-report-2020-04-24", "https://www.nasdaq.com/articles/gileads-remdesivir-reportedly-flopped-in-chinese-covid-19-study-2020-04-23", "https://www.nasdaq.com/articles/jobs-data-treatment-buzz-keep-stock-gains-in-check-2020-04-23", "https://www.nasdaq.com/articles/sp-500-slips-after-report-on-coronavirus-drug-trial-2020-04-23-0", "https://www.nasdaq.com/articles/sp-500-slips-after-report-on-coronavirus-drug-trial-2020-04-23", "https://www.nasdaq.com/articles/who-to-launch-initiative-to-share-covid-19-drugs-tests-and-vaccines-statement-2020-04-23", "https://www.nasdaq.com/articles/wall-street-trims-gains-after-report-on-coronavirus-drug-trial-2020-04-23", "https://www.nasdaq.com/articles/buy-the-dip-in-gilead-stock-because-remdesivir-may-not-be-a-flop-2020-04-23", "https://www.nasdaq.com/articles/stock-market-wrap-up%3A-why-zoom-and-royal-caribbean-shares-jumped-today-2020-04-23", "https://www.nasdaq.com/articles/7-safe-stocks-to-buy-on-the-coronavirus-dip-2020-04-23", "https://www.nasdaq.com/articles/wall-st-rises-on-hopes-worst-for-labor-market-is-over-2020-04-23-0", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-cof-gild-wynn-2020-04-23", "https://www.nasdaq.com/articles/wall-street-pares-gains-on-report-of-potential-coronavirus-drug-failing-trial-2020-04-23", "https://www.nasdaq.com/articles/gileads-coronavirus-drug-flops-in-first-trial-ft-2020-04-23", "https://www.nasdaq.com/articles/first-week-of-gild-july-17th-options-trading-2020-04-23", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-expedia-group-crocs-enzo-biochem-2020-04-23", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-sleep-number-crocs-cassava-sciences-2020-04-23", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-aytu-bioscience-qep-resources-immunomedics-2020-04-23", "https://www.nasdaq.com/articles/is-it-too-late-to-buy-gilead-sciences-2020-04-23", "https://www.nasdaq.com/articles/better-buy%3A-abbvie-vs.-gilead-sciences-2020-04-23", "https://www.nasdaq.com/articles/foreigners-remain-net-sellers-of-japan-stocks-for-10th-week-2020-04-23", "https://www.nasdaq.com/articles/how-banks-have-prepared-for-a-slowdown-2020-04-22", "https://www.nasdaq.com/articles/artificial-intelligence-and-drug-discovery%3A-the-companies-leading-the-way-2020-04-22", "https://www.nasdaq.com/articles/the-10-best-dividend-stocks-for-2020-2020-04-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-immunomedics-helix-energy-sleep-number-corp-2020-04-23", "https://www.nasdaq.com/articles/gilead-sciences-races-to-manufacture-remdesivir-but-chemistry-has-speed-limits-2020-04-22", "https://www.nasdaq.com/articles/4-reasons-why-chesapeake-energy-stock-can-survive-2020-04-22", "https://www.nasdaq.com/articles/3-great-reasons-to-buy-gilead-sciences-stock-2020-04-22", "https://www.nasdaq.com/articles/gilead-onko-innate-announce-research-collaboration-for-cancer-therapy-2020-04-21", "https://www.nasdaq.com/articles/gilead-sciences%3A-possible-covid-19-treatment-already-priced-in-the-stock-says-analyst-2020", "https://www.nasdaq.com/articles/why-these-covid-19-vaccine-stocks-soared-today-2020-04-20", "https://www.nasdaq.com/articles/alexion-pharmaceuticals-to-initiate-phase-3-study-for-ultomiris-as-a-potential-coronavirus", "https://www.nasdaq.com/articles/does-british-american-tobaccos-covid-19-vaccine-make-it-a-buy-2020-04-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-co-diagnostics-xeris-pharma-cyclacel-pharma-2020-04-20", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-vym-gild-cme-usb-2020-04-20", "https://www.nasdaq.com/articles/gilead-sciences-reaches-analyst-target-price-2020-04-20", "https://www.nasdaq.com/articles/stock-market-gains-alongside-economic-pain-some-worry-about-over-optimism-2020-04-20", "https://www.nasdaq.com/articles/novartis-u.s.-drug-regulator-agree-to-malaria-drug-trial-against-covid-19-2020-04-20", "https://www.nasdaq.com/articles/novartis-u.s.-regulators-agree-to-malaria-drug-trial-against-covid-19-2020-04-20", "https://www.nasdaq.com/articles/stock-market-gains-alongside-economic-pain-some-worry-about-over-optimism-2020-04-19", "https://www.nasdaq.com/articles/theres-more-to-gilead-sciences-remdesivir-data-than-meets-the-eye-2020-04-20", "https://www.nasdaq.com/articles/2-best-stocks-to-buy-now-2020-04-19", "https://www.nasdaq.com/articles/can-gilead-sciences-coronavirus-gains-continue-2020-04-19", "https://www.nasdaq.com/articles/why-restaurant-stocks-jumped-today-2020-04-18", "https://www.nasdaq.com/articles/emerging-markets-mexican-peso-rises-on-stimulus-latam-fx-ends-week-in-losses-2020-04-17", "https://www.nasdaq.com/articles/wall-street-gains-on-boeing-surge-and-coronavirus-drug-hopes-2020-04-17", "https://www.nasdaq.com/articles/4-top-stock-trades-for-monday%3A-ba-mrna-slb-ksu-2020-04-17", "https://www.nasdaq.com/articles/global-markets-stocks-rally-as-investors-take-heart-on-u.s.-economic-reopening-plan-2020", "https://www.nasdaq.com/articles/if-you-invested-%241000-in-gilead-sciences-ipo-this-is-how-much-money-youd-have-now-2020-04", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-17-2020%3A-genegildworx-2020-04-17-0", "https://www.nasdaq.com/articles/wall-street-gains-on-boeing-news-trumps-reopening-plan-2020-04-17", "https://www.nasdaq.com/articles/gilead-stock-isnt-worth-chasing-now-despite-recent-remdesivir-success-2020-04-17", "https://www.nasdaq.com/articles/why-shares-of-amc-cinemark-live-nation-and-planet-fitness-popped-today-2020-04-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-17-2020%3A-genegildworx-2020-04-17", "https://www.nasdaq.com/articles/wall-st-climbs-on-boeing-trumps-reopening-plan-2020-04-17", "https://www.nasdaq.com/articles/whether-or-not-gilead-sciences-produces-a-successful-covid-19-therapeutic-its-a-bargain", "https://www.nasdaq.com/articles/wall-street-gains-on-boeing-surge-coronavirus-drug-hopes-2020-04-17-0", "https://www.nasdaq.com/articles/gileads-shares-rise-on-report-of-experimental-drugs-promise-in-covid-19-2020-04-17-0", "https://www.nasdaq.com/articles/global-markets-stocks-race-toward-second-weekly-gain-2020-04-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-schlumberger-biohaven-pharmaceutical-spirit-aerosystems-2020", "https://www.nasdaq.com/articles/wall-st-gains-on-boeing-trumps-restart-plan-2020-04-17", "https://www.nasdaq.com/articles/heres-why-jpmorgan-chase-and-other-bank-stocks-are-up-on-friday-2020-04-17", "https://www.nasdaq.com/articles/stock-market-news%3A-coronavirus-hopes-boost-these-2-stocks-2020-04-17", "https://www.nasdaq.com/articles/boeing-trumps-restart-plan-boost-wall-street-2020-04-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-netflix-cutera-moderna-2020-04-17", "https://www.nasdaq.com/articles/gileads-remdesivir-shows-promise-against-covid-19-in-sneak-peek-at-clinical-trial-data", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ctxs-gild-2020-04-17", "https://www.nasdaq.com/articles/u.s.-housing-secretary-says-gileads-remdesivir-appears-promising-for-covid-19-fox-business", "https://www.nasdaq.com/articles/gileads-shares-rise-on-report-of-experimental-drugs-promise-in-covid-19-2020-04-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-schlumberger-banks-spirit-aerosystems-state-street-2020-04-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-17-2020%3A-mrna-gild-worx-2020-04-17", "https://www.nasdaq.com/articles/boeing-lockdown-easing-hopes-set-to-lift-wall-street-2020-04-17", "https://www.nasdaq.com/articles/emerging-markets-latam-fx-topped-by-chiles-peso-but-eyes-weekly-losses-2020-04-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-pulmatrix-cutera-moderna-spirit-aerosystems-2020-04-17", "https://www.nasdaq.com/articles/coronavirus-drug-results-send-gilead-sciences-stock-flying-jpmorgan-weighs-in-2020-04-17", "https://www.nasdaq.com/articles/global-markets-super-charged-stocks-race-towards-second-weekly-gain-2020-04-17", "https://www.nasdaq.com/articles/daily-markets%3A-investors-cheer-gilead-results-and-reopening-roadmap-2020-04-17", "https://www.nasdaq.com/articles/u.s.-stocks-futures-jump-on-trumps-restart-plan-coronavirus-drug-hopes-2020-04-17", "https://www.nasdaq.com/articles/dont-waste-your-money-on-penny-stocks-these-2-stocks-are-better-buys-2020-04-17", "https://www.nasdaq.com/articles/us-stocks-futures-jump-on-trumps-restart-plan-coronavirus-drug-hopes-2020-04-17", "https://www.nasdaq.com/articles/institutional-investors-tell-big-pharma-to-cooperate-on-coronavirus-2020-04-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-pulmatrix-cutera-moderna-spirit-aerosystems-2020-04-17", "https://www.nasdaq.com/articles/emerging-markets-equities-buoyed-by-u.s.-optimism-as-currencies-dip-2020-04-17", "https://www.nasdaq.com/articles/lonza-focuses-on-coronavirus-projects-as-epidemic-brings-in-new-business-2020-04-17", "https://www.nasdaq.com/articles/south-african-rand-stronger-at-end-of-torrid-week-2020-04-17", "https://www.nasdaq.com/articles/global-markets-asian-stocks-rise-as-re-open-of-u.s-economy-offsets-china-gdp-slump-2020-04", "https://www.nasdaq.com/articles/nikkei-scales-6-week-high-on-hopes-for-virus-treatment-u.s.-plan-to-reopen-2020-04-17", "https://www.nasdaq.com/articles/hopes-for-virus-treatment-u.s.-reopening-snuff-out-dollar-rally-2020-04-17", "https://www.nasdaq.com/articles/uk-shares-surge-on-signs-of-u.s.-restart-rio-tinto-results-2020-04-17", "https://www.nasdaq.com/articles/dollar-wobbles-as-fresh-hopes-for-virus-treatment-prop-up-risk-appetite-2020-04-16", "https://www.nasdaq.com/articles/report-says-covid-19-patients-respond-to-gileads-remdesivir-shares-surge-2020-04-16", "https://www.nasdaq.com/articles/global-markets-asian-stocks-set-to-rise-as-markets-brace-for-china-gdp-data-2020-04-16", "https://www.nasdaq.com/articles/u.s.-stock-futures-jump-late-following-data-on-potential-virus-treatment-trump-guidelines", "https://www.nasdaq.com/articles/gilead-surges-after-report-suggests-covid-19-patients-responding-to-remdesivir-2020-04-16", "https://www.nasdaq.com/articles/gilead-sciences-drug-shows-promising-results-in-covid-19-patients-stock-up-14-2020-04-16", "https://www.nasdaq.com/articles/why-gilead-sciences-stock-is-on-fire-today-2020-04-16", "https://www.nasdaq.com/articles/dollar-slips-as-hopes-for-virus-treatment-prop-up-risk-appetite-2020-04-16", "https://www.nasdaq.com/articles/is-exelixis-a-buy-2020-04-16", "https://www.nasdaq.com/articles/why-arcus-biosciences-stock-is-skyrocketing-today-2020-04-16", "https://www.nasdaq.com/articles/gilead-sciences-remdesivir-data-release-brings-much-needed-relief-for-patients-and", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-16-2020%3A-sngx-gild-rcus-rad-jnj-pfe-abt-mrk-amgn-2020-04", "https://www.nasdaq.com/articles/astrazeneca-to-test-blood-cancer-drug-for-covid-19-treatment-2020-04-15", "https://www.nasdaq.com/articles/chinese-researchers-suspend-trial-of-experimental-coronavirus-treatment-2020-04-15", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-u.s.-oil-stocks-retailers-restaurants-bofa-j.c.-penny-ibm", "https://www.nasdaq.com/articles/report%3A-gilead-is-considering-taking-a-stake-in-arcus-biosciences-2020-04-16", "https://www.nasdaq.com/articles/initial-coronavirus-treatment-trials-look-good-for-gilead-stock-2020-04-15", "https://www.nasdaq.com/articles/gilead-stock-could-get-a-lift-from-a-coronavirus-treatment-2020-04-15", "https://www.nasdaq.com/articles/is-moderna-a-good-coronavirus-stock-to-buy-2020-04-15", "https://www.nasdaq.com/articles/three-reasons-to-consider-buying-regeneron-stock-2020-04-14", "https://www.nasdaq.com/articles/how-good-is-gileads-latest-news-for-coronavirus-drug-remdesivir-2020-04-14", "https://www.nasdaq.com/articles/amrn-chugs-along-athx-to-initiate-pivotal-covid-19-trial-worx-soars-550-2020-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-13-2020%3A-pstiworxgildcanf-2020-04-13", "https://www.nasdaq.com/articles/buying-gilead-sciences-stock-means-buying-into-political-risk-2020-04-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-13-2020%3A-worxgildcanf-2020-04-13", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-netflix-amazon.com-dish-network-ge-amc-entertainment-aurora", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-amazon.com-netflix-royal-caribbean-cruises-sabre-corp", "https://www.nasdaq.com/articles/wall-street-week-ahead-health-tech-staples-could-shine-through-earnings-gloom-2020-04-13", "https://www.nasdaq.com/articles/wall-street-set-to-dip-as-focus-turns-to-earnings-2020-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-13-2020%3A-canf-ctso-gild-jnj-pfe-abt-mrk-amgn-2020-04-13", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-carnival-corp-gilead-sciencs-pluristem-therapeutics-dropbox", "https://www.nasdaq.com/articles/reasons-for-hope%3A-the-drugs-tests-and-tactics-that-may-conquer-coronavirus-2020-04-13", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-april-2020-04-12", "https://www.nasdaq.com/articles/is-galapagos-stock-a-buy-2020-04-12", "https://www.nasdaq.com/articles/eli-lilly-starts-clinical-trial-for-potential-covid-19-treatment-2020-04-11", "https://www.nasdaq.com/articles/early-look-at-gilead-sciences-experimental-coronavirus-treatment-disappoints-2020-04-11", "https://www.nasdaq.com/articles/5-biotech-stocks-winning-the-coronavirus-race-2020-04-11", "https://www.nasdaq.com/articles/bristol-myers-win-in-u.s.-patent-case-against-gilead-boosted-to-%241.2-bln-2020-04-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-09-2020%3A-biocbhcbhc.tortixgild-2020-04-09", "https://www.nasdaq.com/articles/us-stocks-futures-fall-as-focus-turns-to-corporate-earnings-2020-04-13", "https://www.nasdaq.com/articles/gild-may-29th-options-begin-trading-2020-04-09", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ctxs-ual-2020-04-09", "https://www.nasdaq.com/articles/gilead-canada-submits-snds-to-health-canada-for-descovy-quick-facts-2020-04-09", "https://www.nasdaq.com/articles/why-forty-seven-stock-skyrocketed-64.5-in-march-2020-04-08", "https://www.nasdaq.com/articles/good-news-for-remdesivir-is-good-news-for-gilead-sciences-stock-2020-04-08", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-emergent-biosolutions-vs.-gilead-sciences-2020-04-08", "https://www.nasdaq.com/articles/novavax-to-start-human-trial-for-novel-coronavirus-vaccine-2020-04-08", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-09-2020%3A-bhcbhc.tortixgild-2020-04-09", "https://www.nasdaq.com/articles/investors-await-data-on-coronavirus-drugs-as-market-rally-builds-2020-04-07", "https://www.nasdaq.com/articles/tuesday-sector-laggards%3A-utilities-healthcare-2020-04-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-activision-blizzard-gilead-sciences-royal-caribbean-kohls", "https://www.nasdaq.com/articles/is-inovio-pharmaceuticals-a-good-buy-on-coronavirus-potential-2020-04-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-royal-caribbean-kohls-gilead-sciences-electronic-arts-2020-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-roadrunner-transportation-gannett-co-liminal-biosciences-2020", "https://www.nasdaq.com/articles/gilead-unit-completes-acquisition-of-forty-seven-quick-facts-2020-04-07", "https://www.nasdaq.com/articles/graphic-wall-st-volatility-raises-fears-of-another-selloff-2020-04-07", "https://www.nasdaq.com/articles/here-are-all-the-companies-working-on-covid-19-vaccines-treatments-and-testing-2020-04-07", "https://www.nasdaq.com/articles/my-top-biotech-stocks-to-buy-in-the-market-crash-2020-04-07", "https://www.nasdaq.com/articles/gilead-sciences-pins-its-hopes-on-remdesivir-2020-04-07", "https://www.nasdaq.com/articles/doctors-embrace-drug-touted-by-trump-for-covid-19-without-hard-evidence-it-works-2020-04", "https://www.nasdaq.com/articles/monday-sector-laggards%3A-healthcare-energy-2020-04-06", "https://www.nasdaq.com/articles/coronavirus-fighter-gilead-sciences-might-be-expensive-but-its-still-worth-owning-2020-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gilead-sciences-wayfair-immunomedics-akers-bioscience-2020-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-roadrunner-transportation-trevi-therapeutics-gannett-co-2020", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-carnival-corp-capri-holdings-kohls-immunomedics-2020-04-06", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-kohls-carnival-corp-akers-bioscience-immunomedics-2020-04-06", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ctxs-ulta-2020-04-06", "https://www.nasdaq.com/articles/its-tough-to-admit-but-our-new-normal-might-justify-buying-ibio-stock-2020-04-06", "https://www.nasdaq.com/articles/gilead-to-donate-1.5-mln-doses-of-investigational-covid-19-drug-remdesivir-2020-04-06", "https://www.nasdaq.com/articles/gsk-to-partner-with-vir-for-potential-covid-19-treatments-invest-%24250-mln-2020-04-06-0", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-borr-drillng-millendo-therapeutics-menlo-therapeutics", "https://www.nasdaq.com/articles/gsk-to-partner-with-vir-for-potential-covid-19-treatments-invest-%24250-mln-2020-04-06-1", "https://www.nasdaq.com/articles/gilead-second-genome-enter-four-year-strategic-collaboration-quick-facts-2020-04-06", "https://www.nasdaq.com/articles/gilead-has-treated-more-than-1700-covid-19-patients-with-remdesivir-2020-04-06", "https://www.nasdaq.com/articles/the-5-best-coronavirus-stocks-to-buy-right-now-2020-04-05", "https://www.nasdaq.com/articles/should-you-buy-gilead-sciences-stock-right-now-2020-04-05", "https://www.nasdaq.com/articles/yes-the-stock-market-will-probably-go-lower.-heres-why-you-should-invest-anyway.-2020-04", "https://www.nasdaq.com/articles/3-coronavirus-stocks-that-could-lead-the-market-to-recovery-2020-04-05", "https://www.nasdaq.com/articles/should-you-buy-forty-seven-before-gilead-sciences-acquisition-closes-2020-04-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-crescent-point-energy-millendo-therapeutics-menlo", "https://www.nasdaq.com/articles/why-gilead-sciences-is-the-hottest-stock-to-buy-today-2020-04-04", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-mtsi-gild-wynn-2020-04-03", "https://www.nasdaq.com/articles/gilead-sciences-coronavirus-treatment-has-big-time-potential-2020-04-03", "https://www.nasdaq.com/articles/ema-recommends-remdesivir-for-treatment-of-covid-19-under-compassionate-use-rules-2020-04", "https://www.nasdaq.com/articles/ema-recommends-compassionate-use-of-gileads-remdesivir-for-covid-19-2020-04-03", "https://www.nasdaq.com/articles/why-gilead-sciences-shares-rose-7.79-in-march-2020-04-03", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-biogen-2020-04-03", "https://www.nasdaq.com/articles/is-the-end-of-quarter-market-run-up-just-wall-street-dressing-the-window-2020-04-04", "https://www.nasdaq.com/articles/gild-stock-remains-a-smart-play-now-and-in-the-future-2020-04-02", "https://www.nasdaq.com/articles/top-3-healthcare-stocks-to-buy-right-now-2020-04-02", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-abbott-labs-vs.-gilead-sciences-2020-04-02", "https://www.nasdaq.com/articles/my-top-pharma-stocks-to-buy-in-the-market-crash-2020-04-02", "https://www.nasdaq.com/articles/is-ibio-stock-worth-the-risk-as-coronavirus-continues-to-spread-2020-03-31", "https://www.nasdaq.com/articles/5-hot-stocks-for-2020-that-are-soaring-while-the-market-plunges-2020-03-31", "https://www.nasdaq.com/articles/gileads-cash-and-the-coronavirus-make-gild-stock-look-cheap-2020-03-31", "https://www.nasdaq.com/articles/gild-may-22nd-options-begin-trading-2020-04-02", "https://www.nasdaq.com/articles/4-reasons-drug-stocks-are-a-buy-right-now-2020-03-30", "https://www.nasdaq.com/articles/is-it-time-to-buy-stocks-or-is-the-market-heading-even-lower-2020-03-30", "https://www.nasdaq.com/articles/gilead-expands-access-to-investigational-anti-coronavirus-drug-2020-03-30", "https://www.nasdaq.com/articles/gilead-sciences-expands-access-to-experimental-covid-19-treatment-2020-03-29", "https://www.nasdaq.com/articles/3-coronavirus-proof-dividend-stocks-that-are-perfect-for-retirees-2020-03-29", "https://www.nasdaq.com/articles/2-biotech-stocks-in-the-hunt-for-new-coronavirus-drugs-oppenheimer-weighs-in-2020-03-29", "https://www.nasdaq.com/articles/the-3-most-resilient-stocks-in-the-bear-market-today-2020-03-28", "https://www.nasdaq.com/articles/look-for-better-buys-than-coronavirus-play-ino-stock-2020-03-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-rsp-regn-gild-amd-2020-03-27", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-expe-gild-2020-03-27", "https://www.nasdaq.com/articles/for-gilead-its-coronavirus-treatment-is-icing-on-the-cake-2020-03-27", "https://www.nasdaq.com/articles/3-things-to-know-if-chloroquine-wins-the-covid-19-treatment-race-2020-03-27", "https://www.nasdaq.com/articles/7-u.s.-stocks-to-buy-on-coronavirus-weakness-2020-03-26", "https://www.nasdaq.com/articles/this-pr-nightmare-for-gild-stock-will-eventually-fade-2020-03-26", "https://www.nasdaq.com/articles/may-8th-options-now-available-for-gilead-sciences-gild-2020-03-26", "https://www.nasdaq.com/articles/first-week-of-gild-november-20th-options-trading-2020-03-27", "https://www.nasdaq.com/articles/1-safe-haven-stock-for-the-near-term-2020-03-26", "https://www.nasdaq.com/articles/gild-seeks-to-revoke-coveted-status-elox-pauses-trial-prqr-on-watch-2020-03-26", "https://www.nasdaq.com/articles/a-covid-19-immunity-test-is-on-the-way-2020-03-25", "https://www.nasdaq.com/articles/gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-25-2020%3A-gildastcvtgnallk-2020-03-25", "https://www.nasdaq.com/articles/how-are-market-caps-doing-in-a-downturn-2020-03-25", "https://www.nasdaq.com/articles/moderna-ceo-says-a-coronavirus-vaccine-could-be-available-in-emergencies-this-fall-2020-03", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-gilead-sciences-vs.-moderna-2020-03-26", "https://www.nasdaq.com/articles/5-stocks-to-buy-in-the-coronavirus-bear-market-2020-03-25", "https://www.nasdaq.com/articles/4-reasons-biotech-stocks-are-a-buy-right-now-2020-03-25", "https://www.nasdaq.com/articles/coronavirus-drugs-already-in-the-pipeline-2020-03-25", "https://www.nasdaq.com/articles/10-stocks-to-buy-as-they-ride-a-coronavirus-tailwind-2020-03-24", "https://www.nasdaq.com/articles/top-notch-vaccine-technology-makes-ibio-stock-a-smart-bet-2020-03-24", "https://www.nasdaq.com/articles/inovio-could-be-a-bargain-using-probability-analysis-2020-03-24", "https://www.nasdaq.com/articles/3-biotech-stocks-fighting-the-coronavirus-heres-what-to-expect-2020-03-24", "https://www.nasdaq.com/articles/wednesday-sector-laggards%3A-technology-communications-healthcare-2020-03-25", "https://www.nasdaq.com/articles/why-consider-these-2-stocks-when-markets-are-crashing-2020-03-24", "https://www.nasdaq.com/articles/gilead-stock-flies-high-with-a-potential-coronavirus-treatment-2020-03-23", "https://www.nasdaq.com/articles/gilead-sciences-stops-accepting-emergency-use-applications-for-remdesivir-2020-03-23", "https://www.nasdaq.com/articles/dont-forget-about-stocks-to-buy-during-the-coronavirus-crisis-2020-03-23", "https://www.nasdaq.com/articles/3-things-to-watch-in-the-coronavirus-bear-market-this-week-2020-03-23", "https://www.nasdaq.com/articles/coronavirus-crisis%3A-3-biotech-stocks-to-buy-right-now-2020-03-22", "https://www.nasdaq.com/articles/all-the-drugs-proving-anecdotally-effective-against-covid-19-and-the-companies-that-make", "https://www.nasdaq.com/articles/top-pharma-stocks-under-%245-2020-03-24", "https://www.nasdaq.com/articles/gileads-coronavirus-vaccine-candidate-shows-promise-says-cowen-2020-03-20", "https://www.nasdaq.com/articles/trumps-coronavirus-news-conference-on-thursday%3A-3-key-things-that-investors-should-know", "https://www.nasdaq.com/articles/3-of-the-strongest-stocks-to-buy-2020-03-20", "https://www.nasdaq.com/articles/these-4-top-stocks-are-bear-market-tested-2020-03-20", "https://www.nasdaq.com/articles/is-it-too-late-to-buy-coronavirus-biotech-stocks-2020-03-20", "https://www.nasdaq.com/articles/mylan-ramps-up-production-of-hydroxychloroquine-as-a-potential-covid-19-treatment-2020-03", "https://www.nasdaq.com/articles/china-reports-no-new-coronavirus-outbreaks-first-time-since-outbreak-began-2020-03-19", "https://www.nasdaq.com/articles/nonprofit-group-starts-multiple-covid-19-clinical-studies-2020-03-21", "https://www.nasdaq.com/articles/coronavirus-fighting-tech-makes-ibio-stock-an-interesting-play-2020-03-19", "https://www.nasdaq.com/articles/japanese-developed-flu-drug-avigan-seems-effective-against-covid-19-2020-03-19", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-esgu-nee-adbe-gild-2020-03-19", "https://www.nasdaq.com/articles/big-pharmas-fight-against-the-coronavirus-pandemic%3A-good-news-and-bad-news-2020-03-19", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-gilead-sciences-or-regeneron-pharmaceuticals-2020-03-19", "https://www.nasdaq.com/articles/trump-signs-coronavirus-relief-bill-into-law-2020-03-19", "https://www.nasdaq.com/articles/bayer-is-donating-its-malaria-drug-that-could-help-coronavirus-patients-in-the-u.s.-2020", "https://www.nasdaq.com/articles/remdesivir-other-positive-catalysts-should-lift-gilead-stock-2020-03-19", "https://www.nasdaq.com/articles/how-to-survive-the-economic-fallout-from-covid-19-2020-03-18", "https://www.nasdaq.com/articles/8-best-performing-stocks-during-the-2020s-market-meltdown-2020-03-17", "https://www.nasdaq.com/articles/why-regeneron-pharmaceuticals-stock-is-bolting-higher-today-2020-03-17", "https://www.nasdaq.com/articles/3-cloud-computing-stocks-that-are-winning-from-the-coronavirus-2020-03-17", "https://www.nasdaq.com/articles/coronavirus-correction%3A-3-must-own-dividend-stocks-2020-03-17", "https://www.nasdaq.com/articles/will-your-elective-surgery-be-delayed-by-coronavirus-2020-03-17", "https://www.nasdaq.com/articles/will-covid-19-derail-new-drugs-2020-03-18", "https://www.nasdaq.com/articles/as-the-coronavirus-worsens-ino-stock-gets-more-interesting-2020-03-16", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2020-03-16", "https://www.nasdaq.com/articles/can-this-american-biotech-company-save-the-global-economy-2020-03-16", "https://www.nasdaq.com/articles/why-this-coronavirus-stock-will-keep-growing-long-after-the-outbreak-is-over-2020-03-15", "https://www.nasdaq.com/articles/when-will-the-coronavirus-market-crash-be-over-watch-these-3-stocks-2020-03-15", "https://www.nasdaq.com/articles/early-results-dampen-outlook-for-experimental-covid-19-treatment-2020-03-14", "https://www.nasdaq.com/articles/eli-lilly-joins-the-hunt-for-a-coronavirus-treatment-2020-03-13", "https://www.nasdaq.com/articles/european-medicines-agency-offers-free-advice-for-drugmakers-working-on-coronavirus", "https://www.nasdaq.com/articles/why-ibio-pharma-stock-is-not-for-timid-investors-despite-great-potential-2020-03-12", "https://www.nasdaq.com/articles/cdc-releases-list-of-conditions-that-increase-the-risk-of-severe-coronavirus-illness-2020", "https://www.nasdaq.com/articles/10-health-and-pharmaceutical-companies-fighting-the-coronavirus-2020-03-12", "https://www.nasdaq.com/articles/cdc%3A-gilead-sciences-remdesivir-is-being-used-to-treat-coronavirus-patients-2020-03-12", "https://www.nasdaq.com/articles/world-health-organization%3A-coronavirus-disease-covid-19-now-a-pandemic-2020-03-11", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-wdc-ntes-2020-03-11", "https://www.nasdaq.com/articles/sp-500-movers%3A-wcg-dxc-2020-03-11", "https://www.nasdaq.com/articles/the-12-best-low-volatility-stocks-of-the-market-crash-2020-03-13", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-gilead-sciences-vs.-inovio-pharmaceuticals-2020-03-11", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2020-03-11", "https://www.nasdaq.com/articles/fda-postpones-all-foreign-inspections-over-coronavirus-2020-03-11", "https://www.nasdaq.com/articles/the-gates-foundation-and-friends-launch-covid-19-treatment-accelerator-2020-03-10", "https://www.nasdaq.com/articles/covid-19-nearing-pandemic-level-who-warns-2020-03-10", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-large-outflows-detected-at-etf-2020-03-10", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-gild-tsla-2020-03-10", "https://www.nasdaq.com/articles/will-moderna-make-a-fortune-off-its-coronavirus-vaccine-2020-03-11", "https://www.nasdaq.com/articles/abbvie-to-test-hiv-drug-as-a-potential-coronavirus-treatment-2020-03-10", "https://www.nasdaq.com/articles/7-big-pharma-companies-trump-asked-to-fight-the-coronavirus-outbreak-2020-03-10", "https://www.nasdaq.com/articles/how-to-be-greedy-when-others-are-fearful-2020-03-10", "https://www.nasdaq.com/articles/3-profitable-healthcare-stocks-that-are-trouncing-the-market-during-the-coronavirus", "https://www.nasdaq.com/articles/gild-stock-looks-poised-for-a-serious-coronavirus-bump-2020-03-10", "https://www.nasdaq.com/articles/cdc-says-coronavirus-spread-to-continue-into-2021-2020-03-09", "https://www.nasdaq.com/articles/study-warns-number-of-u.s.-covid-19-cases-much-higher-than-reported-2020-03-09", "https://www.nasdaq.com/articles/sp-500-movers%3A-wcg-apa-2020-03-10", "https://www.nasdaq.com/articles/is-inovio-pharmaceuticals-stock-the-cure-for-your-portfolio-2020-03-09", "https://www.nasdaq.com/articles/fda-warns-companies-selling-fraudulent-covid-19-products-2020-03-09", "https://www.nasdaq.com/articles/moderna-stocks-winning-streak-seems-likely-to-end-2020-03-09", "https://www.nasdaq.com/articles/will-gilead-sciences-make-a-fortune-off-its-coronavirus-drug-2020-03-09", "https://www.nasdaq.com/articles/gild-crosses-above-average-analyst-target-2020-03-09", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-gilead-sciences-2020-03-09", "https://www.nasdaq.com/articles/gilead-sciences-could-be-the-first-to-beat-the-coronavirus-2020-03-08", "https://www.nasdaq.com/articles/cdc-advises-americans-to-postpone-cruises-2020-03-09", "https://www.nasdaq.com/articles/3-stocks-that-are-actually-up-because-of-the-coronavirus-2020-03-08", "https://www.nasdaq.com/articles/4-top-stock-trades-for-monday%3A-amd-wmt-crm-gild-2020-03-06", "https://www.nasdaq.com/articles/is-there-a-cure-for-the-sars-cov-2-coronavirus-2020-03-06", "https://www.nasdaq.com/articles/amid-the-coronavirus-frenzy-novavax-remains-a-risky-bet-2020-03-06", "https://www.nasdaq.com/articles/epa-releases-list-of-disinfectants-to-protect-against-coronavirus-2020-03-06", "https://www.nasdaq.com/articles/3-top-u.s.-stocks-to-watch-in-march-2020-03-06", "https://www.nasdaq.com/articles/heres-my-top-stock-to-buy-in-march-2020-03-06", "https://www.nasdaq.com/articles/coronavirus-market-correction%3A-where-to-invest-%241000-right-now-2020-03-08", "https://www.nasdaq.com/articles/inovio-pharmaceuticals-rapidly-becoming-the-premier-coronavirus-play-2020-03-05", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2020-03-05", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-aal-ntes-2020-03-05", "https://www.nasdaq.com/articles/is-inovio-stock-a-buy-on-coronavirus-cure-potential-2020-03-05", "https://www.nasdaq.com/articles/up-2000-on-coronavirus-worries-codx-stock-is-a-short-term-buy-2020-03-05", "https://www.nasdaq.com/articles/3-biotech-stocks-that-are-coronavirus-safe-havens-2020-03-05", "https://www.nasdaq.com/articles/is-inovio-stock-still-a-buy-after-its-massive-150-leap-this-year-2020-03-05", "https://www.nasdaq.com/articles/congress-approves-%248.3-billion-coronavirus-funding-bill-2020-03-05", "https://www.nasdaq.com/articles/china-approves-a-treatment-for-covid-19-complications-2020-03-04", "https://www.nasdaq.com/articles/wednesdays-etf-with-unusual-volume%3A-mdiv-2020-03-04", "https://www.nasdaq.com/articles/why-its-probably-safe-to-start-buying-amd-stock-on-weakness-2020-03-04", "https://www.nasdaq.com/articles/is-gilead-sciences-the-best-buy-in-the-coronavirus-sell-off-2020-03-04", "https://www.nasdaq.com/articles/why-forty-seven-stock-soared-57-in-february-2020-03-04", "https://www.nasdaq.com/articles/buy-regeneron-stock-for-coronavirus-2.0-and-beyond-2020-03-04", "https://www.nasdaq.com/articles/barrick-gold-isnt-the-best-hedge-against-the-coronavirus-2020-03-04", "https://www.nasdaq.com/articles/moderna-ceo-says-its-coronavirus-vaccine-will-be-affordable-2020-03-04", "https://www.nasdaq.com/articles/trump-administration-considers-reimbursing-hospitals-to-treat-uninsured-coronavirus", "https://www.nasdaq.com/articles/kids-may-be-the-hidden-carriers-of-covid-19-2020-03-03", "https://www.nasdaq.com/articles/inovio-has-potential-beyond-its-speculative-coronavirus-vaccine-2020-03-03", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-adsk-tsla-2020-03-03", "https://www.nasdaq.com/articles/nasdaq-ceo-says-capital-is-part-of-curing-the-coronavirus-2020-03-03", "https://www.nasdaq.com/articles/dow-jones-recovers-1300-points-despite-increase-in-u.s.-coronavirus-deaths-2020-03-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-02-2020%3A-codxftsvgildapdnumrx-2020-03-02", "https://www.nasdaq.com/articles/trump-considering-expanded-travel-ban-in-effort-to-slow-the-spread-of-coronavirus-2020-03", "https://www.nasdaq.com/articles/now-is-the-time-to-buy-the-dip-in-amazon-stock-for-the-long-term-2020-03-02", "https://www.nasdaq.com/articles/gilead-sciences-acquiring-cancer-focused-biotech-forty-seven-for-%244.9-billion-2020-03-02", "https://www.nasdaq.com/articles/why-gilead-sciences-forty-seven-and-trillium-therapeutics-are-moving-higher-today-2020-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-02-2020%3A-ftsv-gild-kpti-codx-jnj-pfe-abt-mrk-amgn-2020-03", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-march-2020-03-02", "https://www.nasdaq.com/articles/daily-markets%3A-investors-hoping-central-banks-will-relieve-coronavirus-pressures-2020-03", "https://www.nasdaq.com/articles/forty-sevens-stock-surges-as-gilead-sciences-to-buy-company-in-%244.9-bln-deal-2020-03-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-02-2020%3A-apdnftsvgildumrx-2020-03-02", "https://www.nasdaq.com/articles/2-biotech-stocks-winning-the-coronavirus-race-2020-03-01", "https://www.nasdaq.com/articles/2-stocks-that-can-help-you-protect-your-wealth-from-a-coronavirus-pandemic-2020-03-01", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-pfizer-2020-03-01", "https://www.nasdaq.com/articles/7-stocks-to-buy-as-a-hedge-against-the-coronavirus-threat-2020-03-01", "https://www.nasdaq.com/articles/all-the-stocks-im-selling-if-the-coronavirus-keeps-spreading-2020-03-01", "https://www.nasdaq.com/articles/fda-approves-coronavirus-tests-in-academic-laboratories-across-u.s.-2020-03-01", "https://www.nasdaq.com/articles/coronavirus%3A-emerging-numbers-provide-reasons-for-calm-2020-02-29", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-march-2020-2020-03-02", "https://www.nasdaq.com/articles/heres-why-hype-around-companies-working-on-coronavirus-treatments-is-overblown-2020-02-29", "https://www.nasdaq.com/articles/3-small-caps-that-are-soaring-because-of-coronavirus-panic-2020-02-29", "https://www.nasdaq.com/articles/dow-falls-another-350-points-on-coronavirus-concerns-worst-week-since-2008-2020-02-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-28-2020%3A-dnlialtftsvgildclsn-2020-02-28", "https://www.nasdaq.com/articles/gilead-sciences-gild-shares-cross-4-yield-mark-2020-02-28", "https://www.nasdaq.com/articles/gilead-reportedly-in-talks-to-acquire-cancer-biotech-forty-seven-2020-02-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-28-2020%3A-altftsvgildclsn-2020-02-28", "https://www.nasdaq.com/articles/investors-endure-wild-ride-in-this-biotech-taking-on-covid-19-2020-02-29", "https://www.nasdaq.com/articles/stock-alert%3A-forty-seven-surges-30-2020-02-28", "https://www.nasdaq.com/articles/forty-seven-ftsv-soars-on-reports-of-takeover-interest-2020-02-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-28-2020%3A-ftsv-gild-sgmo-bhvn-jnj-pfe-abt-mrk-amgn-2020-02", "https://www.nasdaq.com/articles/how-gilead-sciences-is-driving-forty-seven-and-trillium-therapeutics-higher-today-2020-02", "https://www.nasdaq.com/articles/this-under-the-radar-stock-is-the-biggest-winner-from-the-coronavirus-outbreak-2020-02-28", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-saia-gild-ma-2020-02-27", "https://www.nasdaq.com/articles/april-9th-options-now-available-for-gilead-sciences-gild-2020-02-27", "https://www.nasdaq.com/articles/traders-are-treating-inovio-like-2018s-pot-stock-stars-2020-02-28", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-aal-gild-2020-02-27", "https://www.nasdaq.com/articles/sp-500-movers%3A-flir-pwr-2020-02-27", "https://www.nasdaq.com/articles/stock-alert%3A-gild-gains-after-initiating-phase-3-studies-for-covid-19-treatment-2020-02-27", "https://www.nasdaq.com/articles/momentum-stocks-benefitting-from-coronavirus-2020-02-27", "https://www.nasdaq.com/articles/why-inovio-pharmaceuticals-gilead-sciences-moderna-and-novavax-are-all-jumping-today-2020", "https://www.nasdaq.com/articles/fighting-the-deadly-coronavirus-2020-02-27", "https://www.nasdaq.com/articles/buy-microsoft-stock-on-the-dip-over-coronavirus-2020-02-27", "https://www.nasdaq.com/articles/wait-for-tesla-stock-to-drop-below-%24700-on-coronavirus-fears-2020-02-27", "https://www.nasdaq.com/articles/airport-screeners-are-likely-missing-2-out-of-3-covid-19-carriers-researchers-warn-2020-02", "https://www.nasdaq.com/articles/resilience-to-coronavirus-concern-is-a-bullish-sign-for-alibaba-stock-2020-02-26", "https://www.nasdaq.com/articles/novavax-to-begin-clinical-testing-of-coronavirus-vaccine-by-late-spring-2020-02-26", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-ibb-gild-vrtx-biib-2020-02-26", "https://www.nasdaq.com/articles/7-safe-stocks-to-buy-on-the-coronavirus-dip-2020-02-26", "https://www.nasdaq.com/articles/gileads-coronavirus-drug-could-propel-gild-stock-much-higher-2020-02-26", "https://www.nasdaq.com/articles/should-you-buy-inovio-pharmaceuticals-stock-right-now-2020-02-26", "https://www.nasdaq.com/articles/gilead-sciences-initiates-late-stage-testing-of-its-promising-coronavirus-drug-2020-02-26", "https://www.nasdaq.com/articles/u.s.-health-official-warns%3A-covid-19-will-hit-the-united-states-2020-02-25", "https://www.nasdaq.com/articles/u.s.-health-officials-start-first-clinical-trial-with-gilead-sciences-experimental", "https://www.nasdaq.com/articles/nio-stock-will-sustain-momentum-in-2020-despite-coronavirus-concerns-2020-02-25", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-gild-regn-2020-02-25", "https://www.nasdaq.com/articles/8-of-the-best-stocks-to-buy-for-esg-investors-2020-02-25", "https://www.nasdaq.com/articles/is-it-too-late-to-buy-high-flying-galapagos-2020-02-25", "https://www.nasdaq.com/articles/11-best-stocks-to-ride-out-the-coronavirus-outbreak-2020-02-25", "https://www.nasdaq.com/articles/meet-the-company-that-just-might-prevent-a-global-recession-2020-02-26", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-24-2020%3A-ngmuthrgildepzm-2020-02-24", "https://www.nasdaq.com/articles/gilead-antiviral-drug-shows-the-most-potential-for-covid-19-says-who-official-2020-02-24", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-24-2020%3A-uthrgildepzm-2020-02-24", "https://www.nasdaq.com/articles/stock-market-news%3A-berkshire-sinks-despite-buffett-optimism-gilead-rises-on-coronavirus", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-aal-gild-2020-02-24", "https://www.nasdaq.com/articles/sp-500-movers%3A-aal-gild-2020-02-24", "https://www.nasdaq.com/articles/3-dividend-stocks-that-raised-their-payouts-in-february-2020-02-22", "https://www.nasdaq.com/articles/modernas-new-covid-19-vaccine-ready-for-human-trials-stock-up-15-2020-02-25", "https://www.nasdaq.com/articles/a-plan-to-use-blockchain-to-stop-counterfeit-drugs-moves-forward-2020-02-21", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-algn-bmrn-2020-02-21", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-stx-unp-gild-2020-02-20", "https://www.nasdaq.com/articles/why-wells-fargo-stock-looks-poised-to-rebound-2020-02-20", "https://www.nasdaq.com/articles/3-contrarian-stocks-to-buy-now-for-absolute-returns-2020-02-19", "https://www.nasdaq.com/articles/where-will-gilead-sciences-be-in-10-years-2020-02-19", "https://www.nasdaq.com/articles/report%3A-gilead-struggling-to-find-subjects-for-covid-19-drug-trial-2020-02-18", "https://www.nasdaq.com/articles/is-gilead-sciences-stock-a-buy-2020-02-22", "https://www.nasdaq.com/articles/2-reasons-to-be-optimistic-about-gilead-sciences-future-2020-02-18", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-outflow-alert-2020-02-18", "https://www.nasdaq.com/articles/is-viking-therapeutics-stock-a-buy-2020-02-18", "https://www.nasdaq.com/articles/moderna-will-rebound-but-wait-for-a-dip-lower-to-buy-shares-2020-02-18", "https://www.nasdaq.com/articles/the-fda-has-a-plan-to-deal-with-the-coronavirus-2020-02-17", "https://www.nasdaq.com/articles/better-buy%3A-abbvie-vs.-gilead-sciences-2020-02-16", "https://www.nasdaq.com/articles/3-high-yielding-u.s.-pharmaceutical-companies-to-consider-2020-02-15", "https://www.nasdaq.com/articles/johnson-johnson-expands-pact-with-u.s.-government-to-seek-a-treatment-for-covid-19-2020-02", "https://www.nasdaq.com/articles/white-house-claims-other-countries-are-free-riding-on-u.s.-drug-development-2020-02-13", "https://www.nasdaq.com/articles/inovios-surge-on-a-coronavirus-vaccine-was-just-speculation-2020-02-13", "https://www.nasdaq.com/articles/3-biotech-stocks-that-made-early-shareholders-millionaires-2020-02-13", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-egle-gild-seas-2020-02-12", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-cern-csgp-2020-02-12", "https://www.nasdaq.com/articles/is-moderna-a-buy-2020-02-12", "https://www.nasdaq.com/articles/pandemic-fears-not-enough-to-buy-inovio-stock-2020-02-12", "https://www.nasdaq.com/articles/sp-500-analyst-moves%3A-gild-2020-02-14", "https://www.nasdaq.com/articles/better-buy%3A-bluebird-bio-vs.-gilead-sciences-2020-02-12", "https://www.nasdaq.com/articles/johnson-johnson-announces-partnership-with-u.s.-government-to-accelerate-coronavirus", "https://www.nasdaq.com/articles/coronavirus-gets-an-official-name-from-the-who-2020-02-11", "https://www.nasdaq.com/articles/johnson-johnson-is-racing-against-time-to-develop-the-first-coronavirus-vaccine-2020-02-11", "https://www.nasdaq.com/articles/is-gilead-sciences-an-acquisition-target-2020-02-11", "https://www.nasdaq.com/articles/3-pros-and-3-cons-for-ino-stock-amid-chinese-coronavirus-outbreak-2020-02-10", "https://www.nasdaq.com/articles/fda-grants-a-priority-review-to-gilead-sciences-cancer-therapy-2020-02-10", "https://www.nasdaq.com/articles/gilead-sciences-looks-ready-to-outpace-abbvie-2020-02-12", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2020-02-10", "https://www.nasdaq.com/articles/could-these-5-stocks-benefit-from-the-coronavirus-outbreak-2020-02-10", "https://www.nasdaq.com/articles/fda-grants-priority-review-for-kites-kte-x19-bla-quick-facts-2020-02-10", "https://www.nasdaq.com/articles/1-big-question-to-ask-yourself-before-buying-gilead-sciences-stock-2020-02-09", "https://www.nasdaq.com/articles/gilead-sciences%3A-still-on-the-path-to-recovery-2020-02-08", "https://www.nasdaq.com/articles/health-officials-say-u.s.-coronavirus-vaccine-is-making-good-progress-2020-02-08", "https://www.nasdaq.com/articles/4-internet-stocks-to-buy-that-are-surging-higher-2020-02-07", "https://www.nasdaq.com/articles/mondays-etf-with-unusual-volume%3A-pjp-2020-02-10", "https://www.nasdaq.com/articles/multiple-positive-catalysts-make-jd.com-stock-worth-buying-2020-02-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-05-2020%3A-vvuscernaimtgild-2020-02-05", "https://www.nasdaq.com/articles/who-confirms-3100-new-confirmed-coronavirus-infections-yesterday-2020-02-05", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-05-2020%3A-cernaimtgild-2020-02-05-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-05-2020%3A-cernaimtgild-2020-02-05", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-ibm-msft-gild-2020-02-05", "https://www.nasdaq.com/articles/daily-dividend-report%3A-mmm-gild-cg-psx-syk-2020-02-05", "https://www.nasdaq.com/articles/3-big-stock-charts-for-friday%3A-barrick-gold-gilead-sciences-and-cloudflare-2020-02-07", "https://www.nasdaq.com/articles/3-important-things-to-know-about-gilead-sciences-q4-results-2020-02-05", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q4-2019-earnings-call-transcript-2020-02-05", "https://www.nasdaq.com/articles/fda-approves-emergency-use-of-coronavirus-test-2020-02-05", "https://www.nasdaq.com/articles/fda-approves-emergency-use-of-coronavirus-test-2020-02-05-0", "https://www.nasdaq.com/articles/gilead-sciences-q4-profit-misses-estimates-2020-02-04", "https://www.nasdaq.com/articles/gilead-announces-q4-financial-results-misses-eps-target-2020-02-04", "https://www.nasdaq.com/articles/gilead-sciences-inc.-q4-adjusted-earnings-miss-estimates-2020-02-04", "https://www.nasdaq.com/articles/gilead-sciences%3A-patience-required-2020-02-05", "https://www.nasdaq.com/articles/3-important-things-to-know-about-gilead-sciences-q4-results-2020-02-05", "https://www.nasdaq.com/articles/momentum-stocks-to-watch%3A-gilead-sciences-inc.-gild-2020-02-04", "https://www.nasdaq.com/articles/gilead-sciences-q4-19-earnings-conference-call-at-4%3A30-pm-et-2020-02-04", "https://www.nasdaq.com/articles/gileads-ebola-drug-shows-positive-signs-in-treating-coronavirus-2020-02-03", "https://www.nasdaq.com/articles/gileads-ebola-drug-shows-positive-signs-in-treating-coronavirus-2020-02-03-0", "https://www.nasdaq.com/articles/heres-why-inovio-pharmaceuticals-and-vir-biotechnology-shares-have-fallen-today-2020-02-03", "https://www.nasdaq.com/articles/gild-crosses-above-key-moving-average-level-2020-02-03", "https://www.nasdaq.com/articles/gilead-sciences-q4-19-earnings-conference-call-at-4%3A30-pm-et-2020-02-04-0", "https://www.nasdaq.com/articles/why-gilead-sciences-stock-is-up-13-today-2020-02-03", "https://www.nasdaq.com/articles/3-big-drugmakers-are-taking-on-the-coronavirus-2020-02-03", "https://www.nasdaq.com/articles/daily-markets%3A-coronavirus-delivers-sharp-shift-to-the-markets-2020-02-03", "https://www.nasdaq.com/articles/where-will-vertex-pharmaceuticals-be-in-10-years-2020-02-02", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2020-01-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-gild-vrtx-biib-2020-01-29", "https://www.nasdaq.com/articles/near-a-7-year-low-is-gilead-sciences-a-buy-2020-01-29", "https://www.nasdaq.com/articles/sp-500-movers%3A-wcg-gild-2020-02-03", "https://www.nasdaq.com/articles/5-biotech-stocks-to-watch-with-the-coronavirus-scare-2020-01-26", "https://www.nasdaq.com/articles/which-big-biotech-has-the-safer-dividend-amgen-or-gilead-sciences-2020-01-26", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2020-01-25", "https://www.nasdaq.com/articles/an-emboldened-bristol-myers-squibb-wants-%241.5-billion-from-gilead-sciences-2020-01-24", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-gilead-sciences-2020-01-24", "https://www.nasdaq.com/articles/gilead-considering-ebola-drug-as-potential-coronavirus-treatment-2020-01-23", "https://www.nasdaq.com/articles/2-dividend-paying-biotech-stocks-worth-owning-in-2020-2020-01-23", "https://www.nasdaq.com/articles/why-novavax-shares-are-jumping-again-today-2020-01-27", "https://www.nasdaq.com/articles/2-small-cap-biotech-stocks-to-watch-in-2020-2020-01-23", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2020-01-21", "https://www.nasdaq.com/articles/pjps-underlying-holdings-could-mean-14-gain-potential-2020-01-14", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-aimt-nke-gild-2020-01-13", "https://www.nasdaq.com/articles/gilead-sciences-to-present-at-j.p.-morgan-conference-webcast-at-12%3A30-pm-et-2020-01-13", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-large-inflows-detected-at-etf-2020-01-13", "https://www.nasdaq.com/articles/gilead-invests-in-kyverna-therapeutics-enters-license-agreement-quick-facts-2020-01-13", "https://www.nasdaq.com/articles/where-will-intercept-pharmaceuticals-be-in-5-years-2020-01-23", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-or-sell-as-pricing-pressures-mount-2020-01-10", "https://www.nasdaq.com/articles/gilead-sciences-licenses-portfolio-of-hiv-antibodies-from-rockefeller-2020-01-09", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-biogen-2020-01-05", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-outflow-alert-2020-01-03", "https://www.nasdaq.com/articles/biotechs-most-volatile-binary-events-for-q1-2020-01-03", "https://www.nasdaq.com/articles/vascepas-future-looks-rosy-but-it-could-still-be-fishy-for-amarin-stock-2019-12-31", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-gild-2019-12-30", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-gilead-sciences-2020-01-11", "https://www.nasdaq.com/articles/3-dividend-stocks-to-buy-for-2020-2019-12-29", "https://www.nasdaq.com/articles/better-buy%3A-editas-medicine-vs.-crispr-therapeutics-2019-12-27", "https://www.nasdaq.com/articles/interesting-gild-put-and-call-options-for-august-2020-2019-12-24", "https://www.nasdaq.com/articles/gileads-japan-unit-in-deal-with-eisai-to-co-promote-ra-drug-filgotinib-2019-12-24", "https://www.nasdaq.com/articles/did-cellectis-just-provide-a-glimpse-of-the-future-of-cellular-medicine-2019-12-23", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-outflow-2019-12-23", "https://www.nasdaq.com/articles/20-high-yield-dividend-stocks-to-buy-in-2020-2019-12-22", "https://www.nasdaq.com/articles/3-big-pharma-stocks-that-pay-big-dividends-2019-12-30", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-20-2019%3A-gildtxgbionlnkmrkabeo-2019-12-20", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-gild-met-pypl-2019-12-20", "https://www.nasdaq.com/articles/2-must-own-dividend-growth-stocks-in-2020-2019-12-19", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2019-12-18", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2019-12-17", "https://www.nasdaq.com/articles/drugs-that-missed-key-goals-in-phase-iii-trials-2019-12-17", "https://www.nasdaq.com/articles/amarins-vascepa-approval-seems-fishy-for-patients-and-amrn-investors-2019-12-16", "https://www.nasdaq.com/articles/how-gilead-sciences-is-helping-fund-bristol-myers-squibbs-celgene-acquisition-2019-12-21", "https://www.nasdaq.com/articles/gilead%3A-phase-2-atlas-data-shows-consistent-improvements-in-liver-histology-2019-12-16", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-amgen-2019-12-15", "https://www.nasdaq.com/articles/bristol-myers-wins-%24752-mln-in-us-patent-case-against-gilead-sciences-2019-12-14", "https://www.nasdaq.com/articles/ibb-gild-vrtx-ilmn%3A-etf-outflow-alert-2019-12-13", "https://www.nasdaq.com/articles/gilds-kte-x19-to-face-fda-ntec-drops-as-nvs-walks-away-kzia-on-watch-2019-12-11", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-gild-gkos-derm-2019-12-11", "https://www.nasdaq.com/articles/gild-named-a-top-socially-responsible-dividend-stock-2019-12-11", "https://www.nasdaq.com/articles/is-amarin-a-%2420-billion-stock-2019-12-16", "https://www.nasdaq.com/articles/apto-on-the-move-plx-to-effect-reverse-split-scyx-plunges-2019-12-10", "https://www.nasdaq.com/articles/no-crispr-required%3A-this-forgotten-gene-editing-stock-is-up-50-in-5-weeks-2019-12-09", "https://www.nasdaq.com/articles/thursday-sector-laggards%3A-energy-healthcare-2019-12-05", "https://www.nasdaq.com/articles/ibb-gild-vrtx-ilmn%3A-large-outflows-detected-at-etf-2019-11-27", "https://www.nasdaq.com/articles/better-buy%3A-editas-medicine-or-sangamo-therapeutics-2019-11-26", "https://www.nasdaq.com/articles/5-top-stock-trades-for-tuesday%3A-nvda-tsla-gild-2019-11-25", "https://www.nasdaq.com/articles/does-amarin-have-a-dark-horse-suitor-2019-11-24", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-el-paso-electric-conmed-and-gilead-sciences-2019-12-10", "https://www.nasdaq.com/articles/3-dividend-stocks-to-buy-on-sale-2019-11-24", "https://www.nasdaq.com/articles/enanta-pharmaceuticals-q4-results-pulled-down-by-abbvies-sinking-hcv-sales-2019-11-22", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-gilead-sciences-gild-2019-11-21", "https://www.nasdaq.com/articles/3-recovering-healthcare-stocks-to-buy-that-already-escaped-flu-season-2019-11-20", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-gild-geo-ttwo-2019-11-14", "https://www.nasdaq.com/articles/gilead-sciences-gild-shares-cross-4-yield-mark-2019-11-14", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-gilead-sciences-docusign-and-western-digital-2019-11-14", "https://www.nasdaq.com/articles/better-buy%3A-abbvie-vs.-glaxosmithkline-2019-11-24", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-11-12", "https://www.nasdaq.com/articles/will-its-hiv-lineup-save-gilead-sciences-2019-11-11", "https://www.nasdaq.com/articles/us-files-complaint-against-gilead-sciences-for-patent-infringement-2019-11-08", "https://www.nasdaq.com/articles/is-the-future-finally-looking-up-for-gilead-sciences-2019-11-08", "https://www.nasdaq.com/articles/heres-why-galapagos-stock-rose-20.5-in-october-2019-11-07", "https://www.nasdaq.com/articles/up-19.2-is-viking-therapeutics-stock-still-a-buy-2019-11-06", "https://www.nasdaq.com/articles/these-3-european-biotechs-can-help-recession-proof-your-portfolio-2019-11-06", "https://www.nasdaq.com/articles/these-superior-dividend-stocks-are-found-in-some-odd-industries-2019-11-13", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-celg-gild-vrtx-2019-11-04", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-gild-amed-tgt-2019-11-01", "https://www.nasdaq.com/articles/3-reasons-crispr-therapeutics-stock-can-reach-record-highs-again-2019-10-30", "https://www.nasdaq.com/articles/the-3-best-sectors-for-long-term-earnings-2019-10-29", "https://www.nasdaq.com/articles/can-new-drugs-help-gilead-sciences-rebound-2019-10-29", "https://www.nasdaq.com/articles/ibb-celg-gild-ilmn%3A-etf-outflow-alert-2019-10-28", "https://www.nasdaq.com/articles/better-buy%3A-abbott-laboratories-vs.-novo-nordisk-2019-10-27", "https://www.nasdaq.com/articles/gild-crosses-above-key-moving-average-level-2019-11-05", "https://www.nasdaq.com/articles/4-top-stock-trades-for-monday%3A-tsla-gild-gld-vz-2019-10-25", "https://www.nasdaq.com/articles/gilead-sciences-q3-revenue-is-flat-and-rd-hits-earnings-2019-10-25", "https://www.nasdaq.com/articles/daily-dividend-report%3A-vfc-bro-cog-grc-gild-2019-10-25", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2019-10-25", "https://www.nasdaq.com/articles/whats-behind-gilead-sciences-lackluster-q3-earnings-results-2019-10-25", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q3-2019-earnings-call-transcript-2019-10-25", "https://www.nasdaq.com/articles/gilead-sciences-inc.-q3-adjusted-earnings-beat-estimates-2019-10-24", "https://www.nasdaq.com/articles/5-top-healthcare-etfs-2019-10-26", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-gild-apls-mat-2019-10-22", "https://www.nasdaq.com/articles/tqqq-cost-chtr-gild%3A-etf-outflow-alert-2019-10-15", "https://www.nasdaq.com/articles/gilead-sciences-names-andrew-dickinson-cfo-quick-facts-2019-10-15", "https://www.nasdaq.com/articles/3-top-healthcare-dividend-stocks-that-are-great-picks-for-retirees-2019-10-13", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-johnson-johnson-2019-10-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-11-2019%3A-acrs-gern-gild-glpg-jnj-pfe-abt-mrk-amgn-2019-10", "https://www.nasdaq.com/articles/mito-empowered-fprx-cuts-another-70-jobs-second-death-in-legionnaires-outbreak-2019-10-11", "https://www.nasdaq.com/articles/interesting-gild-put-and-call-options-for-december-6th-2019-10-24", "https://www.nasdaq.com/articles/3-big-pharma-companies-driving-price-inflation-2019-10-10", "https://www.nasdaq.com/articles/3-companies-to-watch-for-at-novembers-society-for-immunotherapy-of-cancer-meeting-2019-10", "https://www.nasdaq.com/articles/gilead-announces-nda-submission-for-filgotinib-in-japan-quick-facts-2019-10-08", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-celg-gild-ilmn-2019-10-07", "https://www.nasdaq.com/articles/fda-approves-descovy-second-drug-to-prevent-hiv-infection-2019-10-04", "https://www.nasdaq.com/articles/forget-vertex-pharmaceuticals-crispr-therapeutics-is-a-better-biotech-growth-stock-2019-10", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-abbv-gild-swks-2019-10-10", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-october-2019-2019-09-27", "https://www.nasdaq.com/articles/is-glaxosmithkline-a-buy-2019-09-27", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-calm-gild-epay-2019-09-26", "https://www.nasdaq.com/articles/oef-gild-axp-ms%3A-etf-outflow-alert-2019-09-25", "https://www.nasdaq.com/articles/oef-gild-axp-ms%3A-etf-outflow-alert-2019-09-25-0", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-baker-hughes-gilead-sciences-and-jefferies-financial-group", "https://www.nasdaq.com/articles/meet-the-revolutionary-new-diabetes-drug-youve-probably-never-heard-of-2019-09-23", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-pfizer-2019-09-29", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2019-09-21", "https://www.nasdaq.com/articles/3-biotechs-with-the-biggest-cash-stockpiles-2019-09-20", "https://www.nasdaq.com/articles/an-investors-guide-to-disrupting-drugmakers-2019-09-18", "https://www.nasdaq.com/articles/pbe-gild-alxn-incy%3A-large-outflows-detected-at-etf-2019-09-17", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2019-09-15", "https://www.nasdaq.com/articles/better-buy%3A-celgene-vs.-gilead-sciences-2019-09-14", "https://www.nasdaq.com/articles/interesting-gild-put-and-call-options-for-november-1st-2019-09-12", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2019-09-22", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-ex-dividend-date-scheduled-for-september-12-2019-2019-09-11", "https://www.nasdaq.com/articles/4-key-questions-for-gilead-sciences-new-ceo-2019-09-11", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-gilead-sciences-conmed-and-crown-castle-international-2019-09-10", "https://www.nasdaq.com/articles/gilead-sciences-breaks-above-200-day-moving-average-bullish-for-gild-2019-09-09", "https://www.nasdaq.com/articles/ive-cost-mdlz-gild%3A-etf-outflow-alert-2019-09-09", "https://www.nasdaq.com/articles/sum-up-the-parts%3A-esgl-could-be-worth-%2435-2019-09-09", "https://www.nasdaq.com/articles/serving-on-a-board-made-me-a-better-cfo-2019-09-04", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-axdx-gild-mdb-2019-09-11", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-biogen-2019-09-01", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-jnj-gild-glng-2019-08-28", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-gild-celg-vrtx-2019-08-28", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-intuit-gilead-sciences-and-nike-2019-08-26", "https://www.nasdaq.com/articles/5-top-esg-stocks-on-rbc-capitals-best-ideas-list-2019-08-19", "https://www.nasdaq.com/articles/vtv-ge-mo-gild%3A-etf-outflow-alert-2019-08-16", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-xilinx-news-corp-and-gilead-sciences-2019-08-12", "https://www.nasdaq.com/articles/3-high-yield-dividend-stocks-to-buy-on-sale-2019-09-01", "https://www.nasdaq.com/articles/fidelity-national-information-services-achieves-72-analyst-rank-surpassing-gilead-sciences", "https://www.nasdaq.com/articles/analysts-anticipate-susa-to-hit-%24133-2019-08-08", "https://www.nasdaq.com/articles/gilead-sciences-a-top-25-dividend-giant-with-3.94-yield-2019-08-08", "https://www.nasdaq.com/articles/derm-on-watchlist-fda-panel-nod-for-gild-so-long-cvrs-and-avdr-2019-08-08", "https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-gild-evri-plt-2019-08-06", "https://www.nasdaq.com/articles/gild-crosses-above-4-yield-territory-2019-08-06", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-gild-celg-ilmn-2019-08-06", "https://www.nasdaq.com/articles/3-embarrassingly-cheap-dividend-stocks-2019-08-11", "https://www.nasdaq.com/articles/2-small-cap-stocks-that-could-make-you-rich-2019-08-01", "https://www.nasdaq.com/articles/are-amgen-and-gilead-sciences-better-buys-after-second-quarter-earnings-2019-07-31", "https://www.nasdaq.com/articles/gilead-sciences-reports-improving-revenue-in-the-2nd-quarter-2019-07-31", "https://www.nasdaq.com/articles/after-hours%3A-apple-mastercard-and-gilead-sciences-report-earnings-2019-07-31", "https://www.nasdaq.com/articles/gilead-sciences-inc.-q2-adjusted-earnings-beat-estimates-2019-07-30", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-grmn-gild-mcd-2019-07-30", "https://www.nasdaq.com/articles/gilead-gild-2nd-quarter-earnings%3A-what-to-expect-2019-07-30", "https://www.nasdaq.com/articles/heres-why-galapagos-nv-rose-34.5-in-july-2019-08-05", "https://www.nasdaq.com/articles/marijuana-stock-cannttrust-and-whats-behind-gileads-latest-megadeal-2019-07-29", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-august-2019-2019-07-29", "https://www.nasdaq.com/articles/weekly-market-preview%3A-six-stocks-to-watch-for-the-coming-week-bynd-gild-aapl-amd-qcom-sq", "https://www.nasdaq.com/articles/3-perfect-10-biotech-companies-to-buy-2019-07-25", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-24-2019%3A-gildghdxefiiewsgen-2019-07-24", "https://www.nasdaq.com/articles/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-2019-07-23", "https://www.nasdaq.com/articles/8-more-big-pharma-events-in-2019-you-dont-want-to-miss-2019-07-20", "https://www.nasdaq.com/articles/gilead-sciences-q2-19-earnings-conference-call-at-4%3A30-pm-et-2019-07-30", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ibb-gild-celg-vrtx-2019-07-19", "https://www.nasdaq.com/articles/gilead-licenses-respiratory-herpes-antiviral-research-programs-from-novartis-2019-07-19", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-right-now-2019-07-18", "https://www.nasdaq.com/articles/the-multibillion-dollar-race-for-gene-therapy-manufacturing-is-on-2019-07-17", "https://www.nasdaq.com/articles/gileads-galapagos-deal%3A-what-it-means-for-investors-2019-07-17", "https://www.nasdaq.com/articles/3-soaring-biotech-stocks-with-more-fuel-in-the-tank-2019-07-16", "https://www.nasdaq.com/articles/what-happened-in-the-stock-market-today-2019-07-15", "https://www.nasdaq.com/articles/friday-sector-laggards%3A-utilities-healthcare-2019-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-15-2019%3A-caprglpggildomclteva-2019-07-15", "https://www.nasdaq.com/articles/monday-sector-leaders%3A-utilities-healthcare-2019-07-15", "https://www.nasdaq.com/articles/galapagos-deal%3A-glpg-stock-rockets-higher-on-gilead-stake-2019-07-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-15-2019%3A-glpggildomclteva-2019-07-15", "https://www.nasdaq.com/articles/gild-crosses-above-key-moving-average-level-2019-07-15", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-symc-gild-2019-07-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-15-2019%3A-capr-glpg-gild-ntgn-jnj-pfe-abt-mrk-amgn-2019-07", "https://www.nasdaq.com/articles/nasdaq-today%3A-bitcoin-libra-whats-broadcom-doing-2019-07-15", "https://www.nasdaq.com/articles/ibb-gild-celg-ilmn%3A-large-outflows-detected-at-etf-2019-07-11", "https://www.nasdaq.com/articles/august-23rd-options-now-available-for-gilead-sciences-gild-2019-07-08", "https://www.nasdaq.com/articles/we-did-the-math-ovlu-can-go-to-%2430-2019-07-08", "https://www.nasdaq.com/articles/are-natural-killer-cells-the-next-big-thing-in-immunotherapy-2019-07-08", "https://www.nasdaq.com/articles/vti-c-ge-gild%3A-etf-inflow-alert-2019-07-03", "https://www.nasdaq.com/articles/after-hours%3A-sarin-scare-at-facebook-gilead-to-make-arthritis-drug-submission-soon-2019-07", "https://www.nasdaq.com/articles/first-week-of-february-2020-options-trading-for-gilead-sciences-gild-2019-06-27", "https://www.nasdaq.com/articles/why-galapagos-nv-stock-is-soaring-today-2019-07-15", "https://www.nasdaq.com/articles/the-10-biggest-biotech-stocks-2019-06-25", "https://www.nasdaq.com/articles/3-drugs-under-fda-review-with-blockbuster-potential-2019-06-20", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-buy-for-massive-gains-2019-06-19", "https://www.nasdaq.com/articles/gild-crosses-above-key-moving-average-level-2019-06-18", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-mckesson-dish-network-and-gilead-sciences-2019-06-18", "https://www.nasdaq.com/articles/3-big-drugmakers-most-likely-to-make-acquisitions-after-pfizers-surprise-deal-2019-06-18", "https://www.nasdaq.com/articles/5-top-stock-trades-for-tuesday%3A-fb-nflx-gild-tsla-2019-06-17", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-06-25", "https://www.nasdaq.com/articles/better-buy%3A-aurora-cannabis-vs.-gilead-sciences-2019-06-16", "https://www.nasdaq.com/articles/3-top-dividend-stocks-to-buy-in-june-2019-06-14", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-exas-gild-pstg-2019-06-12", "https://www.nasdaq.com/articles/newest-gene-editing-stock-buy-2019-06-11", "https://www.nasdaq.com/articles/gilead-sciences-worth-wait-2019-06-09", "https://www.nasdaq.com/articles/how-pieces-add-%3A-rndv-targets-%2425-2019-06-06", "https://www.nasdaq.com/articles/vanguard-total-world-stock-etf-experiences-big-outflow-2019-06-05", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-gild-biib-vrtx-2019-06-17", "https://www.nasdaq.com/articles/5-top-stock-trades-wednesday%3A-gild-nvda-amd-2019-05-28", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-ual-gild-hp-2019-05-28", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-myl-amd-2019-05-28", "https://www.nasdaq.com/articles/10-top-pot-stocks-to-buy-2019-05-28", "https://www.nasdaq.com/articles/ibb-celg-gild-amgn%3A-etf-inflow-alert-2019-05-23", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-05-23", "https://www.nasdaq.com/articles/3-cancer-stocks-given-lift-amgen-2019-06-04", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2019-05-19", "https://www.nasdaq.com/articles/who-had-better-quarter%3A-gilead-sciences-or-amgen-2019-05-17", "https://www.nasdaq.com/articles/ibb-gild-celg-biib%3A-etf-outflow-alert-2019-05-15", "https://www.nasdaq.com/articles/it-finally-time-buy-gilead-sciences-2019-05-12", "https://www.nasdaq.com/articles/goldfinch-bio-partners-gilead-sciences-quick-facts-2019-05-08", "https://www.nasdaq.com/articles/where-will-gilead-sciences-spend-its-cash-2019-05-07", "https://www.nasdaq.com/articles/analysts-expect-voov-hit-124-2019-05-06", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2019-05-19", "https://www.nasdaq.com/articles/has-gilead-sciences-turned-corner-2019-05-03", "https://www.nasdaq.com/articles/gilead-sciences-returns-growth-first-quarter-2019-05-03", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q1-2019-earnings-call-transcript-2019-05-03", "https://www.nasdaq.com/articles/daily-dividend-report%3A-eog-gild-duk-ecl-ice-2019-05-02", "https://www.nasdaq.com/articles/gilead-sciences-inc.-q1-adjusted-earnings-beat-estimates-2019-05-02", "https://www.nasdaq.com/articles/june-14th-options-now-available-gilead-sciences-gild-2019-05-02", "https://www.nasdaq.com/articles/5-things-you-can-expect-gilead-sciences-its-new-ceo-helm-2019-05-05", "https://www.nasdaq.com/articles/gilead-gild-1st-quarter-earnings%3A-what-expect-2019-05-02", "https://www.nasdaq.com/articles/gilead-sciences-q1-19-earnings-conference-call-4%3A30-pm-et-2019-05-02", "https://www.nasdaq.com/articles/3-things-you-can-expect-gilead-sciences-q1-earnings-update-2019-05-01", "https://www.nasdaq.com/articles/will-gilead-stock-get-needed-boost-weeks-earnings-report-2019-04-30", "https://www.nasdaq.com/articles/2-reasons-gilead-sciences-nash-program-could-bounce-back-2019-04-27", "https://www.nasdaq.com/articles/how-medicare-rule-change-could-bring-car-t-stocks-back-life-2019-04-27", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ibb-celg-gild-biib-2019-04-25", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-galapagos-2019-05-02", "https://www.nasdaq.com/articles/5-top-stock-trades-tuesday-tsla-twtr-ttd-o-2019-04-22", "https://www.nasdaq.com/articles/top-gene-sequencing-stocks-2019-2019-04-19", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-gm-gild-icpt-2019-04-18", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-gm-gild-icpt-2019-04-18-0", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vlue-gm-gild-exc-2019-04-17", "https://www.nasdaq.com/articles/tg-therapeutics-buy-2019-04-17", "https://www.nasdaq.com/articles/why-amgen-stock-could-break-out-new-highs-2019-04-16", "https://www.nasdaq.com/articles/2-best-biotech-buyout-plays-2019-04-23", "https://www.nasdaq.com/articles/interesting-gild-put-options-may-31st-2019-04-15", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2019-04-15-0", "https://www.nasdaq.com/articles/gilead-to-collaborate-with-novo-nordisk-for-nash-treatment-2019-04-15-0", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-biogen-2019-04-14", "https://www.nasdaq.com/articles/better-buy-amgen-vs-gilead-sciences-2019-04-13", "https://www.nasdaq.com/articles/novo-nordisk-and-gilead-team-test-fatty-liver-disease-treatment-2019-04-12", "https://www.nasdaq.com/articles/gilead-teams-insitro-experimental-nash-treatments-2019-04-16", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-adsk-gild-hum-2019-04-11-0", "https://www.nasdaq.com/articles/why-galapagos-nv-stock-bolted-higher-march-2019-04-09", "https://www.nasdaq.com/articles/3-dividend-stocks-perfect-retirees-2019-04-09", "https://www.nasdaq.com/articles/gilead-sciences-gild-stock-sinks-as-market-gains%3A-what-you-should-know-2019-04-08-0", "https://www.nasdaq.com/articles/gilead-files-snda-for-label-expansion-of-hiv-therapy-descovy-2019-04-08-0", "https://www.nasdaq.com/articles/where-will-gilead-sciences-be-5-years-2019-04-07", "https://www.nasdaq.com/articles/better-buy-intercept-pharmaceuticals-vs-gilead-sciences-2019-04-02", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-adsk-gild-hum-2019-04-11", "https://www.nasdaq.com/articles/ibb-gild-celg-vrtx-large-outflows-detected-etf-2019-04-01", "https://www.nasdaq.com/articles/2-incredibly-cheap-pharma-stocks-buy-now-2019-04-01", "https://www.nasdaq.com/articles/gilead-sciences-gild-outpaces-stock-market-gains%3A-what-you-should-know-2019-04-01-0", "https://www.nasdaq.com/articles/why-blackberry-galapagos-and-progress-software-jumped-today-2019-03-29", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-29-2019%3A-glpggildftsvseelaznazn.l-2019-03-29", "https://www.nasdaq.com/articles/why-galapagos-stock-crushing-it-today-2019-03-29", "https://www.nasdaq.com/articles/shares-galapagos-jump-15-pct-after-arthritis-drug-results-2019-03-29", "https://www.nasdaq.com/articles/better-buy-intercept-pharmaceuticals-vs-gilead-sciences-2019-04-02-0", "https://www.nasdaq.com/articles/health-care-sector-update-03292019-glpggildftsvseelaznaznl-2019-03-29-0", "https://www.nasdaq.com/articles/ards-move-glpg-reports-positive-data-prto-plunges-patency-2-results-2019-03-29", "https://www.nasdaq.com/articles/3-top-dividend-stocks-add-your-watchlist-2019-03-27", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2019-03-25", "https://www.nasdaq.com/articles/why-1-top-analyst-thinks-gilead-sciences-will-soar-more-25-2019-03-24", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2019-03-22", "https://www.nasdaq.com/articles/biogen-stock-fell-too-far-unfortunate-news-2019-03-22", "https://www.nasdaq.com/articles/why-blackberry-galapagos-and-progress-software-jumped-today-2019-03-29-0", "https://www.nasdaq.com/articles/does-recent-abbvie-stock-weakness-make-it-buy-3-pros-3-cons-2019-03-21", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2019-03-19", "https://www.nasdaq.com/articles/yeti-gilead-dicks-fedex-and-amazon-highlighted-as-zacks-bull-and-bear-of-the-day-2019-03", "https://www.nasdaq.com/articles/bear-day-gilead-sciences-gild-2019-03-18", "https://www.nasdaq.com/articles/after-hours-most-active-mar-18-2019-elan-lly-bac-mrk-hpq-wmb-qcom-gild-cmcsa-pep-ebay-atvi", "https://www.nasdaq.com/articles/better-buy-amgen-vs-gilead-sciences-2019-03-17", "https://www.nasdaq.com/articles/agenus-wins-%247.5m-milestone-payment-from-gilead-stock-up-2019-03-14", "https://www.nasdaq.com/articles/conatus-cnat-declines-on-failure-of-nash-fibrosis-study-2019-03-22", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2019-2019-03-13", "https://www.nasdaq.com/articles/gilead-sciences-gild-outpaces-stock-market-gains%3A-what-you-should-know-2019-03-13", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-march-2019-03-09", "https://www.nasdaq.com/articles/dont-abandon-gilead-stock-after-weak-q4-results-2019-03-08", "https://www.nasdaq.com/articles/gilead-reports-positive-data-on-hiv-drugs-biktarvy-descovy-2019-03-08", "https://www.nasdaq.com/articles/2-biotech-stocks-major-incoming-catalysts-2019-03-07", "https://www.nasdaq.com/articles/gilead-reports-positive-data-on-hiv-drugs-biktarvy-descovy-2019-03-07", "https://www.nasdaq.com/articles/ibb-celg-biib-gild-large-inflows-detected-etf-2019-03-14", "https://www.nasdaq.com/articles/why-is-gilead-gild-down-4.9-since-last-earnings-report-2019-03-06", "https://www.nasdaq.com/articles/3-big-pharmas-trying-pop-rebate-bubble-2019-03-06", "https://www.nasdaq.com/articles/gilead-sciences-gild-shares-cross-4-yield-mark-2019-03-06", "https://www.nasdaq.com/articles/why-sangamo-therapeutics-lost-229-its-value-february-2019-03-04", "https://www.nasdaq.com/articles/sum-pieces-qqxt-could-be-worth-58-2019-03-04", "https://www.nasdaq.com/articles/eli-lilly-seeks-quell-drug-price-anger-cheaper-insulin-2019-03-04", "https://www.nasdaq.com/articles/after-hours-most-active-mar-4-2019-lthm-lly-atvi-bac-s-ohi-ge-gild-cmcsa-imgn-aapl-sgms", "https://www.nasdaq.com/articles/worlds-second-man-cleared-aids-virus-invigorates-quest-cure-2019-03-06", "https://www.nasdaq.com/articles/intercept-icpt-up-on-q4-revenue-beat-nash-study-in-focus-2019-03-01", "https://www.nasdaq.com/articles/nektar-nktr-q4-earnings-beat-nktr-181-review-extended-2019-03-01", "https://www.nasdaq.com/articles/viking-therapeutics-buy-2019-02-27", "https://www.nasdaq.com/articles/better-buy-bluebird-bio-vs-gilead-sciences-2019-02-23", "https://www.nasdaq.com/articles/2-frustrating-flops-plus-welcome-wrinkle-wars-2019-02-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intercept-gilead-vertex-alkermes-and-clovis-2019-02-21", "https://www.nasdaq.com/articles/what-pharma-investors-need-know-about-pfizers-latest-disaster-2019-02-21", "https://www.nasdaq.com/articles/3-oldest-members-biotechs-billion-burned-club-2019-03-03", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-icpt-strong-on-nash-drug-data-collaborations-more-2019-02-20", "https://www.nasdaq.com/articles/intercept-reports-positive-top-line-data-for-nash-shares-up-2019-02-20", "https://www.nasdaq.com/articles/intercepts-fatty-liver-drug-meets-late-stage-main-goal-shares-soar-2019-02-19", "https://www.nasdaq.com/articles/tuesdays-etf-unusual-volume-pbe-2019-02-19", "https://www.nasdaq.com/articles/better-buy-celgene-vs-gilead-sciences-2019-02-17", "https://www.nasdaq.com/articles/us-medicare-plans-track-car-t-cancer-therapy-outcomes-2019-02-15", "https://www.nasdaq.com/articles/should-you-buy-viking-therapeutics-after-gilead-drug-failure-2019-02-14", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-investors-strap-wild-ride-2019-02-20", "https://www.nasdaq.com/articles/celgene-vs-gilead-stock-whats-better-biotech-buy-2019-02-13", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-jnj-gild-cvs-2019-02-13", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-impresses-in-q4-gilead-slumps-macrogenics-soars-2019-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-ea-2019-02-12", "https://www.nasdaq.com/articles/health-care-sector-update-02122019-kmda-gild-mdgs-jnj-pfe-mrk-abt-amgn-2019-02-12", "https://www.nasdaq.com/articles/despite-ma-spree-biotech-etfs-slide-mixed-earnings-2019-02-14", "https://www.nasdaq.com/articles/gileads-gild-late-stage-study-on-liver-disease-drug-fails-2019-02-12", "https://www.nasdaq.com/articles/health-care-sector-update-02122019-jazzgildkmdaohi-2019-02-12", "https://www.nasdaq.com/articles/5-must-see-stock-charts-wednesday-gild-nflx-ea-2019-02-12", "https://www.nasdaq.com/articles/heres-why-viking-therapeutics-rose-much-139-today-2019-02-12", "https://www.nasdaq.com/articles/health-care-sector-update-02122019-gildkmdaohi-2019-02-12", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-ea-gild-nke-2019-02-12", "https://www.nasdaq.com/articles/gilead-sciences-stock-slides-lower-nash-drug-failure-2019-02-12", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-pfizer-2019-02-12", "https://www.nasdaq.com/articles/why-gilead-sciences-stock-perked-january-2019-02-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-buy-2019-02-10", "https://www.nasdaq.com/articles/why-agenus-inc-stock-took-flight-january-2019-02-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-vertex-celgene-alkermes-and-aveo-2019-02-07", "https://www.nasdaq.com/articles/amgen-top-socially-responsible-dividend-stock-31-yield-amgn-2019-02-06", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-tops-in-q4-gilead-disappoints-alks-aveo-sink-2019-02-06", "https://www.nasdaq.com/articles/wednesday-sector-leaders-healthcare-technology-communications-2019-02-06", "https://www.nasdaq.com/articles/gilead-misses-key-goal-nash-liver-disease-trial-shares-sink-2019-02-11", "https://www.nasdaq.com/articles/health-care-sector-update-02052019-opgn-cnc-gild-jnj-pfe-abt-mrk-amgn-2019-02-05", "https://www.nasdaq.com/articles/7-key-things-you-need-know-gilead-sciences-q4-earnings-update-2019-02-05", "https://www.nasdaq.com/articles/unitedhealth-mercadolibre-alphabet-and-gilead-highlighted-as-zacks-bull-and-bear-of-the", "https://www.nasdaq.com/articles/gilead-gild-q4-earnings-miss-estimates-revenues-beat-2019-02-05", "https://www.nasdaq.com/articles/gilead-sciences-bad-news-buy-2019-02-05", "https://www.nasdaq.com/articles/gilead-sciences-hcv-albatross-weighs-its-results-yet-again-2019-02-05", "https://www.nasdaq.com/articles/stock-market-today-alphabet-grows-while-gilead-sciences-shrinks-2019-02-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-jd-2019-02-05", "https://www.nasdaq.com/articles/daily-dividend-report-gild-exc-avb-chd-utx-2019-02-05", "https://www.nasdaq.com/articles/5-of-the-best-biotech-stocks-to-buy-now-2019-02-04", "https://www.nasdaq.com/articles/midday-stock-market-news-alphabet-gilead-earnings-tap-2019-02-04", "https://www.nasdaq.com/articles/gilead-gild-4th-quarter-earnings-what-expect-2019-02-04", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q4-2018-earnings-conference-call-transcript-2019-02-04", "https://www.nasdaq.com/articles/gilead-sciences-q4-18-earnings-conference-call-430-pm-et-2019-02-04", "https://www.nasdaq.com/articles/gilead-sciences-earnings-gild-stock-dips-q4-eps-miss-revenue-beat-2019-02-04", "https://www.nasdaq.com/articles/5-top-stock-trades-wednesday-googl-gild-el-ba-2019-02-05", "https://www.nasdaq.com/articles/alphabet-googl-outperforms-estimates-gilead-gild-mixed-2019-02-04", "https://www.nasdaq.com/articles/gilead-sciences-gild-misses-q4-earnings-estimates-2019-02-04", "https://www.nasdaq.com/articles/gilead-fourth-quarter-profit-misses-wall-street-estimate-shares-fall-2019-02-04", "https://www.nasdaq.com/articles/notable-monday-option-activity-baby-gild-vrnt-2019-02-04", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-4-2019-googl-gild-avb-hig-itub-are-stx-qgen-aiv-krc", "https://www.nasdaq.com/articles/novartiss-cancer-therapy-wins-uk-backing-after-initial-lymphoma-snub-2019-02-01", "https://www.nasdaq.com/articles/3-top-large-cap-stocks-buy-february-2019-01-31", "https://www.nasdaq.com/articles/gilead-4th-qtr-profit-misses-wall-street-estimate-shares-fall-2019-02-04", "https://www.nasdaq.com/articles/cure-cancer-next-year-stock-market-says-dont-believe-hype-2019-01-30", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-but-lags-market%3A-what-you-should-know-2019-01-30", "https://www.nasdaq.com/articles/avalon-globocare-stock-expensive-mystery-2019-01-29", "https://www.nasdaq.com/articles/nasdaq-100-movers-amd-pcar-2019-01-29", "https://www.nasdaq.com/articles/biggest-biotech-binary-event-2019-just-around-corner-2019-01-29", "https://www.nasdaq.com/articles/analysts-estimate-gilead-sciences-gild-to-report-a-decline-in-earnings%3A-what-to-look-out", "https://www.nasdaq.com/articles/ishares-us-healthcare-etf-experiences-big-inflow-2019-01-24", "https://www.nasdaq.com/articles/will-gilead-gild-q4-earnings-disappoint-on-weak-hcv-sales-2019-01-31", "https://www.nasdaq.com/articles/3-upcoming-readouts-gilead-sciences-you-dont-want-miss-2019-01-23", "https://www.nasdaq.com/articles/gilead-sciences-gild-stock-sinks-as-market-gains%3A-what-you-should-know-2019-01-23", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-january-2019-01-23", "https://www.nasdaq.com/articles/7-stupidly-cheap-stocks-buy-now-2019-01-22", "https://www.nasdaq.com/articles/after-hours-most-active-jan-22-2019-grpn-qqq-intc-xel-gild-amd-2019-01-22", "https://www.nasdaq.com/articles/better-buy-biogen-vs-gilead-sciences-2019-01-19", "https://www.nasdaq.com/articles/notable-friday-option-activity-wynn-gs-gild-2019-01-18", "https://www.nasdaq.com/articles/does-johnson-johnsons-grim-outlook-spell-trouble-big-pharma-stocks-2019-01-24", "https://www.nasdaq.com/articles/zacks-market-edge-highlights%3A-occidental-gilead-abbvie-att-and-verizon-2019-01-17", "https://www.nasdaq.com/articles/1-chart-shows-why-celgene-has-been-bought-out-and-gilead-hasnt-yet-2019-01-17", "https://www.nasdaq.com/articles/will-dividend-stocks-be-hot-stocks-2019-2019-01-16", "https://www.nasdaq.com/articles/heres-why-verastem-tumbled-341-december-2019-01-11", "https://www.nasdaq.com/articles/value-added-7-top-stocks-2019-2019-01-09", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-loxo-celg-gain-j.p.-morgan-healthcare-conference-in-focus-2019-01", "https://www.nasdaq.com/articles/7-things-expect-gilead-sciences-2019-2019-01-08", "https://www.nasdaq.com/articles/why-gilead-sciences-stock-sank-127-2018-2019-01-17", "https://www.nasdaq.com/articles/why-agenus-stock-spiking-today-2019-01-07", "https://www.nasdaq.com/articles/gilead-sciences-present-jp-morgan-conference-webcast-1230-pm-et-2019-01-07", "https://www.nasdaq.com/articles/merck-loses-bid-revive-200-mln-gilead-verdict-us-high-court-2019-01-07", "https://www.nasdaq.com/articles/gilead-gild-collaborates-with-yuhan-for-nash-candidates-2019-01-07", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-but-lags-market%3A-what-you-should-know-2019-01-07", "https://www.nasdaq.com/articles/after-hours-most-active-jan-7-2019-cmcsa-abev-bac-amat-gild-fdc-msft-ctl-symc-qqq-exc-emr", "https://www.nasdaq.com/articles/2019-jp-morgan-healthcare-conference-roundup-2019-01-06", "https://www.nasdaq.com/articles/japan-okays-approves-gilead-sciences-epclusa-2019-01-08", "https://www.nasdaq.com/articles/should-you-invest-invesco-dynamic-biotechnology-genome-etf-pbe-2019-01-04", "https://www.nasdaq.com/articles/3-biopharma-stocks-buy-their-robust-dividend-yields-2019-01-03", "https://www.nasdaq.com/articles/3-pharma-stocks-revving-for-growth-2019-01-02", "https://www.nasdaq.com/articles/gilead-sciences-gild-dips-more-than-broader-markets%3A-what-you-should-know-2018-12-28", "https://www.nasdaq.com/articles/intercept-icpt-benefits-from-ocalivas-recovery-in-2018-2018-12-28", "https://www.nasdaq.com/articles/3-biotech-stocks-are-too-cheap-ignore-2018-12-26", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-acor-drugs-get-fda-nod-agen-up-on-gild-deal-2018-12-26", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-amgen-2019-01-06", "https://www.nasdaq.com/articles/alexions-ultomiris-gets-early-fda-nod-for-rare-blood-disorder-2018-12-24", "https://www.nasdaq.com/articles/acorda-gets-fda-approval-for-parkinsons-disease-drug-inbrija-2018-12-24", "https://www.nasdaq.com/articles/2-beaten-down-biotech-stocks-look-bargains-now-2018-12-23", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-12-21", "https://www.nasdaq.com/articles/agenus-stock-up-23-on-immuno-oncology-deal-with-gilead-2018-12-21", "https://www.nasdaq.com/articles/novartis-nvs-offers-to-buy-french-gene-therapy-manufacturer-2018-12-21", "https://www.nasdaq.com/articles/why-agenus-stock-soaring-today-2018-12-20", "https://www.nasdaq.com/articles/mallinckrodts-inhaled-xenon-gas-therapy-enters-phase-iii-2018-12-24", "https://www.nasdaq.com/articles/us-futures-inch-higher-after-fed-move-2018-12-20", "https://www.nasdaq.com/articles/bristol-myers-to-sell-french-consumer-health-unit-for-%241.6b-2018-12-20", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-december-2018-12-20", "https://www.nasdaq.com/articles/gilead-partners-with-scholar-rock-for-fibrotic-disease-drugs-2018-12-20", "https://www.nasdaq.com/articles/vertexs-vrtx-3rd-study-on-pain-drug-meets-primary-endpoint-2018-12-19", "https://www.nasdaq.com/articles/forget-bluebird-bio-amgen-better-biotech-stock-2018-12-19", "https://www.nasdaq.com/articles/gilead-sciences-scholar-collaborate-novel-therapies-fibrotic-diseases-2018-12-19", "https://www.nasdaq.com/articles/wall-street-sees-cautiously-higher-open-after-fed-move-2018-12-20", "https://www.nasdaq.com/articles/what-happened-car-t-stocks-2018-2018-12-18", "https://www.nasdaq.com/articles/bristol-myers-label-expansion-of-sprycel-gets-chmp-nod-2018-12-18", "https://www.nasdaq.com/articles/3-biotechs-potential-blockbusters-near-finish-line-2018-12-18", "https://www.nasdaq.com/articles/evofem-shares-up-as-birth-control-gel-succeeds-in-phase-iii-2018-12-18", "https://www.nasdaq.com/articles/why-dova-pharmaceuticals-nosediving-today-2018-12-17", "https://www.nasdaq.com/articles/gilead-sciences-gild-stock-moves-0.69%3A-what-you-should-know-2018-12-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-12162018-2018-12-16", "https://www.nasdaq.com/articles/puma-biotechs-nerlynx-ups-survival-in-third-line-breast-cancer-2018-12-18", "https://www.nasdaq.com/articles/3-biotechs-gilead-sciences-could-buy-march-2018-12-15", "https://www.nasdaq.com/articles/mylan-myl-gets-favorable-ruling-against-sanofis-lantus-2018-12-14", "https://www.nasdaq.com/articles/amag-to-acquire-ciraparantag-maker-perosphere-pharmaceuticals-2018-12-14", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-conatus-pharmaceuticals-biogen-ionis", "https://www.nasdaq.com/articles/bausch-bhc-bids-for-assets-of-synergy-pharmaceuticals-2018-12-13", "https://www.nasdaq.com/articles/gilead-sciences-top-socially-responsible-dividend-stock-34-yield-gild-2018-12-13", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilead-to-get-new-ceo-biogen-in-licenses-candidate-2018-12-12", "https://www.nasdaq.com/articles/2-sets-disasters-biotech-will-pay-2019-2018-12-16", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-ndsn-gild-tlrd-2018-12-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-alexion-pharmaceuticals-regeneron", "https://www.nasdaq.com/articles/ex-dividend-reminder-new-jersey-resources-conmed-and-gilead-sciences-2018-12-11", "https://www.nasdaq.com/articles/4-biotech-stocks-investors-can-add-their-portfolio-2019-2018-12-11", "https://www.nasdaq.com/articles/gilead-sciences-gild-appoints-daniel-oday-as-new-ceo-2018-12-11", "https://www.nasdaq.com/articles/roches-tecentriq-gets-fda-approval-for-first-line-nsclc-2018-12-10", "https://www.nasdaq.com/articles/dont-punish-gilead-stock-doing-its-job-2018-12-10", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-13-2018-2018-12-12", "https://www.nasdaq.com/articles/why-crsp-stock-has-added-layers-risk-2018-12-10", "https://www.nasdaq.com/articles/did-gilead-sciences-make-11-billion-blunder-2018-12-09", "https://www.nasdaq.com/articles/vlue-gm-mu-gild-etf-outflow-alert-2018-12-07", "https://www.nasdaq.com/articles/biogen-biib-in-licenses-als-candidate-biib067-from-ionis-2018-12-07", "https://www.nasdaq.com/articles/gileads-gild-harvoni-and-descovy-get-approval-in-china-2018-12-05", "https://www.nasdaq.com/articles/amgens-bite-immunotherapies-show-promise-in-early-studies-2018-12-04", "https://www.nasdaq.com/articles/gilead-gild-announces-data-on-car-t-therapy-candidate-2018-12-04", "https://www.nasdaq.com/articles/gilead-sciences-gild-stock-sinks-as-market-gains%3A-what-you-should-know-2018-12-10", "https://www.nasdaq.com/articles/fda-committee-to-review-amgens-amgn-osteoporosis-candidate-2018-12-03", "https://www.nasdaq.com/articles/gilead-sciences-gild-stock-sinks-as-market-gains%3A-what-you-should-know-2018-12-03", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-xlv-2018-12-03", "https://www.nasdaq.com/articles/key-pharma-players-hiv-focus-ahead-world-aids-day-2018-11-30", "https://www.nasdaq.com/articles/3-top-dividend-stocks-yields-over-3-2018-11-30", "https://www.nasdaq.com/articles/how-google-helping-make-advances-medical-technology-2018-11-29", "https://www.nasdaq.com/articles/catalysts-firdapse-receives-fda-approval-for-rare-disease-2018-11-29", "https://www.nasdaq.com/articles/shires-takhzyro-gets-european-nod-for-hereditary-angioedema-2018-12-03", "https://www.nasdaq.com/articles/merck-mrk-receives-approval-for-2-hiv-medicines-in-eu-2018-11-29", "https://www.nasdaq.com/articles/aileron-inks-collaboration-deal-with-pfizer-for-cancer-combo-2018-11-28", "https://www.nasdaq.com/articles/novartis-nvs-receives-ec-approval-for-neulasta-biosimilar-2018-11-28", "https://www.nasdaq.com/articles/pfizers-epilepsy-drug-lyrica-gets-pediatric-exclusivity-2018-11-28", "https://www.nasdaq.com/articles/celgene-bluebirds-car-t-therapy-study-completes-enrollment-2018-11-28", "https://www.nasdaq.com/articles/5-biotech-stocks-scoop-big-dividends-2018-11-27", "https://www.nasdaq.com/articles/eyenovia-initiates-phase-iii-study-for-mydriasis-candidate-2018-11-27", "https://www.nasdaq.com/articles/how-parts-add-rndv-targets-24-2018-11-29", "https://www.nasdaq.com/articles/zafgen-zfgn-plunges-as-fda-puts-hold-on-diabetes-drug-trial-2018-11-27", "https://www.nasdaq.com/articles/alnylam-vir-begin-phase-i-ii-study-on-hepatitis-b-candidate-2018-11-27", "https://www.nasdaq.com/articles/bristol-myers-opdivo-yervoy-combo-fails-in-lung-cancer-trial-2018-11-27", "https://www.nasdaq.com/articles/gileads-hiv-franchise-car-t-therapy-likely-to-propel-growth-2018-11-26", "https://www.nasdaq.com/articles/after-hours-most-active-nov-26-2018-ctl-ge-qqq-rf-teva-hal-bac-intc-aapl-gild-xel-stld", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-celgene-2018-11-25", "https://www.nasdaq.com/articles/novartis-gets-approval-for-gene-therapy-luxturna-in-europe-2018-11-23", "https://www.nasdaq.com/articles/bayers-trk-inhibitor-gets-fda-nod-for-advanced-solid-tumors-2018-11-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-tsla-adsk-2018-11-21", "https://www.nasdaq.com/articles/should-value-investors-consider-gilead-gild-stock-now-2018-11-21", "https://www.nasdaq.com/articles/emergents-ebs-zika-vaccine-candidate-meets-study-endpoint-2018-11-20", "https://www.nasdaq.com/articles/gileads-vemlidy-gets-approval-in-china-for-hbv-infection-2018-11-20", "https://www.nasdaq.com/articles/tesaro-stock-sinks-aftermath-sale-rumors-2018-11-19", "https://www.nasdaq.com/articles/amgens-blincyto-gets-positive-chmp-opinion-for-line-extension-2018-11-19", "https://www.nasdaq.com/articles/novartis-nvs-gets-fda-nod-for-label-expansion-of-promacta-2018-11-19", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-drug-wins-nod-in-china-arena-up-on-licensing-deal-2018-11-21", "https://www.nasdaq.com/articles/ibb-gild-celg-ilmn-etf-outflow-alert-2018-11-16", "https://www.nasdaq.com/articles/bristol-myers-opdivo-receives-positive-chmp-opinion-for-rcc-2018-11-16", "https://www.nasdaq.com/articles/sangamos-shares-drop-on-rating-downgrade-pipeline-woes-2018-11-15", "https://www.nasdaq.com/articles/acorda-down-more-than-30-in-the-past-3-months%3A-heres-why-2018-11-15", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilead-regeneron-present-data-cocrystal-pharma-surges-2018-11-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-15-2018-2018-11-14", "https://www.nasdaq.com/articles/roches-tecentriq-gets-priority-review-for-breast-cancer-2018-11-14", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-11182018-2018-11-18", "https://www.nasdaq.com/articles/medicines-company-mdco-q3-loss-widens-inclisiran-in-focus-2018-11-12", "https://www.nasdaq.com/articles/cronos-cron-to-report-q3-earnings%3A-whats-in-the-offing-2018-11-12", "https://www.nasdaq.com/articles/tilray-tlry-to-report-q3-earnings%3A-whats-in-the-cards-2018-11-12", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-beats-on-q3-earnings-and-sales-2018-11-09", "https://www.nasdaq.com/articles/endo-endp-stock-declines-despite-q3-earnings-revenue-beat-2018-11-09", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q3-earnings-top-revenues-rise-stock-up-2018-11-08", "https://www.nasdaq.com/articles/prothena-prta-reports-narrower-than-expected-loss-in-q3-2018-11-08", "https://www.nasdaq.com/articles/amarins-vascepa-cuts-heart-risk-in-outcomes-test-stock-down-2018-11-13", "https://www.nasdaq.com/articles/aerie-aeri-q3-earnings-miss-rhopressa-gains-traction-2018-11-08", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-08-2018-2018-11-07", "https://www.nasdaq.com/articles/pacira-pcrx-q3-earnings-and-revenues-surpass-estimates-2018-11-05", "https://www.nasdaq.com/articles/why-gilead-sciences-inc-stock-broke-down-october-2018-11-05", "https://www.nasdaq.com/articles/puma-biotech-pbyi-q3-loss-narrows-nerlynx-pulls-stock-down-2018-11-05", "https://www.nasdaq.com/articles/3-top-biotech-stocks-pes-below-14-2018-11-03", "https://www.nasdaq.com/articles/emergent-ebs-q3-earnings-and-revenues-fall-shy-of-estimates-2018-11-02", "https://www.nasdaq.com/articles/validea-benjamin-graham-strategy-daily-upgrade-report-1182018-2018-11-08", "https://www.nasdaq.com/articles/bluebird-blue-q3-loss-narrower-than-expected-revenues-beat-2018-11-02", "https://www.nasdaq.com/articles/radius-health-rdus-posts-narrower-than-expected-q3-loss-2018-11-02", "https://www.nasdaq.com/articles/agios-agio-q3-earnings-beat-tibsovo-sales-drive-stock-2018-11-02", "https://www.nasdaq.com/articles/acorda-acor-q3-earnings-top-estimates-ampyra-sales-view-up-2018-11-01", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-walmart-prologis-and-incyte-2018-11-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-amgen-vertex-pharmaceuticals-celgene", "https://www.nasdaq.com/articles/intercept-icpt-gains-on-earnings-and-revenue-beat-in-q3-2018-11-01", "https://www.nasdaq.com/articles/conatus-cnat-q3-loss-in-line-revenues-lag-estimates-2018-11-02", "https://www.nasdaq.com/articles/sptm-txn-gild-lmt-large-inflows-detected-etf-2018-10-31", "https://www.nasdaq.com/articles/nasdaq-100-movers-ea-nflx-2018-10-31", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-730590-14425-points-2018-10-31", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-amgen-vertex-impress-in-q3-drna-soars-on-lly-deal-2018-10", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-gilead-sciences-2018-10-30", "https://www.nasdaq.com/articles/can-strong-economy-save-stock-market-2018-10-30", "https://www.nasdaq.com/articles/7-rising-healthcare-stocks-consider-2018-10-29", "https://www.nasdaq.com/articles/aduro-adro-q3-loss-narrower-than-expected-revenues-lag-2018-10-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-roche-gilead-and-bristol-myers-revised-2018-10-29", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2018-10-29", "https://www.nasdaq.com/articles/dr.-reddys-rdy-earnings-and-revenues-improve-y-y-in-q2-2018-10-29", "https://www.nasdaq.com/articles/abbvie-takes-aim-vertex-pharmaceuticals-incorporated-2018-10-27", "https://www.nasdaq.com/articles/where-will-gilead-sciences-inc-be-5-years-2018-10-27", "https://www.nasdaq.com/articles/daily-dividend-report-mac-cog-gild-agn-duk-2018-10-26", "https://www.nasdaq.com/articles/gilead-gild-beats-on-q3-earnings-sales-updates-view-2018-10-26", "https://www.nasdaq.com/articles/analysts-see-18-upside-holdings-jkf-2018-10-29", "https://www.nasdaq.com/articles/gilead-sciences-stock-back-base-go-long-2018-10-26", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q3-2018-earnings-conference-call-transcript-2018-10-26", "https://www.nasdaq.com/articles/vertex-vrtx-q3-earnings-and-revenues-surpass-estimates-2018-10-25", "https://www.nasdaq.com/articles/bristol-myers-bmy-beats-on-q3-earnings-raises-eps-view-2018-10-25", "https://www.nasdaq.com/articles/sarepta-srpt-q3-earnings-sales-miss-exondys-51-sales-up-2018-10-25", "https://www.nasdaq.com/articles/new-batch-q3-earnings-amzn-googl-intc-more-2018-10-25", "https://www.nasdaq.com/articles/earnings-reaction-history-gilead-sciences-inc-583-follow-through-indicator-45-sensitive", "https://www.nasdaq.com/articles/gilead-sciences-3rd-quarter-good-news-gets-better-bad-news-gets-worse-2018-10-26", "https://www.nasdaq.com/articles/investors-are-underestimating-gilead-sciences-stock-2018-10-24", "https://www.nasdaq.com/articles/drug-stocks-earnings-due-on-oct-25%3A-mrk-bmy-gild-celg-2018-10-24", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-right-now-2018-10-24", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-gild-wing-veev-2018-10-24", "https://www.nasdaq.com/articles/alkermes-alks-exceeds-q3-earnings-estimates-raises-outlook-2018-10-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-roche-gilead-and-bristol-myers-2018-10-23", "https://www.nasdaq.com/articles/why-casi-pharmaceuticals-inc-rocketing-higher-today-2018-10-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-25-2018-amzn-googl-intc-gild-syk-ftv-dfs-dlr-rsg-cern", "https://www.nasdaq.com/articles/will-gilead-gild-hiv-sales-offset-hcv-sales-decline-in-q3-2018-10-22", "https://www.nasdaq.com/articles/can-unitedhealth-group-and-johnson-johnson-continue-their-winning-ways-2018-10-18", "https://www.nasdaq.com/articles/sangamo-therapeutics-inc-buy-2018-10-18", "https://www.nasdaq.com/articles/gilead-sciences-gild-dips-more-than-broader-markets%3A-what-you-should-know-2018-10-18", "https://www.nasdaq.com/articles/forget-gilead-sciences-intercept-pharmaceuticals-inc-better-growth-stock-2018-10-16", "https://www.nasdaq.com/articles/gilead-sciences-breaks-above-200-day-moving-average-bullish-gild-2018-10-16", "https://www.nasdaq.com/articles/can-tiny-biotech-revolutionize-35-billion-market-2018-10-16", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-10-22", "https://www.nasdaq.com/articles/2-pharmaceutical-stocks-buy-dividends-3-or-better-2018-10-15", "https://www.nasdaq.com/articles/ibb-gild-biib-celg-large-inflows-detected-etf-2018-10-12", "https://www.nasdaq.com/articles/gilead-sciences-gild-outpaces-stock-market-gains%3A-what-you-should-know-2018-10-12", "https://www.nasdaq.com/articles/arbutus-abus-plunges-on-disappointing-hbv-pipeline-updates-2018-10-10", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-biib-present-data-vtgn-gains-on-fast-track-status-2018-10-10", "https://www.nasdaq.com/articles/5-best-dividend-stocks-buy-hands-down-2018-10-10", "https://www.nasdaq.com/articles/better-buy-crispr-therapeutics-ag-vs-editas-2018-10-09", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-gs-cmg-gild-2018-10-16", "https://www.nasdaq.com/articles/gilead-sciences-gild-stock-moves-0.24%3A-what-you-should-know-2018-10-05", "https://www.nasdaq.com/articles/merck-reports-positive-efficacy-data-from-phase-iii-hiv-study-2018-10-05", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-gild-biib-celg-2018-10-04", "https://www.nasdaq.com/articles/jjs-phase-iii-data-shows-switch-to-its-hiv-drug-beneficial-2018-10-04", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-pfizer-2018-10-04", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-cblk-gild-amtd-2018-10-04", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-right-now-2018-10-04", "https://www.nasdaq.com/articles/gilead-announces-positive-data-from-ongoing-biktarvy-study-2018-10-05", "https://www.nasdaq.com/articles/gilead-hifibio-collaborate-to-develop-t-cell-receptors-2018-10-03", "https://www.nasdaq.com/articles/5-top-healthcare-mutual-funds-to-buy-in-october-2018-10-02", "https://www.nasdaq.com/articles/3-reasons-why-buying-viking-therapeutics-dip-could-pay-big-2018-10-02", "https://www.nasdaq.com/articles/5-reasons-buy-gilead-stock-today-2018-10-01", "https://www.nasdaq.com/articles/better-buy-vertex-pharmaceuticals-incorporated-vs-galapagos-nv-2018-09-28", "https://www.nasdaq.com/articles/alexion-alxn-to-acquire-biotech-syntimmune-for-%241.2-billion-2018-09-27", "https://www.nasdaq.com/articles/look-under-hood-spyv-has-11-upside-2018-09-27", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-on-acquisition-spree-fda-nod-for-regn-amgn-drugs-2018-10-03", "https://www.nasdaq.com/articles/ibb-biib-gild-celg-etf-inflow-alert-2018-09-26", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-soliris-successful-respite-for-sarepta-amrn-soars-2018-09-26", "https://www.nasdaq.com/articles/gilead-sciences-latest-tactic-go-generic-2018-09-26", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2018-09-26", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-isrg-celg-gild-2018-09-26", "https://www.nasdaq.com/articles/gilead-undercutting-its-own-drugs-heres-why-2018-09-26", "https://www.nasdaq.com/articles/5-biotech-stocks-play-sectors-next-big-trend-nash-2018-09-26", "https://www.nasdaq.com/articles/guide-crispr-stocks-latest-apple-fed-gdp-news-free-lunch-2018-09-27", "https://www.nasdaq.com/articles/3-ways-unpack-some-hidden-treasure-tesaro-stock-2018-09-24", "https://www.nasdaq.com/articles/exelixis-ipsen-receive-positive-chmp-opinion-for-cabometyx-2018-09-24", "https://www.nasdaq.com/articles/chmp-reconfirms-negative-opinion-for-sareptas-exondys-2018-09-24", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-09-23", "https://www.nasdaq.com/articles/how-do-drugs-compete-against-each-other-2018-09-21", "https://www.nasdaq.com/articles/fda-confirms-positive-safety-profile-of-acadias-nuplazid-2018-09-21", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-buy-2018-09-21", "https://www.nasdaq.com/articles/gilead-gild-to-launch-generics-for-leading-hcv-treatments-2018-09-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-pharmaceuticals-celgene-sanofi-and-gilead", "https://www.nasdaq.com/articles/exelixis-partner-ipsen-gets-approval-for-cabometyx-in-canada-2018-09-20", "https://www.nasdaq.com/articles/ultragenyxs-shares-surge-more-than-80-in-the-year-so-far-2018-09-20", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celg-regn-present-data-vktx-soars-on-drugs-success-2018-09-19", "https://www.nasdaq.com/articles/viking-therapeutics-liver-candidate-passes-test-shares-soar-2018-09-19", "https://www.nasdaq.com/articles/dr.-reddys-rdy-presence-in-generics-market-remains-strong-2018-09-19", "https://www.nasdaq.com/articles/is-gilead-gild-a-suitable-stock-for-value-investors-now-2018-09-19", "https://www.nasdaq.com/articles/molecular-templates-surges-50-inks-cancer-deal-with-takeda-2018-09-20", "https://www.nasdaq.com/articles/theravance-mylan-report-positive-data-on-copd-drug-yupelri-2018-09-18", "https://www.nasdaq.com/articles/agenus-receives-milestone-payment-of-%245-million-from-incyte-2018-09-18", "https://www.nasdaq.com/articles/galapagos-nv-buy-now-2018-09-18", "https://www.nasdaq.com/articles/after-hours-most-active-sep-18-2018-f-t-abev-symc-qqq-mo-nly-intc-gild-fe-foxa-grpn-2018", "https://www.nasdaq.com/articles/viking-therapeutics-and-madrigal-pharmaceuticals-are-racing-finish-line-nash-2018-09-18", "https://www.nasdaq.com/articles/should-value-investors-pick-gilead-sciences-gild-stock-2018-09-17", "https://www.nasdaq.com/articles/why-gilead-stock-sleepy-giant-waiting-break-out-2018-09-17", "https://www.nasdaq.com/articles/gilead-sciences-gild-outpaces-stock-market-gains%3A-what-you-should-know-2018-09-19", "https://www.nasdaq.com/articles/ibb-biib-gild-celg-large-outflows-detected-etf-2018-09-14", "https://www.nasdaq.com/articles/unity-ubx-catches-eye%3A-stock-jumps-8.8-2018-09-14", "https://www.nasdaq.com/articles/brawl-brewing-between-abbvie-and-gilead-sciences-arthritis-2018-09-14", "https://www.nasdaq.com/articles/gilead-inks-gene-editing-collaboration-deal-for-hbv-infection-2018-09-13", "https://www.nasdaq.com/articles/company-news-for-sep-13-2018-2018-09-13", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-biogen-2018-09-13", "https://www.nasdaq.com/articles/whats-next-gilead-sciences-after-its-latest-clinical-success-2018-09-13", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-9162018-2018-09-16", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-arthritis-drug-successful-in-phase-iii-prqr-soars-2018-09-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-mxim-gild-2018-09-12", "https://www.nasdaq.com/articles/mercks-antibacterial-drug-succeeds-in-label-expansion-study-2018-09-12", "https://www.nasdaq.com/articles/regeneron-sanofis-sbla-for-praluent-to-be-reviewed-by-fda-2018-09-12", "https://www.nasdaq.com/articles/3-top-stocks-investing-pharmas-next-35-billion-market-2018-09-12", "https://www.nasdaq.com/articles/incyte-foundation-medicine-partner-for-companion-diagnostics-2018-09-12", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-13-2018-2018-09-12", "https://www.nasdaq.com/articles/heres-why-galapagos-nv-skyrocketing-183-today-2018-09-12", "https://www.nasdaq.com/articles/why-altria-group-galapagos-and-laredo-petroleum-jumped-today-2018-09-12", "https://www.nasdaq.com/articles/gileads-rheumatoid-arthritis-drug-successful-in-phase-iii-2018-09-12", "https://www.nasdaq.com/articles/endocyte-announces-fdas-acceptance-of-trial-endpoint-change-2018-09-11", "https://www.nasdaq.com/articles/ex-dividend-reminder-el-paso-electric-dte-energy-and-gilead-sciences-2018-09-11", "https://www.nasdaq.com/articles/inovios-early-mid-stage-vaccine-pipeline-exhibits-growth-2018-09-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-abbott-gilead-fedex-archer-daniels-and-cbre-2018-09-10", "https://www.nasdaq.com/articles/gilead-sciences-gild-outpaces-stock-market-gains%3A-what-you-should-know-2018-09-10", "https://www.nasdaq.com/articles/gilead-sciences-reports-market-moving-news-2018-09-12", "https://www.nasdaq.com/articles/inovio-initiates-dosing-in-phase-i-iia-study-on-mers-vaccine-2018-09-07", "https://www.nasdaq.com/articles/top-research-reports-abbott-gilead-fedex-2018-09-07", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-ubnt-roku-gild-2018-09-07", "https://www.nasdaq.com/articles/arrowhead-stock-not-done-rallying-after-its-38-jump-2018-09-07", "https://www.nasdaq.com/articles/proqr-up-more-than-120-on-favorable-eye-disorder-study-data-2018-09-06", "https://www.nasdaq.com/articles/puma-biotech-gets-eu-nod-for-breast-cancer-drug-nerlynx-2018-09-06", "https://www.nasdaq.com/articles/ibb-gild-celg-regn-large-outflows-detected-etf-2018-09-06", "https://www.nasdaq.com/articles/shires-adhd-portfolio-remains-strong-amid-competition-2018-09-10", "https://www.nasdaq.com/articles/bluebird-blue-reports-updated-data-on-lenti-d-gene-therapy-2018-09-06", "https://www.nasdaq.com/articles/gilead-galapagos-spondylitis-drug-meets-primary-endpoint-2018-09-06", "https://www.nasdaq.com/articles/mannkind-stock-up-on-licensing-deal-with-united-therapeutics-2018-09-05", "https://www.nasdaq.com/articles/horizon-pharma-completes-enrollment-in-eye-disease-study-2018-09-05", "https://www.nasdaq.com/articles/bayer-bayry-misses-on-q2-earnings-closes-monsanto-buyout-2018-09-05", "https://www.nasdaq.com/articles/inovio-ino-initiates-phase-i-study-on-hepatitis-c-vaccine-2018-09-04", "https://www.nasdaq.com/articles/now-good-time-buy-gilead-sciences-2018-09-04", "https://www.nasdaq.com/articles/3-top-big-pharma-stocks-buy-now-2018-09-06", "https://www.nasdaq.com/articles/novo-nordisks-ozempic-lowers-risk-of-cardiovascular-events-revised-2018-09-04", "https://www.nasdaq.com/articles/astrazenecas-lupus-drug-misses-primary-endpoint-in-study-2018-09-03", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-09-02", "https://www.nasdaq.com/articles/glaxos-asthma-drug-gets-eu-nod-for-pediatric-population-2018-08-31", "https://www.nasdaq.com/articles/vertex-inks-deal-with-genomics-to-make-serious-disease-drugs-2018-08-31", "https://www.nasdaq.com/articles/bayers-bayry-jivi-gets-fda-approval-to-treat-hemophilia-a-2018-08-31", "https://www.nasdaq.com/articles/alnylam-gets-european-nod-for-first-ever-rnai-therapeutic-2018-08-31", "https://www.nasdaq.com/articles/alnylams-shares-up-as-onpattro-gets-fda-and-eu-approvals-2018-09-04", "https://www.nasdaq.com/articles/bristol-myers-sprycel-seeks-label-expansion-in-the-u.s.-2018-08-31", "https://www.nasdaq.com/articles/5-enticing-dividend-stocks-primed-long-term-growth-2018-08-31", "https://www.nasdaq.com/articles/ultragenyx-to-file-nda-for-lc-faod-candidate-on-existing-data-2018-08-30", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2018-08-30", "https://www.nasdaq.com/articles/gilead-sciences-gild-gains-as-market-dips%3A-what-you-should-know-2018-08-30-0", "https://www.nasdaq.com/articles/affimed-afmd-surges-on-collaboration-contract-with-roche-revised-2018-08-30", "https://www.nasdaq.com/articles/bausch-bhc-resubmits-nda-for-duobrii-for-plaque-psoriasis-2018-08-30", "https://www.nasdaq.com/articles/merck-mrk-receives-fda-approval-for-two-hiv-medicines-2018-08-31", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-gets-ec-nod-for-yescarta-amgn-submits-kyprolis-snda-2018-08-29", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-right-now-2018-08-29", "https://www.nasdaq.com/articles/time-to-take-some-profits-in-sarepta-therapeutics-stock-2018-08-29", "https://www.nasdaq.com/articles/amgen-files-for-once-weekly-regimen-for-myeloma-drug-kyprolis-2018-08-28", "https://www.nasdaq.com/articles/gileads-car-t-therapy-yescarta-gets-approval-in-europe-2018-08-28", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-week-2018-08-28", "https://www.nasdaq.com/articles/ultragenyxs-rare-disease-drug-mepsevii-gets-eu-approval-2018-08-28", "https://www.nasdaq.com/articles/affimed-afmd-surges-on-collaboration-contract-with-roche-2018-08-29", "https://www.nasdaq.com/articles/play-the-future-of-gene-therapy-with-these-5-biotech-stocks-2018-08-27", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-biib-gild-celg-2018-08-27", "https://www.nasdaq.com/articles/novartis-car-t-therapy-kymriah-gets-approval-in-europe-2018-08-27", "https://www.nasdaq.com/articles/novo-nordisks-ozempic-lowers-risk-of-cardiovascular-events-2018-08-27", "https://www.nasdaq.com/articles/bausch-bhc-gets-fda-approval-for-altreno-for-acne-vulgaris-2018-08-27", "https://www.nasdaq.com/articles/why-is-gilead-gild-down-6.2-since-last-earnings-report-2018-08-24", "https://www.nasdaq.com/articles/shires-takhzyro-gets-fda-nod-for-hereditary-angioedema-2018-08-24", "https://www.nasdaq.com/articles/bayers-blood-thinner-xarelto-fails-in-line-extension-studies-2018-08-28", "https://www.nasdaq.com/articles/3-big-drug-stocks-big-cash-stockpiles-should-you-spend-your-cash-buying-them-2018-08-24", "https://www.nasdaq.com/articles/abbvie-posts-positive-data-on-elagolix-for-uterine-fibroids-2018-08-23", "https://www.nasdaq.com/articles/exact-sciences-inks-cologuard-co-promotion-deal-with-pfizer-2018-08-23", "https://www.nasdaq.com/articles/4-biotech-stocks-investors-can-bet-post-solid-q2-earnings-2018-08-23", "https://www.nasdaq.com/articles/mallinckrodts-stannsoporfin-gets-complete-response-letter-2018-08-23", "https://www.nasdaq.com/articles/dont-worry-about-inverted-yield-curveyet-2018-08-23", "https://www.nasdaq.com/articles/pacira-pcrx-rides-high-on-robust-exparel-performance-2018-08-22", "https://www.nasdaq.com/articles/roche-rhhby-gets-fda-approval-for-cobas-efgr-mutation-test-2018-08-24", "https://www.nasdaq.com/articles/infinity-focuses-on-developing-ipi-549-for-solid-tumors-2018-08-22", "https://www.nasdaq.com/articles/alnylam-completes-enrollment-in-phase-iii-givosiran-study-2018-08-22", "https://www.nasdaq.com/articles/5-drug-stocks-to-buy-while-the-pharma-sector-is-on-sale-2018-08-22", "https://www.nasdaq.com/articles/alexions-bla-for-alxn1210-gets-priority-review-from-fda-2018-08-21", "https://www.nasdaq.com/articles/china-biologic-products-cbpo-looks-good%3A-stock-adds-8.7-in-session-2018-08-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amazon-petroleo-brazileiro-gilead-sciences-and-kla", "https://www.nasdaq.com/articles/cost-cures-how-investing-biotech-stocks-could-soon-be-radically-changed-2018-08-21", "https://www.nasdaq.com/articles/allergan-falls-on-fdas-rejection-of-uterine-fibroids-drug-2018-08-22", "https://www.nasdaq.com/articles/8-undervalued-biotech-stocks-to-watch-2018-08-20", "https://www.nasdaq.com/articles/bristol-myers-opdivo-gets-fda-nod-for-small-cell-lung-cancer-2018-08-20", "https://www.nasdaq.com/articles/novo-nordisk-buys-ziylo-to-develop-glucose-responsive-insulin-2018-08-20", "https://www.nasdaq.com/articles/time-jackson-hole-global-week-ahead-2018-08-20", "https://www.nasdaq.com/articles/viking-therapeutics-inc-buy-2018-08-19", "https://www.nasdaq.com/articles/has-gilead-sciences-gild-outpaced-other-medical-stocks-this-year-2018-08-17", "https://www.nasdaq.com/articles/has-gilead-sciences-gild-outpaced-other-medical-stocks-this-year-2018-08-17-0", "https://www.nasdaq.com/articles/japan-nods-to-astrazenecas-tagrisso-for-first-line-nsclc-2018-08-21", "https://www.nasdaq.com/articles/zacks-value-trader-highlights%3A-sony-carrizo-oil-gas-intel-united-rentals-and-gilead-2018", "https://www.nasdaq.com/articles/glaxo-jjs-dual-drug-hiv-regimen-succeeds-in-phase-iii-study-2018-08-17", "https://www.nasdaq.com/articles/notable-friday-option-activity-adbe-fb-gild-2018-08-17", "https://www.nasdaq.com/articles/inovio-pharmaceuticals-initiates-dosing-in-hiv-vaccine-study-2018-08-16", "https://www.nasdaq.com/articles/lessons-legendary-value-investor-2018-08-16", "https://www.nasdaq.com/articles/vertexs-cystic-fibrosis-drug-gets-fda-nod-for-children-2018-08-16", "https://www.nasdaq.com/articles/should-gilead-be-worried-about-new-monthly-hiv-medication-2018-08-16", "https://www.nasdaq.com/articles/regeneron-teva-announce-positive-data-on-osteoarthritis-drug-2018-08-17", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/bayer-plunges-as-monsanto-fined-%24289m-in-roundup-lawsuit-2018-08-14", "https://www.nasdaq.com/articles/shire-shionogi-file-nda-for-intuniv-for-adults-in-japan-2018-08-13", "https://www.nasdaq.com/articles/ligand-lgnd-proposes-to-buy-u.k.s-drug-discovery-biotech-2018-08-13", "https://www.nasdaq.com/articles/alnylam-alny-gets-fda-nod-for-first-ever-rnai-therapeutic-2018-08-13", "https://www.nasdaq.com/articles/amicus-fold-gets-fda-nod-for-fabry-disease-drug-galafold-2018-08-13", "https://www.nasdaq.com/articles/gild-makes-notable-cross-below-critical-moving-average-2018-08-15", "https://www.nasdaq.com/articles/agenus-agen-q2-loss-narrower-than-expected-revenues-beat-2018-08-10", "https://www.nasdaq.com/articles/gild-top-25-dividend-giant-523b-held-etfs-2018-08-10", "https://www.nasdaq.com/articles/biotech-etfs-focus-string-q2-earnings-beat-2018-08-10", "https://www.nasdaq.com/articles/keryxs-kerx-loss-wider-than-expected-in-q2-sales-lag-2018-08-09", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q2-earnings-top-revenues-slump-y-y-2018-08-09", "https://www.nasdaq.com/articles/crispr-therapeutics-stock-grossly-overvalued-2018-08-09", "https://www.nasdaq.com/articles/aerie-aeri-earnings-miss-in-q2-rhopressa-performs-well-2018-08-09", "https://www.nasdaq.com/articles/puma-biotech-pbyi-q2-loss-narrows-nerlynx-drives-sales-2018-08-10", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-prgo-oxy-gild-2018-08-09", "https://www.nasdaq.com/articles/novo-nordisk-nvo-beats-q2-earnings-and-sales-estimates-2018-08-08", "https://www.nasdaq.com/articles/inovio-ino-q2-loss-narrows-revenues-surpass-estimates-2018-08-08", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q2-loss-in-line-revenues-miss-2018-08-08", "https://www.nasdaq.com/articles/merrimack-mack-suffers-wider-than-expected-loss-in-q2-2018-08-08", "https://www.nasdaq.com/articles/vivus-vvus-q2-loss-wider-than-expected-revenues-up-y-y-2018-08-08", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2018-08-08", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q2-earnings-sales-beat-shares-rise-2018-08-09", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-shines-blue-surges-once-plunges-2018-08-08", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-august-2018-08-08", "https://www.nasdaq.com/articles/radius-rdus-q2-loss-narrower-than-expected-tymlos-sales-up-2018-08-07", "https://www.nasdaq.com/articles/alnylams-alny-q2-loss-wider-than-expected-sales-beat-2018-08-06", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-08-06", "https://www.nasdaq.com/articles/q2-scorecard-research-reports-gilead-american-tower-others-2018-08-06", "https://www.nasdaq.com/articles/bluebird-blue-q2-loss-wider-than-expected-revenues-miss-2018-08-03", "https://www.nasdaq.com/articles/prothena-prta-q2-earnings-lag-estimates-pipeline-in-focus-2018-08-08", "https://www.nasdaq.com/articles/intercept-icpt-gains-on-solid-q2-results-ocaliva-recovers-2018-08-03", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-biogen-thermo-fisher-hca-gilead-and-qualcomm-2018", "https://www.nasdaq.com/articles/ultragenyx-rare-posts-narrower-than-expected-loss-in-q2-2018-08-03", "https://www.nasdaq.com/articles/epizyme-epzm-q2-loss-narrows-shares-crash-24-on-setbacks-2018-08-03", "https://www.nasdaq.com/articles/5-cheap-peg-stocks-suitable-for-garp-investors-2018-08-02", "https://www.nasdaq.com/articles/zoetis-zts-beats-on-q2-earnings-sales-updates-18-view-2018-08-02", "https://www.nasdaq.com/articles/the-5-best-dividend-stocks-to-buy-hands-down-2018-08-02", "https://www.nasdaq.com/articles/acorda-acor-q2-earnings-and-revenues-surpass-estimates-2018-08-03", "https://www.nasdaq.com/articles/endocyte-ecyt-posts-narrower-than-expected-loss-in-q2-2018-08-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-amgen-vertex-impress-in-q2-gileads-ceo-to-exit-2018-08-01", "https://www.nasdaq.com/articles/sanofis-sny-q2-earnings-surpass-estimates-sales-miss-2018-07-31", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2018-07-31", "https://www.nasdaq.com/articles/gilead-sciences-sudden-change-leadership-good-thing-2018-07-30", "https://www.nasdaq.com/articles/3-cheap-big-pharma-dividend-stocks-you-can-buy-now-and-hold-years-2018-07-29", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-07-27", "https://www.nasdaq.com/articles/shires-shpg-earnings-and-revenues-beat-estimates-in-q2-2018-08-01", "https://www.nasdaq.com/articles/after-hours-most-active-jul-27-2018-qqq-wfc-csco-ms-db-nok-czr-mo-ko-gild-soxx-symc-2018", "https://www.nasdaq.com/articles/2-reasons-market-frowned-after-abbvies-blowout-q2-and-1-reason-it-should-be-excited-2018", "https://www.nasdaq.com/articles/allergan-agn-beats-on-q2-earnings-unveils-buyback-plan-2018-07-26", "https://www.nasdaq.com/articles/astrazenecas-azn-q2-earnings-and-sales-beat-stock-up-2018-07-26", "https://www.nasdaq.com/articles/alexions-alxn-earnings-beat-estimates-in-q2-guidance-up-2018-07-26", "https://www.nasdaq.com/articles/microsoft-hr-block-facebook-qualcomm-and-gilead-highlighted-as-zacks-bull-and-bear-of-the", "https://www.nasdaq.com/articles/gilead-gild-q2-earnings-sales-beat-eclipsed-by-ceo-exit-2018-07-26", "https://www.nasdaq.com/articles/forget-gilead-sciences-ceo-departure-was-biotechs-big-news-2018-07-27", "https://www.nasdaq.com/articles/daily-dividend-report-schw-mck-cvx-cmcsa-gild-2018-07-26", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-fbt-2018-07-26", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biogen-gains-on-q2-results-agios-gets-fda-nod-for-leukemia-drug", "https://www.nasdaq.com/articles/facebook-misses-1st-time-11-quarters-plus-gild-qcom-2018-07-25", "https://www.nasdaq.com/articles/gilead-sciences-gild-q2-earnings-and-revenues-surpass-estimates-2018-07-25", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-grpn-gild-spwr-2018-07-25", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-25-2018-fb-v-pypl-gild-qcom-su-mdlz-lvs-vrtx-f-now-algn", "https://www.nasdaq.com/articles/ceo-departure-gilead-sciences-upstages-good-second-quarter-results-2018-07-26", "https://www.nasdaq.com/articles/daily-dividend-report-schw-mck-cvx-cmcsa-gild-2018-07-26", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-will-it-beat-again-2018-07-23", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-celgene-2018-07-23", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-wells-fargo-philip-morris-and-gilead-sciences-2018-07-23", "https://www.nasdaq.com/articles/will-strong-hiv-sales-fuel-gilead-gild-in-q2-earnings-2018-07-23", "https://www.nasdaq.com/articles/why-i-finally-sold-my-gilead-sciences-stock-position-2018-07-23", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-abbvie-abbv-in-q2-earnings-2018-07-24", "https://www.nasdaq.com/articles/4-biotech-bets-watch-industry-rebounds-month-2018-07-20", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-july-2018-07-20", "https://www.nasdaq.com/articles/will-hiv-sales-drive-gilead-gild-to-beat-in-q2-earnings-2018-07-20", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-gild-amgn-2018-07-19", "https://www.nasdaq.com/articles/5-biotech-stocks-well-poised-to-beat-q2-earnings-estimates-2018-07-19", "https://www.nasdaq.com/articles/jjs-darunavir-based-single-tablet-hiv-regimen-gets-fda-nod-2018-07-18", "https://www.nasdaq.com/articles/4-biggest-hiv-drugs-2024-which-stocks-are-poised-profit-2018-07-16", "https://www.nasdaq.com/articles/3-key-things-watch-gilead-sciences-q2-earnings-report-2018-07-22", "https://www.nasdaq.com/articles/3-best-big-pharma-stocks-buy-2nd-half-2018-2018-07-15", "https://www.nasdaq.com/articles/3-biotech-stocks-big-news-coming-nash-2018-07-14", "https://www.nasdaq.com/articles/if-youre-thinking-about-buying-gilead-sciences-stock-nows-time-do-it-2018-07-12", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-gild-amgn-biib-2018-07-11", "https://www.nasdaq.com/articles/3-huge-biotech-winners-2018-so-far-2018-07-11", "https://www.nasdaq.com/articles/gilead-sciences-gild-shares-cross-3-yield-mark-2018-07-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-mastercard-gilead-goldman-sachs-pepsico-and-aetna-2018", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-7152018-2018-07-15", "https://www.nasdaq.com/articles/is-invesco-zacks-multi-asset-income-etf-cvy-a-hot-etf-right-now-2018-07-10", "https://www.nasdaq.com/articles/top-research-reports-mastercard-gilead-goldman-sachs-2018-07-09", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-gild-2018-07-09", "https://www.nasdaq.com/articles/biotech-etfs-surge-biogens-positive-drug-trial-result-2018-07-09", "https://www.nasdaq.com/articles/why-biotech-stocks-rallied-biogens-alzheimers-test-2018-07-06", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-gild-omc-adsk-2018-07-06", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-positive-chmp-nod-regulatory-updates-more-2018-07-05", "https://www.nasdaq.com/articles/trade-of-the-day%3A-gilead-sciences-gild-2018-07-10", "https://www.nasdaq.com/articles/is-gilead-sciences-a-great-stock-for-value-investors-2018-07-03", "https://www.nasdaq.com/articles/gileads-gild-car-t-therapy-gets-positive-chmp-opinion-2018-07-02", "https://www.nasdaq.com/articles/novartis-to-spin-off-alcon-as-separate-trading-company-2018-07-02", "https://www.nasdaq.com/articles/4-biotech-stocks-bet-second-half-2018-2018-06-29", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-pbyi-soars-mack-crashes-gilds-biktarvy-gets-ec-nod-2018-06-27", "https://www.nasdaq.com/articles/gileads-gild-biktarvy-gets-ec-nod-for-hiv-1-infection-2018-06-26", "https://www.nasdaq.com/articles/after-hours-most-active-jun-26-2018-pfe-f-qqq-msft-flnt-bwp-teva-gild-t-intc-mdt-2018-06", "https://www.nasdaq.com/articles/ibb-gild-amgn-biib-large-outflows-detected-etf-2018-07-03", "https://www.nasdaq.com/articles/health-care-sector-update-06252018-drio-sybx-gild-2018-06-25", "https://www.nasdaq.com/articles/we-did-math-qqxt-can-go-58-2018-06-25", "https://www.nasdaq.com/articles/health-care-sector-update-06252018-driovlrxgildsybx-2018-06-25", "https://www.nasdaq.com/articles/health-care-sector-update-06252018-vlrxgildsybx-2018-06-25", "https://www.nasdaq.com/articles/2-high-flying-biotech-stocks-even-more-room-grow-2018-06-20", "https://www.nasdaq.com/articles/crispr-science-and-stocks-knowing-enough-invest-2018-06-20", "https://www.nasdaq.com/articles/3-great-reasons-buy-gilead-sciences-2018-06-19", "https://www.nasdaq.com/articles/ibb-gild-biib-celg-etf-inflow-alert-2018-06-25", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-6172018-2018-06-17", "https://www.nasdaq.com/articles/1-under-radar-dividend-growth-stock-buy-right-now-2018-06-17", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-gild-celg-2018-06-15", "https://www.nasdaq.com/articles/zacks-value-investor-highlights%3A-gilead-sciences-biogen-celgene-lannett-and-valeant-2018", "https://www.nasdaq.com/articles/nash-space-focus-galmed-glmd-posts-positive-data-2018-06-14", "https://www.nasdaq.com/articles/galmed-glmd-soars-on-positive-nash-data-on-aramchol-2018-06-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2018-2018-06-13", "https://www.nasdaq.com/articles/novartis-announces-positive-data-on-car-t-therapy-kymriah-2018-06-18", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-anet-tpx-gild-2018-06-13", "https://www.nasdaq.com/articles/ex-dividend-reminder-chesapeake-utilities-gilead-sciences-and-owens-minor-2018-06-12", "https://www.nasdaq.com/articles/after-hours-most-active-jun-12-2018-cmcsa-f-edr-mu-knx-wmb-ge-mgm-amat-intc-gild-agnc-2018", "https://www.nasdaq.com/articles/jak-inhibitors-prospects-strong-4-stocks-ruling-space-2018-06-11", "https://www.nasdaq.com/articles/gilead-sciences-top-socially-responsible-dividend-stock-32-yield-gild-2018-06-11", "https://www.nasdaq.com/articles/should-you-stick-gilead-sciences-2018-06-07", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-06-06", "https://www.nasdaq.com/articles/drug-stocks-next-hot-industry-or-value-traps-2018-06-13", "https://www.nasdaq.com/articles/2-cheap-dividend-stocks-you-can-buy-right-now-2018-06-06", "https://www.nasdaq.com/articles/gilead-collaborates-with-hookipa-for-hbv-and-hiv-therapies-2018-06-06", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-ma-gild-wdc-2018-06-04", "https://www.nasdaq.com/articles/3-reasons-gilead-sciences-better-value-stock-amgen-2018-06-03", "https://www.nasdaq.com/articles/has-gilead-sciences-buy-argument-collapsed-2018-06-01", "https://www.nasdaq.com/articles/better-know-biotech-2-stocks-youve-got-know-about-2018-06-01", "https://www.nasdaq.com/articles/madrigals-nash-study-data-encouraging-stock-skyrockets-2018-06-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-celgene-amgen-impress-at-asco-2018-06-06", "https://www.nasdaq.com/articles/2-cheap-dividend-stocks-you-can-buy-right-now-2018-06-06", "https://www.nasdaq.com/articles/glaxosmithkline-plc-stock-buy-2018-05-31", "https://www.nasdaq.com/articles/gilead-galapagos-announce-positive-data-on-filgotinib-2018-05-31", "https://www.nasdaq.com/articles/2018-asco-conference-roundup-2018-05-31", "https://www.nasdaq.com/articles/why-is-gilead-sciences-gild-down-7.2-since-its-last-earnings-report-2018-05-31", "https://www.nasdaq.com/articles/asco-conference-preview-heres-what-biotech-investors-need-watch-2018-05-31", "https://www.nasdaq.com/articles/read-you-buy-immuno-oncology-stocks-2018-05-30", "https://www.nasdaq.com/articles/5-top-stocks-buy-june-2018-06-01", "https://www.nasdaq.com/articles/3-top-value-stocks-buy-now-2018-05-29", "https://www.nasdaq.com/articles/3-healthcare-stocks-are-undeniably-dirt-cheap-right-now-2018-05-27", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-gild-tmo-cvs-2018-05-25", "https://www.nasdaq.com/articles/bluebirds-lenti-d-gets-breakthrough-therapy-status-from-fda-2018-05-24", "https://www.nasdaq.com/articles/we-did-math-mgv-can-go-86-2018-05-23", "https://www.nasdaq.com/articles/glaxo-and-jjs-two-drug-hiv-regimen-juluca-gets-eu-approval-2018-05-22", "https://www.nasdaq.com/articles/3-biotechs-fdas-naughty-list-should-be-investors-buy-lists-2018-05-22", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-epclusas-china-approval-bmrn-palynziqs-fda-nod-2018-05-30", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-etf-inflow-alert-2018-05-17", "https://www.nasdaq.com/articles/3-high-yield-stocks-virtual-monopolies-2018-05-17", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-16-2018-2018-05-15", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-may-11-2018-2018-05-10", "https://www.nasdaq.com/articles/why-bristol-myers-squibb-stock-crashed-april-2018-05-09", "https://www.nasdaq.com/articles/3-stocks-turned-10000-1-million-2018-05-09", "https://www.nasdaq.com/articles/intercept-icpt-q1-loss-narrower-than-expected-sales-lag-2018-05-08", "https://www.nasdaq.com/articles/should-fda-be-shaming-drug-companies-financial-advisors-daily-digest-2018-05-21", "https://www.nasdaq.com/articles/after-hours-most-active-may-7-2018-cmcsa-qqq-gild-mu-fnsr-crzo-2018-05-07", "https://www.nasdaq.com/articles/top-stock-reports-bp-gilead-enterprise-products-colgate-2018-05-04", "https://www.nasdaq.com/articles/celgene-celg-q1-earnings-sales-beat-on-revlimid-strength-2018-05-04", "https://www.nasdaq.com/articles/5-value-stocks-to-book-gains-using-price-to-book-ratio-2018-05-04", "https://www.nasdaq.com/articles/gilead-sciences-stock-finally-bargain-2018-05-04", "https://www.nasdaq.com/articles/notable-friday-option-activity-gild-exel-rig-2018-05-04", "https://www.nasdaq.com/articles/gilead-sciences-inc-stock-will-recover-eventually-2018-05-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bp-gilead-enterprise-products-and-colgate-2018-05-07", "https://www.nasdaq.com/articles/company-news-for-may-3-2018-2018-05-03", "https://www.nasdaq.com/articles/thursdays-vital-data-snap-inc-snap-gilead-sciences-inc-gild-and-weatherford-international", "https://www.nasdaq.com/articles/earnings-season-keeping-markets-wobbly-2018-05-03", "https://www.nasdaq.com/articles/5-reasons-you-shouldnt-worry-about-gilead-sciences-ugly-q1-results-2018-05-03", "https://www.nasdaq.com/articles/relative-strength-alert-gilead-sciences-2018-05-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-aapl-2018-05-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-snap-gilead-and-t-mobile-u.s.-2018-05-02", "https://www.nasdaq.com/articles/did-gilead-sciences-make-big-mistake-2018-05-03", "https://www.nasdaq.com/articles/gilead-gild-q1-earnings-sales-miss-estimates-on-weak-hcv-2018-05-02", "https://www.nasdaq.com/articles/gilead-sciences-first-quarter-twist-weak-hiv-sales-2018-05-02", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-710090-down-2980-points-2018-05-02", "https://www.nasdaq.com/articles/why-molson-coors-gilead-sciences-and-yum-china-holdings-slumped-today-2018-05-02", "https://www.nasdaq.com/articles/5-top-stock-trades-thursday-morning-2018-05-02", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-large-outflows-detected-etf-2018-05-01", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q1-2018-earnings-conference-call-transcript-2018-05-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-vrtx-post-solid-results-gild-disappoints-in-q1-2018-05-02", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2018-05-01", "https://www.nasdaq.com/articles/apple-aapl-iphone-sales-mark-shares-also-snap-gild-tmus-2018-05-01", "https://www.nasdaq.com/articles/gilead-gild-shares-slip-earnings-miss-revenues-down-over-20-2018-05-01", "https://www.nasdaq.com/articles/after-hours-earnings-report-may-1-2018-aapl-gild-su-mdlz-apc-all-fisv-oke-cxo-eix-dvn-vrsk", "https://www.nasdaq.com/articles/earnings-reaction-history-gilead-sciences-inc-545-follow-through-indicator-43-sensitive", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-agios-agio-in-q1-earnings-2018-04-30", "https://www.nasdaq.com/articles/whats-in-store-for-immunogen-imgn-this-earnings-season-2018-04-30", "https://www.nasdaq.com/articles/gilead-sciences-inc-stock-declined-after-earnings-miss-2018-05-01", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2018-05-01", "https://www.nasdaq.com/articles/apple-aapl-iphone-sales-mark-shares-also-snap-gild-tmus-2018-05-01", "https://www.nasdaq.com/articles/gilead-gild-shares-slip-earnings-miss-revenues-down-over-20-2018-05-01", "https://www.nasdaq.com/articles/abbvies-first-quarter-can-we-quit-worrying-about-humira-now-2018-04-28", "https://www.nasdaq.com/articles/whats-in-the-cards-for-conatus-cnat-this-earnings-season-2018-04-27", "https://www.nasdaq.com/articles/3-things-you-need-know-about-abbvies-monster-q1-earnings-2018-04-27", "https://www.nasdaq.com/articles/health-care-sector-update-04272018-acadgildhrcsny-2018-04-27", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-investors-this-earnings-season-2018-04-30", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-to-watch-on-may-1%3A-pfe-mrk-more-2018-04-30", "https://www.nasdaq.com/articles/glaxo-gsk-q1-earnings-lag-shingrix-vaccines-sales-solid-2018-04-26", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-gilead-gild-in-q1-earnings-2018-04-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-immune-design-imdz-in-q1-earnings-2018-04-26", "https://www.nasdaq.com/articles/whats-in-the-offing-for-keryx-kerx-this-earnings-season-2018-04-26", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-gilead-sciences-2018-04-26", "https://www.nasdaq.com/articles/eye-biotech-todays-editors-picks-2018-04-26", "https://www.nasdaq.com/articles/hiv-segment-to-aid-gilead-gild-beat-q1-earnings-estimates-2018-04-27", "https://www.nasdaq.com/articles/interesting-gild-put-and-call-options-july-20th-2018-04-25", "https://www.nasdaq.com/articles/stocks-drop-10-year-yield-touches-3-2018-04-25", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-inc-buy-2018-04-24", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-04-24", "https://www.nasdaq.com/articles/3-bargain-stocks-you-can-buy-right-now-2018-04-24", "https://www.nasdaq.com/articles/your-guide-investing-zinc-finger-zfn-gene-editing-2018-04-24", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-bristol-myers-bmy-in-q1-earnings-2018-04-23", "https://www.nasdaq.com/articles/notable-thursday-option-activity-mar-gild-abbv-2018-04-26", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-alexion-alxn-this-earnings-season-2018-04-23", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-gilead-sciences-2018-04-23", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-gild-vs-pfizer-pfe-2018-04-22", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-04-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-ibm-mcdonalds-gilead-phillips-66-and-lam-research-2018", "https://www.nasdaq.com/articles/4-beaten-down-funds-set-soar-dividends-109-2018-04-19", "https://www.nasdaq.com/articles/health-care-sector-update-04192018-nvs-dhr-algn-gild-4503t-2018-04-19", "https://www.nasdaq.com/articles/analysts-expect-14-gains-ahead-spyg-2018-04-23", "https://www.nasdaq.com/articles/top-research-reports-ibm-mcdonalds-gilead-2018-04-19", "https://www.nasdaq.com/articles/health-care-sector-update-04192018-gildnvsdhr-2018-04-19", "https://www.nasdaq.com/articles/big-biotech-etf-can-bounce-back-2018-04-18", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alks-up-cldx-down-alxn-to-acquire-wilson-therapeutics-2018-04-18", "https://www.nasdaq.com/articles/gilead-gild-presents-encouraging-data-on-nash-therapies-2018-04-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-4152018-2018-04-15", "https://www.nasdaq.com/articles/bristol-myers-collaborates-with-harvard-fibrosis-network-2018-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-04192018-agnshpggildnvsdhr-2018-04-19", "https://www.nasdaq.com/articles/top-research-reports-ibm-mcdonalds-gilead-2018-04-19", "https://www.nasdaq.com/articles/health-care-sector-update-04192018-gildnvsdhr-2018-04-19", "https://www.nasdaq.com/articles/why-one-drug-flop-tanked-incytes-stock-2018-04-12", "https://www.nasdaq.com/articles/little-known-company-should-have-gileads-and-celgenes-investors-nervous-2018-04-11", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-buy-2018-04-11", "https://www.nasdaq.com/articles/biotech-fire-sale-2-top-stocks-buy-next-week-2018-04-08", "https://www.nasdaq.com/articles/4-top-stocks-investing-pharmas-next-35-billion-market-2018-04-08", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-april-2018-04-13", "https://www.nasdaq.com/articles/can-been-there-biotech-entrepreneur-arie-belldegrun-do-it-yet-again-2018-04-06", "https://www.nasdaq.com/articles/pfizer-inks-new-car-t-deal-in-talks-with-pg-for-unit-sale-2018-04-04", "https://www.nasdaq.com/articles/which-big-pharma-ceos-least-deserved-their-big-pay-increases-2018-04-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-united-technologies-medtronic-gilead-hewlett-packard", "https://www.nasdaq.com/articles/top-stock-reports-united-technologies-medtronic-gilead-2018-04-02", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-gilead-sciences-2018-03-30", "https://www.nasdaq.com/articles/celgene-loses-17.8-in-3-months%3A-time-to-reshuffle-portfolio-2018-03-28", "https://www.nasdaq.com/articles/cellectis-sa-stock-buy-now-2018-04-07", "https://www.nasdaq.com/articles/can-been-there-biotech-entrepreneur-arie-belldegrun-do-it-yet-again-2018-04-06", "https://www.nasdaq.com/articles/3-blockbuster-drug-launches-watch-2018-2018-03-26", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-biogen-inc-2018-03-25", "https://www.nasdaq.com/articles/gilead-sciences-investors-better-watch-regeneron-alnylam-deal-2018-03-24", "https://www.nasdaq.com/articles/celgene-corporation-looks-cheap-considering-its-potential-2018-03-23", "https://www.nasdaq.com/articles/stemline-therapeutics-inc-stock-investors-are-betting-not-investing-2018-03-23", "https://www.nasdaq.com/articles/gilead-sciences-gild-shares-cross-3-yield-mark-2018-03-22", "https://www.nasdaq.com/articles/gilead-sciences-beaten-biotech-stock-buy-2018-03-27", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-gild-2018-03-21", "https://www.nasdaq.com/articles/why-its-so-dang-hard-value-biotech-deals-2018-03-21", "https://www.nasdaq.com/articles/despite-struggles-celgene-corporation-stock-still-buy-2018-03-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-david-dreman-3182018-2018-03-18", "https://www.nasdaq.com/articles/gilead-sciences-14-billion-year-threat-2018-03-18", "https://www.nasdaq.com/articles/3-revolutionary-cancer-treatments-2018-03-17", "https://www.nasdaq.com/articles/5-must-see-quotes-abbvies-management-2018-03-16", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-03-21", "https://www.nasdaq.com/articles/is-gilead-sciences-gild-a-great-stock-for-value-investors-2018-03-15", "https://www.nasdaq.com/articles/ibb-amgn-gild-regn-etf-outflow-alert-2018-03-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-15-2018-2018-03-14", "https://www.nasdaq.com/articles/bull-day-regeneron-regn-2018-03-14", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-ddd-gild-hd-2018-03-14", "https://www.nasdaq.com/articles/gilead-sciences-trying-put-itself-out-business-2018-03-14", "https://www.nasdaq.com/articles/3-biotech-stocks-with-rising-earnings-estimates-post-q4-2018-03-13", "https://www.nasdaq.com/articles/3-reasons-crispr-stocks-could-keep-soaring-2018-03-16", "https://www.nasdaq.com/articles/how-pricing-can-be-vital-drugmakers-profitability-2018-03-12", "https://www.nasdaq.com/articles/how-drugmakers-approach-efficacy-key-success-2018-03-12", "https://www.nasdaq.com/articles/after-hours-most-active-mar-12-2018-pfe-qcom-f-cbs-bac-qqq-celg-hst-sohu-ge-ctsh-gild-2018", "https://www.nasdaq.com/articles/heres-what-lifted-sangamo-therapeutics-inc-february-2018-03-11", "https://www.nasdaq.com/articles/revolutionary-new-hiv-drug-youve-probably-never-heard-2018-03-11", "https://www.nasdaq.com/articles/how-biopharmas-battle-billions-2018-03-10", "https://www.nasdaq.com/articles/gilead-sciences-gild-down-3.4-since-earnings-report%3A-can-it-rebound-2018-03-08", "https://www.nasdaq.com/articles/1-big-risk-every-drugmaker-fears-2018-03-12", "https://www.nasdaq.com/articles/biotech-stock-round-up%3A-regeneron-submits-sbla-biogen-to-withdraw-zinbryta-2018-03-08", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwb-amgn-gild-utx-2018-03-06", "https://www.nasdaq.com/articles/gilead-announces-positive-data-on-new-hiv-therapy-biktarvy-2018-03-06", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-gild-le-pypl-2018-03-06", "https://www.nasdaq.com/articles/heres-why-crispr-therapeutics-ag-jumped-again-february-2018-03-04", "https://www.nasdaq.com/articles/heres-why-gilead-sciences-jump-gene-editing-important-2018-03-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-bny-mellon-state-street-alliant-energy-and", "https://www.nasdaq.com/articles/2-cheap-growth-stocks-buy-right-now-2018-03-08", "https://www.nasdaq.com/articles/intangibles-hold-key-valeant-pharmaceuticals-intl-inc-stock-2018-03-01", "https://www.nasdaq.com/articles/apples-cure-soaring-costs-tech-savvy-healthcare-clinics-2018-03-01", "https://www.nasdaq.com/articles/biotech-etfs-head-to-head%3A-xbi-vs.-ibb.-2018-03-01", "https://www.nasdaq.com/articles/health-care-sector-update-02282018-htbx-sgyp-codx-gild-2018-02-28", "https://www.nasdaq.com/articles/health-care-sector-update-02282018-gildsgypcphtohtbxcodx-2018-02-28", "https://www.nasdaq.com/articles/top-analyst-reports-gilead-bny-mellon-state-street-2018-02-28", "https://www.nasdaq.com/articles/biotech-stock-round-up%3A-celgene-suffers-setback-gilead-teams-up-with-sangamo-2018-02-28", "https://www.nasdaq.com/articles/gilead-sciences-history-points-future-success-2018-03-01", "https://www.nasdaq.com/articles/gilead-sciences-oncology-company-2018-02-26", "https://www.nasdaq.com/articles/how-gilead-sciences-betting-big-gene-editing-2018-02-23", "https://www.nasdaq.com/articles/why-sangamo-therapeutics-rocketed-higher-today-2018-02-22", "https://www.nasdaq.com/articles/health-care-sector-update-02222018-sgmo-gild-clvs-nvo-nvs-bkd-2018-02-22", "https://www.nasdaq.com/articles/5-drugs-are-critical-gilead-sciences-future-2018-02-22", "https://www.nasdaq.com/articles/health-care-sector-update-02222018-clvssgmogildbkd-2018-02-22-0", "https://www.nasdaq.com/articles/health-care-sector-update-02222018-clvssgmogildbkd-2018-02-22", "https://www.nasdaq.com/articles/spdr-portfolio-sp-500-growth-etf-experiences-big-inflow-2018-02-26", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-2182018-2018-02-18", "https://www.nasdaq.com/articles/how-celgene-hopes-cash-car-t-2018-02-17", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-spyg-crm-gild-chtr-2018-02-16", "https://www.nasdaq.com/articles/intercept-icpt-q4-earnings-sales-lag-on-dull-ocaliva-2018-02-15", "https://www.nasdaq.com/articles/3-great-acquisition-targets-gilead-sciences-and-1-iffy-candidate-2018-02-15", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-15-2018-2018-02-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2018-2018-02-13", "https://www.nasdaq.com/articles/abbvie-or-gilead-sciences-stock-better-buy-2018-02-19", "https://www.nasdaq.com/articles/how-huge-latest-hiv-drug-approval-gilead-sciences-2018-02-12", "https://www.nasdaq.com/articles/why-biotech-stocks-soared-trumps-first-year-office-2018-02-11", "https://www.nasdaq.com/articles/better-buy-pfizer-inc-vs-glaxosmithkline-plc-2018-02-11", "https://www.nasdaq.com/articles/3-etfs-to-watch-on-biotech-earnings-2018-02-10", "https://www.nasdaq.com/articles/glaxos-gsk-begins-phase-iii-hiv-two-drug-regimen-study-2018-02-09", "https://www.nasdaq.com/articles/glaxo-gsk-earnings-and-revenues-surpass-estimates-in-q4-2018-02-08", "https://www.nasdaq.com/articles/fda-approves-gilead-gild-hiv-triple-therapy-stock-up-2018-02-08", "https://www.nasdaq.com/articles/intercept-starts-oca-trial-for-nash-patients-with-cirrhosis-2018-02-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-stock-still-solid-value-play-2018-02-08", "https://www.nasdaq.com/articles/why-crispr-therapeutics-ag-stock-bolted-higher-january-2018-02-08", "https://www.nasdaq.com/articles/gilead-gild-beats-on-q4-earnings-2018-view-lacks-lustre-2018-02-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-walt-disney-chipotle-snap-and-gilead-sciences-2018-02", "https://www.nasdaq.com/articles/gilead-sciences-inc-delivers-deja-vu-fourth-quarter-2018-02-07", "https://www.nasdaq.com/articles/daily-dividend-report-gild-ctsh-ice-apc-glw-2018-02-07", "https://www.nasdaq.com/articles/5-things-gilead-sciences-management-just-said-you-need-know-2018-02-07", "https://www.nasdaq.com/articles/heres-what-gilead-sciences-just-said-about-its-future-2018-02-08", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-q4-2017-earnings-conference-call-transcript-2018-02-06", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-shares-slide-weak-outlook-2018-02-06", "https://www.nasdaq.com/articles/new-quarterly-earnings-results-dis-cmg-snap-and-more-2018-02-06", "https://www.nasdaq.com/articles/gilead-gild-posts-earnings-beat-total-product-sales-see-yoy-decline-2018-02-06", "https://www.nasdaq.com/articles/earnings-reaction-history-gilead-sciences-inc-636-follow-through-indicator-44-sensitive", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-6-2018-dis-gild-apc-pxd-cern-mchp-mkl-paa-akam-udr", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-cmi-mu-gild-2018-02-05", "https://www.nasdaq.com/articles/gilead-gild-4th-quarter-earnings-what-expect-2018-02-06", "https://www.nasdaq.com/articles/gileads-gild-hcv-segment-to-decline-further-in-q4-earnings-2018-02-02", "https://www.nasdaq.com/articles/3-top-biotherapeutics-stocks-buy-now-2018-02-02", "https://www.nasdaq.com/articles/will-gilead-gild-disappoint-investors-in-q4-earnings-2018-02-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvie-4q-results-impress-ablynx-be-acquired-sanofi-2018-02-01", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-01-31", "https://www.nasdaq.com/articles/vertex-vrtx-other-drug-stocks-fda-catalysts-february-2018-01-31", "https://www.nasdaq.com/articles/3-headwinds-q4-earnings-results-make-merck-mediocre-stock-2018-02-04", "https://www.nasdaq.com/articles/3-big-biotech-stocks-major-catalysts-way-2018-01-30", "https://www.nasdaq.com/articles/after-hours-most-active-jan-30-2018-etp-msft-ete-fe-epd-mrk-t-csco-intc-qqq-gild-fb-2018", "https://www.nasdaq.com/articles/us-stocks-slump-declines-telecom-utilities-sectors-weigh-2018-01-29", "https://www.nasdaq.com/articles/nasdaq-100-movers-wynn-gild-2018-01-29", "https://www.nasdaq.com/articles/gilead-sciences-take-two-interactive-hit-buys-after-vertex-breakout-2018-01-29", "https://www.nasdaq.com/articles/monday-sector-leaders-consumer-products-healthcare-2018-01-29", "https://www.nasdaq.com/articles/3-small-biotechs-big-drugmakers-are-probably-drooling-over-2018-01-28", "https://www.nasdaq.com/articles/gild-crosses-above-average-analyst-target-2018-01-30", "https://www.nasdaq.com/articles/why-biopharma-behemoth-could-soon-become-acquisitive-2018-01-26", "https://www.nasdaq.com/articles/dont-chase-abbvie-inc-stock-after-its-huge-earnings-win-2018-01-26", "https://www.nasdaq.com/articles/5-biotech-and-pharmaceutical-stocks-going-bonkers-2018-01-26", "https://www.nasdaq.com/articles/notable-friday-option-activity-sbux-gild-itw-2018-01-26", "https://www.nasdaq.com/articles/celgene-celg-q4-earnings-sales-beat-on-solid-revlimid-2018-01-25", "https://www.nasdaq.com/articles/will-2018-be-bellicum-pharmaceuticals-incs-best-year-yet-2018-01-25", "https://www.nasdaq.com/articles/celgene-reverses-fourth-quarter-otezla-sales-rebound-2018-01-25", "https://www.nasdaq.com/articles/it-finally-safe-buy-gilead-sciences-stock-1-analyst-thinks-so-2018-01-26", "https://www.nasdaq.com/articles/celgene-celg-to-acquire-juno-therapeutics-for-%249-billion-2018-01-23", "https://www.nasdaq.com/articles/analysts-more-bullish-celgene-juno-sales-outlook-nags-2018-01-23", "https://www.nasdaq.com/articles/celgenes-9-billion-buyout-juno-it-good-deal-investors-2018-01-22", "https://www.nasdaq.com/articles/3-stocks-worlds-best-investors-are-buying-right-now-2018-01-22", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwb-amgn-gild-abt-2018-01-22", "https://www.nasdaq.com/articles/what-expect-amgen-inc-2018-2018-01-21", "https://www.nasdaq.com/articles/better-buy-glaxosmithkline-plc-vs-eli-lilly-2018-01-21", "https://www.nasdaq.com/articles/bluebird-up-on-buyout-speculation-after-celgene-juno-deal-2018-01-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-jpmorgan-abbvie-gilead-and-simon-property-group", "https://www.nasdaq.com/articles/gilead-collaborates-with-pfizer-for-yescarta-combo-study-2018-01-19", "https://www.nasdaq.com/articles/top-10-value-stocks-sp-500-2018-01-19", "https://www.nasdaq.com/articles/merck-co-inc-stock-could-still-soar-another-10-here-2018-01-18", "https://www.nasdaq.com/articles/3-top-ranked-drug-stocks-are-broker-favorites-2018-01-18-0", "https://www.nasdaq.com/articles/novartis-sbla-for-car-t-therapy-kymriah-accepted-by-fda-2018-01-18", "https://www.nasdaq.com/articles/no-reason-rush-juno-therapeutics-inc-stock-after-big-pop-2018-01-18", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-pfizer-inc-2018-01-21", "https://www.nasdaq.com/articles/top-research-reports-apple-jpmorgan-abbvie-2018-01-18", "https://www.nasdaq.com/articles/juno-hits-52-week-high-on-celgenes-rumored-buyout-interest-2018-01-18", "https://www.nasdaq.com/articles/why-celgenes-rumored-acquisition-juno-actually-makes-sense-2018-01-17", "https://www.nasdaq.com/articles/why-juno-therapeutics-stock-soaring-today-2018-01-17", "https://www.nasdaq.com/articles/whats-juno-therapeutics-worth-celgene-2018-01-17", "https://www.nasdaq.com/articles/is-celgene-celg-looking-to-take-over-juno-therapeutics-2018-01-17", "https://www.nasdaq.com/articles/3-top-ranked-drug-stocks-are-broker-favorites-2018-01-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-surges-acquisition-rumor-concert-down-patent-news-2018-01-17", "https://www.nasdaq.com/articles/juno-therapeutics-stock-rockets-report-celgene-buyout-talks-2018-01-16", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-gild-wdc-bmy-2018-01-16", "https://www.nasdaq.com/articles/10-value-stocks-buy-2018-and-beyond-2018-01-12", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-etf-outflow-alert-2018-01-12", "https://www.nasdaq.com/articles/2017-was-year-forget-gilead-sciences-inc-year-could-be-better-2018-01-12", "https://www.nasdaq.com/articles/3-reasons-dividend-monster-pfizer-inc-could-explode-higher-2018-01-12", "https://www.nasdaq.com/articles/gilead-sciences-inc-buy-2018-2018-01-17", "https://www.nasdaq.com/articles/big-pharma-ceos-speak-about-impact-of-tax-reform-on-ma-2018-01-11", "https://www.nasdaq.com/articles/7-must-see-numbers-abbvies-j-p-morgan-presentation-2018-01-11", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-intl-inc-stock-is-worth-the-risk-2018-01-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-acquire-impact-jp-morgan-healthcare-conference-focus-2018-01", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-january-2018-01-09", "https://www.nasdaq.com/articles/5-ways-gilead-sciences-plans-return-growth-2018-01-09", "https://www.nasdaq.com/articles/galapagos-reports-topline-data-from-osteoarthritis-study-2018-01-08", "https://www.nasdaq.com/articles/can-biotech-keep-last-years-momentum-alive-in-2018-2018-01-11", "https://www.nasdaq.com/articles/5-biggest-new-drugs-2018-and-how-you-can-profit-their-makers-2018-01-07", "https://www.nasdaq.com/articles/why-2017-was-year-remember-gilead-sciences-inc-2018-01-05", "https://www.nasdaq.com/articles/dynavax-launch-hepatitis-b-vaccine-acquisition-coming-2018-01-05", "https://www.nasdaq.com/articles/biotech-tide-turning-2018-01-05", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-gild-avxs-uaa-2018-01-05", "https://www.nasdaq.com/articles/why-juno-therapeutics-stock-cooled-december-2018-01-04", "https://www.nasdaq.com/articles/xlv-amgn-gild-lly-large-outflows-detected-etf-2018-01-04", "https://www.nasdaq.com/articles/celgene-to-acquire-impact-biomedicines-to-boost-pipeline-2018-01-08", "https://www.nasdaq.com/articles/why-perfect-level-buy-celgene-corporation-stock-2018-01-03", "https://www.nasdaq.com/articles/generalists-biotech-sidelines-tax-reform-sweeps-us-2018-01-03", "https://www.nasdaq.com/articles/3-biotech-and-pharma-stocks-fda-catalysts-january-2018-01-02", "https://www.nasdaq.com/articles/heres-how-bluebird-bio-inc-crushed-it-2017-2018-01-02", "https://www.nasdaq.com/articles/why-2017-was-year-remember-juno-therapeutics-2018-01-02", "https://www.nasdaq.com/articles/why-these-2-biotechs-could-outperform-amid-hyper-competition-2018-01-02", "https://www.nasdaq.com/articles/3-biggest-breakthroughs-cancer-treatment-2017-2017-12-30", "https://www.nasdaq.com/articles/18-reasons-i-biotech-stocks-2018-2018-01-04", "https://www.nasdaq.com/articles/celgene-celg-in-troubled-waters-in-17%3A-what-does-2018-hold-2017-12-29", "https://www.nasdaq.com/articles/why-gilead-sciences-stock-should-be-avoided-2018-2017-12-29", "https://www.nasdaq.com/articles/5-best-performing-biotech-stocks-2017-2017-12-28", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-gild-lly-biib-2017-12-27", "https://www.nasdaq.com/articles/4-biotech-stocks-ready-to-crush-the-market-in-2018-2017-12-27", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-rl-wba-gild-2017-12-27", "https://www.nasdaq.com/articles/qa-vertex-chief-talks-about-companys-transformational-year-2017-12-22", "https://www.nasdaq.com/articles/intercept-icpt-stock-loses-sheen-in-2017%3A-what-lies-ahead-2017-12-29", "https://www.nasdaq.com/articles/gilead-maybe-2018-wont-be-its-year-either-2017-12-21", "https://www.nasdaq.com/articles/interesting-gild-put-and-call-options-august-2018-2017-12-20", "https://www.nasdaq.com/articles/3-pharma-biotech-pipeline-areas-keep-eye-2018-2017-12-20", "https://www.nasdaq.com/articles/biotechs-not-so-darn-scary-after-all-2017-12-20", "https://www.nasdaq.com/articles/biotechs-not-so-darn-scary-after-all-sa-marketplace-roundtable-2017-12-20", "https://www.nasdaq.com/articles/3-questions-keeping-juno-therapeutics-investors-night-2017-12-19", "https://www.nasdaq.com/articles/why-these-biotech-stocks-could-be-taken-over-2018-2017-12-19", "https://www.nasdaq.com/articles/better-buy-glaxosmithkline-plc-vs-bristol-myers-squibb-2017-12-22", "https://www.nasdaq.com/articles/3-top-stocks-are-cash-cows-2017-12-17", "https://www.nasdaq.com/articles/even-rich-market-gilead-sciences-inc-offering-investors-value-2017-12-16", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vym-abbv-gild-lly-2017-12-15", "https://www.nasdaq.com/articles/galapagos-cozies-closer-gilead-sciences-2017-12-15", "https://www.nasdaq.com/articles/car-t-stocks-in-focus-with-ash-2017-meet%3A-gild-juno-more-2017-12-15", "https://www.nasdaq.com/articles/can-teva-jump-start-its-restructuring-swiping-some-gileads-sales-2017-12-15", "https://www.nasdaq.com/articles/after-hours-most-active-dec-18-2017-epd-gm-intc-bp-ete-qqq-lc-aapl-mplx-gild-cmcsa-akam", "https://www.nasdaq.com/articles/why-no-large-cap-biotech-franchise-safe-threats-2018-2017-12-18", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-14-2017-2017-12-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-ash-data-focus-gilead-buy-cell-design-labs-2017-12-13", "https://www.nasdaq.com/articles/ex-dividend-reminder-conmed-merck-and-gilead-sciences-2017-12-12", "https://www.nasdaq.com/articles/bluebirds-shares-jump-on-strong-data-for-car-t-therapy-2017-12-12", "https://www.nasdaq.com/articles/ash-2017-car-t-wallops-blood-cancer-2017-12-12", "https://www.nasdaq.com/articles/juno-reports-additional-data-on-car-t-therapy-shares-drop-2017-12-12", "https://www.nasdaq.com/articles/notable-friday-option-activity-intc-lmt-gild-2017-12-15", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-blue-stock-skyrocketed-today-2017-12-11", "https://www.nasdaq.com/articles/company-news-for-dec-11-2017-2017-12-11", "https://www.nasdaq.com/articles/3-stocks-focus-biotech-ma-hopes-2018-rise-2017-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12112017-vstm-mrk-ions-gild-imgn-juno-celg-regn-bivv-2017-12-11", "https://www.nasdaq.com/articles/gilead-gild-posts-updated-data-on-car-t-therapy-yescarta-2017-12-11", "https://www.nasdaq.com/articles/novartis-reports-updated-results-from-kymriahs-juliet-study-2017-12-11", "https://www.nasdaq.com/articles/whats-causing-juno-therapeutics-shares-tumble-119-today-2017-12-11", "https://www.nasdaq.com/articles/jim-simons-pioneer-quant-manager-2017-12-12", "https://www.nasdaq.com/articles/now-perfect-time-buy-juno-therapeutics-stock-2017-12-10", "https://www.nasdaq.com/articles/youll-be-stunned-how-many-cancer-immunotherapies-are-being-developed-2017-12-10", "https://www.nasdaq.com/articles/why-biotech-stocks-may-wait-while-feeling-love-2017-12-08", "https://www.nasdaq.com/articles/gilead-sciences-to-acquire-cell-design-labs-for-%24567-million-2017-12-08", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-ual-gild-abbv-2017-12-08", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-gild-2017-12-07", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-vlue-gild-f-nsc-2017-12-07", "https://www.nasdaq.com/articles/gilead-sciences-inc-buy-2017-12-10", "https://www.nasdaq.com/articles/now-perfect-time-buy-juno-therapeutics-stock-2017-12-10", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-1262017-2017-12-06", "https://www.nasdaq.com/articles/5-top-biotech-stocks-buy-now-2017-12-03", "https://www.nasdaq.com/articles/gilead-3-other-drug-stocks-focus-world-aids-day-2017-12-01", "https://www.nasdaq.com/articles/glaxo-begins-phase-iii-study-on-injection-to-prevent-hiv-2017-12-01", "https://www.nasdaq.com/articles/10-blockbuster-drugs-future-big-pharma-stocks-2017-11-30", "https://www.nasdaq.com/articles/better-buy-ziopharm-oncology-inc-vs-celldex-therapeutics-inc-2017-11-30", "https://www.nasdaq.com/articles/why-gilead-could-have-greatest-ever-hiv-drug-launches-2017-12-06", "https://www.nasdaq.com/articles/no-1-ranked-medical-stock-tests-support-new-base-2017-11-30", "https://www.nasdaq.com/articles/5-biotech-and-pharma-stocks-fda-catalysts-december-2017-11-30", "https://www.nasdaq.com/articles/does-gileads-kite-acquisition-offer-new-buying-opportunity-2017-11-30", "https://www.nasdaq.com/articles/gilead-sciences-stock-upgraded-power-free-2017-11-30", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-qual-blk-mmc-gild-2017-11-29", "https://www.nasdaq.com/articles/3-dividend-stocks-better-yields-mcdonalds-2017-11-29", "https://www.nasdaq.com/articles/how-will-u.s.-tax-reform-impact-pharma-biotech-industry-2017-11-29", "https://www.nasdaq.com/articles/morning-movers-sears-soars-earnings-kroger-gains-2017-11-30", "https://www.nasdaq.com/articles/glaxo-pfizers-viiv-healthcare-begins-hiv-drug-combo-study-2017-11-28", "https://www.nasdaq.com/articles/gilead-gild-down-7.9-since-earnings-report%3A-can-it-rebound-2017-11-28", "https://www.nasdaq.com/articles/sphera-funds-management-ltd-buys-cellcom-israel-allergan-plc-teva-pharmaceutical-0", "https://www.nasdaq.com/articles/hedge-funds-are-snapping-up-these-3-strong-buy-stocks-2017-11-27", "https://www.nasdaq.com/articles/biotech-poised-for-growth%3A-3-healthy-fund-choices-2017-11-24", "https://www.nasdaq.com/articles/jj-glaxos-jucala-approval-puts-spotlight-on-hiv-space-2017-11-24", "https://www.nasdaq.com/articles/car-t-therapy-space-2017-progress-report-2017-11-24", "https://www.nasdaq.com/articles/health-care-sector-update-11282017-coolpzrxpetx-mdtgildpfe-2017-11-28", "https://www.nasdaq.com/articles/1-thing-missing-gilead-sciences-2018-priority-list-2017-11-21", "https://www.nasdaq.com/articles/united-therapeutics-pah-drugs-exclusivity-period-extended-2017-11-21", "https://www.nasdaq.com/articles/gilead-sciences-enters-oversold-territory-2017-11-20", "https://www.nasdaq.com/articles/after-hours-most-active-nov-20-2017-acm-qqq-bac-lc-eufn-pfe-wfc-t-urbn-fitb-gild-aapl-2017", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-2017-11-18", "https://www.nasdaq.com/articles/celgene-car-t-therapy-gets-breakthrough-therapy-designation-2017-11-17", "https://www.nasdaq.com/articles/biotechs-trading-lower-in-q4-on-macro-uncertainty-tepid-q3-2017-11-17", "https://www.nasdaq.com/articles/jj-glaxo-get-fda-approval-for-first-two-drug-hiv-regimen-2017-11-22", "https://www.nasdaq.com/articles/biotech-industry-small-innovators-outflank-big-caps-blockbuster-drug-patent-cliff-looms", "https://www.nasdaq.com/articles/hampstead-capital-llp-buys-merck-inc-american-international-group-inc-pioneer-natural-2017", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-16-2017-2017-11-15", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-president-and-ceo-john-f-milligan-sold-16-million-shares-2017-11", "https://www.nasdaq.com/articles/gild-makes-notable-cross-below-critical-moving-average-2017-11-14", "https://www.nasdaq.com/articles/temasek-holdings-private-ltd-buys-visa-inc-virtu-financial-inc-ctrip-2017-11-14", "https://www.nasdaq.com/articles/biotechs-sell-droves-are-investors-seeking-mergers-2017-11-14", "https://www.nasdaq.com/articles/summit-street-capital-management-llc-buys-fluor-corp-hawaiian-holdings-inc-kulicke-2017-11", "https://www.nasdaq.com/articles/what-investors-need-know-about-investing-low-pe-stocks-2017-11-13", "https://www.nasdaq.com/articles/3-top-biotech-stocks-2018-2017-11-12", "https://www.nasdaq.com/articles/notable-friday-option-activity-icpt-gild-clvs-2017-11-10", "https://www.nasdaq.com/articles/youll-be-stunned-gilead-sciences-ceos-prediction-2018-2017-11-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-delivers-strong-q3-results-cellectis-clinical-hold-lifted", "https://www.nasdaq.com/articles/sphera-funds-management-ltd-buys-cellcom-israel-allergan-plc-teva-pharmaceutical", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-09-2017-2017-11-08", "https://www.nasdaq.com/articles/7-life-science-stocks-to-buy-today-2017-11-14", "https://www.nasdaq.com/articles/3-etfs-watch-biotech-earnings-2017-11-06", "https://www.nasdaq.com/articles/3-things-youll-want-closely-watch-cvs-healths-q3-results-2017-11-04", "https://www.nasdaq.com/articles/3-reasons-its-smart-buy-celgenes-stock-now-2017-11-03", "https://www.nasdaq.com/articles/westend-advisors-llc-buys-bank-america-corporation-spdr-portfolio-short-term-corporate", "https://www.nasdaq.com/articles/intercept-icpt-q3-loss-narrower-than-expected-sales-beat-2017-11-02", "https://www.nasdaq.com/articles/5-biotech-and-pharma-stocks-key-fda-catalysts-november-2017-11-02", "https://www.nasdaq.com/articles/sharp-drop-celgene-corporation-stock-may-have-just-created-entry-point-2017-11-02", "https://www.nasdaq.com/articles/3-stocks-changing-future-healthcare-2017-11-06", "https://www.nasdaq.com/articles/whats-behind-gilead-sciences-incs-78-billion-slide-october-2017-11-02", "https://www.nasdaq.com/articles/why-juno-therapeutics-shares-are-going-212-today-2017-11-02", "https://www.nasdaq.com/articles/how-blood-disease-data-sent-these-2-biotech-stocks-flying-2017-11-01", "https://www.nasdaq.com/articles/can-juno-therapeutics-outmaneuver-its-car-t-competitors-2017-11-01", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-gilead-sciences-2017-11-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-jpmorgan-chase-gilead-conocophillips-general-electric", "https://www.nasdaq.com/articles/ionis-down-big-analyst-miss-2017-10-31", "https://www.nasdaq.com/articles/notable-thursday-option-activity-vmc-gild-mic-2017-11-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-pfe-incy-and-acor-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-jbht-shpg-2017-10-30", "https://www.nasdaq.com/articles/company-news-for-oct-30-2017-2017-10-30", "https://www.nasdaq.com/articles/how-celgene-gileads-pricing-woes-continue-haunt-biotech-stocks-2017-10-30", "https://www.nasdaq.com/articles/top-research-reports-jpmorgan-chase-gilead-conocophillips-2017-10-30", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-stock-isnt-worth-it-here-2017-10-29", "https://www.nasdaq.com/articles/5-things-you-need-know-gilead-sciences-q3-update-2017-10-29", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-value-factor-etf-experiences-big-inflow-2017-10-30", "https://www.nasdaq.com/articles/validea-benjamin-graham-strategy-daily-upgrade-report-10282017-2017-10-28", "https://www.nasdaq.com/articles/gilead-gild-down-on-weak-hcv-sales-despite-q3-earnings-beat-2017-10-27", "https://www.nasdaq.com/articles/dow-stock-merck-abbvie-top-earnings-views-light-sales-2017-10-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-baidu-inc-adr-bidu-gilead-sciences-inc.-gild-and-mattel-inc.", "https://www.nasdaq.com/articles/daily-dividend-report-spg-pfg-gild-agn-itw-2017-10-27", "https://www.nasdaq.com/articles/gilead-sciences-inc-stock-buy-when-it-seems-it-shouldnt-be-2017-10-27", "https://www.nasdaq.com/articles/gilead-sciences-inc.-stock-looks-good-regardless-of-quarterly-earnings-report-2017-10-26", "https://www.nasdaq.com/articles/3-etfs-to-watch-on-biotech-earnings-2017-10-29", "https://www.nasdaq.com/articles/gilead-gild-q3-earnings-and-revenues-sink-2017-10-26", "https://www.nasdaq.com/articles/rsi-alert-gilead-sciences-now-oversold-2017-10-26", "https://www.nasdaq.com/articles/gilead-tops-sales-profit-views-misses-hep-c-shares-fall-2017-10-26", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-getting-battered-too-hard-for-comfort-2017-10-26", "https://www.nasdaq.com/articles/earnings-reaction-history-gilead-sciences-inc-667-follow-through-indicator-48-sensitive", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-26-2017-msft-amzn-googl-intc-gild-bidu-cb-syk-wdc-ftv", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-agenus-agen-this-earnings-season-2017-10-25", "https://www.nasdaq.com/articles/gilead-sciences-inc-still-singing-hcv-blues-3rd-quarter-2017-10-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-q3-earnings-gileads-car-t-drug-gets-fda-nod-2017-10-25", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-gild-wyn-orly-2017-10-25", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-alexion-alxn-this-earnings-season-2017-10-24", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-2017-10-24", "https://www.nasdaq.com/articles/3-healthcare-value-stocks-2017-10-24", "https://www.nasdaq.com/articles/why-agenus-inc-stock-briefly-popped-today-2017-10-23", "https://www.nasdaq.com/articles/is-gilead-gild-poised-for-a-beat-this-earnings-season-2017-10-23", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-gilead-sciences-gild-this-earnings-season-2017-10-25", "https://www.nasdaq.com/articles/3-gene-therapy-stocks-could-make-you-rich-2017-10-23", "https://www.nasdaq.com/articles/3-things-you-should-expect-gilead-sciences-q3-results-2017-10-23", "https://www.nasdaq.com/articles/ibds-no-1-group-under-pressure-these-6-key-earnings-loom-sp-500-futures-2017-10-23", "https://www.nasdaq.com/articles/whats-in-store-for-biomarin-bmrn-this-earnings-season-2017-10-23", "https://www.nasdaq.com/articles/celgene-could-be-best-car-t-stock-buy-not-gilead-sciences-2017-10-20", "https://www.nasdaq.com/articles/gilead-gild-car-t-therapy-yescarta-clinches-fda-approval-2017-10-20", "https://www.nasdaq.com/articles/gilead-sciences-shows-rising-relative-price-performance-still-shy-key-threshold-2017-10-20", "https://www.nasdaq.com/articles/gilead-drug-approval-fuels-interest-car-t-space-3-stocks-consider-2017-10-23", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-value-factor-etf-experiences-big-inflow-2017-10-19", "https://www.nasdaq.com/articles/nasdaq-100-movers-ctrp-adbe-2017-10-19", "https://www.nasdaq.com/articles/does-gilead-now-have-new-multi-billion-dollar-franchise-2017-10-19", "https://www.nasdaq.com/articles/zacks-market-edge-highlights%3A-gilead-biogen-teva-abbvie-and-aetna-2017-10-19", "https://www.nasdaq.com/articles/gilead-slaps-mega-price-its-newly-approved-car-t-2017-10-19", "https://www.nasdaq.com/articles/after-hours-most-active-oct-19-2017-v-aapl-cmcsa-baba-pypl-pfe-t-kw-ge-qqq-adbe-gild-2017", "https://www.nasdaq.com/articles/sp-500-futures-these-5-top-stocks-are-big-overnight-movers-2017-10-18", "https://www.nasdaq.com/articles/sellers-come-nasdaq-apple-lags-another-ipo-soars-2017-10-19", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-gilead-teva-pfizer-and-amgen-2017-10-17", "https://www.nasdaq.com/articles/where-find-value-healthcare-stocks-2017-10-17", "https://www.nasdaq.com/articles/better-buy-ziopharm-oncology-inc-vs-celldex-therapeutics-2017-10-17", "https://www.nasdaq.com/articles/ibd-biotech-innovator-awards-2017-10-16", "https://www.nasdaq.com/articles/kite-pharma-cancer-treatment-stands-out-hot-car-t-field-2017-10-16", "https://www.nasdaq.com/articles/notable-monday-option-activity-tgtx-gild-rt-2017-10-16", "https://www.nasdaq.com/articles/trump-likely-sign-executive-order-drug-pricing-any-day-2017-10-16", "https://www.nasdaq.com/articles/top-stock-reports-ibm-celgene-and-procter-gamble-2017-10-18", "https://www.nasdaq.com/articles/its-time-to-start-buying-beaten-up-gilead-sciences-inc.-gild-stock-2017-10-13", "https://www.nasdaq.com/articles/bristol-myers-bmy-target-extend-partnership-for-nash-study-2017-10-13", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-stock-is-primed-after-kite-pharma-buy-2017-10-13", "https://www.nasdaq.com/articles/3-healthcare-value-stocks-2017-10-13", "https://www.nasdaq.com/articles/why-these-biotech-players-look-poised-crush-earnings-views-2017-10-13", "https://www.nasdaq.com/articles/antipodes-partners-ltd-buys-kt-corp-michael-kors-holdings-oracle-corp-sells-dynegy-inc", "https://www.nasdaq.com/articles/no-1-ranked-medical-stock-breaking-out-q3-earnings-due-2017-10-12", "https://www.nasdaq.com/articles/exane-asset-management-buys-att-inc-verizon-communications-inc-cnh-industrial-nv-sells", "https://www.nasdaq.com/articles/5-game-changing-cancer-drug-innovations-being-developed-right-now-2017-10-12", "https://www.nasdaq.com/articles/abbvie-best-dividend-stock-healthcare-2017-10-11", "https://www.nasdaq.com/articles/going-long-pfizer-inc.-pfe-stock-is-an-easy-pill-to-swallow-2017-10-10", "https://www.nasdaq.com/articles/50000-year-prescription-drugs-you-likely-know-someone-who-used-least-much-2017-10-10", "https://www.nasdaq.com/articles/horan-capital-management-buys-tjx-inc-chipotle-mexican-grill-inc-nike-inc-sells-berkshire", "https://www.nasdaq.com/articles/healthcare-are-these-best-dividend-stocks-buy-now-2017-10-10", "https://www.nasdaq.com/articles/bitcoin-vs-biotech-which-smarter-investment-2017-10-08", "https://www.nasdaq.com/articles/non-alcoholic-steatohepatitis-2017-progress-update-2017-10-12", "https://www.nasdaq.com/articles/dirt-cheap-biotech-stock-bargain-buy-2017-10-07", "https://www.nasdaq.com/articles/heres-why-juno-therapeutics-stock-may-still-be-worth-buying-2017-10-07", "https://www.nasdaq.com/articles/intercept-dives-along-ocaliva-prescriptions-fda-warning-2017-10-06", "https://www.nasdaq.com/articles/5-stocks-bull-market-left-behind-2017-10-06", "https://www.nasdaq.com/articles/everything-going-right-abbvie-it-best-biotech-stock-buy-right-now-2017-10-06", "https://www.nasdaq.com/articles/heres-whats-has-happened-in-the-hcv-space-lately-2017-10-06", "https://www.nasdaq.com/articles/5-undervalued-stocks-free-cash-flow-burn-2017-10-05", "https://www.nasdaq.com/articles/abbvies-fast-becoming-top-stock-buy-now-2017-10-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-endocyte-shoots-deal-amgen-abbvie-settle-humira-litigation-2017-10", "https://www.nasdaq.com/articles/5-etf-picks-october-2017-10-04", "https://www.nasdaq.com/articles/why-bluebird-bio-inc-stock-gained-10-september-2017-10-03", "https://www.nasdaq.com/articles/will-gilead-abbvie-benefit-mercks-decision-drop-two-hcv-programs-2017-10-03", "https://www.nasdaq.com/articles/5-best-ma-deals-2017-so-far-2017-10-03", "https://www.nasdaq.com/articles/good-news-and-bad-news-gilead-sciences-which-carries-more-weight-2017-10-03", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-blue-stock-falling-today-2017-10-02", "https://www.nasdaq.com/articles/fxh-alny-algn-gild-large-inflows-detected-etf-2017-10-04", "https://www.nasdaq.com/articles/merck-drops-two-hcv-combination-programs-amid-competition-2017-10-02", "https://www.nasdaq.com/articles/4-biotech-stocks-and-1-etf-to-buy-as-they-bolt-higher-2017-10-02", "https://www.nasdaq.com/articles/best-buy-johnson-johnson-pfizer-or-gilead-sciences-2017-10-01", "https://www.nasdaq.com/articles/keep-riding-the-gopro-inc-gpro-stock-wave-2017-09-29", "https://www.nasdaq.com/articles/go-long-costco-wholesale-corporation-cost-stock-for-big-time-gains-2017-09-29", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-stock-got-its-mojo-back-2017-09-29", "https://www.nasdaq.com/articles/how-will-trumps-proposed-tax-reform-impact-drug-companies-2017-09-29", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-pfizer-2017-10-02", "https://www.nasdaq.com/articles/gilead-gild-gets-approval-for-hcv-drug-sovaldi-in-china-2017-09-28", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-gilead-sciences-cystic-fibrosis-2017-09-28", "https://www.nasdaq.com/articles/why-gilead-sciences-pier-1-imports-and-petmed-express-slumped-today-2017-09-28", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-645345-19-points-2017-09-28", "https://www.nasdaq.com/articles/gilead-tumbles-report-hiv-drug-whistleblower-case-reopened-2017-09-28", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-gild-bmy-xom-2017-09-28", "https://www.nasdaq.com/articles/indexes-mixed-apple-and-gilead-down-here-threat-autohome-stock-2017-09-28", "https://www.nasdaq.com/articles/novartis-could-acquire-biotech-why-deal-very-logical-2017-09-28", "https://www.nasdaq.com/articles/gilead-gild-gets-approval-for-hcv-drug-sovaldi-in-china-2017-09-28", "https://www.nasdaq.com/articles/intercept-icpt-provides-safety-guidelines-for-ocaliva-2017-09-27", "https://www.nasdaq.com/articles/if-familiarity-breeds-contempt-what-do-debt-and-complacency-breed-2017-09-27", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-fta-gps-gild-lea-2017-09-26", "https://www.nasdaq.com/articles/kite-pharma-triples-so-far-in-2017%3A-whats-driving-the-rally-2017-09-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-ocaliva-safety-issues", "https://www.nasdaq.com/articles/fda-chief-gottlieb-addresses-opioids-cancer-new-therapies-2017-09-26", "https://www.nasdaq.com/articles/biotechs-beating-market-are-they-buy-range-2017-09-28", "https://www.nasdaq.com/articles/first-week-may-2018-options-trading-gilead-sciences-gild-2017-09-25", "https://www.nasdaq.com/articles/why-cash-rich-gilead-sciences-inc-borrowing-3-billion-2017-09-22", "https://www.nasdaq.com/articles/3-big-biotech-stocks-buy-fall-2017-09-22", "https://www.nasdaq.com/articles/juno-therapeutics-inc-juno-stock%3A-to-buy-or-not-to-buy-2017-09-22", "https://www.nasdaq.com/articles/oddly-juno-therapeutics-jumping-113-today-2017-09-22", "https://www.nasdaq.com/articles/gileads-gild-epclusa-receives-label-expansion-in-canada-2017-09-22", "https://www.nasdaq.com/articles/immunize-juno-therapeutics-inc-juno-stock-trade-2017-09-21", "https://www.nasdaq.com/articles/3-sector-specific-trades-to-start-the-week-off-right-2017-09-25", "https://www.nasdaq.com/articles/4-sell-ranked-biotech-stocks-with-falling-estimates-to-avoid-2017-09-21", "https://www.nasdaq.com/articles/should-value-investors-consider-gilead-sciences-gild-stock-2017-09-19", "https://www.nasdaq.com/articles/yes-juno-therapeutics-juno-just-became-a-great-car-t-trade-2017-09-19", "https://www.nasdaq.com/articles/gilead-sciences-kite-pharma-deal-has-already-paid-itself-investors-2017-09-19", "https://www.nasdaq.com/articles/3-biotech-stocks-that-are-just-getting-started-2017-09-18", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-moat-gild-gwre-vfc-2017-09-18", "https://www.nasdaq.com/articles/3-value-stocks-smart-investors-2017-09-18", "https://www.nasdaq.com/articles/3-biotech-stocks-major-catalysts-incoming-2017-09-21", "https://www.nasdaq.com/articles/3-great-income-stocks-could-double-their-dividends-2017-09-17", "https://www.nasdaq.com/articles/after-gilead-sciences-more-biotech-ma-2017-09-15", "https://www.nasdaq.com/articles/3-reasons-why-gilead-sciences-stock-buy-now-2017-09-15", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-9152017-2017-09-15", "https://www.nasdaq.com/articles/3-dividend-healthcare-stocks-2017-09-15", "https://www.nasdaq.com/articles/car-t-therapy-fda-approved-slingshot-insights-idea-month-2017-09-14", "https://www.nasdaq.com/articles/nasdaq-100-movers-hsic-ctrp-2017-09-14", "https://www.nasdaq.com/articles/why-bellicum-pharmaceuticals-stock-rising-today-2017-09-18", "https://www.nasdaq.com/articles/4-biotech-stocks-that-show-promise-on-sustainable-growth-2017-09-14", "https://www.nasdaq.com/articles/3-pharma-biotech-sector-bargains-for-a-healthy-portfolio-2017-09-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2017-2017-09-13", "https://www.nasdaq.com/articles/3-biotech-stocks-have-already-quadrupled-2017-2017-09-13", "https://www.nasdaq.com/articles/sell-intercept-pharmaceuticals-stock-overblown-2017-09-13", "https://www.nasdaq.com/articles/gilead-sciences-incs-best-investment-2017-hint-it-wasnt-kite-pharmaceuticals-2017-09-13", "https://www.nasdaq.com/articles/ex-dividend-reminder-gilead-sciences-hill-rom-holdings-and-owens-minor-2017-09-12", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-gilead-sciences-gild-stock-2017-09-14", "https://www.nasdaq.com/articles/3-stocks-future-millionaires-2017-09-12", "https://www.nasdaq.com/articles/5-top-ranked-biotech-stocks-buy-right-now-2017-09-11", "https://www.nasdaq.com/articles/5-tough-questions-gilead-sciences-about-kite-pharma-acquisition-2017-09-11", "https://www.nasdaq.com/articles/top-stock-reports-gilead-oracle-morgan-stanley-2017-09-11", "https://www.nasdaq.com/articles/the-move-in-spdr-sp-biotech-etf-xbi-etf-is-coming-get-on-board-2017-09-11", "https://www.nasdaq.com/articles/why-exelixis-inc-could-be-gold-mine-growth-investors-2017-09-10", "https://www.nasdaq.com/articles/car-t-mania-could-juno-therapeutics-get-acquired-next-2017-09-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-oracle-morgan-stanley-expedia-and-kroger-2017-09", "https://www.nasdaq.com/articles/3-stocks-future-millionaires-2017-09-12", "https://www.nasdaq.com/articles/top-ranked-income-stocks-to-buy-for-september-8th-2017-09-08", "https://www.nasdaq.com/articles/after-hours-most-active-sep-8-2017-knx-aapl-iusg-iusv-qqq-vips-itub-chk-gild-jblu-t-xom", "https://www.nasdaq.com/articles/4-biotech-stocks-to-improve-your-portfolios-health-2017-09-08", "https://www.nasdaq.com/articles/5-things-youll-want-know-celgene-corporations-latest-presentation-2017-09-07", "https://www.nasdaq.com/articles/5-things-gilead-sciences-management-just-said-youll-want-know-2017-09-07", "https://www.nasdaq.com/articles/kymriah-first-car-t-therapy-approved%3A-4-pharma-stocks-in-focus-2017-09-07", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-itot-gild-slb-cvs-2017-09-08", "https://www.nasdaq.com/articles/buy-these-5-large-caps-on-extraordinary-roi-potential-2017-09-06", "https://www.nasdaq.com/articles/mallinckrodt-down-as-district-court-invalidates-inomax-patents-2017-09-06", "https://www.nasdaq.com/articles/heres-what-lifted-bluebird-bio-inc-stock-40-higher-august-2017-09-06", "https://www.nasdaq.com/articles/why-kite-pharma-soared-648-august-2017-09-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-pharmaceuticals-activision-blizzard-intuit", "https://www.nasdaq.com/articles/gilead-sciences-couldnt-have-timed-its-splash-car-t-better-2017-09-05", "https://www.nasdaq.com/articles/are-these-healthcare-stocks-top-takeover-targets-2017-09-07", "https://www.nasdaq.com/articles/why-juno-therapeutics-shares-vaulted-46-higher-august-2017-09-05", "https://www.nasdaq.com/articles/4-biotech-stocks-to-improve-your-portfolios-health-2017-09-05", "https://www.nasdaq.com/articles/only-2-biotech-stocks-higher-dividend-yield-sp-500-2017-09-04", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-johnson-johnson-2017-09-03", "https://www.nasdaq.com/articles/heres-best-dividend-stock-big-pharma-2017-09-03", "https://www.nasdaq.com/articles/why-gilead-sciences-shares-soared-106-august-2017-09-03", "https://www.nasdaq.com/articles/3-biotech-stocks-skyrocketed-week-2017-09-02", "https://www.nasdaq.com/articles/biotech-stocks-back-favor-will-rally-continue-2017-09-05", "https://www.nasdaq.com/articles/fridays-vital-data%3A-apple-inc.-aapl-advanced-micro-devices-inc.-amd-and-gilead-sciences", "https://www.nasdaq.com/articles/3-reasons-gilead-sciences-jumped-buy-kite-pharma-2017-09-01", "https://www.nasdaq.com/articles/5-winning-stocks-beat-september-blues-2017-09-01", "https://www.nasdaq.com/articles/valeant-vrx-continues-to-lose-ground%3A-can-it-bounce-back-2017-09-01", "https://www.nasdaq.com/articles/gilead-sciences-oncology-ma-strategy-explained-2017-09-01", "https://www.nasdaq.com/articles/you-reached-retirement-3-stocks-consider-today-2017-09-01", "https://www.nasdaq.com/articles/wonder-why-gilead-sciences-bought-kite-pharma-heres-answer-2017-09-01", "https://www.nasdaq.com/articles/gilead-buys-kite-future-car-t-and-visit-new-whole-foods-2017-09-01", "https://www.nasdaq.com/articles/novartis-nvs-car-t-therapy-kymriah-receives-fda-approval-2017-08-31", "https://www.nasdaq.com/articles/stock-market-news-for-august-31-2017-2017-08-31", "https://www.nasdaq.com/articles/novartis-475000-price-tag-sets-stage-price-war-gilead-sciences-2017-08-31", "https://www.nasdaq.com/articles/biotech-stock-roundup-car-t-focus-gilead-kite-deal-incyte-baricitinib-update-2017-08-31", "https://www.nasdaq.com/articles/after-hours-most-active-aug-31-2017-dow-dd-sbac-bac-qqq-msft-teva-pfe-ge-amat-gild-intc", "https://www.nasdaq.com/articles/why-bluebird-bio-inc-continued-its-march-higher-again-today-2017-08-31", "https://www.nasdaq.com/articles/could-gilead-sciences-stock-skyrocket-25-1-analyst-thinks-so-2017-08-31", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-bbh-2017-08-31", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-broadcom-cbre-group-sandvik-applied-materials-and-gilead", "https://www.nasdaq.com/articles/juno-bluebird-hot-acquisition-targets-after-kite-gilead-deal-2017-08-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-kite-pharma-abbvies-and-novartis-ag", "https://www.nasdaq.com/articles/gilead-gild-up-2.1-since-earnings-report%3A-can-it-continue-2017-08-30", "https://www.nasdaq.com/articles/has-gilead-sciences-big-bounce-begun-kite-pharma-buyout-2017-08-30", "https://www.nasdaq.com/articles/why-analog-devices-gilead-sciences-and-universal-display-jumped-today-2017-08-30", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-breaking-higher-2017-08-30", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-pkw-2017-08-30", "https://www.nasdaq.com/articles/amgen-presents-new-repatha-analysis-from-fourier-study-2017-08-29", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-stock-still-has-room-to-grow-2017-08-29", "https://www.nasdaq.com/articles/company-news-for-august-29-2017-2017-08-29", "https://www.nasdaq.com/articles/can-gilead-sciences-squeeze-12-billion-kite-pharma-2017-08-29", "https://www.nasdaq.com/articles/5-top-roe-stocks-buy-hurricane-harvey-wreaks-havoc-2017-08-29", "https://www.nasdaq.com/articles/heres-what-else-gilead-sciences-gets-buying-kite-pharma-2017-08-29", "https://www.nasdaq.com/articles/indecision-wont-kill-you-it-will-take-your-money-2017-08-29", "https://www.nasdaq.com/articles/why-novatis-475k-car-t-cancer-treatment-actually-cheap-2017-08-30", "https://www.nasdaq.com/articles/gilead-to-fly-high-with-kite-pharma-acquisition-for-%2411.9b-2017-08-29", "https://www.nasdaq.com/articles/juno-therapeutics-juno-continues-gains-after-gilead-kite-acquisition-2017-08-29", "https://www.nasdaq.com/articles/why-juno-therapeutics-stock-blasting-today-2017-08-29", "https://www.nasdaq.com/articles/uqm-technologies-kite-pharma-jump-monday-2017-08-28", "https://www.nasdaq.com/articles/midday-update-sectors-split-hurricane-harveys-impact-spreads-through-wall-street-2017-08", "https://www.nasdaq.com/articles/gilead-sciences-buy-kite-pharma-119-billion-it-enough-move-needle-2017-08-28", "https://www.nasdaq.com/articles/3-reasons-applaud-gilead-sciences-acquisition-kite-pharma-2017-08-28", "https://www.nasdaq.com/articles/get-ready-more-acquisitions-gilead-sciences-2017-08-29", "https://www.nasdaq.com/articles/health-care-sector-update-08282017-jnj-pfe-abt-mrk-amgn-kite-gild-aveo-nvs-2017-08-28", "https://www.nasdaq.com/articles/morning-movers-gilead-jumps-kite-acquisition-expedia-drops-ceo-leaves-uber-2017-08-28", "https://www.nasdaq.com/articles/pre-market-most-active-aug-28-2017-kite-wfm-gild-juno-tvix-mycc-qqq-fcau-bhp-q-db-baba", "https://www.nasdaq.com/articles/roches-gazyva-gets-priority-review-for-follicular-lymphoma-2017-08-28", "https://www.nasdaq.com/articles/astrazenecas-faslodex-gets-fda-nod-in-first-line-setting-2017-08-28", "https://www.nasdaq.com/articles/close-update-shares-mixed-hurricane-batters-energy-sector-underpins-construction-home", "https://www.nasdaq.com/articles/novartis-announces-positive-data-on-cardiovascular-drug-2017-08-28", "https://www.nasdaq.com/articles/stock-futures-perk-despite-potential-economic-damage-hurricane-2017-08-28", "https://www.nasdaq.com/articles/health-care-sector-update-08282017-jnj-pfe-abt-mrk-amgn-kite-gild-aveo-nvs-2017-08-28", "https://www.nasdaq.com/articles/why-did-kite-pharma-kite-stock-skyrocket-today-2017-08-28", "https://www.nasdaq.com/articles/gileads-plan-cash-car-t-2017-08-28", "https://www.nasdaq.com/articles/why-i-love-abbvie-inc-2017-08-27", "https://www.nasdaq.com/articles/novartis-nvs-receives-ec-approval-for-breast-cancer-drug-2017-08-25", "https://www.nasdaq.com/articles/will-endo-endp-continue-to-disappoint-investors-in-2017-2017-08-25", "https://www.nasdaq.com/articles/why-thor-industries-ixys-corporation-and-kite-pharma-jumped-today-2017-08-28", "https://www.nasdaq.com/articles/roche-rhhby-hemophilia-a-drug-granted-priority-review-2017-08-24", "https://www.nasdaq.com/articles/top-ranked-income-stocks-to-buy-for-august-24th-2017-08-24", "https://www.nasdaq.com/articles/pfizers-ibrance-in-first-line-combo-breast-cancer-study-2017-08-23", "https://www.nasdaq.com/articles/are-glaxos-successful-new-drugs-enough-to-drive-growth-2017-08-23", "https://www.nasdaq.com/articles/3-reasons-abbvie-better-dividend-stock-gilead-sciences-2017-08-23", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-fxh-algn-cnc-gild-2017-08-22", "https://www.nasdaq.com/articles/alkermes-initiates-rolling-submission-of-depression-drug-2017-08-22", "https://www.nasdaq.com/articles/why-im-hanging-loser-2017-08-24", "https://www.nasdaq.com/articles/alexions-alxn-soliris-label-expansion-approved-in-europe-2017-08-22", "https://www.nasdaq.com/articles/3-value-stocks-smart-investors-2017-08-21", "https://www.nasdaq.com/articles/mondays-etf-unusual-volume-bbh-2017-08-21", "https://www.nasdaq.com/articles/abbvies-hcv-combo-drug-mavyret-clinches-approval-in-canada-2017-08-18", "https://www.nasdaq.com/articles/gilead-gild-hcv-drug-vosevi-receives-approval-in-canada-2017-08-18", "https://www.nasdaq.com/articles/pfizers-pfe-besponsa-gets-fda-nod-with-a-boxed-warning-2017-08-18", "https://www.nasdaq.com/articles/mylan-finalizes-settlement-agreement-with-doj-for-%24465m-2017-08-18", "https://www.nasdaq.com/articles/4-biotech-stocks-add-your-portfolio-post-q2-earnings-2017-08-22", "https://www.nasdaq.com/articles/3-value-stocks-retirees-2017-08-17", "https://www.nasdaq.com/articles/falling-earnings-estimates-signal-weakness-ahead-for-mylan-myl-2017-08-16", "https://www.nasdaq.com/articles/sterneck-capital-management-llc-buys-corenergy-infrastructure-trust-inc-chicago-bridge", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-drops-rsv-antibody-gilead-hiv-drug-gets-priority-review", "https://www.nasdaq.com/articles/regenerons-regn-rsv-drug-suptavumab-fails-nursery-trial-2017-08-16", "https://www.nasdaq.com/articles/chiron-investment-management-llc-buys-ishares-iboxx-investment-grade-corporate-bond-gilead", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-coca-cola-femsa-banco-bilbao-vizcaya-argentaria-lantheus", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-best-biotech-stock-buy-2017-08-17", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-16-2017-2017-08-15", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-broadcom-limited-cbre-group-sandvik-ab-applied-materials", "https://www.nasdaq.com/articles/gilead-gild-nda-for-hiv-combo-regimen-gets-priority-review-2017-08-14", "https://www.nasdaq.com/articles/3-healthcare-stocks-are-looking-cheap-right-now-2017-08-14", "https://www.nasdaq.com/articles/5-discounted-peg-stocks-for-garp-investors-2017-08-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-15-2017-2017-08-14", "https://www.nasdaq.com/articles/why-has-2017-been-horrible-year-so-far-biotech-acquisitions-2017-08-13", "https://www.nasdaq.com/articles/mallinckrodt-mnk-looks-strong-on-acthar-generics-weak-2017-08-15", "https://www.nasdaq.com/articles/forget-teva-teva-buy-these-4-drug-stocks-instead-2017-08-11", "https://www.nasdaq.com/articles/markets-remain-choppy-continuing-conflicts-5-top-picks-2017-08-11", "https://www.nasdaq.com/articles/bb-biotech-ag-buys-avexis-inc-sells-regeneron-pharmaceuticals-inc-puma-biotechnology-inc", "https://www.nasdaq.com/articles/alnylam-alny-q2-loss-narrower-than-expected-sales-miss-2017-08-10", "https://www.nasdaq.com/articles/prothena-prta-q2-loss-narrows-as-roche-makes-%2430m-payment-2017-08-09", "https://www.nasdaq.com/articles/after-hours-most-active-aug-9-2017-vg-abev-ggb-t-cor-qqq-brcd-momo-odp-adp-nee-gild-2017", "https://www.nasdaq.com/articles/validea-david-dreman-strategy-daily-upgrade-report-892017-2017-08-09", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-value-factor-etf-experiences-big-inflow-2017-08-11", "https://www.nasdaq.com/articles/forget-bayer-buy-these-3-drug-stocks-instead-2017-08-08", "https://www.nasdaq.com/articles/pioneer-investments-buys-citigroup-berkshire-gilead-2017-08-08", "https://www.nasdaq.com/articles/mallinckrodt-mnk-tops-q2-earnings-generics-segment-weak-2017-08-08", "https://www.nasdaq.com/articles/drug-stocks-q2-earnings-roster-for-aug-8%3A-acad-jazz-more-2017-08-07", "https://www.nasdaq.com/articles/these-3-biotechs-just-crushed-analyst-expectations-2017-08-07", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-august-7th-2017-08-07", "https://www.nasdaq.com/articles/valeant-vrx-beats-q2-earnings-sales-in-line-trims-view-2017-08-09", "https://www.nasdaq.com/articles/abbvie-about-deliver-blow-gilead-sciences-guidance-2017-08-05", "https://www.nasdaq.com/articles/celgene-vs-gilead-sciences-who-reported-better-earnings-2017-08-04", "https://www.nasdaq.com/articles/infinity-infi-q2-loss-wider-than-expected-view-intact-2017-08-04", "https://www.nasdaq.com/articles/radius-rdus-q2-loss-wider-than-expected-on-higher-expenses-2017-08-04", "https://www.nasdaq.com/articles/domini-social-investments-llc-buys-first-solar-inc-sunpower-corp-sells-sunrun-inc-fitbit", "https://www.nasdaq.com/articles/itot-mdt-gild-slb-large-inflows-detected-etf-2017-08-03", "https://www.nasdaq.com/articles/should-you-buy-vertex-pharmaceuticals-incorporated-vrtx-stock-3-pros-3-cons-2017-08-03", "https://www.nasdaq.com/articles/10-reasons-cancer-drugs-usually-cost-100000-or-more-year-2017-08-06", "https://www.nasdaq.com/articles/3-strong-buy-high-yield-dividend-stocks-2017-08-03", "https://www.nasdaq.com/articles/aerie-aeri-reports-narrower-than-expected-loss-in-q2-2017-08-02", "https://www.nasdaq.com/articles/top-ranked-income-stocks-to-buy-for-august-2nd-2017-08-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-q2-earnings-gilead-celg-more-dynavax-panel-vote-2017-08-02", "https://www.nasdaq.com/articles/3-etfs-to-watch-out-for-on-biotech-earnings-2017-08-01", "https://www.nasdaq.com/articles/intercept-icpt-posts-narrower-than-expected-loss-in-q2-2017-08-01", "https://www.nasdaq.com/articles/gilead-sciences-top-25-dividend-giant-274-yield-gild-2017-08-01", "https://www.nasdaq.com/articles/regeneron-regn-beats-on-q2-earnings-sales-raises-view-2017-08-03", "https://www.nasdaq.com/articles/5-things-gilead-sciences-q2-earnings-numbers-didnt-tell-you-2017-07-31", "https://www.nasdaq.com/articles/united-therapeutics-uthr-incurs-loss-in-q2-sales-top-2017-07-28", "https://www.nasdaq.com/articles/4-drug-stocks-focus-world-hepatitis-day-2017-07-28", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-stock-has-tremendous-potential-even-post-rally-2017-07-27", "https://www.nasdaq.com/articles/whoops-twitter-inc-twtr-stock-tanks-as-user-growth-vanishes-2017-07-27", "https://www.nasdaq.com/articles/score-hot-profits-on-a-netflix-inc.-nflx-stock-cooldown-2017-07-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-thursday%3A-buffalo-wild-wings-bwld-gilead-sciences-inc.-gild-and", "https://www.nasdaq.com/articles/general-american-investors-co-inc-buys-oracle-corp-now-inc-ebay-inc-sells-imax-corp-2017", "https://www.nasdaq.com/articles/validea-benjamin-graham-strategy-daily-upgrade-report-7272017-2017-07-27", "https://www.nasdaq.com/articles/daily-dividend-report-su-mck-syf-cvx-cmcsa-gild-unp-2017-07-27", "https://www.nasdaq.com/articles/voo-mdt-gild-bmy-large-outflows-detected-etf-2017-07-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-biogen-top-q2-estimates-update-incyte-ra-drug-2017-07-26", "https://www.nasdaq.com/articles/gilead-sciences-has-3-available-options-only-1-makes-sense-2017-07-26", "https://www.nasdaq.com/articles/gilead-sciences-inc-boosts-its-full-year-outlook-thanks-stronger-expected-hep-c-sales-2017", "https://www.nasdaq.com/articles/gilead-gild-shares-pop-q2-earnings-and-revenue-beats-2017-07-26", "https://www.nasdaq.com/articles/gilead-gild-tops-q2-earnings-revenue-estimates-stock-up-2017-07-27", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-26-2017-fb-gild-pypl-su-lvs-vrtx-psa-lrcx-ew-dfs-abx-now", "https://www.nasdaq.com/articles/can-intercept-icpt-beat-estimates-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/will-radius-health-rdus-disappoint-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-gilead-sciences-gild-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-bear-markets-2017-07-25", "https://www.nasdaq.com/articles/gilead-sciences-inc.-gild-stock-is-a-2-for-1-deal-2017-07-24", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-agenus-agen-this-earnings-season-2017-07-24", "https://www.nasdaq.com/articles/earnings-reaction-history-gilead-sciences-inc-727-follow-through-indicator-51-sensitive", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-gilead-sciences-inc-2017-07-22", "https://www.nasdaq.com/articles/better-buy-abbvie-inc-vs-johnson-johnson-2017-07-22", "https://www.nasdaq.com/articles/what-to-expect-from-keryx-kerx-this-earnings-season-2017-07-21", "https://www.nasdaq.com/articles/whats-in-the-offing-for-bristol-myers-bmy-in-q2-earnings-2017-07-21", "https://www.nasdaq.com/articles/hca-healthcare-hca-q2-earnings%3A-will-it-beat-estimates-2017-07-21", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-whats-in-the-cards-2017-07-21", "https://www.nasdaq.com/articles/warren-buffetts-net-worth-would-be-100-billion-right-now-if-not-2017-07-21"], "Content": []}